compound_id,standard_inchi_key,compound_name,synonym,target_id,target_pref_name,gene_names,wildtype_or_mutant,mutation_info,pubmed_id,standard_type,standard_relation,standard_value,standard_units,activity_comment,ep_action_mode,assay_format,assaytype,assay_subtype,inhibitor_type,detection_tech,assay_cell_line,compound_concentration_value,compound_concentration_value_unit,substrate_type,substrate_relation,substrate_value,substrate_units,assay_description,title,journal,doc_type,annotation_comments
CHEMBL12,AAOVKJBEBIDNHE-UHFFFAOYSA-N,DIAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12,AAOVKJBEBIDNHE-UHFFFAOYSA-N,DIAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1090526,ABDWUBPDHWDFCV-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,0.7,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1090526,ABDWUBPDHWDFCV-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20800486.0,KI,=,0.7,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL60435,ABEZUHIZVKNNOT-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,95499.26,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL990,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,BUTENAFINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL990,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,BUTENAFINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3577956,ABJWJGMTLYSISP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25893048.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 1 uM,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2205816,ABONQAUMSMWLEK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205816,ABONQAUMSMWLEK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL270853,ABOWDNIHZHLENL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256659,ABWRXTVIPWIMTE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,IC50,=,11000,NM,,,,binding,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,IC50,=,17000,NM,,,,binding,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,IC50,=,23000,NM,,,,binding,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,Ki,=,20.6,NM,,,cell_based,binding,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,Ki,=,58.8,NM,,,cell_based,binding,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,Ki,=,140,NM,,,,binding,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27639363.0,Ki,=,16.6,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27639363.0,Ki,=,115,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27639363.0,Ki,=,186,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27639363.0,Ki,=,1998,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,24,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,247,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,268,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,290,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,293,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,327,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,553,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,560,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,822,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,998,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,1087,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,1437,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,3224,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27717652.0,Ki,=,3867,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27839919.0,KI,>,10000,NM,,,cell_based,binding,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,5.8,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11809864.0,KI,=,5.01,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11809864.0,KI,=,63.1,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,6.31,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,8.91,NM,,,,,,,,,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL765,ACGDKVXYNVEAGU-UHFFFAOYSA-N,GUANETHIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL765,ACGDKVXYNVEAGU-UHFFFAOYSA-N,GUANETHIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL496,ACGUYXCXAPNIKK-UHFFFAOYSA-N,HEXACHLOROPHENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL496,ACGUYXCXAPNIKK-UHFFFAOYSA-N,HEXACHLOROPHENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14638,ACQBHJXEAYTHCY-UHFFFAOYSA-N,CIPROXIFAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12606603.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL14638,ACQBHJXEAYTHCY-UHFFFAOYSA-N,CIPROXIFAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15033391.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL14638,ACQBHJXEAYTHCY-UHFFFAOYSA-N,CIPROXIFAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15608078.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL14638,ACQBHJXEAYTHCY-UHFFFAOYSA-N,CIPROXIFAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18683917.0,KI,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor,The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL14638,ACQBHJXEAYTHCY-UHFFFAOYSA-N,CIPROXIFAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,KI,>,2511.89,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272694,ACRMNEFOWLXFLY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL96732,ACTVOFFLDWZANE-KHMGXFTDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,27,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL329566,ACTVOFFLDWZANE-NSISKUIASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,0.54,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL329566,ACTVOFFLDWZANE-NSISKUIASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,0.43,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL92667,ACTVOFFLDWZANE-ODFWGIBRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,0.7,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL329268,ACTVOFFLDWZANE-PWIZWCRZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,0.63,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL327651,ACTVOFFLDWZANE-VDGAXYAQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,3.74,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1069,ACWBQPMHZXGDFX-QFIPXVFZSA-N,VALSARTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1069,ACWBQPMHZXGDFX-QFIPXVFZSA-N,VALSARTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2030634,ADGIWWYGVBZYMC-UHFFFAOYSA-N,N-(CYCLOHEXYLMETHYL)PYRROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL249797,ADICJNUDACADIN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17892934.0,INHIBITION,=,2,%,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor at 1 uM,Discovery of 5-HT6 receptor ligands based on virtual HTS.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669412,ADLLYWYUHVDQBH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,4.3,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL115769,ADQZGIYHFQQPRB-UHFFFAOYSA-N,RWJ-68354,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL115769,ADQZGIYHFQQPRB-UHFFFAOYSA-N,RWJ-68354,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1934523,ADRZQEOBUFIYAZ-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22172695.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to H1 receptor at 10 uM relative to control,Identification of biaryl sulfone derivatives as antagonists of the histamine H3 receptor: discovery of (R)-1-(2-(4'-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1702607,ADVPTQAUNPRNPO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL322194,ADZSGFZICHOKOJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.42,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL322194,ADZSGFZICHOKOJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,381,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220637,AEBYLHALALJXOL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.01,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220637,AEBYLHALALJXOL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL470564,AECNWVFAWBLCAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,3500,NM,,,,,,,,,,,,,,,,,,,
CHEMBL470564,AECNWVFAWBLCAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,8800,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL252557,AEMRFAOFKBGASW-UHFFFAOYSA-N,GLYCOLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL252557,AEMRFAOFKBGASW-UHFFFAOYSA-N,GLYCOLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220892,AEOZDVJZTYYDHL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL3220892,AEOZDVJZTYYDHL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1651091,AETDFAXPCFASDB-UHFFFAOYSA-N,PULICATINS F,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21028889.0,ACTIVITY,=,517,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor by radioligand displacement assay,"Pulicatins A-E, neuroactive thiazoline metabolites from cone snail-associated bacteria.",J. Nat. Prod.,PUBLICATION,
CHEMBL44884,AEUTYOVWOVBAKS-UWVGGRQHSA-N,ETHAMBUTOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44884,AEUTYOVWOVBAKS-UWVGGRQHSA-N,ETHAMBUTOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL513893,AEWLECDUIOHVBW-QBNMFFNISA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18768318.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Synthesis and evaluation of a spiro-isobenzofuranone class of histamine H3 receptor inverse agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171022,AEWQIKDEAWAPPV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,100,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL398996,AFNIUHMJOXEVTF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1221,AFNXATANNDIXLG-UHFFFAOYSA-N,SULCONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1221,AFNXATANNDIXLG-UHFFFAOYSA-N,SULCONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL486964,AFTLSANLJDCKNX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,2300,NM,,,,,,,,,,,,,,,,,,,
CHEMBL486964,AFTLSANLJDCKNX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,6000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL486964,AFTLSANLJDCKNX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,8800,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL508112,AFZSMODLJJCVPP-UHFFFAOYSA-N,BENZOTHIAZYL DISULFIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL508112,AFZSMODLJJCVPP-UHFFFAOYSA-N,BENZOTHIAZYL DISULFIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL134342,AGBQKNBQESQNJD-SSDOTTSWSA-N,LIPOIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL134342,AGBQKNBQESQNJD-SSDOTTSWSA-N,LIPOIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267744,AGHANLSBXUWXTB-UHFFFAOYSA-N,TICRYNAFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267744,AGHANLSBXUWXTB-UHFFFAOYSA-N,TICRYNAFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL270376,AGHXSXMZVMLSGU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,1000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207386,AGKMPGSBLMAGAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23141912.0,INHIBITION,=,9.48,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM by radioligand displacement assay,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1741,AGOYDEPGAOXOCK-KCBOHYOISA-N,CLARITHROMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1741,AGOYDEPGAOXOCK-KCBOHYOISA-N,CLARITHROMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL330172,AHIOIWMCDDMDRL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.38,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL330172,AHIOIWMCDDMDRL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,416,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402422,AHTVKTAOAOXKMG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1090186,AIGMIQVSRPRWAQ-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,1.3,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL583,AIJTTZAVMXIJGM-UHFFFAOYSA-N,GREPAFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL583,AIJTTZAVMXIJGM-UHFFFAOYSA-N,GREPAFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567993,AIMNRLCNWYRUPJ-HDICACEKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773162.0,IC50,=,1600,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767144,AIQKTJZHRRQKTE-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,>,1584.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL180233,AITHPZKEMCVCDZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15686917.0,KI,=,9.55,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human Histamine H1 receptor in CHO K1 cells,5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14,AIXAANGOTKPUOY-UHFFFAOYSA-N,CARBACHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14,AIXAANGOTKPUOY-UHFFFAOYSA-N,CARBACHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL408169,AJBBNBBBDUCRTB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,PKI,,,,Not Determined,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3633757,AJIMVLSQIMXLNV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26475518.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from recombinant human histamine H1 receptor at 10 uM after 1.5 hrs by Microbeta scintillation counting analysis relative to control,Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT2A receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL54440,AJLFOPYRIVGYMJ-INTXDZFKSA-N,MEVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54440,AJLFOPYRIVGYMJ-INTXDZFKSA-N,MEVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1618305,AJPSBXJNFJCCBI-YOHUGVJRSA-N,NALOXONAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1618305,AJPSBXJNFJCCBI-YOHUGVJRSA-N,NALOXONAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1258754,AJUFRGDVXUPOOW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,1,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208426,AJUWTQZJBKWQNV-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208426,AJUWTQZJBKWQNV-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,100,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1210209,AKCGOXREZJOGPS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,11,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL593494,AKEGHAUFMKCWGX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,64,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL364713,AKNNEGZIBPJZJG-MSOLQXFVSA-N,NOSCAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL364713,AKNNEGZIBPJZJG-MSOLQXFVSA-N,NOSCAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL158352,AKTMNFPHGGUJFY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.61,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL158352,AKTMNFPHGGUJFY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,251.19,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL158352,AKTMNFPHGGUJFY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,398107170553497,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1258755,AKYDPJMTCVQONP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,3,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1255834,ALFGDCNSEBJYSP-UHFFFAOYSA-N,BW-723C86,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8730737.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1255834,ALFGDCNSEBJYSP-UHFFFAOYSA-N,BW-723C86,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1255834,ALFGDCNSEBJYSP-UHFFFAOYSA-N,BW-723C86,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1783963,ALOWJQCLRWGVOV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,110,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783963,ALOWJQCLRWGVOV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,730,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL60143,ALQYYBXQKWSMNS-HHHXNRCGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,5495.41,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL240567,ALWGROOEKGXBRR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3357035,AMBATUWSQRROKC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25318072.0,KI,=,1274,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells by scintillation counting method,Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2.,J. Med. Chem.,PUBLICATION,
CHEMBL2207284,AMEQLQYPRVOFMB-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,25.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1909080,AMGRXJSJSONEEG-UHFFFAOYSA-L,STRONTIUM CHLORIDE HEXAHYDRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909080,AMGRXJSJSONEEG-UHFFFAOYSA-L,STRONTIUM CHLORIDE HEXAHYDRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2208420,AMQPWRCXJRAWTN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208420,AMQPWRCXJRAWTN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,12.59,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1946256,ANQFIBHZMVNJLK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,,,,Not Active,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1242950,ANTKBACNWQHQJE-UHFFFAOYSA-N,AC-42,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20684563.0,KI,=,610,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor by radioligand displacement assay,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,PUBLICATION,
CHEMBL451,ANTSCNMPPGJYLG-UHFFFAOYSA-N,CHLORDIAZEPOXIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,1795,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL451,ANTSCNMPPGJYLG-UHFFFAOYSA-N,CHLORDIAZEPOXIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,208,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL397429,ANYPUOSSIOCSJC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,5.7,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL521589,ANZXOIAKUNOVQU-UHFFFAOYSA-N,BAMBUTEROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL521589,ANZXOIAKUNOVQU-UHFFFAOYSA-N,BAMBUTEROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL460499,AOCCBINRVIKJHY-UHFFFAOYSA-N,CARMOFUR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL460499,AOCCBINRVIKJHY-UHFFFAOYSA-N,CARMOFUR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL194206,AOENLUNXEDMDRT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16143528.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards cloned Histamine H1 receptor,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,DOXORUBICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,DOXORUBICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL417,AOJJSUZBOXZQNB-VTZDEGQISA-N,EPIRUBICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL417,AOJJSUZBOXZQNB-VTZDEGQISA-N,EPIRUBICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL96442,AOMZRTTZRBZOAC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.44,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL96442,AOMZRTTZRBZOAC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,366,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277492,AOSLQNBDHSOLAE-HAQQTFLXSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,199.53,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL1200623,AOXRBFRFYPMWLR-XGXHKTLJSA-N,ETHYLESTRENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200623,AOXRBFRFYPMWLR-XGXHKTLJSA-N,ETHYLESTRENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3287723,AOYJKNKRKBOUAP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24735492.0,INHIBITION,=,0.2,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM by radioligand displacement assay,Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence.,J. Med. Chem.,PUBLICATION,
CHEMBL1784685,APARPRRWRUIPGQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21570838.0,INHIBITION,<,50,%,Active,,,,,,,,,,,,,,Inhibition of human recombinant H1 receptor at 10 uM by radioligand binding assay,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL267345,APKFDSVGJQXUKY-INPOYWNPSA-N,AMPHOTERICIN B,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267345,APKFDSVGJQXUKY-INPOYWNPSA-N,AMPHOTERICIN B,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL494982,APQJKSFOISLQFF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18433114.0,INHIBITION,<,20,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1257376,AQACZABFCRPMGE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,17,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL878,AQCHWTWZEMGIFD-UHFFFAOYSA-N,METOLAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL878,AQCHWTWZEMGIFD-UHFFFAOYSA-N,METOLAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL452861,AQHHHDLHHXJYJD-AWEZNQCLSA-N,(-)-PROPANOLOL ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL452861,AQHHHDLHHXJYJD-AWEZNQCLSA-N,(-)-PROPANOLOL ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL275742,AQHHHDLHHXJYJD-CQSZACIVSA-N,DEXPROPRANOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL275742,AQHHHDLHHXJYJD-CQSZACIVSA-N,DEXPROPRANOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL27,AQHHHDLHHXJYJD-UHFFFAOYSA-N,PROPRANOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL27,AQHHHDLHHXJYJD-UHFFFAOYSA-N,PROPRANOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL27,AQHHHDLHHXJYJD-UHFFFAOYSA-N,PROPRANOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30,AQIXAKUUQRKLND-UHFFFAOYSA-N,CIMETIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL30,AQIXAKUUQRKLND-UHFFFAOYSA-N,CIMETIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30,AQIXAKUUQRKLND-UHFFFAOYSA-N,CIMETIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30,AQIXAKUUQRKLND-UHFFFAOYSA-N,CIMETIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL2171045,AQIZHUDMGJRAMJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,39.81,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL768,AQNDDEOPVVGCPG-UHFFFAOYSA-N,ESMOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL768,AQNDDEOPVVGCPG-UHFFFAOYSA-N,ESMOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL517244,AQQFXOLTZFTABW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,40,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3094114,AQRDKFVOYVDLCT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,KI,=,1000,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158791,AQVKRBFXFFKXJV-NDEPHWFRSA-N,AZ-12436092,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,158.49,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL571819,ARFONFXLNJVMPP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,,,,Not Active,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1614641,ARPYQKTVRGFPIS-VIFPVBQESA-N,FLUNOXAPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1614641,ARPYQKTVRGFPIS-VIFPVBQESA-N,FLUNOXAPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1276860,ASARBMLXIRIMCK-SABQLHICSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,39.81,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL3220649,ASNXLJAURZJRJQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.01,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220649,ASNXLJAURZJRJQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL659,ASUTZQLVASHGKV-JDFRZJQESA-N,GALANTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL659,ASUTZQLVASHGKV-JDFRZJQESA-N,GALANTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL446,ASWVTGNCAZCNNR-UHFFFAOYSA-N,SULFAMETHAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL446,ASWVTGNCAZCNNR-UHFFFAOYSA-N,SULFAMETHAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL444633,ATEBXHFBFRCZMA-VXTBVIBXSA-N,RIFABUTIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL444633,ATEBXHFBFRCZMA-VXTBVIBXSA-N,RIFABUTIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171021,ATPAZLJUTRYFNR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,25.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1945848,AUHYFUJMJOAHEZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22197136.0,INHIBITION,<,30,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,"Synthesis and structure-activity relationship of 5-pyridazin-3-one phenoxypiperidines as potent, selective histamine H(3) receptor inverse agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL158780,AUTKMGMMFJXIDV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,175,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL50588,AUVVAXYIELKVAI-CKBKHPSWSA-N,EMETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL50588,AUVVAXYIELKVAI-CKBKHPSWSA-N,EMETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1544,AUYYCJSJGJYCDS-LBPRGKRZSA-N,LIOTHYRONINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1544,AUYYCJSJGJYCDS-LBPRGKRZSA-N,LIOTHYRONINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL964,AUZONCFQVSMFAP-UHFFFAOYSA-N,DISULFIRAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL964,AUZONCFQVSMFAP-UHFFFAOYSA-N,DISULFIRAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL66388,AVBATPOOKQCBKS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12798320.0,KI,=,4085,NM,,,,,,,,,,,,,,,Compound was tested for its binding affinity towards human H1 receptor,"A new class of histamine H(3)-receptor antagonists: synthesis and structure-activity relationships of 7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563451,AVFYUSOOXDDQAW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,1.5,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL174,AVKUERGKIZMTKX-NJBDSQKTSA-N,AMPICILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL174,AVKUERGKIZMTKX-NJBDSQKTSA-N,AMPICILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2205829,AVNYJOIRGGOFFW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205829,AVNYJOIRGGOFFW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL456,AVOLMBLBETYQHX-UHFFFAOYSA-N,ETHACRYNIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL456,AVOLMBLBETYQHX-UHFFFAOYSA-N,ETHACRYNIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3094128,AVVIXBQVVAAVHK-QHCPKHFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,KI,>,2511.89,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL603049,AVZFSLTZULXZCC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,31,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1946122,AWIYLVWAILOVMX-RLAPIPATSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,=,4149,NM,,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3321789,AWIYLVWAILOVMX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25070422.0,KI,=,4149,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767165,AWKFJGDSZGEFRY-UUWRZZSWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,INHIBITION,,,,Active,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization at 100 nM incubated for 30 mins measured after washout followed by repeat histamine challenge at intervals of 90 and 270 mins by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767165,AWKFJGDSZGEFRY-UUWRZZSWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KD,=,1.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization at 100 nM after 30 mins by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767165,AWKFJGDSZGEFRY-UUWRZZSWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,7.94,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL64479,AWRHPMGJQNISSW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,870.96,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL540982,AWYSEPZPTVMKBT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19663387.0,KI,=,11,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.,J. Med. Chem.,PUBLICATION,
CHEMBL60559,AXEYQIQVIRZLKE-JOCHJYFZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,9772.37,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095819,AXIFLPLKZRNVDP-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,0.9,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1087089,AXIFLPLKZRNVDP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,0.5,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL440294,AXKPFOAXAHJUAG-UHFFFAOYSA-N,PIPAMPERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,2400,NM,,,,,,,,,,,,,,,,,,,
CHEMBL18972,AXNGJCOYCMDPQG-UHFFFAOYSA-N,GLEMANSERIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15999145.0,KI,=,1604,NM,,,,,,,,,,,,,,,,,,,
CHEMBL2440659,AXVLPJHYYFHCHK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24074843.0,INHIBITION,>,35,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-Pyrilamine from human recombinant histamine H1 receptor expressed in CHO-K1 cells at 10 uM relative to control,Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL21278,AYEQNAFPDMJGOZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,8.03,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556506,AYEYSXMZCARQKR-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19663387.0,KI,=,1.3,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.,J. Med. Chem.,PUBLICATION,
CHEMBL556506,AYEYSXMZCARQKR-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,1.3,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556506,AYEYSXMZCARQKR-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20800486.0,KI,=,1.5,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556506,AYEYSXMZCARQKR-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,1.3,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1951055,AYHCJXIBRDMYBV-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22450133.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,Substituted phenoxypropyl-(R)-2-methylpyrrolidine aminomethyl ketones as histamine-3 receptor inverse agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158790,AYPGYVOWMUSFPT-NDEPHWFRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,31.62,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1278113,AYWYOYAKLYFQAR-JVPYDEADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,100,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL2031471,AZBGZTWRYFLSNW-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22617490.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM by radioligand binding assay,"Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H(3) receptor inverse agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL395743,AZIHSCHAYYVWIY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,7.4,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL3238444,BAAHTFHSCKWFDS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24650714.0,KI,=,29512.09,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHO cell membrane after 120 mins by liquid scintillation counting analysis,Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL559664,BACLISNXCXJOMR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,40,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559664,BACLISNXCXJOMR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,40,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2158778,BATQCPTUBUKUDO-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,398.11,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL565551,BAZQBEOFVYAFHT-CALCHBBNSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773162.0,IC50,=,810,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669420,BBPIYFSEHZGVJE-INIZCTEOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,48,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1222695,BBQVIKFUQPNVLK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,79.43,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2387282,BCCVUKGKQRRJOM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL11,BCGWQEUPMDMJNV-UHFFFAOYSA-N,IMIPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,16,NM,,,,,,,,,,,,,,,,,,,
CHEMBL11,BCGWQEUPMDMJNV-UHFFFAOYSA-N,IMIPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,37,NM,,,,,,,,,,,,,,,,,,,
CHEMBL11,BCGWQEUPMDMJNV-UHFFFAOYSA-N,IMIPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23919353.0,IC50,=,27,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by radioligand binding assay,Polypharmacology - foe or friend?,J. Med. Chem.,PUBLICATION,
CHEMBL3220888,BCHZZFRPLSLIAG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.04,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220888,BCHZZFRPLSLIAG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL499301,BCIVIRNJAROBHW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,8700,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL442171,BCZAHYKUHLEQBO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL442171,BCZAHYKUHLEQBO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta; no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL1077861,BDBQKEQJJZXSDB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1077861,BDBQKEQJJZXSDB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1783974,BDDPDGBPFDDYBY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,2790,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783974,BDDPDGBPFDDYBY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL157273,BDMUROBIUYESLK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.67,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157273,BDMUROBIUYESLK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,398.11,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157273,BDMUROBIUYESLK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,251188643150958,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1774498,BDOFZYNAHBHVET-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,54,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL271073,BDRCTGAXOWRNQU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608689,BDSUMBDGCUOHGR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,70,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1276859,BEAHZBHBRZMAIL-OSHJFMDRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,31.62,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL2164389,BECROBIDPQYXRW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22770500.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM by radioligand binding assay,"3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.",J. Med. Chem.,PUBLICATION,
CHEMBL310940,BELFTABQPVPWDW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,PIC50,,,,Not Determined,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand; n.t. means not tested,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL150161,BETHXCLHMRGYBW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16621538.0,KI,=,259.6,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor by radioligand binding assay,"Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL150161,BETHXCLHMRGYBW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16621538.0,KI,=,1467,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor by radioligand binding assay,"Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL150161,BETHXCLHMRGYBW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,259.6,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL150161,BETHXCLHMRGYBW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,1467,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL94834,BEYBSSSCFNIKNG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.33,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL94834,BEYBSSSCFNIKNG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,473,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL42442,BEZZFPOZAYTVHN-UHFFFAOYSA-N,OXFENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42442,BEZZFPOZAYTVHN-UHFFFAOYSA-N,OXFENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL588119,BFCDFTHTSVTWOG-YLJYHZDGSA-N,SULOCTIDIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,5176.8,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL588119,BFCDFTHTSVTWOG-YLJYHZDGSA-N,SULOCTIDIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,2475.9,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL256481,BFIAPIAYPVHYPQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2013045,BFKPZXXQVYWHKU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22365751.0,INHIBITION,<,20,%,,,,,,,,,,,,,,,Inhibition of human H1 receptor at 10 uM,"Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL691,BFPYWIDHMRZLRN-SLHNCBLASA-N,ETHINYL ESTRADIOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL691,BFPYWIDHMRZLRN-SLHNCBLASA-N,ETHINYL ESTRADIOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL283036,BFQIOOYNLCWKIJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL509387,BFVXDLZRORZNHX-OCIDDWSYSA-N,(-)-TABERSONINE HCL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,9182127.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Displacement of radioligand from histamine H1 receptor by liquid scintillation spectrometry,"Perhydrogenation of tabersonine, ans Aspidiosperma indole alkaloid.",J. Nat. Prod.,PUBLICATION,
CHEMBL1200604,BGDKAVGWHJFAGW-UHFFFAOYSA-N,TROPICAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200604,BGDKAVGWHJFAGW-UHFFFAOYSA-N,TROPICAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL315790,BGGSRICBOHRXMJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,PIC50,,,,Not Determined,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand; not tested,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL267044,BGRJTUBHPOOWDU-NSHDSACASA-N,LEVOSULPIRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267044,BGRJTUBHPOOWDU-NSHDSACASA-N,LEVOSULPIRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL26,BGRJTUBHPOOWDU-UHFFFAOYSA-N,SULPIRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL26,BGRJTUBHPOOWDU-UHFFFAOYSA-N,SULPIRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1092812,BHMPPLVSPUZBNL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,120,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL205596,BHQCQFFYRZLCQQ-OELDTZBJSA-N,CHOLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL205596,BHQCQFFYRZLCQQ-OELDTZBJSA-N,CHOLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64667,BHZVLTKKVOPLTE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,1047.13,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3622346,BIALXFMHWCNRAQ-OQIWPSSASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25801931.0,INHIBITION,=,19,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM relative to control,Pseudosaccharin amines as potent and selective KV1.5 blockers.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3084803,BIDUPMYXGFNAEJ-APGVDKLISA-N,ASTROMICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3084803,BIDUPMYXGFNAEJ-APGVDKLISA-N,ASTROMICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1629810,BIIFEDMBGOQTDO-USCPGHQQSA-N,2-HYDROXYPROPYL-BETA-CYCLODEXTRIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1629810,BIIFEDMBGOQTDO-USCPGHQQSA-N,2-HYDROXYPROPYL-BETA-CYCLODEXTRIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1935426,BITWXVYTBYRISR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153342.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,"Synthesis and evaluation of 4-alkoxy-[1'-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4'-piperidine)] analogues as histamine-3 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078746,BIXSTJUYDSCGLQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078746,BIXSTJUYDSCGLQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL445206,BJIOGJUNALELMI-ARJAWSKDSA-N,ISOEUGENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL445206,BJIOGJUNALELMI-ARJAWSKDSA-N,ISOEUGENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402794,BJQHLKABXJIVAM-BGYRXZFFSA-N,BIS(2-ETHYLHEXYL)PHTHALATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402794,BJQHLKABXJIVAM-BGYRXZFFSA-N,BIS(2-ETHYLHEXYL)PHTHALATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL430368,BKLPUYQJSHHECO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157138,BKRGVLQUQGGVSM-KBXCAEBGSA-N,LISURIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,160,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL157138,BKRGVLQUQGGVSM-KBXCAEBGSA-N,LISURIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,19,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL600053,BKYSPAJPVPEZOE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19954972.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL278172,BLFLLBZGZJTVJG-UHFFFAOYSA-N,BENZOCAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL278172,BLFLLBZGZJTVJG-UHFFFAOYSA-N,BENZOCAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL15245,BLGXFZZNTVWLAY-SCYLSFHTSA-N,YOHIMBINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL15245,BLGXFZZNTVWLAY-SCYLSFHTSA-N,YOHIMBINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL499,BLJRIMJGRPQVNF-JTQLQIEISA-N,TIMOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL499,BLJRIMJGRPQVNF-JTQLQIEISA-N,TIMOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1306,BLSQLHNBWJLIBQ-OZXSUGGESA-N,TERCONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1306,BLSQLHNBWJLIBQ-OZXSUGGESA-N,TERCONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567597,BLUAFEHZUWYNDE-DKGJTOOQSA-N,ARTEMISININ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567597,BLUAFEHZUWYNDE-DKGJTOOQSA-N,ARTEMISININ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1070,BLXXJMDCKKHMKV-UHFFFAOYSA-N,NABUMETONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1070,BLXXJMDCKKHMKV-UHFFFAOYSA-N,NABUMETONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2203713,BLZNLOLTHDUEOL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22840695.0,INHIBITION,=,3,%,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells at 10 uM after 60 mins,"Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.",Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1381010,BMBIEKJDTGAZCY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,Ki,<,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor expressed in HEK293T cells after 1 to 1.5 hrs by liquid scintillation counting analysis,Structure-based virtual screening for fragment-like ligands of the G protein-coupled histamine H4receptor,MedChemComm,PUBLICATION,
CHEMBL1078735,BMCMMMRTWLCMFW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078735,BMCMMMRTWLCMFW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2432063,BMHWWKPJPARTBN-RAOGCBAWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL302005,BMMSDSQQAGDCHS-RQZCQDPDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,KI,=,11,NM,,,,,,,,,,,,,,,Inhibition constant against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL302005,BMMSDSQQAGDCHS-RQZCQDPDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22931505.0,KI,=,11,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Chemokine receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL486153,BMUUWLQTYRICEF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,6000,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL192,BNRNXUUZRGQAQC-UHFFFAOYSA-N,SILDENAFIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL192,BNRNXUUZRGQAQC-UHFFFAOYSA-N,SILDENAFIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3124968,BNSBTAITEDOQSS-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24410637.0,ACTIVITY,>,10,%,,,,,,,,,,,,,,,Activity at histamine H1 receptor (unknown origin) at 10 uM relative to control,Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.,J. Med. Chem.,PUBLICATION,
CHEMBL197796,BNXUKTBRYQQOIZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16143528.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards cloned Histamine H1 receptor,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200545,BOBLHFUVNSFZPJ-JOYXJVLSSA-N,DIFLORASONE DIACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200545,BOBLHFUVNSFZPJ-JOYXJVLSSA-N,DIFLORASONE DIACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL214311,BOQXUEKBVIXPKQ-JSGCOSHPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16942032.0,EC50,>,10000,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in 293-EBNA cells by luciferase reporter gene assay,Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.,J. Med. Chem.,PUBLICATION,
CHEMBL214311,BOQXUEKBVIXPKQ-JSGCOSHPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16942032.0,IC50,=,8500,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1 receptor expressed in 293-EBNA cells assessed as inhibition of histamine agonist activity by luciferase reporter gene assay,Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.,J. Med. Chem.,PUBLICATION,
CHEMBL213886,BOQXUEKBVIXPKQ-TZMCWYRMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16942032.0,EC50,>,10000,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in 293-EBNA cells by luciferase reporter gene assay,Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.,J. Med. Chem.,PUBLICATION,
CHEMBL213886,BOQXUEKBVIXPKQ-TZMCWYRMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16942032.0,IC50,=,6800,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1 receptor expressed in 293-EBNA cells assessed as inhibition of histamine agonist activity by luciferase reporter gene assay,Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.,J. Med. Chem.,PUBLICATION,
CHEMBL427216,BOVGTQGAOIONJV-UHFFFAOYSA-N,GLICLAZIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL427216,BOVGTQGAOIONJV-UHFFFAOYSA-N,GLICLAZIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL539843,BOYLPLUVCXUHDJ-UHFFFAOYSA-N,VAPITADINE DIHYDROCHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771458.0,KI,=,19,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for H1 histamine receptor expressed in CHO cells,"Norpiperidine imidazoazepines as a new class of potent, selective, and nonsedative H1 antihistamines.",J. Med. Chem.,PUBLICATION,
CHEMBL1940420,BPDDCCYSOYRMEC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22245230.0,KI,=,262,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor by liquid scintillation counting,Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1774504,BPDWWCSMAZGENY-AQHIEDMUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,63,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL240178,BPDXEOHDRPKAKE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL400224,BPXYTXXFLQUXFX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL275507,BPZGZNLONLANFE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.69,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL275507,BPZGZNLONLANFE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,794.33,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL275507,BPZGZNLONLANFE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,501187233627271,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL398615,BQDBKDMTIJBJLA-UHFFFAOYSA-N,METOPIMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,Ki,=,8.4,NM,,,,binding,,,,,,,,,,,,,,,
CHEMBL257606,BQWBRQKHFWLAJX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,5,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 1 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257606,BQWBRQKHFWLAJX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,9,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 10 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3218986,BRAGRHFEIYNRST-UXHICEINSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INHIBITION,=,50,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) at 10 uM by displacement assay relative to control,,MedChemComm,PUBLICATION,
CHEMBL3220884,BRGLCLCWSZIUEA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL3220884,BRGLCLCWSZIUEA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL232104,BRIVIXLMMUIBJY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17606674.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,"Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL1783964,BRMMBDRDSQRBHU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,120,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783964,BRMMBDRDSQRBHU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,500,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL513883,BRPONMOKDIJLJF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,1400,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL303044,BRUVXRVRSSLLEL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL303044,BRUVXRVRSSLLEL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; - means no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL193639,BSOLCASXROXPRZ-MQSINFNDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,0.52,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL193639,BSOLCASXROXPRZ-MQSINFNDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,0.6,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL366164,BSOLCASXROXPRZ-MUKKUYKPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,1.4,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL363581,BSOLCASXROXPRZ-SHZHJNINSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,1.2,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL1808426,BSUNLXLBVQPAFJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21724392.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL320003,BSVGNAQMDXJFNE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.39,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL25,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,ASPIRIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL25,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,ASPIRIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL104344,BTCOIJOGNYPDOY-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,2500,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL239964,BTGWCFVBMYAJIJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3220653,BTLGXJUDLJOGSO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL106596,BTQCFHMSBTVCNT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,7762.47,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL328573,BTSCZNWXJQSJIE-QFBILLFUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,0.64,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL83658,BTSCZNWXJQSJIE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,6.76,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL83658,BTSCZNWXJQSJIE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL83658,BTSCZNWXJQSJIE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,6.76,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL83658,BTSCZNWXJQSJIE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12443779.0,IC50,=,6.76,NM,,,,,,,,,,,,,,,Binding affinity against Histamine H1 receptor,2-(Dimethylaminomethyl)-tetrahydroisoxazolopyridobenzazepine derivatives. Synthesis of a new 5-HT(2C) antagonist with potential anxiolytic properties.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL105071,BTXYSVCTMDAUJN-QHCPKHFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,2300,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1762,BUJAGSGYPOAWEI-UHFFFAOYSA-N,TOCAINIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1762,BUJAGSGYPOAWEI-UHFFFAOYSA-N,TOCAINIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3590089,BUVAGKGIBHOSMY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25936259.0,ACTIVITY,=,-2,%,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant H1 receptor expressed in HEK-293 cells assessed as intracellular Ca2+ release at 1 uM by fluorimetry,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3590089,BUVAGKGIBHOSMY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25936259.0,INHIBITION,=,-6,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]-pyrilamine from human cloned H1 receptor expressed in HEK293 cells at 1 uM by scintillation counting analysis,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3590089,BUVAGKGIBHOSMY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25936259.0,INHIBITION,=,63,%,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant H1 receptor expressed in HEK-293 cells assessed as inhibition of histamine-induced intracellular Ca2+ release at 1 uM by fluorimetry,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3633184,BUYVTPGEWYQFCF-RSPOEFSDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26428869.0,ACTIVITY,=,0.17,%,,,cell_based,,,,,,,,,,,,Agonist activity at histamine H1 receptor (unknown origin) expressed in CHO cells assessed as calcium mobilization at 3 uM,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3633184,BUYVTPGEWYQFCF-RSPOEFSDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26428869.0,INHIBITION,=,5.59,%,,,cell_based,,,,,,,,,,,,Antagonist activity at histamine H1 receptor (unknown origin) expressed in CHO cells assessed as calcium mobilization at 3 uM,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3633184,BUYVTPGEWYQFCF-RSPOEFSDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26428869.0,INHIBITION,=,6,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) at 3 uM by radioligand-binding assay,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL481280,BUZBVOKDNAZIIM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18588282.0,INHIBITION,=,22,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,PUBLICATION,
CHEMBL257901,BVMLPMCCWDUGDH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1092496,BVRYNXDISKCAFZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,69,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1910379,BWBDWEIXBARWJD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,776.25,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077636,BWNYFRHMGXLSFD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1077636,BWNYFRHMGXLSFD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL63003,BWVYMOZIPOAYMY-MUUNZHRXSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,1995.26,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL294502,BXDDBQXEMSRCFW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,1905.46,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1765111,BXUKKRHEMKVWOY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,15.85,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1460,BXZVVICBKDXVGW-NKWVEPMBSA-N,DIDANOSINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1460,BXZVVICBKDXVGW-NKWVEPMBSA-N,DIDANOSINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL91,BYBLEWFAAKGYCD-UHFFFAOYSA-N,MICONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL91,BYBLEWFAAKGYCD-UHFFFAOYSA-N,MICONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL292275,BYKHDCPMWIUHPJ-VGOFMYFVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,616.6,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256650,BYMRLNXYRMIIKD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL628,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,PENTOXIFYLLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL628,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,PENTOXIFYLLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL242603,BZIIORPIORBBJU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,5.9,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL20,BZKPWHYZMXOIDC-UHFFFAOYSA-N,ACETAZOLAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL20,BZKPWHYZMXOIDC-UHFFFAOYSA-N,ACETAZOLAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1808437,BZMIEAZWZMSACC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21724392.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1630579,BZRYYBWNOUALTQ-UHFFFAOYSA-N,MYRTECAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1630579,BZRYYBWNOUALTQ-UHFFFAOYSA-N,MYRTECAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220886,BZTLHEUBSUYQTK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.12,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220886,BZTLHEUBSUYQTK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL147077,CAAOWRJNPRFDJE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,9857099.0,KI,=,491,NM,,,,,,,,,,,,,,,Binding affinity for recombinant human Histamine H1 receptor using [3H]pyrilamine as radioligand.,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,PUBLICATION,
CHEMBL3220643,CABAUJLNRQAJJX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL855,CBEQULMOCCWAQT-WOJGMQOQSA-N,TRIPROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7925364.0,KI,=,1,NM,,,,,,,,,,,,,,,,,,,
CHEMBL855,CBEQULMOCCWAQT-WOJGMQOQSA-N,TRIPROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8496700.0,ACTIVITY,=,80,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from histamine H1 receptor assessed as specific binding relative to total binding,The role of receptor binding in drug discovery.,J. Nat. Prod.,PUBLICATION,
CHEMBL855,CBEQULMOCCWAQT-WOJGMQOQSA-N,TRIPROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8496700.0,KI,=,1.6,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from histamine H1 receptor,The role of receptor binding in drug discovery.,J. Nat. Prod.,PUBLICATION,
CHEMBL855,CBEQULMOCCWAQT-WOJGMQOQSA-N,TRIPROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8903934.0,KI,=,1,NM,,,,,,,,,,,,,,,,,,,
CHEMBL855,CBEQULMOCCWAQT-WOJGMQOQSA-N,TRIPROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,1.11,NM,,,,,,,,,,,,,,,,,,,
CHEMBL855,CBEQULMOCCWAQT-WOJGMQOQSA-N,TRIPROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,1.53,NM,,,,,,,,,,,,,,,,,,,
CHEMBL855,CBEQULMOCCWAQT-WOJGMQOQSA-N,TRIPROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12626648.0,KI,=,3.01,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1159650,CBGUOGMQLZIXBE-XGQKBEPLSA-N,CLOBETASOL PROPIONATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1159650,CBGUOGMQLZIXBE-XGQKBEPLSA-N,CLOBETASOL PROPIONATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL395110,CBHCDHNUZWWAPP-UHFFFAOYSA-N,MEPAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,27,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL395110,CBHCDHNUZWWAPP-UHFFFAOYSA-N,MEPAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,3.13,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL115,CBVCZFGXHXORBI-PXQQMZJSSA-N,INDINAVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL115,CBVCZFGXHXORBI-PXQQMZJSSA-N,INDINAVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2387289,CCDWSMJPLNHEDZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171020,CCJZAFYMSHLKFH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,25.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL277848,CCLANJAQOUQKCP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,9.05,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL21520,CCLXLBBRGDWTKH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,7.61,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158825,CCXXDPNVVABEGJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,15.85,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL10,CDMGBJANTYXAIV-UHFFFAOYSA-N,SB-203580,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL10,CDMGBJANTYXAIV-UHFFFAOYSA-N,SB-203580,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2107687,CEJGGHKJHDHLAZ-UHFFFAOYSA-M,VALETHAMATE BROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2107687,CEJGGHKJHDHLAZ-UHFFFAOYSA-M,VALETHAMATE BROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL494093,CEUMRIVIGREJGB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,9120.11,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1112,CEUORZQYGODEFX-UHFFFAOYSA-N,ARIPIPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,29.7,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1112,CEUORZQYGODEFX-UHFFFAOYSA-N,ARIPIPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12784105.0,KI,=,25.1,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1112,CEUORZQYGODEFX-UHFFFAOYSA-N,ARIPIPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27173799.0,IC50,=,420,NM,,,,,,,,,,,,,,,Antagonistic activity at histamine1 receptor (unknown origin) after 10 mins by FLIPR assay,"Synthesis, structure-activity relationships, and biological evaluation of a series of benzamides as potential multireceptor antipsychotics.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1112,CEUORZQYGODEFX-UHFFFAOYSA-N,ARIPIPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,25.1,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1112,CEUORZQYGODEFX-UHFFFAOYSA-N,ARIPIPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,100,NM,,,,,,,,,,,,,,,Binding affinity to H1 histamine receptor (unknown origin) by PDSP assay,,MedChemComm,PUBLICATION,
CHEMBL93321,CEXVQARQHVKRBU-RMNMTYGKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,9.6,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL61070,CFANDXVYVGVAJZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,602.56,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL508102,CFOYWRHIYXMDOT-UHFFFAOYSA-N,CARBIMAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL508102,CFOYWRHIYXMDOT-UHFFFAOYSA-N,CARBIMAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL27979,CFUHKRLMDNFZED-SFTDATJTSA-N,"A-349,821",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657274.0,KI,=,2344.23,NM,,,,,,,,,,,,,,,Binding affinity towards human histaminergic (H1) receptor,Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: novel and selective histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62421,CGDJUGZQGOTFLF-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,35481.34,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL6,CGIGDMFJXJATDK-UHFFFAOYSA-N,INDOMETHACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6,CGIGDMFJXJATDK-UHFFFAOYSA-N,INDOMETHACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL95076,CGNVNXXLENQGRB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.35,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158773,CGPUMTTUBWGRHT-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,15.85,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1081318,CGWIQIDEPCKACR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL560386,CHCVZZOPCAVWNV-HTAPYJJXSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19520574.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,"Synthesis, structure-activity relationships, and biological profiles of a dihydrobenzoxathiin class of histamine H(3) receptor inverse agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL64021,CHEGJFNZXABNBU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,380.19,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370232,CHFVEWGLPHGQML-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16275087.0,INHIBITION,<,50,%,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2037531,CHGXPKZHRZIZSQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22520153.0,KI,=,52,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 histamine receptor by liquid scintillation assay,Benzothiazoles as probes for the 5HT(1A) receptor and the serotonin transporter (SERT): A search for new dual-acting agents as potential antidepressants.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL85892,CHMIKIFFWBMPHB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12182854.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Competitive binding at Histamine H1 receptor at 10 uM; NA means compound failed to compete,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL56337,CHNUOJQWGUIOLD-NFZZJPOKSA-N,EPALRESTAT,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL56337,CHNUOJQWGUIOLD-NFZZJPOKSA-N,EPALRESTAT,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL241694,CHNXZKVNWQUJIB-CEGNMAFCSA-N,ETHISTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL241694,CHNXZKVNWQUJIB-CEGNMAFCSA-N,ETHISTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL243709,CHUTWLUGUSZHNG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.2,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL2172192,CHVVPMVMKPMDFR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22664127.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Binding affinity to histamine receptor H1 at 1 uM by radioligand displacement assay,"Antagonists of 5-HT(6) receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432039,CHZUEGVOEFMIJH-ZKRSMWHSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,=,4736,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146813,CIAWHNGOFJZBCL-MGBGTMOVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,1,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146813,CIAWHNGOFJZBCL-MGBGTMOVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,17.38,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1572,CIDUJQMULVCIBT-MQDUPKMGSA-N,NETILMICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1572,CIDUJQMULVCIBT-MQDUPKMGSA-N,NETILMICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL79496,CIIWLVZNBDXUIV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL464811,CILDROBPHGWMGB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,190,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL156131,CISTXXCPQIZSIS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Determined,,,,,,,,,,,,,,Intrinsic activity; Low affinity for the receptor: not tested for the efficacy,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL156131,CISTXXCPQIZSIS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,31622776601683.8,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL156131,CISTXXCPQIZSIS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL196,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,ASCORBATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL196,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,ASCORBATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL459,CJCSPKMFHVPWAR-JTQLQIEISA-N,METHYLDOPA,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL459,CJCSPKMFHVPWAR-JTQLQIEISA-N,METHYLDOPA,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2105617,CJDRUOGAGYHKKD-FUIWMBJSSA-N,AJMALINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2105617,CJDRUOGAGYHKKD-FUIWMBJSSA-N,AJMALINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL481153,CJGNMVAAMQAWEF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23707254.0,KI,=,29,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor (unknown origin) by PDSP assay,Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL73706,CJHFYNOETGOKCU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15081022.0,KI,=,550,NM,,,cell_based,,,,,CHO-K1,,,,,,,In vitro binding affinity towards histamine H1 receptor expressed in CHO-K1 cells,5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767145,CJMVJEMHSLDPMO-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,0.501,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL237967,CJWPNMMSQZADAG-GFPUREGVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17929797.0,INHIBITION,=,41,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,"Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL64884,CJXQVUBYAQWRHD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,56.23,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432060,CKFQOWSPJPMWEK-IINHSQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL157843,CKIRNALZCRYDMF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Active,,,,,,,,,,,,,,Intrinsic activity; Tested up to 100 uM: no effects up to 10 uM,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157843,CKIRNALZCRYDMF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,1000000000000000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157843,CKIRNALZCRYDMF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1082723,CKLPLPZSUQEDRT-WPCRTTGESA-N,NITD609,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20813948.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to human recombinant histamine H1 receptor,"Spiroindolones, a potent compound class for the treatment of malaria.",Science,PUBLICATION,
CHEMBL274767,CKMBGNSZMPWQNH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10737740.0,PKP,=,6.21,,,,tissue,,,,,,,,,,,,Negative logarithm of receptor dissociation constant Kp was reported in guinea pig ileum whole segments.,"Histaprodifens: synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H(1)-receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL274767,CKMBGNSZMPWQNH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.09,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL274767,CKMBGNSZMPWQNH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,794328234724282,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL274767,CKMBGNSZMPWQNH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1923528,CLEGTFPJUAEKOX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,2290.87,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1200558,CLKOFPXJLQSYAH-ABRJDSQDSA-N,BACITRACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200558,CLKOFPXJLQSYAH-ABRJDSQDSA-N,BACITRACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL270602,CLKWUUNGQCSMKW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,1584.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257605,CLLYBOQQZBVCTG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 1 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257605,CLLYBOQQZBVCTG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 10 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208432,CLQMFOOMFPNKNA-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208432,CLQMFOOMFPNKNA-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3357042,CLTMMUQENFHOIL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25318072.0,KI,=,289,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells by scintillation counting method,Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2.,J. Med. Chem.,PUBLICATION,
CHEMBL1515611,CMCCHHWTTBEZNM-UHFFFAOYSA-N,BROMISOVALUM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1515611,CMCCHHWTTBEZNM-UHFFFAOYSA-N,BROMISOVALUM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL88,CMSMOCZEIVJLDB-UHFFFAOYSA-N,CYCLOPHOSPHAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL88,CMSMOCZEIVJLDB-UHFFFAOYSA-N,CYCLOPHOSPHAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL154,CMWTZPSULFXXJA-VIFPVBQESA-N,NAPROXEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL154,CMWTZPSULFXXJA-VIFPVBQESA-N,NAPROXEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1651092,CMXJVCRUSKHTHR-UHFFFAOYSA-N,PULICATINS G,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21028889.0,ACTIVITY,=,678,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor by radioligand displacement assay,"Pulicatins A-E, neuroactive thiazoline metabolites from cone snail-associated bacteria.",J. Nat. Prod.,PUBLICATION,
CHEMBL1210084,CMZXJSAVTRAMNW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432047,CNPQMMDLXZBMLB-KPCGFGSOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL242599,CNYTYKJCKVUZFG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.9,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL270239,COKSKIXACCXTRS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,BUSULFAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,BUSULFAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL478617,CPDKHEPGGZULPR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,635.4,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1454946,CPEUVMUXAHMANV-UHFFFAOYSA-N,FLUBENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1454946,CPEUVMUXAHMANV-UHFFFAOYSA-N,FLUBENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL16073,CPJSUEIXXCENMM-UHFFFAOYSA-N,PHENACETIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL16073,CPJSUEIXXCENMM-UHFFFAOYSA-N,PHENACETIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2387293,CPLAFNKZMOZIDZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432051,CPLYGLAQLNAQOI-SEDVZXITSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,=,5569,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL404956,CPNTXNSOEZESIH-QZTJIDSGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,KI,=,10,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL427563,CPNTXNSOEZESIH-ROUUACIJSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1784673,CPOQTXKWWFQYCF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21570838.0,INHIBITION,<,50,%,Not Active,,,,,,,,,,,,,,Inhibition of human recombinant H1 receptor at 10 uM by radioligand binding assay,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3289442,CPSGCDLKARETBW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24852118.0,INHIBITION,=,27,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 3 uM by radioligand displacement assay relative to control,"Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M4 muscarinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1321,CPTBDICYNRMXFX-UHFFFAOYSA-N,PROCARBAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1321,CPTBDICYNRMXFX-UHFFFAOYSA-N,PROCARBAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL82714,CQGTWGRGLDAJSE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,1.66,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL82714,CQGTWGRGLDAJSE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,61.66,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL510139,CQIUKKVOEOPUDV-IYSWYEEDSA-N,CITRININ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL510139,CQIUKKVOEOPUDV-IYSWYEEDSA-N,CITRININ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1257728,CQIVACKSIGNLEU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,5,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL310018,CQJJYGDKIDMYJM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,676.08,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1210154,CQUWKHKELQQYRI-KGENOOAVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20591666.0,IC50,>,10000,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells,A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL102416,CRGOWMIZBWIMTB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,575.44,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3127675,CRWYIZWOHXWIGZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24410637.0,ACTIVITY,>,10,%,,,,,,,,,,,,,,,Activity at histamine H1 receptor (unknown origin) at 10 uM relative to control,Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.,J. Med. Chem.,PUBLICATION,
CHEMBL486963,CSAKAHRWRJLYBQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,2900,NM,,,,,,,,,,,,,,,,,,,
CHEMBL3233427,CSRUCKYTDYTZMI-VXKWHMMOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24559051.0,INHIBITION,=,9,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 100 nM,Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL2171024,CSSKAGWIWQOQME-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,125.89,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1289,CTETYYAZBPJBHE-UHFFFAOYSA-N,HALOPROGIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1289,CTETYYAZBPJBHE-UHFFFAOYSA-N,HALOPROGIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL94726,CTPOZVITFCJCLL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.59,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2387315,CTQMYZRBBXTDJI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1068,CTRLABGOLIVAIY-UHFFFAOYSA-N,OXCARBAZEPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1068,CTRLABGOLIVAIY-UHFFFAOYSA-N,OXCARBAZEPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2158824,CUIDNQSCWXAPRS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,63.1,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205822,CUIQKJJPRAKRJM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL318369,CUKBOHPSSFJJFQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.02,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207388,CULSPSVPJXBZMJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23141912.0,INHIBITION,=,10.12,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM by radioligand displacement assay,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL477181,CUPKCDUMNJWBHZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18606542.0,INHIBITION,<,25,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 3 uM,Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1123,CURUTKGFNZGFSE-UHFFFAOYSA-N,DICYCLOMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1123,CURUTKGFNZGFSE-UHFFFAOYSA-N,DICYCLOMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL444353,CVHQTOGEHBNYHC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771458.0,KI,=,12,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for H1 histamine receptor expressed in CHO cells,"Norpiperidine imidazoazepines as a new class of potent, selective, and nonsedative H1 antihistamines.",J. Med. Chem.,PUBLICATION,
CHEMBL278462,CVKJAXCQPFOAIN-VXGBXAGGSA-N,CIPRALISANT,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15608078.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL3335556,CVKXGRRJHJHUFY-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25221667.0,ACTIVITY,=,93,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) at 10 uM by radioligand binding assay,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL256653,CVPRWHZDWBRVGS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3981.07,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL550818,CVUXESFCUHCXHB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,3.9,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL550818,CVUXESFCUHCXHB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20347297.0,KI,=,3.9,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,"The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL550818,CVUXESFCUHCXHB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,3.9,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1835782,CWDYYODRDVPEOW-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21906941.0,INHIBITION,<,30,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,"Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030631,CWEGCQIIDCZZED-UHFFFAOYSA-N,N-BENZYLPYRROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL64334,CWMROIPYLYIONF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,660.69,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158781,CWXOTCCLEKNUJY-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,158.49,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1231530,CWXYHOHYCJXYFQ-UHFFFAOYSA-N,BETAMIPRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1231530,CWXYHOHYCJXYFQ-UHFFFAOYSA-N,BETAMIPRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL590615,CWYDYWFZPBTTIM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19954972.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1276948,CXDSZAINFKAKPN-AKRCKQFNSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,6.31,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL239510,CXJWCTREHRSRNG-BDQAORGHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL239080,CXJWCTREHRSRNG-VEIFNGETSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL16,CXOFVDLJLONNDW-UHFFFAOYSA-N,PHENYTOIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL16,CXOFVDLJLONNDW-UHFFFAOYSA-N,PHENYTOIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL210578,CXQUOFVDYCOSEZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16621538.0,KI,=,8780,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor by radioligand binding assay,"Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL210578,CXQUOFVDYCOSEZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,8780,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL210578,CXQUOFVDYCOSEZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25070422.0,KI,=,8780,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL271702,CXSFVUWINAYILW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201024,CXYRUNPLKGGUJF-XKTSLVMZSA-M,METHSCOPOLAMINE BROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201024,CXYRUNPLKGGUJF-XKTSLVMZSA-M,METHSCOPOLAMINE BROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171014,CYAXTHULEFHIMG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404520,CYDMQBQPVICBEU-XRNKAMNCSA-N,CHLORTETRACYCLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL404520,CYDMQBQPVICBEU-XRNKAMNCSA-N,CHLORTETRACYCLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3094318,CYPDLWIUOMSUJR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24238903.0,INHIBITION,=,5.2,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL75880,CYXKNKQEMFBLER-UHFFFAOYSA-N,PERHEXILINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL75880,CYXKNKQEMFBLER-UHFFFAOYSA-N,PERHEXILINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL197669,CYYQMAWUIRPCNW-UHFFFAOYSA-N,ST1535,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16250647.0,INHIBITION,<,10,%,,,,,,,,,,,,,,,Percent inhibition against Histamine H1 receptor at 1 uM,"2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.",J. Med. Chem.,PUBLICATION,
CHEMBL1783961,CZCOISNXSIJAAK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,650,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783961,CZCOISNXSIJAAK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,930,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL311469,CZIHNRWJTSTCEX-UHFFFAOYSA-N,2-ACETYLAMINOFLUORENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL311469,CZIHNRWJTSTCEX-UHFFFAOYSA-N,2-ACETYLAMINOFLUORENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL98350,CZQHHVNHHHRRDU-UHFFFAOYSA-N,LY-294002,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL98350,CZQHHVNHHHRRDU-UHFFFAOYSA-N,LY-294002,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1092600,CZXWYWSRENNIBD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,11.9,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277125,DADRXTGBZRBZMD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,100,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL241329,DARWEDNPGILOPQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18020391.0,KI,=,270,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,From astemizole to a novel hit series of small-molecule somatostatin 5 receptor antagonists via GPCR affinity profiling.,J. Med. Chem.,PUBLICATION,
CHEMBL241329,DARWEDNPGILOPQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1094231,DAXGWLCLIPNRDH-UHFFFAOYSA-N,"1-(3-CHLORO-4-FLUOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20427184.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL897,DBABZHXKTCFAPX-UHFFFAOYSA-N,PROBENECID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL897,DBABZHXKTCFAPX-UHFFFAOYSA-N,PROBENECID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL710,DBEPLOCGEIEOCV-WSBQPABSSA-N,FINASTERIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL710,DBEPLOCGEIEOCV-WSBQPABSSA-N,FINASTERIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1277217,DBFNYFZBHMQFLI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,158.49,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL248702,DBGIVFWFUFKIQN-VIFPVBQESA-N,DEXFENFLURAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL248702,DBGIVFWFUFKIQN-VIFPVBQESA-N,DEXFENFLURAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1062,DBPWSSGDRRHUNT-CEGNMAFCSA-N,HYDROXYPROGESTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1062,DBPWSSGDRRHUNT-CEGNMAFCSA-N,HYDROXYPROGESTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL871,DBVJJBKOTRCVKF-UHFFFAOYSA-N,ETIDRONIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL871,DBVJJBKOTRCVKF-UHFFFAOYSA-N,ETIDRONIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3186763,DCAMTBFFNOHDAW-DYTRJAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25244572.0,INHIBITION,=,12.31,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor at 10 uM,"Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.",J. Med. Chem.,PUBLICATION,
CHEMBL2205833,DCGVCGVBZDMLGR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205833,DCGVCGVBZDMLGR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1767140,DCGYGKIBQOAKTB-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,0.316,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL139,DCOPUUMXTXDBNB-UHFFFAOYSA-N,DICLOFENAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL139,DCOPUUMXTXDBNB-UHFFFAOYSA-N,DICLOFENAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2158817,DCPIUFZZSDRFTC-AJZOCDQUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,19.95,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158818,DCPIUFZZSDRFTC-PPUHSXQSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,100,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL105669,DCSHODGQAYSURK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,27.54,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1729,DCSUBABJRXZOMT-UHFFFAOYSA-N,CISAPRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1729,DCSUBABJRXZOMT-UHFFFAOYSA-N,CISAPRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL40,DDBREPKUVSBGFI-UHFFFAOYSA-N,PHENOBARBITAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL40,DDBREPKUVSBGFI-UHFFFAOYSA-N,PHENOBARBITAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL476323,DDDZBLNULGDPGA-UHFFFAOYSA-N,MK-0249,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18598020.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,"Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL558467,DDHSIUUOIYFUOU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,1.8,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2367892,DDTDNCYHLGRFBM-YZEKDTGTSA-N,TEICOPLANIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2367892,DDTDNCYHLGRFBM-YZEKDTGTSA-N,TEICOPLANIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL562,DDUHZTYCFQRHIY-RBHXEPJQSA-N,GRISEOFULVIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL562,DDUHZTYCFQRHIY-RBHXEPJQSA-N,GRISEOFULVIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1258193,DDZUOFCXBAZBJH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,33,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL244278,DEIXGWIQADAVTO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,7.4,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL2432053,DEOOAAFCKARVDM-CAUKCHDASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3350037,DEQANNDTNATYII-JDBXKHNRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3350037,DEQANNDTNATYII-JDBXKHNRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL43064,DERZBLKQOCDDDZ-JLHYYAGUSA-N,CINNARIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,74,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL43064,DERZBLKQOCDDDZ-JLHYYAGUSA-N,CINNARIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,8.62,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923522,DFBFDRZHAVAEKE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,61.66,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1923522,DFBFDRZHAVAEKE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,62,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1873703,DFBKLUNHFCTMDC-PICURKEMSA-N,DIELDRIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1873703,DFBKLUNHFCTMDC-PICURKEMSA-N,DIELDRIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL460402,DFBYKWKCUIKCPG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,686,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935436,DFNGZIPWXHTTPA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,1,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2178582,DFOFEBXXZMVAGG-MZJWZYIUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22931505.0,KI,=,20,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Chemokine receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1140,DFPAKSUCGFBDDF-UHFFFAOYSA-N,NIACINAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1140,DFPAKSUCGFBDDF-UHFFFAOYSA-N,NIACINAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL451821,DFTFGLPAHCOAEP-TVSVWYSMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18683917.0,KI,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor,The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL540634,DFUGESMXMUMLJG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL452,DGBIGWXXNGSACT-UHFFFAOYSA-N,CLONAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL452,DGBIGWXXNGSACT-UHFFFAOYSA-N,CLONAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL470563,DGJMWXIXZSWRLP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,6200,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL425358,DGLAILDSPYOZLT-GDLZYMKVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,305,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL316561,DGMKFQYCZXERLX-UHFFFAOYSA-N,PROGLUMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL316561,DGMKFQYCZXERLX-UHFFFAOYSA-N,PROGLUMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1783890,DGWKVXVCPCPOAK-UHFFFAOYSA-N,GSK207040,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24269482.0,KI,=,1584.89,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2146812,DGZLHXBKGBELTQ-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,3.98,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146812,DGZLHXBKGBELTQ-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,1.29,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL287052,DHGUFKPZDMQBED-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12626648.0,KI,=,1780,NM,,,,,,,,,,,,,,,,,,,
CHEMBL287052,DHGUFKPZDMQBED-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,1.28,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL287052,DHGUFKPZDMQBED-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,1995.26,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL287052,DHGUFKPZDMQBED-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,158489319246111,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078642,DHHDEHNHEBYRPQ-UHFFFAOYSA-N,UR-PI376,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,KI,=,25703.96,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078642,DHHDEHNHEBYRPQ-UHFFFAOYSA-N,UR-PI376,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078642,DHHDEHNHEBYRPQ-UHFFFAOYSA-N,UR-PI376,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078642,DHHDEHNHEBYRPQ-UHFFFAOYSA-N,UR-PI376,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078642,DHHDEHNHEBYRPQ-UHFFFAOYSA-N,UR-PI376,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.07,%,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL773,DHMQDGOQFOQNFH-UHFFFAOYSA-N,GLYCINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL773,DHMQDGOQFOQNFH-UHFFFAOYSA-N,GLYCINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2205821,DHQYUPWRESNGBC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL48449,DHZBEENLJMYSHQ-XCVPVQRUSA-N,CANTHARIDIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL48449,DHZBEENLJMYSHQ-XCVPVQRUSA-N,CANTHARIDIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL253597,DHZBNHMEIOBPAE-JVVVGQRLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18067245.0,ACTIVITY,<,50,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor at 10 uM,Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.,J. Med. Chem.,PUBLICATION,
CHEMBL571390,DIADJINIBFEMEL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,16,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783959,DICDOOGFHQRKKL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,100,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783959,DICDOOGFHQRKKL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,410,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL102840,DIEXZKWJXAPYGJ-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,14000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL95051,DIPBPGRFGZKMEF-UHFFFAOYSA-N,MDL-28163,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,IC50,=,59,NM,,,,,,,,,,,,,,,Inhibitory concentration against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL95051,DIPBPGRFGZKMEF-UHFFFAOYSA-N,MDL-28163,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,7.23,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL95051,DIPBPGRFGZKMEF-UHFFFAOYSA-N,MDL-28163,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,59,NM,,,,,,,,,,,,,,,Compound was evaluated for the antagonistic activity against H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL240393,DIQMIXLXBUWZKA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,3162.28,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL580,DIWRORZWFLOCLC-UHFFFAOYSA-N,LORAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL580,DIWRORZWFLOCLC-UHFFFAOYSA-N,LORAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2208430,DIXSEWSBXAEKKY-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208430,DIXSEWSBXAEKKY-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,31.62,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL487894,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,DIPYRONE SODIUM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL487894,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,DIPYRONE SODIUM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171016,DJGWTFPDOGEBKS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,25.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL273165,DJHAFQLSNXBKIX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,1000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1093058,DJILKXZJMQURGL-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,4.4,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL519240,DJKJVWJQAVGLHJ-YPMHNXCESA-N,A-987306,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18983139.0,ACTIVITY,=,63.9,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM relative to control,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,PUBLICATION,
CHEMBL519240,DJKJVWJQAVGLHJ-YPMHNXCESA-N,A-987306,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18983139.0,INHIBITION,=,36,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,PUBLICATION,
CHEMBL519240,DJKJVWJQAVGLHJ-YPMHNXCESA-N,A-987306,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18983139.0,KI,=,3548.13,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,PUBLICATION,
CHEMBL331603,DJUHRAPXNFPKDW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25318072.0,KI,=,171,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells by scintillation counting method,Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2.,J. Med. Chem.,PUBLICATION,
CHEMBL267930,DKGZKTPJOSAWFA-UHFFFAOYSA-N,SPIPERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,476.19,NM,,,,,,,,,,,,,,,,,,,
CHEMBL267930,DKGZKTPJOSAWFA-UHFFFAOYSA-N,SPIPERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,480,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1531134,DKMFBWQBDIGMHM-UHFFFAOYSA-N,MELPERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,580,NM,,,,,,,,,,,,,,,,,,,
CHEMBL660,DKNWSYNQZKUICI-UHFFFAOYSA-N,AMANTADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL660,DKNWSYNQZKUICI-UHFFFAOYSA-N,AMANTADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL321320,DKTSZKSSVLOHMC-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,3600,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158830,DKVGJRLHFIQFEM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,39.81,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL75435,DKYWVDODHFEZIM-NSHDSACASA-N,DEXKETOPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL75435,DKYWVDODHFEZIM-NSHDSACASA-N,DEXKETOPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL571,DKYWVDODHFEZIM-UHFFFAOYSA-N,KETOPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL571,DKYWVDODHFEZIM-UHFFFAOYSA-N,KETOPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909050,DLDAZIVPAOLETE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909050,DLDAZIVPAOLETE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL513,DLGOEMSEDOSKAD-UHFFFAOYSA-N,CARMUSTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL513,DLGOEMSEDOSKAD-UHFFFAOYSA-N,CARMUSTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1915535,DLKAQKCVCFAVIS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21955944.0,KI,>,10000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL288772,DLMPCEBSXNLTAT-XMMPIXPASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10937710.0,KI,=,398,NM,,,,,,,,,,,,,,,Selectivity screen against human Histamine H1 receptor,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207664,DLONTNINHYMHFB-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,10,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3233432,DLXKEWOEEPMPHX-PMACEKPBSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24559051.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin),Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL3220657,DMBSVUXJHYRIDG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.02,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220657,DMBSVUXJHYRIDG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL217053,DMFOOUGJUFPBOG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17154491.0,INHIBITION,<,30,%,,,,,,,,,,,,,,,Inhibition of human H1 receptor at 10 uM,Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.,J. Med. Chem.,PUBLICATION,
CHEMBL127,DMJNNHOOLUXYBV-PQTSNVLCSA-N,MEROPENEM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL127,DMJNNHOOLUXYBV-PQTSNVLCSA-N,MEROPENEM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL281365,DMLAXLOYQGGDLU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,8.12,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1774494,DMMAFYCLHWGPBF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,128,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL434684,DMQAXIJUTYJHIV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12593665.0,KI,=,28.84,NM,,,cell_based,,,,,CHO-K1,,,,,,,Compound was evaluated for binding affinity towards cloned human histamine H1 receptors stably expressed in CHO-K1 cells using [3H]mepyramine,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2158831,DMQWGZFKPDYZCH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,63.1,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220661,DMRPXOXQOJCTMB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.01,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220661,DMRPXOXQOJCTMB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL286398,DNIAPMSPPWPWGF-UHFFFAOYSA-N,PROPYLENE GLYCOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL286398,DNIAPMSPPWPWGF-UHFFFAOYSA-N,PROPYLENE GLYCOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL570695,DNIULMBWQYTFJT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,155,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1258078,DNJOROZLUNUHBO-ZDUSSCGKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,-16,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200709,DNTGGZPQPQTDQF-XBXARRHUSA-N,CROTAMITON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200709,DNTGGZPQPQTDQF-XBXARRHUSA-N,CROTAMITON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1405,DNXHEGUUPJUMQT-CBZIJGRNSA-N,ESTRONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1405,DNXHEGUUPJUMQT-CBZIJGRNSA-N,ESTRONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1466,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,DICUMAROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1466,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,DICUMAROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL822,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,TERBINAFINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL822,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,TERBINAFINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1210085,DOPXZUHPZHYPBJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL271083,DOTHXJXYLNKQOQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL231042,DOTSBJMFBWVNQU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17498953.0,ACTIVITY,=,-15,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor at 10 uM,A new class of histamine H3 receptor antagonists derived from ligand based design.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,IMIQUIMOD,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,IMIQUIMOD,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257393,DOWPOCRAKNLQAU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 1 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257393,DOWPOCRAKNLQAU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 10 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL74779,DOXXMQHNZRHZPH-RPBOFIJWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15081022.0,KI,=,660,NM,,,cell_based,,,,,CHO-K1,,,,,,,In vitro binding affinity towards histamine H1 receptor expressed in CHO-K1 cells,5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208436,DPJWTHMHDTUYEX-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208436,DPJWTHMHDTUYEX-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,501.19,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3094208,DPRCEQIDVGCQRH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,PKI,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL83220,DQAMCNMFLLPWQR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL19019,DQCKKXVULJGBQN-XFWGSAIBSA-N,NALTREXONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19019,DQCKKXVULJGBQN-XFWGSAIBSA-N,NALTREXONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1198,DQKXQSGTHWVTAD-UHFFFAOYSA-N,PRAMOXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1198,DQKXQSGTHWVTAD-UHFFFAOYSA-N,PRAMOXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL856,DQMZLTXERSFNPB-UHFFFAOYSA-N,PRIMIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL856,DQMZLTXERSFNPB-UHFFFAOYSA-N,PRIMIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2165644,DRBIFKPSERWRDO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,<,6,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL63002,DRCFWAFIBAFOCV-RUZDIDTESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,4365.16,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207278,DREBLEJJYUKNLT-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,7.94,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL836,DRHKJLXJIQTDTD-OAHLLOKOSA-N,TAMSULOSIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10841797.0,SELECTIVITY RATIO,,,,No data,,,,,,,,,,,,,,Selectivity ratio against central Histamine H1 receptor; Not determined,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL213696,DRJMNIQKKSSTQS-SAPNQHFASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16730977.0,KB,>,30000,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant H1R expressed in sf9 cells assessed as inhibition of histamine-stimulated GTP hydrolysis,Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL45,DRLFMBDRBRZALE-UHFFFAOYSA-N,MELATONIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL45,DRLFMBDRBRZALE-UHFFFAOYSA-N,MELATONIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1557680,DRQJSDYVORTCEY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15798001.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL396196,DSABCKFCVLVXGS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17498953.0,ACTIVITY,=,8,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor at 10 uM,A new class of histamine H3 receptor antagonists derived from ligand based design.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL244086,DSJQIICDRFEFMZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,7.1,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL434001,DSKGOKHOBPYUEE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,5370.32,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1783889,DSNALXIKDKGHLJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25893048.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 1 uM,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL517407,DSRXHDAICZGTCK-ORBVJSQLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,295,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2252949,DSSYKIVIOFKYAU-OIBJUYFYSA-N,(-)-CAMPHOR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2252949,DSSYKIVIOFKYAU-OIBJUYFYSA-N,(-)-CAMPHOR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL504760,DSSYKIVIOFKYAU-XCBNKYQSSA-N,CAMPHOR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL504760,DSSYKIVIOFKYAU-XCBNKYQSSA-N,CAMPHOR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1083162,DTGZGHPOXFQXNP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20452213.0,EC50,>,10000,NM,,,cell_based,,,,,SK-N-MC,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in human SK-N-MC cells,Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1092598,DTQWVENQVGQFAP-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,0.8,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL238870,DTTUPIQCRQKVGO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL96467,DTYAFBJXWWLRMA-QMHKHESXSA-N,SNAP-7915,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10956183.0,KI,=,54,NM,,,,,,,,,,,,,,,"Binding affinity towards Histamine H1 receptor in human brain tissue preparation, using [3H]rauwolscine as radioligand.",De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailability.,J. Med. Chem.,PUBLICATION,
CHEMBL2207285,DTYDZUZTWZDAGL-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,5.01,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3357049,DUCSQMQJPSZEAW-JOCHJYFZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25318072.0,KI,=,4647,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells by scintillation counting method,Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2.,J. Med. Chem.,PUBLICATION,
CHEMBL137781,DUKNIHFTDAXJON-MUIJYRPGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12213075.0,KI,=,500,NM,,,,,,,,,,,,,,,Binding affinity against Histamine H1 receptor,"Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).",J. Med. Chem.,PUBLICATION,
CHEMBL343755,DUKNIHFTDAXJON-ORPLUIKVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12213075.0,KI,=,2500,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor,"Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).",J. Med. Chem.,PUBLICATION,
CHEMBL138989,DUKNIHFTDAXJON-RCZCSUKSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12213075.0,KI,=,1400,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor,"Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).",J. Med. Chem.,PUBLICATION,
CHEMBL328187,DUTDDZFCPPOWFH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,1500,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL1783970,DUUHEGAGOHEODE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,320,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783970,DUUHEGAGOHEODE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,7940,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608560,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19954972.0,INHIBITION,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608560,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608560,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2432049,DUZKXKAAUHDBQA-CAUKCHDASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL334255,DVBJBNKEBPCGSY-UHFFFAOYSA-M,CETYLPYRIDINIUM BROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL334255,DVBJBNKEBPCGSY-UHFFFAOYSA-M,CETYLPYRIDINIUM BROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL200416,DVSLSPWSCJLOGG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16275087.0,INHIBITION,<,50,%,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3104091,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24365159.0,KI,=,50,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from histamine H1 receptor (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3104091,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24365159.0,KI,=,50.12,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from histamine H1 receptor (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220663,DVVYVZQFUWZIPD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,-0.02,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220663,DVVYVZQFUWZIPD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,=,5.05,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1774499,DVZWFDDQIOLGDS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,75,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL273170,DWIXBLOYUJIYNT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17998160.0,KI,=,8,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158815,DWNROPYUHGRJJG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,63.1,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1319362,DWSGTFTVBLXELC-RDYJJYPNSA-N,HOMATROPINE HYDROBROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1319362,DWSGTFTVBLXELC-RDYJJYPNSA-N,HOMATROPINE HYDROBROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL120055,DWSOZYFSYVOVOC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,>,10000,NM,,,,,,,,,,,,,,,Compound was tested for its affinity towards histaminergic (H 1) receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1651208,DWTYHCYVKJONSP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23009245.0,IC50,=,8150,NM,,,,,,,,,,,,,,,Inhibition of radioligand binding to human histamine H1 receptor,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,PUBLICATION,
CHEMBL1651208,DWTYHCYVKJONSP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23009245.0,INHIBITION,=,59,%,,,,,,,,,,,,,,,Inhibition of radioligand binding to human histamine H1 receptor at 10 uM,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,PUBLICATION,
CHEMBL497031,DXBRVISEKVIIAR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,9,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272300,DXIJUOOAQKSDNE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL340199,DXJUCAUQIHNOAF-AEFFLSMTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,122,NM,,,,,,,,,,,,,,,,,,,
CHEMBL340199,DXJUCAUQIHNOAF-AEFFLSMTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,129,NM,,,,,,,,,,,,,,,,,,,
CHEMBL127307,DXJUCAUQIHNOAF-SJLPKXTDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,1.65,NM,,,,,,,,,,,,,,,,,,,
CHEMBL127307,DXJUCAUQIHNOAF-SJLPKXTDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,2.5,NM,,,,,,,,,,,,,,,,,,,
CHEMBL104945,DXJUCAUQIHNOAF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,2.49,NM,,,,,,,,,,,,,,,,,,,
CHEMBL104945,DXJUCAUQIHNOAF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,4.26,NM,,,,,,,,,,,,,,,,,,,
CHEMBL104945,DXJUCAUQIHNOAF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,13.6,NM,,,,,,,,,,,,,,,,,,,
CHEMBL104945,DXJUCAUQIHNOAF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,14.7,NM,,,,,,,,,,,,,,,,,,,
CHEMBL3402679,DXJUCAUQIHNOAF-WMZOPIPTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,29.9,NM,,,,,,,,,,,,,,,,,,,
CHEMBL3402679,DXJUCAUQIHNOAF-WMZOPIPTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,42.4,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1096467,DXRCWRDHBIVBIS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20427184.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL31714,DXTYGLAQRALLEG-LFYBBSHMSA-N,CP-96021,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibitory concentration against H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767142,DXZJJDOMGLPHDI-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,398.11,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL269994,DYDLMZLLICKPBG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL240352,DYKCULOUGOBIOM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,=,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL316068,DYRUSALPYKCZDY-RYLMWKJUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,1.2,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL196598,DZKYLEMMURXALW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16143528.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards cloned Histamine H1 receptor,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL101634,DZXOBJYKYJVJJV-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,11000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL850,DZZWHBIBMUVIIW-DTORHVGOSA-N,SPARFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL850,DZZWHBIBMUVIIW-DTORHVGOSA-N,SPARFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL182150,FAIMGWSOSCFGRU-IYBDPMFKSA-N,ATC-0175,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773162.0,IC50,=,150,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1560,FAKRSMQSSFJEIM-RQJHMYQMSA-N,CAPTOPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1560,FAKRSMQSSFJEIM-RQJHMYQMSA-N,CAPTOPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200600,FAOZLTXFLGPHNG-KNAQIMQKSA-N,FLUOROMETHOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200600,FAOZLTXFLGPHNG-KNAQIMQKSA-N,FLUOROMETHOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2208416,FAPBWZUNGKHHJO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,IC50,=,5011.87,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1278020,FAXDKDSDNWXAIS-NASUQTAISA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,15.85,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL418658,FAZLRTUIRXGMGN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,724.44,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL196370,FBDANPRMCCLYRK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16143528.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards cloned Histamine H1 receptor,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL457957,FBGLPECKCFZJFU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,559,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL34259,FBOZXECLQNJBKD-ZDUSSCGKSA-N,METHOTREXATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL34259,FBOZXECLQNJBKD-ZDUSSCGKSA-N,METHOTREXATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL689,FBPFZTCFMRRESA-KVTDHHQDSA-N,MANNITOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL689,FBPFZTCFMRRESA-KVTDHHQDSA-N,MANNITOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL606036,FCDNLGMRDAOTCR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,98,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL160933,FCRIMCQUUZFBDN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,25,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL563271,FDBNTQCFINBNNL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,88,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL21,FDDDEECHVMSUSB-UHFFFAOYSA-N,SULFANILAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL21,FDDDEECHVMSUSB-UHFFFAOYSA-N,SULFANILAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL476,FDKXTQMXEQVLRF-ZHACJKMWSA-N,DACARBAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL476,FDKXTQMXEQVLRF-ZHACJKMWSA-N,DACARBAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1078745,FDVIZOQPGHRQNB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,3600,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62596,FDVYBGCVXDDGND-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,10000,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL423666,FDVYBGCVXDDGND-SFHVURJKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,21877.62,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL989,FEBLZLNTKCEFIT-VSXGLTOVSA-N,FLUOCINOLONE ACETONIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL989,FEBLZLNTKCEFIT-VSXGLTOVSA-N,FLUOCINOLONE ACETONIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL244277,FEBUQPUIWDHVMW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1774490,FEHNLVPCVHLEHQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,140,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2207276,FEIOPVQTLJUJBR-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,79.43,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1808432,FEJYXUSNDZMQOV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21724392.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL46,FELGMEQIXOGIFQ-UHFFFAOYSA-N,ONDANSETRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL46,FELGMEQIXOGIFQ-UHFFFAOYSA-N,ONDANSETRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL243896,FEQJNVMOFHFOGP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,,,,Not Determined,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
,FERVXSHGEVPGHF-UHFFFAOYSA-N,41149-66-0,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8335064.0,KI,=,6,NM,,,,,,,,,,,,,,,,,,,
CHEMBL274119,FFEARJCKVFRZRR-UHFFFAOYSA-N,RACEMETHIONINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL310604,FFFHZYDWPBMWHY-UHFFFAOYSA-N,HOMOCYSTEINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL108,FFGPTBGBLSHEPO-UHFFFAOYSA-N,CARBAMAZEPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL108,FFGPTBGBLSHEPO-UHFFFAOYSA-N,CARBAMAZEPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL108,FFGPTBGBLSHEPO-UHFFFAOYSA-N,CARBAMAZEPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL291882,FFIKBIOXICZKHW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,79.43,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1222728,FFNIMQCKAVUSKV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20667729.0,IC50,>,20000,NM,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor,Discovery of substituted benzyl tetrazoles as histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1259188,FGHKCRNDQSRICR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,,,,Not Determined,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL1940403,FGTGRXMIFIZGBG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25070422.0,KI,=,115,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171034,FGWSLMPEBIIYTF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,50.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219916,FGXWKSZFVQUSTL-UHFFFAOYSA-N,DOMPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,1344,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL219916,FGXWKSZFVQUSTL-UHFFFAOYSA-N,DOMPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,156,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267648,FHFYDNQZQSQIAI-UHFFFAOYSA-N,PEFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267648,FHFYDNQZQSQIAI-UHFFFAOYSA-N,PEFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1125,FHPIXVHJEIZKJW-UHFFFAOYSA-N,DESMETHYLOLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,22,NM,,,,,,,,,,,,,,,In vitro binding affinity of compound against histamine H1 neuronal receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2387292,FHQXJBWKUFXPSH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1092766,FHUODQKGUFFZJE-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,2.9,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62660,FHVOGKHFMPAIBO-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,46773.51,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL458019,FIKAKWIAUPDISJ-UHFFFAOYSA-L,PARAQUAT DICHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL458019,FIKAKWIAUPDISJ-UHFFFAOYSA-L,PARAQUAT DICHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1278201,FIMFEAXKPOZWDG-VUNKPPBISA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,15.85,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL3233411,FINYFOYZAZLCFE-FPOVZHCZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24559051.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin),Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL154695,FJCPGOQOVQYZGS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Determined,,,,,,,,,,,,,,Intrinsic activity; Low affinity for the receptor: not tested for the efficacy,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL154695,FJCPGOQOVQYZGS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,15848931924611.1,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL154695,FJCPGOQOVQYZGS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3417585,FJHKZEVPGYADEG-XOKHGSTOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25827402.0,KI,>,10000,NM,,,,,,,,,,,,,,,Inhibition of human H1R,"3,4-Diaza-bicyclo[4.1.0]hept-4-en-2-one phenoxypropylamine analogs of irdabisant (CEP-26401) as potent histamine-3 receptor inverse agonists with robust wake-promoting activity.",Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3417586,FJHKZEVPGYADEG-XYPHTWIQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25827402.0,KI,>,10000,NM,,,,,,,,,,,,,,,Inhibition of human H1R,"3,4-Diaza-bicyclo[4.1.0]hept-4-en-2-one phenoxypropylamine analogs of irdabisant (CEP-26401) as potent histamine-3 receptor inverse agonists with robust wake-promoting activity.",Eur. J. Med. Chem.,PUBLICATION,
CHEMBL934,FJLBFSROUSIWMA-UHFFFAOYSA-N,METYRAPONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL934,FJLBFSROUSIWMA-UHFFFAOYSA-N,METYRAPONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2220442,FJLGEFLZQAZZCD-VAWYXSNFSA-N,FLUVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2220442,FJLGEFLZQAZZCD-VAWYXSNFSA-N,FLUVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL507360,FJPDUNSHNPHJFS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18952421.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL242601,FJVFFJPYYUVVJU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,<,5.6,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL312082,FJXRDARXFNFHEP-NBXNUCLWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15081022.0,KI,=,190,NM,,,cell_based,,,,,CHO-K1,,,,,,,In vitro binding affinity towards histamine H1 receptor expressed in CHO-K1 cells,5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077756,FJZUWLCPOQUBLF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL403,FKENQMMABCRJMK-RITPCOANSA-N,SULBACTAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL403,FKENQMMABCRJMK-RITPCOANSA-N,SULBACTAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL282829,FKHBXKAEVUTBRK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL43860,FKKPXTRMLVLGJG-JOCHJYFZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10937710.0,KI,=,19,NM,,,,,,,,,,,,,,,Selectivity screen against human Histamine H1 receptor,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1210141,FKLHVDCNUGKVGO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,12,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158816,FLDDBSYUKQDTDX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,63.1,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1242923,FLGSUSWMWSZVMP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20684563.0,KI,=,780,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor by radioligand displacement assay,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,PUBLICATION,
CHEMBL94906,FLHDOLQPNXOYNQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.6,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401576,FLIIXHVRMXEDPQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,630.96,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL16192,FLNYLINBEZROPL-NSOVKSMOSA-N,CP-96345,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,~,10000,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL18735,FLOJCNYYPGNYBP-RQJHMYQMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,9871662.0,RATIO,>>,550,,,,,,,,,,,,,,,,Ratio of ED50 of H1 receptor to that of ED50 of H3 receptor was determined,"Trans-4-methyl-3-imidazoyl pyrrolidine as a potent, highly selective histamine H3 receptor agonist in vivo.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207665,FLTAIVXWWOKLBO-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,5.01,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL10971,FLTBEMVEAFMWDD-UHFFFAOYSA-N,SCH-37370,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,IC50,=,100,NM,,,,,,,,,,,,,,,Inhibitory concentration against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL550337,FLZIWHXEHDCVMN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,2.2,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1475,FMHHVULEAZTJMA-UHFFFAOYSA-N,TRIOXSALEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1475,FMHHVULEAZTJMA-UHFFFAOYSA-N,TRIOXSALEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3115074,FMJSLPJYTAKVLJ-CQVJSGDESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26091726.0,INHIBITION,=,7,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM relative to control,Discovery and characterization of a potent and selective EP4 receptor antagonist.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL31184,FMMWHPNWAFZXNH-UHFFFAOYSA-N,BENZO[DEF]CHRYSENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL31184,FMMWHPNWAFZXNH-UHFFFAOYSA-N,BENZO[DEF]CHRYSENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2146810,FNEORDYLRZOEEP-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.631,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL359122,FNLZNEYPJNEYFH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,1,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL359122,FNLZNEYPJNEYFH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,2511.89,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL359122,FNLZNEYPJNEYFH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,199526231496888,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078641,FNNKUKJCHFTVMH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078641,FNNKUKJCHFTVMH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL585,FNYLWPVRPXGIIP-UHFFFAOYSA-N,TRIAMTERENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL585,FNYLWPVRPXGIIP-UHFFFAOYSA-N,TRIAMTERENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL238872,FOCPBTUUAJZSNL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3220656,FOIPOBUIXCOHPE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL2158827,FOQNONLDPFMOKP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,19.95,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205813,FOTUXOOYRRRHFQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077908,FPAJMJGGDZGJPZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,199,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL51,FPCCSQOGAWCVBH-UHFFFAOYSA-N,KETANSERIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22694093.0,KI,=,2,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.,J. Med. Chem.,PUBLICATION,
CHEMBL100454,FPDIERBPQFAFSI-UHFFFAOYSA-N,2-HYDROXY-METHYLOLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,6,NM,,,,,,,,,,,,,,,In vitro binding affinity of compound against histamine H1 neuronal receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205835,FPHVMMXTLGSYHV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205835,FPHVMMXTLGSYHV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL519609,FPUKGJMTLUQGFZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23707254.0,KI,=,430,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor (unknown origin) by PDSP assay,Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2024087,FQIJPHXWIONJLF-JKOKRWQUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22171543.0,INHIBITION,=,41.4,%,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from H1 histamine receptor at 10 uM,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,PUBLICATION,
CHEMBL255619,FQKBVZIGJYRJIJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1370561,FQPFAHBPWDRTLU-UHFFFAOYSA-N,AMINOPHYLLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1370561,FQPFAHBPWDRTLU-UHFFFAOYSA-N,AMINOPHYLLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1094514,FQPJRGDRIOAJCS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20427184.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3311308,FQUAFMNPXPXOJE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24881566.0,IC50,>,39810.72,NM,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor by luminescence assay,Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1082036,FRDOPYUUNJUZKI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,38400,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL427836,FRHJULSNWZOUMW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767156,FRUMSZUUBXPHHF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,1,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL560741,FRXWLMMHSBOBJK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19663387.0,KI,=,0.6,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.,J. Med. Chem.,PUBLICATION,
CHEMBL1909049,FSIWGHXVLYRBFQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909049,FSIWGHXVLYRBFQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076211,FSKFPVLPFLJRQB-UHFFFAOYSA-N,TOLPERISONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076211,FSKFPVLPFLJRQB-UHFFFAOYSA-N,TOLPERISONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1222625,FSQHSKMGRAIYLO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,31.62,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL189171,FSQKKOOTNAMONP-UHFFFAOYSA-N,ACEMETACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL189171,FSQKKOOTNAMONP-UHFFFAOYSA-N,ACEMETACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL213912,FSRSEANZUZHDHK-UHFFFAOYSA-N,VUF-6884,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16854056.0,ACTIVITY,=,-1,,,,cell_based,,,,,SK-N-MC,,,,,,,Agonist activity at human histamine H1 receptor transfected in SK-N-MC cells,Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL213912,FSRSEANZUZHDHK-UHFFFAOYSA-N,VUF-6884,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16854056.0,EC50,=,6.76,NM,,,cell_based,,,,,,,,,,,,Activity at human histamine H1 receptor transfected in COS7 cells by NF-kappaB luciferase reporter assay,Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL213912,FSRSEANZUZHDHK-UHFFFAOYSA-N,VUF-6884,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16854056.0,KI,=,7.76,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor,Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL213912,FSRSEANZUZHDHK-UHFFFAOYSA-N,VUF-6884,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16854056.0,LOG EC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Activity at human histamine H1 receptor transfected in COS7 cells by NF-kappaB luciferase reporter assay,Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL213912,FSRSEANZUZHDHK-UHFFFAOYSA-N,VUF-6884,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19053770.0,KI,=,7.76,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach.,J. Med. Chem.,PUBLICATION,
CHEMBL213912,FSRSEANZUZHDHK-UHFFFAOYSA-N,VUF-6884,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,8.318,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL976,FSVJFNAIGNNGKK-UHFFFAOYSA-N,PRAZIQUANTEL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL976,FSVJFNAIGNNGKK-UHFFFAOYSA-N,PRAZIQUANTEL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL744,FTALBRSUTCGOEG-UHFFFAOYSA-N,RILUZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL744,FTALBRSUTCGOEG-UHFFFAOYSA-N,RILUZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
,FTCWKSGDHXCEMZ-UHFFFAOYSA-N,K117,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15798001.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1097489,FTGVBWSFHSXAON-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20382540.0,ACTIVITY,=,42,%,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells at 10 uM after 60 mins by beta scintillation counting,In silico directed chemical probing of the adenosine receptor family.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL223881,FTXDYUFGZQUOPZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15566302.0,ACTIVITY,=,0,%,,,,,,,,,,,,,,,Displacement of [3H]ketanserin from histamine H1 receptor in human cortex membranes at 500 mM,Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL2031476,FUSIKFQZDFZEIR-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22617490.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM by radioligand binding assay,"Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H(3) receptor inverse agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL83668,FUSNMLFNXJSCDI-UHFFFAOYSA-N,TOLNAFTATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL83668,FUSNMLFNXJSCDI-UHFFFAOYSA-N,TOLNAFTATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL113310,FUUPFUIGNBPCAY-BYPYZUCNSA-N,CGP-44532,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7650684.0,INHIBITION,=,22,%,,,,,,,,,,,,,,,Inhibition of [3H]- doxepine binding to histamine 1 receptor at 10e-5 M,Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL105567,FUYGZJGUDRONJU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,758.58,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL214021,FVFURMJFTAJXRH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17234405.0,INHIBITION,=,65,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10uM,"An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL12948,FVLVBPDQNARYJU-UHFFFAOYSA-N,SEMUSTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12948,FVLVBPDQNARYJU-UHFFFAOYSA-N,SEMUSTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1946253,FVMDOYQNOWAVCQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,=,1247,NM,,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3094215,FVUHMXKJJTVQKK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,KI,=,1995.26,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3094211,FWDVKDASAFTDAN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,PKI,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL594721,FWRAMRVPMYVJMR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773175.0,KI,>,1000,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in Sf9 cells co-expressing RGS4,"2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL64773,FWXQEINBRJTOSP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,1202.26,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256477,FXBRDXOXJHZPDA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,630.96,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL193435,FXHLGRYCQSRFHY-MQSINFNDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,42,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL195856,FXHLGRYCQSRFHY-SHZHJNINSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor; Not tested,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL319000,FXIPXWLVYIHFEP-OAQYLSRUSA-N,A-331440,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,1905.46,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL160581,FYCXANKHKYEXTR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,>,1000,NM,,,,,,,,,,,,,,,Compound was tested for its affinity towards histaminergic (H 1) receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL602850,FYGREZKTJIXWIH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19954972.0,INHIBITION,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL602850,FYGREZKTJIXWIH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL602850,FYGREZKTJIXWIH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL608,FYPMFJGVHOHGLL-UHFFFAOYSA-N,PROBUCOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL608,FYPMFJGVHOHGLL-UHFFFAOYSA-N,PROBUCOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923521,FZBQOBOSIQUVSG-UHFFFAOYSA-N,4-(2-BENZYLPHENOXY)PIPERIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,ACTIVITY,,,,Active,,cell_based,,,,,HEK293,,,,,,,Inverse agonist activity at human histamine H1 receptor expressed in HEK293 cells assessed as inhibition of histamine-induced [3Hinositol phosphate accumulation after 1 hr by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1923521,FZBQOBOSIQUVSG-UHFFFAOYSA-N,4-(2-BENZYLPHENOXY)PIPERIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,6,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1923521,FZBQOBOSIQUVSG-UHFFFAOYSA-N,4-(2-BENZYLPHENOXY)PIPERIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,6.31,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1643900,FZIIBLBHXXRTMG-RAOGCBAWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21146989.0,KI,=,2376,NM,,,,,,,,,,,,,,,Inhibition of H1 receptor,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643900,FZIIBLBHXXRTMG-RAOGCBAWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,=,2376,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1258722,FZPKLZHGBRKKCP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20727749.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643901,GACBJAOXQGFNDL-RAOGCBAWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21146989.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643901,GACBJAOXQGFNDL-RAOGCBAWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,>,10000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3218989,GAHQIUCRVXIXRV-UXHICEINSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INHIBITION,=,50,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) at 10 uM by displacement assay relative to control,,MedChemComm,PUBLICATION,
CHEMBL116463,GALCSZPFCCZIBC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11585444.0,IC50,=,454,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
CHEMBL553025,GBABOYUKABKIAF-IELIFDKJSA-N,VINORELBINE BASE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL553025,GBABOYUKABKIAF-IELIFDKJSA-N,VINORELBINE BASE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL578,GBXSMTUPTTWBMN-XIRDDKMYSA-N,ENALAPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL578,GBXSMTUPTTWBMN-XIRDDKMYSA-N,ENALAPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL471724,GCEYKTZXUXSFFO-UHFFFAOYSA-N,UR-PI287,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,=,0.35,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL471724,GCEYKTZXUXSFFO-UHFFFAOYSA-N,UR-PI287,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,EC50,=,2570.4,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL1395,GCKMFJBGXUYNAG-HLXURNFRSA-N,METHYLTESTOSTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1395,GCKMFJBGXUYNAG-HLXURNFRSA-N,METHYLTESTOSTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1783962,GDGRKDCFXHOMEX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,>,10000,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783962,GDGRKDCFXHOMEX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL181,GDLBFKVLRPITMI-UHFFFAOYSA-N,DIAZOXIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL181,GDLBFKVLRPITMI-UHFFFAOYSA-N,DIAZOXIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,85,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,9.83,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171037,GDRRHBZSXZXDLL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1091774,GDVOQNXWYQVYJH-INIZCTEOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,IC50,=,6100,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL210291,GECAJSXILIIQAM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,PKI,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL314107,GEDGEGJCGBTAON-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,16.98,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL47482,GEICAQNIOJFRQN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,197,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2158785,GEMBQNHUTJFAFL-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,501.19,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1092377,GETROLYXSDDSDH-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,2.7,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2355126,GFBKORZTTCHDGY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,4,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1201,GFBKORZTTCHDGY-UWVJOHFNSA-N,THIOTHIXENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,5.88,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1201,GFBKORZTTCHDGY-UWVJOHFNSA-N,THIOTHIXENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,4.4,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1201,GFBKORZTTCHDGY-UWVJOHFNSA-N,THIOTHIXENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,6,NM,,,,,,,,,,,,,,,,,,,
CHEMBL556782,GFGGZTNVJUNZEE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL213357,GFJYCIFKTFCPQN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16730977.0,KB,>,30000,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant H1R expressed in sf9 cells assessed as inhibition of histamine-stimulated GTP hydrolysis,Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1451,GFNANZIMVAIWHM-OBYCQNJPSA-N,TRIAMCINOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1451,GFNANZIMVAIWHM-OBYCQNJPSA-N,TRIAMCINOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1767149,GFOPLENUCATIPC-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,0.251,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL2205817,GFQHCUYWLHSGJR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404363,GGTFAVLCBBVKHN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,3981.07,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL561981,GGTPJIUWVNXICI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,>,500,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL880,GGXKWVWZWMLJEH-UHFFFAOYSA-N,FAMCICLOVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL880,GGXKWVWZWMLJEH-UHFFFAOYSA-N,FAMCICLOVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,FLUOROURACIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,FLUOROURACIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL319535,GHVPKFCDNOFWEW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.6,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559060,GHZHZIJXYOTTAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,4.5,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL558468,GIEBQTVDYXTBCS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,2.4,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL152221,GIGMUWUHKTVYOI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.46,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL152221,GIGMUWUHKTVYOI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,3981.07,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL152221,GIGMUWUHKTVYOI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,501187233627271,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1201203,GIJXKZJWITVLHI-PMOLBWCYSA-N,BENZTROPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,3.18,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201203,GIJXKZJWITVLHI-PMOLBWCYSA-N,BENZTROPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.37,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL116590,GIJXKZJWITVLHI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,1.1,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1277035,GIZCWMURBFLMON-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,199.53,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL2207277,GJJRSPSNZFRQIQ-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,63.1,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277584,GJQONOYIKURBSD-IYRGYZHQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,19.95,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL328250,GJSLOMWRLALDCT-UHFFFAOYSA-N,ADINAZOLAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL134,GJSURZIOUXUGAL-UHFFFAOYSA-N,CLONIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL134,GJSURZIOUXUGAL-UHFFFAOYSA-N,CLONIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL698,GKCBAIGFKIBETG-UHFFFAOYSA-N,TETRACAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL698,GKCBAIGFKIBETG-UHFFFAOYSA-N,TETRACAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL194837,GKDBTHSYQZTDAJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16134937.0,IC50,=,3.5,NM,,,,,,,,,,,,,,,Inhibitory concentration against histamine H1 receptor,"6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and investigation of binding mode.",J. Med. Chem.,PUBLICATION,
CHEMBL256016,GKDLNLYIGUXYSK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL251005,GKGCLPKLLFABEQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17892934.0,INHIBITION,>,90,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,Discovery of 5-HT6 receptor ligands based on virtual HTS.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL954,GKIRPKYJQBWNGO-OCEACIFDSA-N,ENCLOMIPHENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL954,GKIRPKYJQBWNGO-OCEACIFDSA-N,ENCLOMIPHENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2158772,GKKOWDZJMOVEBY-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,31.62,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171050,GKKYKABOCZBQRA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,1000,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL515428,GKMDOAPQOLIJEW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,,,,Not Determined,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL515428,GKMDOAPQOLIJEW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL460291,GKQPCPXONLDCMU-CCEZHUSRSA-N,LACIDIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL460291,GKQPCPXONLDCMU-CCEZHUSRSA-N,LACIDIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL199824,GKTQBPYMIGXPKG-JVVVGQRLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16392798.0,KI,=,150,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,"Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.",J. Med. Chem.,PUBLICATION,
CHEMBL1771,GKTWGGQPFAXNFI-HNNXBMFYSA-N,CLOPIDOGREL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1771,GKTWGGQPFAXNFI-HNNXBMFYSA-N,CLOPIDOGREL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1929407,GLCQRAIQXFEUAC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22019465.0,INHIBITION,,,,Not Active,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at histamine H1 receptor expressed in HEK293 cells co-transfected with pCRE-Luc gene assessed as inhibition of forskolin/histamine-induced cAMP accumulation at 1 uM after 5 hrs by luciferase reporter gene assay,"Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1783975,GLNBRPIPBOSSGY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,7570,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783975,GLNBRPIPBOSSGY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,MERCAPTOPURINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,MERCAPTOPURINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL73135,GLXQEUGDWMYWCC-AREMUKBSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15081022.0,KI,=,150,NM,,,cell_based,,,,,CHO-K1,,,,,,,In vitro binding affinity towards histamine H1 receptor expressed in CHO-K1 cells,5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL73135,GLXQEUGDWMYWCC-AREMUKBSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,KI,=,150,NM,,,,,,,,,,,,,,,Inhibition constant against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL25719,GLZPCOQZEFWAFX-JXMROGBWSA-N,GERANIOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL25719,GLZPCOQZEFWAFX-JXMROGBWSA-N,GERANIOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL330462,GMDILGHWZUFMEQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.8,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL323562,GMFZCHLJVCOHAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,426.58,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL350878,GMNSEVXCXMPGAC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Determined,,,,,,,,,,,,,,Intrinsic activity; Low affinity for the receptor: not tested for the efficacy,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL350878,GMNSEVXCXMPGAC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,<,10000000000000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL350878,GMNSEVXCXMPGAC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibitory activity against human H1 receptor; Low affinity for the receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL36715,GMZVRMREEHBGGF-UHFFFAOYSA-N,PIRACETAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL36715,GMZVRMREEHBGGF-UHFFFAOYSA-N,PIRACETAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL256471,GNAFTHDBPJUMAT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,1584.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL11553,GNBOIGBQIBQOIA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12626648.0,KI,=,400,NM,,,,,,,,,,,,,,,,,,,
CHEMBL304027,GNMIPEYDMWERLO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,1023.29,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201117,GNXFOGHNGIVQEH-UHFFFAOYSA-N,METHOCARBAMOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201117,GNXFOGHNGIVQEH-UHFFFAOYSA-N,METHOCARBAMOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL642,GOEMGAFJFRBGGG-UHFFFAOYSA-N,ACEBUTOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL642,GOEMGAFJFRBGGG-UHFFFAOYSA-N,ACEBUTOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64124,GOVWCMLTQFJSCR-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,45708.82,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205819,GOYQRMVWIWPDFU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL7568,GPKJTRJOBQGKQK-UHFFFAOYSA-N,QUINACRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL7568,GPKJTRJOBQGKQK-UHFFFAOYSA-N,QUINACRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL191703,GPLGAQQQNWMVMM-MYAJQUOBSA-N,CONESSINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18683917.0,KI,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor,The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1730,GPRBEKHLDVQUJE-QSWIMTSFSA-N,CEFOTAXIME,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1730,GPRBEKHLDVQUJE-QSWIMTSFSA-N,CEFOTAXIME,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2208427,GPRHHSZIXIDKDN-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208427,GPRHHSZIXIDKDN-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,63.1,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL96429,GPVDPKZTACUYNW-IPKCRJEZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,2.36,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1276947,GPWMNUXSJDSCAV-NZICPMOKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,31.62,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL2031737,GPZMWOXSIRVXQW-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22313227.0,KI,=,7055,NM,,,,,,,,,,,,,,,Binding affinity to human recombinant H1 receptor,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,PUBLICATION,
CHEMBL569832,GQLPRIVQAONOIR-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19722526.0,ACTIVITY,<,10,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM,Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity.,J. Med. Chem.,PUBLICATION,
CHEMBL1767167,GQWSXILTLUTBAJ-PGUFJCEWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,INHIBITION,,,,Active,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization at 100 nM incubated for 30 mins measured after washout followed by repeat histamine challenge at intervals of 90 and 270 mins by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767167,GQWSXILTLUTBAJ-PGUFJCEWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KD,=,1.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization at 100 nM after 30 mins by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767167,GQWSXILTLUTBAJ-PGUFJCEWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,12.59,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL514,GQYIWUVLTXOXAJ-UHFFFAOYSA-N,LOMUSTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL514,GQYIWUVLTXOXAJ-UHFFFAOYSA-N,LOMUSTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL303369,GRAGHFIYRPTBJY-HSZRJFAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,16595.87,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62592,GRAGHFIYRPTBJY-QHCPKHFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,19054.61,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1910380,GREREVYRUNFCTM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,602.56,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL485958,GRHNPETZKNATKG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,7000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL485958,GRHNPETZKNATKG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,4300,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL102452,GRJGKRWJSKONHR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,3548.13,NM,,,,,,,,,,,,,,,Binding affinity at human cortical Histamine 1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL594138,GRKYNTKPAFRLLZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,386,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL243859,GRQQDQSHIQXVLZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,7.1,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL303824,GRWARSULWXLZOY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12798320.0,KI,=,1000,NM,,,,,,,,,,,,,,,Compound was tested for its binding affinity towards human H1 receptor,"A new class of histamine H(3)-receptor antagonists: synthesis and structure-activity relationships of 7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL81977,GSCPDZHWVNUUFI-UHFFFAOYSA-N,3-AMINOBENZAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL81977,GSCPDZHWVNUUFI-UHFFFAOYSA-N,3-AMINOBENZAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL33,GSDSWSVVBLHKDQ-JTQLQIEISA-N,LEVOFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL33,GSDSWSVVBLHKDQ-JTQLQIEISA-N,LEVOFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL4,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,OFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL4,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,OFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171041,GSQPHXFZLYFUQD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,25.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277491,GSUXFSXZSCBDQK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,199.53,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL1210030,GTUKZINNLXNLAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,89,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1257850,GUBYCKMGWYDLAE-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,-2,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1257729,GUBYCKMGWYDLAE-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,2,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL434785,GUDHMDVRURNAHL-SNVBAGLBSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,10715.19,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL211270,GUGKMZYVUWVKDE-DYTRJAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16730977.0,KB,>,30000,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant H1R expressed in sf9 cells assessed as inhibition of histamine-stimulated GTP hydrolysis,Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL303454,GUGOEEXESWIERI-SSEXGKCCSA-N,R-TERFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8903934.0,KI,=,3.16,NM,,,,,,,,,,,,,,,,,,,
CHEMBL303454,GUGOEEXESWIERI-SSEXGKCCSA-N,R-TERFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11809864.0,KI,=,2,NM,,,,,,,,,,,,,,,,,,,
CHEMBL17157,GUGOEEXESWIERI-UHFFFAOYSA-N,TERFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12747773.0,KI,=,58,NM,,,,,,,,,,,,,,,Binding affinity towards histamine H1 receptor,Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior.,J. Med. Chem.,PUBLICATION,
CHEMBL17157,GUGOEEXESWIERI-UHFFFAOYSA-N,TERFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,40,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL17157,GUGOEEXESWIERI-UHFFFAOYSA-N,TERFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25494650.0,IC50,=,1,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin),CNS drug design: balancing physicochemical properties for optimal brain exposure.,J. Med. Chem.,PUBLICATION,
CHEMBL17157,GUGOEEXESWIERI-UHFFFAOYSA-N,TERFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,22,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL17157,GUGOEEXESWIERI-UHFFFAOYSA-N,TERFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,563,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL17157,GUGOEEXESWIERI-UHFFFAOYSA-N,TERFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,2.59,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1091782,GUNAZEDORZMWRN-LBPRGKRZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,4.6,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1940412,GUOQPFNLBAXWIZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22245230.0,KI,=,62.9,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor by liquid scintillation counting,Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2387311,GURFDWVYTCEBLB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL360202,GUUFVYCRQBZPLO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,50,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL111988,GUXOMTZBNDDVQC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,15800,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1774492,GUYGSIXDIXLGLA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,255,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL345185,GVDNUYAKHMLSKZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.72,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL345185,GVDNUYAKHMLSKZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,1995.26,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL345185,GVDNUYAKHMLSKZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,50118723362727.1,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1096430,GVGOZYJHWUIVHV-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,=,89.13,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1096430,GVGOZYJHWUIVHV-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EMAX,=,0.41,%,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL486965,GVGOZYJHWUIVHV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,280,NM,,,,,,,,,,,,,,,,,,,
CHEMBL486965,GVGOZYJHWUIVHV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,910,NM,,,,,,,,,,,,,,,,,,,
CHEMBL486965,GVGOZYJHWUIVHV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,5300,NM,,,,,,,,,,,,,,,,,,,
CHEMBL486965,GVGOZYJHWUIVHV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,140,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1096431,GVGOZYJHWUIVHV-ZDUSSCGKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,=,66.07,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1096431,GVGOZYJHWUIVHV-ZDUSSCGKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EMAX,=,0.51,%,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL47,GVJHHUAWPYXKBD-IEOSBIPESA-N,VITAMIN E,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL47,GVJHHUAWPYXKBD-IEOSBIPESA-N,VITAMIN E,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL561690,GWLKWIJXTVRQMT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,IC50,=,80.5,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1169587,GWQZQMFGEAWNQU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,7.85,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078240,GWSJPOPJXLJSLF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,1013,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL13341,GWUSZQUVEVMBPI-UHFFFAOYSA-N,NIMETAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL13341,GWUSZQUVEVMBPI-UHFFFAOYSA-N,NIMETAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207657,GWVFJNPANMKQSY-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,2.51,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3121096,GWVIOFUJTJGECV-MSOLQXFVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24513042.0,INHIBITION,<,10,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,"Discovery of (1R,6S)-5-[4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl]-3,4-diaza-bicyclo[4.1.0]hept-4-en-2-one (R,S-4a): Histamine H3 receptor inverse agonist demonstrating potent cognitive enhancing and wake promoting activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3121095,GWVIOFUJTJGECV-ZWKOTPCHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24513042.0,INHIBITION,<,10,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,"Discovery of (1R,6S)-5-[4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl]-3,4-diaza-bicyclo[4.1.0]hept-4-en-2-one (R,S-4a): Histamine H3 receptor inverse agonist demonstrating potent cognitive enhancing and wake promoting activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL296419,GXDALQBWZGODGZ-UHFFFAOYSA-N,ASTEMIZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,0.8,NM,,,,,,,,,,,,,,,,,,,
CHEMBL296419,GXDALQBWZGODGZ-UHFFFAOYSA-N,ASTEMIZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12747773.0,KI,=,3,NM,,,,,,,,,,,,,,,Binding affinity towards histamine H1 receptor,Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior.,J. Med. Chem.,PUBLICATION,
CHEMBL296419,GXDALQBWZGODGZ-UHFFFAOYSA-N,ASTEMIZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,2.09,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL296419,GXDALQBWZGODGZ-UHFFFAOYSA-N,ASTEMIZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,14,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL296419,GXDALQBWZGODGZ-UHFFFAOYSA-N,ASTEMIZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1.61,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL239975,GXILWBIQFGWJQN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3220640,GXMHMYPDQCEMKW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.03,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220640,GXMHMYPDQCEMKW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5.3,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL408,GXPHKUHSUJUWKP-UHFFFAOYSA-N,TROGLITAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL408,GXPHKUHSUJUWKP-UHFFFAOYSA-N,TROGLITAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3290012,GXZWKZAOGQRNTL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24805037.0,KB,=,140,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant H1 receptor assessed as inhibition of histamine-induced intracellular Ca2+ release,Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia.,J. Med. Chem.,PUBLICATION,
CHEMBL3290012,GXZWKZAOGQRNTL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24805037.0,KI,=,69,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant H1 receptor expressed in HEK293 cells,Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia.,J. Med. Chem.,PUBLICATION,
CHEMBL293033,GYCWHNUGCXMJDF-OAQYLSRUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,16218.1,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL877,GYDJEQRTZSCIOI-LJGSYFOKSA-N,TRANEXAMIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL877,GYDJEQRTZSCIOI-LJGSYFOKSA-N,TRANEXAMIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2205825,GYKFQDQFKGGVKD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL422931,GZAMCYJCPQMIHJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23477943.0,INHIBITION,,,,Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL25688,GZAZQKHMIYBBFL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,5011.87,NM,,,,,,,,,,,,,,,Binding affinity at human cortical Histamine 1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62312,GZGINHDPANJTJY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,398.11,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL12713,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,SERTINDOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,130,NM,,,,,,,,,,,,,,,,,,,
CHEMBL12713,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,SERTINDOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,320,NM,,,,,,,,,,,,,,,,,,,
CHEMBL12713,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,SERTINDOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,130,NM,,,,,,,,,,,,,,,,,,,
CHEMBL12713,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,SERTINDOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14998318.0,KI,=,570,NM,,,,,,,,,,,,,,,Binding affinity towards human histamine H1 receptor,Selective optimization of side activities: another way for drug discovery.,J. Med. Chem.,PUBLICATION,
CHEMBL12713,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,SERTINDOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,0.51,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,RALOXIFENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,RALOXIFENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1910382,GZUNLKUPHLSRKX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,100,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257536,HAJIPROMBKTILW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL696,HAPOVYFOVVWLRS-UHFFFAOYSA-N,ETHOSUXIMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL696,HAPOVYFOVVWLRS-UHFFFAOYSA-N,ETHOSUXIMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL696,HAPOVYFOVVWLRS-UHFFFAOYSA-N,ETHOSUXIMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL433257,HAVJATCHLFRDHY-KSZYUSJVSA-N,HARRINGTONINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL433257,HAVJATCHLFRDHY-KSZYUSJVSA-N,HARRINGTONINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2165643,HBDHANBWOOALDQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,<,6,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1255600,HBHVWXDHDUQMRV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,-4,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL90997,HBMJQYDGBNSZMC-UHFFFAOYSA-N,S-34324,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771448.0,KI,>,1000,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to Histamine H1 receptor,Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity.,J. Med. Chem.,PUBLICATION,
CHEMBL129,HBOMLICNUCNMMY-XLPZGREQSA-N,ZIDOVUDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL129,HBOMLICNUCNMMY-XLPZGREQSA-N,ZIDOVUDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL352375,HBRHULDGKNIFGB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12593665.0,KI,=,218.78,NM,,,cell_based,,,,,CHO-K1,,,,,,,Compound was evaluated for binding affinity towards cloned human histamine H1 receptors stably expressed in CHO-K1 cells using [3H]mepyramine,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL352375,HBRHULDGKNIFGB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12593665.0,KI,=,2454.71,NM,,,cell_based,,,,,CHO-K1,,,,,,,Compound was evaluated for binding affinity towards cloned human histamine H1 receptors stably expressed in CHO-K1 cells using [3H]mepyramine,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1257486,HBRVUVJCCFXDJC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,3,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1568,HBUBKKRHXORPQB-FJFJXFQQSA-N,FLUDARABINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1568,HBUBKKRHXORPQB-FJFJXFQQSA-N,FLUDARABINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,120,NM,,,,,,,,,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,60,NM,,,,,,,,,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1168,HDACQVRGBOVJII-JBDAPHQKSA-N,RAMIPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1168,HDACQVRGBOVJII-JBDAPHQKSA-N,RAMIPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1277769,HDDLHPPRMNRBQB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,50.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL513039,HDDMVAQKQDEVQJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,2900,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL37161,HDDSHPAODJUKPD-UHFFFAOYSA-N,FENBENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL37161,HDDSHPAODJUKPD-UHFFFAOYSA-N,FENBENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL48885,HDNYARDFRMPQKD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16730977.0,KB,>,30000,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant H1R expressed in sf9 cells assessed as inhibition of histamine-stimulated GTP hydrolysis,Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1349,HDOVUKNUBWVHOX-QMMMGPOBSA-N,VALACYCLOVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1349,HDOVUKNUBWVHOX-QMMMGPOBSA-N,VALACYCLOVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL285802,HDOZVRUNCMBHFH-UHFFFAOYSA-N,ZOTEPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,0.62,NM,,,,,,,,,,,,,,,,,,,
CHEMBL285802,HDOZVRUNCMBHFH-UHFFFAOYSA-N,ZOTEPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,3.3,NM,,,,,,,,,,,,,,,,,,,
CHEMBL285802,HDOZVRUNCMBHFH-UHFFFAOYSA-N,ZOTEPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11170639.0,KI,=,0.62,NM,,,,,,,,,,,,,,,Binding affinity towards human H1 receptor,Current and novel approaches to the drug treatment of schizophrenia.,J. Med. Chem.,PUBLICATION,
CHEMBL285802,HDOZVRUNCMBHFH-UHFFFAOYSA-N,ZOTEPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14998318.0,KI,=,3.4,NM,,,,,,,,,,,,,,,Binding affinity towards human histamine H1 receptor,Selective optimization of side activities: another way for drug discovery.,J. Med. Chem.,PUBLICATION,
CHEMBL237087,HDRIBIYPLKZUDQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19524331.0,KI,>,10000,NM,,,cell_based,,,,,SK-N-MC,,,,,,,Displacement of [3H]N-alpha-methylhistamine from histamine H1 receptor expressed in SK-N-MC cells,Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2205820,HDZWTAJVYGVJEQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205820,HDZWTAJVYGVJEQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL44618,HEDRZPFGACZZDS-UHFFFAOYSA-N,CHLOROFORM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44618,HEDRZPFGACZZDS-UHFFFAOYSA-N,CHLOROFORM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL561489,HEFAAVYYGFTJLY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,75.2,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL175,HEFNNWSXXWATRW-JTQLQIEISA-N,DEXIBUPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL175,HEFNNWSXXWATRW-JTQLQIEISA-N,DEXIBUPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL427526,HEFNNWSXXWATRW-SNVBAGLBSA-N,(R)-IBUPROPHEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL427526,HEFNNWSXXWATRW-SNVBAGLBSA-N,(R)-IBUPROPHEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL521,HEFNNWSXXWATRW-UHFFFAOYSA-N,IBUPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL521,HEFNNWSXXWATRW-UHFFFAOYSA-N,IBUPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL457,HEMJJKBWTPKOJG-UHFFFAOYSA-N,GEMFIBROZIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL457,HEMJJKBWTPKOJG-UHFFFAOYSA-N,GEMFIBROZIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL34139,HFGZFHCWKKQGIS-NOZJJQNGSA-N,GENACONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL34139,HFGZFHCWKKQGIS-NOZJJQNGSA-N,GENACONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1230813,HFHDHCJBZVLPGP-RWMJIURBSA-N,ALFADEX,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1230813,HFHDHCJBZVLPGP-RWMJIURBSA-N,ALFADEX,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220658,HFLDZGHUVQHMTJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.03,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220658,HFLDZGHUVQHMTJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1091791,HFLPUFFCCFMOMB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,390,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171047,HFWLILWGBZWYRI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669421,HGLDEVLFUAEPJC-INIZCTEOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,162,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1243394,HGLGWLWXYRAXPK-HNNXBMFYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20690643.0,KI,=,280,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.,J. Med. Chem.,PUBLICATION,
CHEMBL1243395,HGLGWLWXYRAXPK-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20690643.0,KI,=,48,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.,J. Med. Chem.,PUBLICATION,
CHEMBL1783893,HGMKONUWLRPGDN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19577344.0,INHIBITION,<,20,%,,,,,,,,,,,,,,,Inhibition histamine H1 receptor at 1 uM,Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2391541,HGRHWEAUHXYNNP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23602445.0,KI,=,936,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2391541,HGRHWEAUHXYNNP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23602445.0,KI,=,1258.93,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2391541,HGRHWEAUHXYNNP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,<,10000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2391541,HGRHWEAUHXYNNP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,=,501.19,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2024089,HGSHFGWWOPXUPH-WHOFXGATSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22171543.0,INHIBITION,=,30.5,%,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from H1 histamine receptor at 10 uM,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,PUBLICATION,
CHEMBL401777,HGTGAIQIJPCZMF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL30327,HGUFODBRKLSHSI-UHFFFAOYSA-N,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30327,HGUFODBRKLSHSI-UHFFFAOYSA-N,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL29808,HGWVDBLPHYBBTH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219146,HHJUWIANJFBDHT-KOTLKJBCSA-N,VINDESINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL219146,HHJUWIANJFBDHT-KOTLKJBCSA-N,VINDESINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL474617,HICAAISICQLQCN-UHFFFAOYSA-N,UR-PI147,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,,,,Not Determined,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL474617,HICAAISICQLQCN-UHFFFAOYSA-N,UR-PI147,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL748,HIGSLXSBYYMVKI-UHFFFAOYSA-N,PRALIDOXIME CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL748,HIGSLXSBYYMVKI-UHFFFAOYSA-N,PRALIDOXIME CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL563920,HILDNLJIJXAVHA-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19663387.0,KI,=,0.9,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.,J. Med. Chem.,PUBLICATION,
CHEMBL11584,HJHFHKLECBMBFW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Active,,,,,,,,,,,,,,Intrinsic activity; Tested up to 100 uM: no effects up to 10 uM,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL11584,HJHFHKLECBMBFW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,125892541179417,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL11584,HJHFHKLECBMBFW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1779058,HJKLOGARPBXZTP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21555222.0,KI,=,2372,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,"Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (s) receptor ligands modulates off-target activity and subtype selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1779058,HJKLOGARPBXZTP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,=,2372,NM,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1220,HJLSLZFTEKNLFI-UHFFFAOYSA-N,TINIDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1220,HJLSLZFTEKNLFI-UHFFFAOYSA-N,TINIDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1669408,HJNGVQMITVXZEN-HNNXBMFYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,13,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030623,HJOLMLNXMCFYQQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783969,HJSAIEMTRYMFMF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,>,10000,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783969,HJSAIEMTRYMFMF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL456807,HKOOXMFOFWEVGF-UHFFFAOYSA-N,PHENYLHYDRAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL456807,HKOOXMFOFWEVGF-UHFFFAOYSA-N,PHENYLHYDRAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1210028,HKWFGRSZAYZTSU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,81,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL446885,HKYLTVCKKUPKSQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,436.52,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL11879,HKZSTMPUPMSPLU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Active,,,,,,,,,,,,,,Intrinsic activity; Tested up to 100 uM: no effects up to 10 uM,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL11879,HKZSTMPUPMSPLU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,398107170553497,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL11879,HKZSTMPUPMSPLU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL238456,HLBPILNTTPELKS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,3162.28,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3220659,HLDXQMQDJIEKFI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,-0.01,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220659,HLDXQMQDJIEKFI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1454,HLFSDGLLUJUHTE-SNVBAGLBSA-N,LEVAMISOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1454,HLFSDGLLUJUHTE-SNVBAGLBSA-N,LEVAMISOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257811,HLHVJNKYUMTXDA-HDICACEKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,-3,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 1 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257811,HLHVJNKYUMTXDA-HDICACEKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,7,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 10 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257607,HLHVJNKYUMTXDA-QZTJIDSGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,-4,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 10 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257607,HLHVJNKYUMTXDA-QZTJIDSGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,0,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 1 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257812,HLHVJNKYUMTXDA-ROUUACIJSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,8,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 1 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257812,HLHVJNKYUMTXDA-ROUUACIJSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,14,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 10 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404288,HLHVJNKYUMTXDA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,10,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 1 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404288,HLHVJNKYUMTXDA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,21,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 10 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158782,HLXZPGHNFUSVMT-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,100,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3221637,HMPMHACJMYGXPE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,>,4000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,,MedChemComm,PUBLICATION,
CHEMBL64775,HMRCFAPWUJGFPW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,275.42,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL348302,HMWYNGSUVFCIHB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,3,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL189676,HMXDWDSNPRNUKI-UHFFFAOYSA-N,SURINABANT,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15131245.0,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL242600,HMXWHDMFAKYACA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,,,,Not Determined,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL3220654,HMXYGNGUTHIEDM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL28997,HNCAIEASLRMRKM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207632,HNCOLMVXXZHGHT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL317524,HNDKQQSKDXJMDG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,204,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1411979,HNJJXZKZRAWDPF-UHFFFAOYSA-N,METHAPYRILENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,16,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1411979,HNJJXZKZRAWDPF-UHFFFAOYSA-N,METHAPYRILENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1.8,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1767157,HNLNXYUSMGCHFW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,63.1,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,IFOSFAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,IFOSFAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1094209,HOMRLSWXGFQYGM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20427184.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1092813,HOUUGSUKNBXWNT-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,17,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669413,HOXVEGPFZJNLIG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,2.8,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL483400,HOYKNPXNYUOCRM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18841880.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,LETROZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,LETROZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL866,HPNSFSBZBAHARI-RUDMXATFSA-N,MYCOPHENOLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL866,HPNSFSBZBAHARI-RUDMXATFSA-N,MYCOPHENOLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2323582,HPRWHXGAJGUOCP-UHFFFAOYSA-N,BODILISANT,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1662,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1092651,HPVUAGMZZRSSHI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,0.8,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL493677,HQZBFDAIHIKVRO-CXAGYDPISA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18817368.0,IC50,=,6000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,"Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.",J. Med. Chem.,PUBLICATION,
CHEMBL271844,HRBGKICNPOCYPZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207637,HRHSURDPAJFNRA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,=,2600,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL534737,HRQFLVPRFGMKJO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2146805,HRSYZRFBUGIVHN-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.316,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146805,HRSYZRFBUGIVHN-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.347,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL270227,HRUTWQCXFHLYSD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL980,HSRJKNPTNIJEKV-UHFFFAOYSA-N,GUAIFENESIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL980,HSRJKNPTNIJEKV-UHFFFAOYSA-N,GUAIFENESIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL23,HSUGRBWQSSZJOP-RTWAWAEBSA-N,DILTIAZEM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL23,HSUGRBWQSSZJOP-RTWAWAEBSA-N,DILTIAZEM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL272511,HTADTAUIMFMPFI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,794.33,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL239101,HTCLEEXSMMUUES-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1584.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1767141,HTHMMDLGLVQHEM-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,0.2,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1491,HTIQEAQVCYTUBX-UHFFFAOYSA-N,AMLODIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1491,HTIQEAQVCYTUBX-UHFFFAOYSA-N,AMLODIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2376803,HTLDHQKBLGJBRF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23558237.0,KI,=,16595.87,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]histamine from human histamine H1 receptor expressed in HEK cells,"A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1016,HTQMVQVXFRQIKW-UHFFFAOYSA-N,CANDESARTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1016,HTQMVQVXFRQIKW-UHFFFAOYSA-N,CANDESARTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1939222,HTSQRRQNKJNSLH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22191331.0,INHIBITION,=,1,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM by radioligand displacement assay,ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis.,J. Med. Chem.,PUBLICATION,
CHEMBL403815,HULQLOOBDVQQSC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,1584.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1521,HUNXMJYCHXQEGX-UHFFFAOYSA-N,ZALEPLON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1521,HUNXMJYCHXQEGX-UHFFFAOYSA-N,ZALEPLON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL898,HUPFGZXOMWLGNK-UHFFFAOYSA-N,DIFLUNISAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL898,HUPFGZXOMWLGNK-UHFFFAOYSA-N,DIFLUNISAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1669427,HUPZZDHJGMFMTN-SFHVURJKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,15.2,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL129198,HUQJRYMLJBBEDO-UHFFFAOYSA-N,JNJ-7777120,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14722321.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL129198,HUQJRYMLJBBEDO-UHFFFAOYSA-N,JNJ-7777120,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18983139.0,KI,=,977.24,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,PUBLICATION,
CHEMBL129198,HUQJRYMLJBBEDO-UHFFFAOYSA-N,JNJ-7777120,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,46773.51,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1084132,HVBAGGJDXDXSAY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20153647.0,KI,=,2511.89,NM,,,,,,,,,,,,,,,Activity at histamine H1 receptor,"The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207641,HVGNYVOUQOKFLU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,=,1000,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL516088,HVJOIRMQZXEGPW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19329329.0,KI,=,944,NM,,,,,,,,,,,,,,,Inhibition of human cloned histamine H1 receptor by competitive binding experiment,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1085672,HVSRNYNPOUFDNJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20153647.0,KI,=,1995.26,NM,,,,,,,,,,,,,,,Activity at histamine H1 receptor,"The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1490,HWHLPVGTWGOCJO-UHFFFAOYSA-N,TRIHEXYPHENIDYL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1490,HWHLPVGTWGOCJO-UHFFFAOYSA-N,TRIHEXYPHENIDYL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL398812,HWRLDLIRHAWZST-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,=,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL239963,HWSMMNKRBIFEDV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1527608,HWXIGFIVGWUZAO-UHFFFAOYSA-N,DOXOFYLLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1527608,HWXIGFIVGWUZAO-UHFFFAOYSA-N,DOXOFYLLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL106545,HWYZEJDWSUNZPS-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,3715.35,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL309904,HXBMOXWVYIRYHK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,151.36,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1483,HXHWSAZORRCQMX-UHFFFAOYSA-N,ALBENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1483,HXHWSAZORRCQMX-UHFFFAOYSA-N,ALBENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1824784,HXOMGUPFBWZKBK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21788137.0,KI,<,10000,NM,,,,,,,,,,,,,,,Inhibition of H1 receptor by NIMH PDSP,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1258194,HXPHDFPROQRYEG-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,11,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1258308,HXPHDFPROQRYEG-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,13,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL74355,HXTGXYRHXAGCFP-OAQYLSRUSA-N,VOLINANSERIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,1000,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
,HXTGXYRHXAGCFP-UHFFFAOYSA-N,MDL 100907,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15999145.0,KI,=,66.7,NM,,,,,,,,,,,,,,,,,,,
CHEMBL595,HYAFETHFCAUJAY-UHFFFAOYSA-N,PIOGLITAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL595,HYAFETHFCAUJAY-UHFFFAOYSA-N,PIOGLITAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL193,HYIMSNHJOBLJNT-UHFFFAOYSA-N,NIFEDIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL193,HYIMSNHJOBLJNT-UHFFFAOYSA-N,NIFEDIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL56367,HYWYRSMBCFDLJT-UHFFFAOYSA-N,NIMESULIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL56367,HYWYRSMBCFDLJT-UHFFFAOYSA-N,NIMESULIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2165645,HYXYTRGSUZNOIN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,<,6,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL686,HYYBABOKPJLUIN-UHFFFAOYSA-N,MEFENAMIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL686,HYYBABOKPJLUIN-UHFFFAOYSA-N,MEFENAMIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64100,HZCFDQSTHWNXEC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,354.81,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL250401,HZHGVNZFZLEQOX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17892934.0,INHIBITION,=,65,%,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor at 1 uM,Discovery of 5-HT6 receptor ligands based on virtual HTS.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL568400,HZPGVFKYDDQWIZ-GASCZTMLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773162.0,IC50,=,390,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL474447,IACQTGSSMZJQPH-UHFFFAOYSA-N,UR-PI104,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,=,0,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL474447,IACQTGSSMZJQPH-UHFFFAOYSA-N,UR-PI104,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,PKB,=,5.68,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as inhibition of histamine-induced gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL107,IAKHMKGGTNLKSZ-INIZCTEOSA-N,COLCHICINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL107,IAKHMKGGTNLKSZ-INIZCTEOSA-N,COLCHICINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1950643,IAUVZRBJEZBOFA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22290075.0,INHIBITION,<,10,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,4-phenoxypiperidine pyridazin-3-one histamine H(3) receptor inverse agonists demonstrating potent and robust wake promoting activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL504,IAZDPXIOMUYVGZ-UHFFFAOYSA-N,DIMETHYL SULFOXIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL504,IAZDPXIOMUYVGZ-UHFFFAOYSA-N,DIMETHYL SULFOXIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL239099,IBEQZETWFPHMMF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1090527,IBILQKIYEWGQDQ-GFCCVEGCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,0.3,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3215298,IBSREHMXUMOFBB-JFUDTMANSA-N,ABAMECTIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3215298,IBSREHMXUMOFBB-JFUDTMANSA-N,ABAMECTIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207660,IBTMKWBYOYIWBF-GFCCVEGCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,39.81,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL592752,IBUHDDLETPJVGP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,40,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL592752,IBUHDDLETPJVGP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,146,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as reduction of histamine-induced intracellular calcium spike at phase 2 treated 20 to 30 seconds after histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL104994,IBVAFMSEJOGFLC-RDJZCZTQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,43000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608151,IBZJKEOJOGAMGJ-COPLHBTASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20170186.0,KI,=,1000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL595180,ICAQZJCLBRKWBG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773175.0,KI,>,1000,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in Sf9 cells co-expressing RGS4,"2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL101748,ICDXLEXUWOLRPG-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,8900,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2164371,ICGMZCVSHDKQTE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22770500.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM by radioligand binding assay,"3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.",J. Med. Chem.,PUBLICATION,
CHEMBL1935573,ICIGFIHEQAKGAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153663.0,KI,=,6422,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]histamine from human H1 receptor expressed in HEK cell membranes,Ligand based design of novel histamine H4 receptor antagonists; fragment optimization and analysis of binding kinetics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220655,ICIRCFWIGBIEDT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1200585,ICMWWNHDUZJFDW-DHODBPELSA-N,OXYMETHOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200585,ICMWWNHDUZJFDW-DHODBPELSA-N,OXYMETHOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2386917,ICTBPKWPCGSFPZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23622982.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor by radioligand binding assay,"Discovery of 2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as novel PKM2 activators.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL435949,IDBBDQXTEVOOKW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1083499,IDCKXHIGLKQWMM-UHFFFAOYSA-N,RWJ-671818,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20102150.0,INHIBITION,>,10,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,"Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif.",J. Med. Chem.,PUBLICATION,
CHEMBL1910383,IDNLJMLLYBSJEB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,223.87,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432044,IDXFKHDXIHNWAI-RAOGCBAWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL826,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,ENOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL826,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,ENOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2106399,IEMDOFXTVAPVLX-YWQHLDGFSA-N,KITASAMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2106399,IEMDOFXTVAPVLX-YWQHLDGFSA-N,KITASAMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL85735,IEMJYQZKJFERDW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,5.89,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2,IENZQIKPVFGBNW-UHFFFAOYSA-N,PRAZOSIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2,IENZQIKPVFGBNW-UHFFFAOYSA-N,PRAZOSIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1940419,IESJRUUOIHDONG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22245230.0,KI,=,212,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor by liquid scintillation counting,Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL591568,IESQFAFNQAYROM-SDNWHVSQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,345,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL591568,IESQFAFNQAYROM-SDNWHVSQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,2130,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as reduction of histamine-induced intracellular calcium spike at phase 2 treated 20 to 30 seconds after histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL475965,IFWGJAXMPXZADJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19146417.0,INHIBITION,<,10,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,"The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.",J. Med. Chem.,PUBLICATION,
CHEMBL153062,IGFHQQFPSIBGKE-UHFFFAOYSA-N,4-NONYLPHENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL153062,IGFHQQFPSIBGKE-UHFFFAOYSA-N,4-NONYLPHENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171038,IGLADUDHPDHSRD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,50.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935441,IGUBZXXWVQQSPY-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,1,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171048,IGXXJZSHANKJAD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,25.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207658,IGYNNXYCDMNULT-LLVKDONJSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,15.85,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767151,IGZMIXBCHNOMPG-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,79.43,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL179166,IHIXIJGXTJIKRB-UHFFFAOYSA-N,SODIUM ORTHOVANAD,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL179166,IHIXIJGXTJIKRB-UHFFFAOYSA-N,SODIUM ORTHOVANAD,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL264374,IIBYAHWJQTYFKB-UHFFFAOYSA-N,BEZAFIBRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL264374,IIBYAHWJQTYFKB-UHFFFAOYSA-N,BEZAFIBRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL923,IIDJRNMFWXDHID-UHFFFAOYSA-N,RISEDRONIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL923,IIDJRNMFWXDHID-UHFFFAOYSA-N,RISEDRONIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1222692,IIRIKFXWBJTDCC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,63.1,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1222692,IIRIKFXWBJTDCC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,125.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL418971,IISBACLAFKSPIT-UHFFFAOYSA-N,BISPHENOL A,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL418971,IISBACLAFKSPIT-UHFFFAOYSA-N,BISPHENOL A,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1808425,IISCUUOMDCMADJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21724392.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669414,IIVFRUJVDGTOEB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,49,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669424,IJFPVAYNHAMKAK-SFHVURJKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,13.9,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL479383,IJHSPFFWIXGDBB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18588282.0,INHIBITION,<,10,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,PUBLICATION,
CHEMBL138458,IJKYJDDNDXAREJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11784148.0,IC50,=,8000,NM,,,,,,,,,,,,,,,Inhibition of mepyramine binding to Histamine H1 receptor,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,PUBLICATION,
CHEMBL264418,IJMPFBJUROFOGZ-NVXWUHKLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,KI,=,10,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL264680,IJMPFBJUROFOGZ-RDJZCZTQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL589147,IJQSFAYWVZPICY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,66,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207279,IKBGPCPPFWCFRO-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,12.59,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL255566,IKHRYIGPRIAKFA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,1000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208424,IKNJHFAJDYZLNM-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208424,IKNJHFAJDYZLNM-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,0.316,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257525,ILAPINSYTQOSTH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL274525,ILLGYRJAYAAAEW-QMMMGPOBSA-N,ABT-418,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7518514.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL595449,ILPANLYEJQKXKY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19646882.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL476934,ILSADQLMJBGMFK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL255220,IMFZWBPHAPCFAZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767166,IMKMPTLRTHMERW-MGBGTMOVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,INHIBITION,,,,Active,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization at 100 nM incubated for 30 mins measured after washout followed by repeat histamine challenge at intervals of 90 and 270 mins by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767166,IMKMPTLRTHMERW-MGBGTMOVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KD,=,3.98,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization at 100 nM after 30 mins by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767166,IMKMPTLRTHMERW-MGBGTMOVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,12.59,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1201146,IMONTRJLAWHYGT-ZCPXKWAGSA-N,NORETHINDRONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201146,IMONTRJLAWHYGT-ZCPXKWAGSA-N,NORETHINDRONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201151,IMSSROKUHAOUJS-MJCUULBUSA-N,MESTRANOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201151,IMSSROKUHAOUJS-MJCUULBUSA-N,MESTRANOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL428880,IMZMKUWMOSJXDT-UHFFFAOYSA-N,CROMOLYN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL428880,IMZMKUWMOSJXDT-UHFFFAOYSA-N,CROMOLYN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL506,INDBQLZJXZLFIT-UHFFFAOYSA-N,PRIMAQUINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL506,INDBQLZJXZLFIT-UHFFFAOYSA-N,PRIMAQUINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1078358,INJHTQJNDUHTDR-UHFFFAOYSA-N,UR-PI97,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL862,INJOMKTZOLKMBF-UHFFFAOYSA-N,GUANFACINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL862,INJOMKTZOLKMBF-UHFFFAOYSA-N,GUANFACINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923523,INKZIWWVJYBNOA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,426.58,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL101691,INULYJUFVOFQOR-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,9100,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1087,INWLQCZOYSRPNW-UHFFFAOYSA-N,MEPIVACAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1087,INWLQCZOYSRPNW-UHFFFAOYSA-N,MEPIVACAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3094214,IOCXEAYYBZJHHK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,KI,=,1000,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207638,IOFOPIMDJBEBFZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,=,5500,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL429132,IOJIPFCHEXMFMJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,5011.87,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469748,IOXIWMMKUMCFIG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,4000,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL614,IPEHBUMCGVEMRF-UHFFFAOYSA-N,PYRAZINAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL614,IPEHBUMCGVEMRF-UHFFFAOYSA-N,PYRAZINAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1257608,IPFHLWSNKYSNJW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,-26,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL214268,IPKZCLGGYKRDES-ZDUSSCGKSA-N,PHA-543613,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16821801.0,INHIBITION,<,10,%,,,,,,,,,,,,,,,Inhibition of central histamine H1 receptor at 1 uM,"Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.",J. Med. Chem.,PUBLICATION,
CHEMBL1201346,IPOKCKJONYRRHP-FMQUCBEESA-N,BALSALAZID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201346,IPOKCKJONYRRHP-FMQUCBEESA-N,BALSALAZID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL93556,IPQSEKMUUNQIQD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,IC50,=,309,NM,,,,,,,,,,,,,,,Inhibitory concentration against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL93556,IPQSEKMUUNQIQD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.48,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL93556,IPQSEKMUUNQIQD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,309,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL155188,IPTWWGFBGODTAQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.62,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL155188,IPTWWGFBGODTAQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,1000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL155188,IPTWWGFBGODTAQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,1000000000000000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL64608,IPWACKIXHGZBDD-INIZCTEOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,1513.56,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL61288,IPWACKIXHGZBDD-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,1737.8,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL255158,IQFXDOJWHPEPAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277311,IQNSUCJNGFOYPQ-JNDNBTNTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,125.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL1502,IQPSEEYGBUAQFF-UHFFFAOYSA-N,PANTOPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1502,IQPSEEYGBUAQFF-UHFFFAOYSA-N,PANTOPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1091775,IQWBKNWLBVZZLG-HNNXBMFYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,3.9,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277312,IRGGYSVFJCBILG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,50.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL313604,IRIGJBAWLKWASO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,15.49,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL182,IRSCQMHQWWYFCW-UHFFFAOYSA-N,GANCICLOVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL182,IRSCQMHQWWYFCW-UHFFFAOYSA-N,GANCICLOVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL695,IRYJRGCIQBGHIV-UHFFFAOYSA-N,TRIMETHADIONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL695,IRYJRGCIQBGHIV-UHFFFAOYSA-N,TRIMETHADIONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1915540,ISBHYKVAFKTATD-SNVBAGLBSA-N,PF-03893787,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23558237.0,PKI,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]histamine from human histamine H1 receptor expressed in HEK cells,"A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14060,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,PHENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14060,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,PHENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL592753,ITLPFSDCSSQVPC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,30,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1774491,ITNVSKVARAVDNB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,41,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1650,ITRJWOMZKQRYTA-RFZYENFJSA-N,CORTISONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1650,ITRJWOMZKQRYTA-RFZYENFJSA-N,CORTISONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL272480,ITTGLZWHTWLHSG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030622,ITUMTGGIBOPIJQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL13,IUBSYMUCCVWXPE-UHFFFAOYSA-N,METOPROLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL13,IUBSYMUCCVWXPE-UHFFFAOYSA-N,METOPROLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL499815,IUCNQFHEWLYECJ-CXCSZTQTSA-L,ATRACTYLOSIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL499815,IUCNQFHEWLYECJ-CXCSZTQTSA-L,ATRACTYLOSIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1258614,IUEKKZWRWOFGRT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20727749.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158837,IUIGATKKQCOBAF-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,50.12,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL127516,IUWVALYLNVXWKX-UHFFFAOYSA-N,BUTAMBEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL127516,IUWVALYLNVXWKX-UHFFFAOYSA-N,BUTAMBEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL702,IVBHGBMCVLDMKU-GXNBUGAJSA-N,PIPERACILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL702,IVBHGBMCVLDMKU-GXNBUGAJSA-N,PIPERACILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL59715,IVCVMDSHKKVJIF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,524.81,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL421026,IVRXDSYEBGHJBD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,2884.03,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1088882,IVVSQFRLZUQKBC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,12,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL589148,IWEWIZBBORJKBV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,40,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL589148,IWEWIZBBORJKBV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,131,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as reduction of histamine-induced intracellular calcium spike at phase 2 treated 20 to 30 seconds after histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1210374,IWMGBKBZSBHXDP-OAQYLSRUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,97,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL557151,IWTDNEMUIUNTEA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17154494.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Agonist activity at human histamine H1 receptor at 100 uM,Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist.,J. Med. Chem.,PUBLICATION,
CHEMBL1643,IWUCXVSUMQZMFG-AFCXAGJDSA-N,RIBAVIRIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1643,IWUCXVSUMQZMFG-AFCXAGJDSA-N,RIBAVIRIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1517,IWVCMVBTMGNXQD-PXOLEDIWSA-N,OXYTETRACYCLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1517,IWVCMVBTMGNXQD-PXOLEDIWSA-N,OXYTETRACYCLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL256488,IWYNZVSUMFYFCF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,1584.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201237,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,LEVOBUNOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201237,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,LEVOBUNOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL90063,IXZDLPYKIIELLK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.54,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL90063,IXZDLPYKIIELLK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,3162.28,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL90063,IXZDLPYKIIELLK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,25118864315095.8,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1277679,IYAJUPFWKMPDJJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,50.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL1278116,IYDOAHOHMRQFTJ-QWAKEFERSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,3.98,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL60189,IYDTWLIGTRMAPG-SSEXGKCCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,12022.64,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL327497,IYGHJULMISLCJX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.62,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL327497,IYGHJULMISLCJX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,240,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL417990,IYGYMKDQCDOMRE-ZWKOTPCHSA-N,BICUCULLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL633,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,AMIODARONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL633,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,AMIODARONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL559147,IYOZTVGMEWJPKR-IJLUTSLNSA-N,Y-27632,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL559147,IYOZTVGMEWJPKR-IJLUTSLNSA-N,Y-27632,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1743259,IZBNNCFOBMGTQX-UHFFFAOYSA-N,ETOPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,3100,NM,,,,,,,,,,,,,,,,,,,
CHEMBL932,IZEKFCXSFNUWAM-UHFFFAOYSA-N,DIPYRIDAMOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL932,IZEKFCXSFNUWAM-UHFFFAOYSA-N,DIPYRIDAMOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564380,IZNDREQWHAUAMX-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19722526.0,ACTIVITY,<,10,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM,Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity.,J. Med. Chem.,PUBLICATION,
CHEMBL11603,IZVUQTNTFFLRBB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Determined,,,,,,,,,,,,,,Intrinsic activity; Low affinity for the receptor: not tested for the efficacy,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL11603,IZVUQTNTFFLRBB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,<,10000000000000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL11603,IZVUQTNTFFLRBB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibitory activity against human H1 receptor; Low affinity for the receptor: not tested for the efficacy,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2397268,JAKRIQWSQWQJHM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23627311.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of H1 histamine receptor (unknown origin) at 5 uM by psychoactive drug screening programme assay,Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.,J. Med. Chem.,PUBLICATION,
CHEMBL1172,JAUOIFJMECXRGI-UHFFFAOYSA-N,DESLORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,IC50,=,16000,NM,,,,binding,,,,,,,,,,,,,,,
CHEMBL1172,JAUOIFJMECXRGI-UHFFFAOYSA-N,DESLORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,0.97,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1172,JAUOIFJMECXRGI-UHFFFAOYSA-N,DESLORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,9.98,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1172,JAUOIFJMECXRGI-UHFFFAOYSA-N,DESLORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1.16,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL440864,JAUZYQXKUMRTOO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,208.93,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1222694,JAWGTZDKZCZPKP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,50.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL152122,JAXLDMXXLBSGOC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.78,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL152122,JAXLDMXXLBSGOC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,1258.93,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL152122,JAXLDMXXLBSGOC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,251188643150958,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL153479,JBDGDEWWOUBZPM-XYPYZODXSA-N,AMBROXOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL153479,JBDGDEWWOUBZPM-XYPYZODXSA-N,AMBROXOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1381098,JBDOSUUXMYMWQH-UHFFFAOYSA-N,1-NAPHTHYLISOTHIOCYANATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1381098,JBDOSUUXMYMWQH-UHFFFAOYSA-N,1-NAPHTHYLISOTHIOCYANATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1433,JBIWCJUYHHGXTC-AKNGSSGZSA-N,DOXYCYCLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1433,JBIWCJUYHHGXTC-AKNGSSGZSA-N,DOXYCYCLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL272899,JCCIEQKRVYXDHE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,311,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 (unknown origin),,Med Chem Res,PUBLICATION,
CHEMBL998,JCCNYMKQOSZNPW-UHFFFAOYSA-N,LORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,IC50,=,1500000,NM,,,,binding,,,,,,,,,,,,,,,
CHEMBL998,JCCNYMKQOSZNPW-UHFFFAOYSA-N,LORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,414,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL998,JCCNYMKQOSZNPW-UHFFFAOYSA-N,LORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771458.0,KI,=,37,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for H1 histamine receptor expressed in CHO cells,"Norpiperidine imidazoazepines as a new class of potent, selective, and nonsedative H1 antihistamines.",J. Med. Chem.,PUBLICATION,
CHEMBL998,JCCNYMKQOSZNPW-UHFFFAOYSA-N,LORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,IC50,=,290,NM,,,,,,,,,,,,,,,Inhibitory concentration against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL998,JCCNYMKQOSZNPW-UHFFFAOYSA-N,LORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25318072.0,KI,=,311,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells by scintillation counting method,Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2.,J. Med. Chem.,PUBLICATION,
CHEMBL998,JCCNYMKQOSZNPW-UHFFFAOYSA-N,LORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,170,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL998,JCCNYMKQOSZNPW-UHFFFAOYSA-N,LORATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,20,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL571391,JCHIUKROMYHWKE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,64,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,CHLORAMBUCIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,CHLORAMBUCIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567791,JCSAJCBJJWFNIO-CALCHBBNSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773162.0,IC50,=,800,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256651,JCUBTYXXBDFOHF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL101168,JCXKHYLLVKZPKE-UHFFFAOYSA-N,1-AMINOBENZOTRIAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL101168,JCXKHYLLVKZPKE-UHFFFAOYSA-N,1-AMINOBENZOTRIAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1643899,JDFBBZLNLYXHDC-CAUKCHDASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21146989.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643899,JDFBBZLNLYXHDC-CAUKCHDASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL302445,JDYFFOLXVFGXNI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,6025.6,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1455766,JEJWQCTZDAJWOX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24690494.0,KI,<,1000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin),Antagonists of the kappa opioid receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1808433,JEZVWAQXXDFILV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21724392.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL21525,JFFGAZQGKHLJLH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,8.47,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL571758,JFIOFXPCIFBCIW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19743867.0,ACTIVITY,<,10,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 1 uM,"Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL290106,JFIOVJDNOJYLKP-UHFFFAOYSA-N,BITHIONOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL290106,JFIOVJDNOJYLKP-UHFFFAOYSA-N,BITHIONOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL589389,JGJNEIOIBJGSFV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,104,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL353846,JGOAIQNSOGZNBX-UHFFFAOYSA-N,ADIPHENINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,IC50,=,112201.85,NM,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL240187,JGPLBVWXJOJNGO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL252556,JGPMMRGNQUBGND-UHFFFAOYSA-N,IDEBENONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL252556,JGPMMRGNQUBGND-UHFFFAOYSA-N,IDEBENONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL20713,JGQRXMOKSXAUDF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,7.54,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL102925,JGRFHTWWWXEAHZ-QFIPXVFZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,2300,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL29,JGSARLDLIJGVTE-MBNYWOFBSA-N,BENZYLPENICILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL29,JGSARLDLIJGVTE-MBNYWOFBSA-N,BENZYLPENICILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1257964,JGXUYJUQTMMZNX-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,11,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1257851,JGXUYJUQTMMZNX-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,-4,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1257607,JGXWDNPDGKMFIY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,-1,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432056,JHFKLSFCMAHSDK-LLOIJXFCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2158820,JHJPBZPNRYMQKP-DEOSSOPVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,25.12,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158819,JHJPBZPNRYMQKP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,50.12,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158821,JHJPBZPNRYMQKP-XMMPIXPASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,100,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077513,JHLQVARXXDBCGQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1077513,JHLQVARXXDBCGQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL394144,JHRLWHBYMHILPR-FSRHSHDFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL239300,JHRLWHBYMHILPR-FYZYNONXSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1200679,JIAARYAFYJHUJI-UHFFFAOYSA-L,ZINC CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200679,JIAARYAFYJHUJI-UHFFFAOYSA-L,ZINC CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1055,JIVPVXMEBJLZRO-UHFFFAOYSA-N,CHLORTHALIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1055,JIVPVXMEBJLZRO-UHFFFAOYSA-N,CHLORTHALIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL516,JJCFRYNCJDLXIK-UHFFFAOYSA-N,CYPROHEPTADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7925364.0,KI,=,0.06,NM,,,,,,,,,,,,,,,,,,,
CHEMBL516,JJCFRYNCJDLXIK-UHFFFAOYSA-N,CYPROHEPTADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,KD,=,5400,NM,,,,,,,,,,,,,,,Dissociation constant against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL516,JJCFRYNCJDLXIK-UHFFFAOYSA-N,CYPROHEPTADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,3.7,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL516,JJCFRYNCJDLXIK-UHFFFAOYSA-N,CYPROHEPTADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.43,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL326263,JJKPSOUEWPDPFS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11585444.0,IC50,=,795,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
CHEMBL2030627,JJTSIVODPMDGBG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1006,JKOQGQFVAUAYPM-UHFFFAOYSA-N,AMIFOSTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1006,JKOQGQFVAUAYPM-UHFFFAOYSA-N,AMIFOSTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL443,JLKIGFTWXXRPMT-UHFFFAOYSA-N,SULFAMETHOXAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL443,JLKIGFTWXXRPMT-UHFFFAOYSA-N,SULFAMETHOXAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2208428,JMGBVGDZPLNFAE-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208428,JMGBVGDZPLNFAE-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,199.53,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL12131,JMPFSEBWVLAJKM-UHFFFAOYSA-N,CLOSANTEL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12131,JMPFSEBWVLAJKM-UHFFFAOYSA-N,CLOSANTEL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL437,JNMRHUJNCSQMMB-UHFFFAOYSA-N,SULFATHIAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL437,JNMRHUJNCSQMMB-UHFFFAOYSA-N,SULFATHIAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL589390,JNODQFNWMXFMEV-UHFFFAOYSA-N,LATREPIRDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,160,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL589390,JNODQFNWMXFMEV-UHFFFAOYSA-N,LATREPIRDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,1580,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL589390,JNODQFNWMXFMEV-UHFFFAOYSA-N,LATREPIRDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,158,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL589390,JNODQFNWMXFMEV-UHFFFAOYSA-N,LATREPIRDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,1580,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as reduction of histamine-induced intracellular calcium spike at phase 2 treated 20 to 30 seconds after histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1540,JNTOCHDNEULJHD-UHFFFAOYSA-N,PENCICLOVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1540,JNTOCHDNEULJHD-UHFFFAOYSA-N,PENCICLOVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL255567,JNTWHFOMVSHHKK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL590241,JNUCCWMHZZUFKE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20045641.0,KI,=,242,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human cloned histamine H1 receptor,"9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL418666,JOFVFDZMGRFHQG-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,4677.35,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL302829,JOFVFDZMGRFHQG-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,2089.3,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL302829,JOFVFDZMGRFHQG-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,70794.58,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2204360,JOJYHYRCIYAVHN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21486038.0,KI,=,180,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,PUBLICATION,
CHEMBL560517,JONUVZHQXKYZDL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,>,500,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL462547,JOYRKODLDBILNP-UHFFFAOYSA-N,URETHANE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL462547,JOYRKODLDBILNP-UHFFFAOYSA-N,URETHANE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL271909,JOZMHQIYXRYITJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,251.19,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207286,JPDUMUHTXIBGHJ-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,12.59,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1940404,JPTSMZMSIACDAD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25070422.0,KI,=,698.6,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL96141,JPUGXAMECQJERZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.47,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL271066,JQEQULOLEPTBRS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,158.49,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL392713,JQJNQYUMEBRJKC-FERBBOLQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL239081,JQJNQYUMEBRJKC-GMUIIQOCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2165642,JQLNALKYFVFHLP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,=,6.32,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1885748,JQSJAVBMIMDUFO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23642479.0,INHIBITION,=,12,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM relative to control,Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL270852,JQVYPXIHEOFUGD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL374478,JQXXHWHPUNPDRT-WLSIYKJHSA-N,RIFAMPICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL374478,JQXXHWHPUNPDRT-WLSIYKJHSA-N,RIFAMPICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL926,JRWZLRBJNMZMFE-UHFFFAOYSA-N,DOBUTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL926,JRWZLRBJNMZMFE-UHFFFAOYSA-N,DOBUTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1592,JSDRRTOADPPCHY-HSQYWUDLSA-N,QUINAPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1592,JSDRRTOADPPCHY-HSQYWUDLSA-N,QUINAPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL323517,JSPIFTWKMOPKHZ-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,37000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1110,JSWZEAMFRNKZNL-UHFFFAOYSA-N,ALOSETRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1110,JSWZEAMFRNKZNL-UHFFFAOYSA-N,ALOSETRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL411921,JTCQOAITNDJYSA-HKUYNNGSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258930,JTCQOAITNDJYSA-IEBWSBKVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,KI,=,10,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL141,JTEGQNOMFQHVDC-NKWVEPMBSA-N,LAMIVUDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL141,JTEGQNOMFQHVDC-NKWVEPMBSA-N,LAMIVUDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL315772,JTLCTTWVUAIQHD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,2.34,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL315772,JTLCTTWVUAIQHD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12443779.0,IC50,=,2.34,NM,,,,,,,,,,,,,,,Binding affinity against Histamine H1 receptor,2-(Dimethylaminomethyl)-tetrahydroisoxazolopyridobenzazepine derivatives. Synthesis of a new 5-HT(2C) antagonist with potential anxiolytic properties.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL84158,JTVPZMFULRWINT-UHFFFAOYSA-N,TIAPRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL84158,JTVPZMFULRWINT-UHFFFAOYSA-N,TIAPRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1537,JTWOMNBEOCYFNV-NFFDBFGFSA-N,AZLOCILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1537,JTWOMNBEOCYFNV-NFFDBFGFSA-N,AZLOCILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL22152,JUBIZZJGPDRTNO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,7.21,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL102984,JUQYDUYFGBPURU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,3467.37,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL255417,JURMKPGGUGOQIP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL429023,JUVIOZPCNVVQFO-HBGVWJBISA-N,ROTENONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL429023,JUVIOZPCNVVQFO-HBGVWJBISA-N,ROTENONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2203551,JUWUZLUBIRHYMM-LBPRGKRZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,EFFICACY,=,55,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2203551,JUWUZLUBIRHYMM-LBPRGKRZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor after 1.5 hrs by microbeta scintillation counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL236610,JVCJWEYSNNCGKX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,266,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158832,JVDFBAQLTSMMBQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,50.12,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030625,JVHYCBRRZUMPEJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783968,JVIRLKXDBNCSGU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,220,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783968,JVIRLKXDBNCSGU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220664,JVOHQFDCXLCXBA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,-0.01,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220664,JVOHQFDCXLCXBA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,=,5.26,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL591803,JVPBPESGJIUWIZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,35,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200559,JVTAAEKCZFNVCJ-UHFFFAOYSA-N,LACTIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200559,JVTAAEKCZFNVCJ-UHFFFAOYSA-N,LACTIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1670,JWBOIMRXGHLCPP-UHFFFAOYSA-N,MITOTANE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1670,JWBOIMRXGHLCPP-UHFFFAOYSA-N,MITOTANE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1767147,JWDZDXFXHWMSGR-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,2,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL631,JWHAUXFOSRPERK-UHFFFAOYSA-N,PROPAFENONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL631,JWHAUXFOSRPERK-UHFFFAOYSA-N,PROPAFENONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL240395,JWVDVKRDYUKSCG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL103828,JWVSNNPXFZNTNU-APWZRJJASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,56000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL320174,JWVSNNPXFZNTNU-LPHOPBHVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,60000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL91157,JWYUBODPEUBFLH-FSTMKDAKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771448.0,KI,=,113,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to Histamine H1 receptor,Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity.,J. Med. Chem.,PUBLICATION,
CHEMBL434,JWZZKOKVBUJMES-UHFFFAOYSA-N,ISOPROTERENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL434,JWZZKOKVBUJMES-UHFFFAOYSA-N,ISOPROTERENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL159,JXLYSJRDGCGARV-CFWMRBGOSA-N,VINBLASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL159,JXLYSJRDGCGARV-CFWMRBGOSA-N,VINBLASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL305338,JXOCVUPTHGIJET-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,56.23,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL389621,JYGXADMDTFJGBT-VWUMJDOOSA-N,HYDROCORTISONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL389621,JYGXADMDTFJGBT-VWUMJDOOSA-N,HYDROCORTISONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL244275,JYLNFWODPITKFP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.4,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1090197,JYRXHQCPLUTCMM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,7.7,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL63323,JZFPYUNJRRFVQU-UHFFFAOYSA-N,NIFLUMIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL63323,JZFPYUNJRRFVQU-UHFFFAOYSA-N,NIFLUMIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64461,JZOQPCYGADPKSS-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,37153.52,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL117405,JZQKKSLKJUAGIC-NSHDSACASA-N,S(-)-PINDOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL117405,JZQKKSLKJUAGIC-NSHDSACASA-N,S(-)-PINDOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL500,JZQKKSLKJUAGIC-UHFFFAOYSA-N,PINDOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL500,JZQKKSLKJUAGIC-UHFFFAOYSA-N,PINDOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL435,JZUFKLXOESDKRF-UHFFFAOYSA-N,HYDROCHLOROTHIAZIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL435,JZUFKLXOESDKRF-UHFFFAOYSA-N,HYDROCHLOROTHIAZIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1091778,KAWDUHFGBOIYCO-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,79000,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1091777,KAWDUHFGBOIYCO-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,IC50,=,3500,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1091776,KAWDUHFGBOIYCO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,10000,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL42335,KAXNWVHHUKHNDK-JOCHJYFZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10937710.0,KI,=,91,NM,,,,,,,,,,,,,,,Selectivity screen against human Histamine H1 receptor,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432048,KBAKPEFQDPCCTP-RAOGCBAWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL408208,KBAMXOZNCXYSJT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220890,KBGFJVRVFPLUSS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,-0.02,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220890,KBGFJVRVFPLUSS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,=,5.11,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL2387291,KBIMBEHOSLKBMG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3589978,KCCOADNQWWNYBT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25936259.0,INHIBITION,=,5,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]-pyrilamine from human cloned H1 receptor expressed in HEK293 cells at 1 uM by scintillation counting analysis,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL272588,KCFSZIDRLPEDRQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1196,KCLANYCVBBTKTO-UHFFFAOYSA-N,PROPARACAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1196,KCLANYCVBBTKTO-UHFFFAOYSA-N,PROPARACAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL271729,KCLMHEWINSXASY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158838,KCLONPRRKHVPLU-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,31.62,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1092494,KCSVGYHUQTUHTM-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,8,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL382276,KCVXUVKSHFDJIV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,PKI,,,,Not Determined,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1753,KDLRVYVGXIQJDK-AWPVFWJPSA-N,CLINDAMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1753,KDLRVYVGXIQJDK-AWPVFWJPSA-N,CLINDAMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1092118,KEDAYBZXXNOGOP-LBPRGKRZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,5.2,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1259187,KEEXCUUQRQNRNF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,64,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL3334797,KEGBICCDHKITSP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25164761.0,INHIBITION,=,22.7,%,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor at 10 uM relative to control,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL400612,KENVEDVQQZAGDU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL245118,KEOZDNQHXGUGES-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,5.7,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL392532,KEQCAAQBOMIVCB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL68167,KEVKUIQZOLROBW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL68167,KEVKUIQZOLROBW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta; no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL351231,KFHYZKCRXNRKRC-MRXNPFEDSA-N,ABT-239,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15608078.0,KI,=,1621.81,NM,,,,,,,,,,,,,,,,,,,
CHEMBL273166,KFMDKMLEGDZMCX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL101692,KGDAOALFCOEYFT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,501.19,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256474,KGDPFNITOFAOLP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3590090,KGSZZVYNXYDZEW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25936259.0,INHIBITION,=,3,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]-pyrilamine from human cloned H1 receptor expressed in HEK293 cells at 1 uM by scintillation counting analysis,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL287671,KGZWRXWYLPRJCF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL942,KHOITXIGCFIULA-UHFFFAOYSA-N,BISACODYL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL942,KHOITXIGCFIULA-UHFFFAOYSA-N,BISACODYL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL272297,KHTUQDQSUXMHQA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL175782,KIAVPENCSGKVQP-UHFFFAOYSA-N,METHIMEPIP,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771452.0,KI,<,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine binding to COS-7 cell membranes expressing human histamine H1 receptor,N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.,J. Med. Chem.,PUBLICATION,
CHEMBL2376804,KICLSPYVVBSUFF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23558237.0,KI,=,20892.96,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]histamine from human histamine H1 receptor expressed in HEK cells,"A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL26880,KINYVKAOICLKCC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657274.0,KI,<,1905.46,NM,,,,,,,,,,,,,,,Binding affinity towards human histamine (H1) receptor,Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: novel and selective histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL609579,KISZTEOELCMZPY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,2758,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL64120,KIUNCIUUHAZFFW-HSZRJFAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,46773.51,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
,KIWQWJKWBHZMDT-GSVOUGTGSA-N,D-HOMOCYSTEINE THIOLACTONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL568892,KIZHXXNZJUOENQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,20,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078105,KJDJVVOSJQUKQQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078105,KJDJVVOSJQUKQQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL196220,KJLOHSGXUVVIEV-MUUNZHRXSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,KD,=,410,NM,,,,,,,,,,,,,,,Dissociation constant against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL13209,KJONHKAYOJNZEC-UHFFFAOYSA-N,NITRAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL13209,KJONHKAYOJNZEC-UHFFFAOYSA-N,NITRAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL13209,KJONHKAYOJNZEC-UHFFFAOYSA-N,NITRAZEPAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL293492,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,CINNAMALDEHYDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL293492,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,CINNAMALDEHYDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1092126,KJQCJXUDPPZASI-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,9.3,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220641,KJWJXDFLNPYZBC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,-0.03,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220641,KJWJXDFLNPYZBC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL63631,KJWJYNTUXOGLFR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,11220.18,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14192,KKKDZZRICRFGSD-UHFFFAOYSA-N,BENZYLIMIDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14192,KKKDZZRICRFGSD-UHFFFAOYSA-N,BENZYLIMIDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1289626,KKLZGWQBNXJWGZ-UHFFFAOYSA-N,WMS-1410,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20965739.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from histamine H1 receptor at 1 to 3 uM,"Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3094312,KKYAPAJUTFYVRD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24238903.0,INHIBITION,=,15.6,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,MITOXANTRONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,MITOXANTRONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL479,KLBQZWRITKRQQV-UHFFFAOYSA-N,THIORIDAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,16.12,NM,,,,,,,,,,,,,,,,,,,
CHEMBL479,KLBQZWRITKRQQV-UHFFFAOYSA-N,THIORIDAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,16,NM,,,,,,,,,,,,,,,,,,,
CHEMBL479,KLBQZWRITKRQQV-UHFFFAOYSA-N,THIORIDAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,19,NM,,,,,,,,,,,,,,,,,,,
CHEMBL479,KLBQZWRITKRQQV-UHFFFAOYSA-N,THIORIDAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,72,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL479,KLBQZWRITKRQQV-UHFFFAOYSA-N,THIORIDAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,8.41,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1092765,KLFVGKSTNOVPOR-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,1.7,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669669,KLFVWQCQUXXLOU-UHFFFAOYSA-N,RO-5212773,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21237643.0,INHIBITION,=,6,%,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells,Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL321709,KLHSXAZZKUOFFG-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,1500,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2381116,KLJVDMAOKMSBQX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23535330.0,INHIBITION,=,21,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 1 ug/mL relative to control,Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207668,KLPJSXVRXSMWBK-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,501.19,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL460,KLPWJLBORRMFGK-UHFFFAOYSA-N,MOLINDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL460,KLPWJLBORRMFGK-UHFFFAOYSA-N,MOLINDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL460,KLPWJLBORRMFGK-UHFFFAOYSA-N,MOLINDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL460,KLPWJLBORRMFGK-UHFFFAOYSA-N,MOLINDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,2130,NM,,,,,,,,,,,,,,,,,,,
CHEMBL2030635,KLUCWWVQVUXBSE-UHFFFAOYSA-N,N-(2-PHENYLETHYL)PYRROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL64896,KMEARAZYHMRMGA-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,10000,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL305144,KMEARAZYHMRMGA-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,12589.25,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2146803,KMFDXNUGIFDFHQ-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.513,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2207633,KMVWYPYWHLOVLW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1518,KNAHARQHSZJURB-UHFFFAOYSA-N,PROPYLTHIOURACIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1518,KNAHARQHSZJURB-UHFFFAOYSA-N,PROPYLTHIOURACIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432046,KNBHNNRMMAKKFI-SEDVZXITSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,=,1359,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2387306,KNEPUUPQUYRNID-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL565,KNHUKKLJHYUCFP-UHFFFAOYSA-N,CLOFIBRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL565,KNHUKKLJHYUCFP-UHFFFAOYSA-N,CLOFIBRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL105952,KNMJAZUTBMPTPA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,162.18,NM,,,,,,,,,,,,,,,Binding affinity at human cortical Histamine 1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220651,KNXOFOSIAFVPGD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL429136,KNZNKJDEMHGXSO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18023344.0,KI,=,18.3,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256694,KNZNKJDEMHGXSO-YFKPBYRVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18023344.0,KI,=,2.6,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208417,KOACYGPEOVSJCA-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208417,KOACYGPEOVSJCA-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,501.19,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078045,KOQOOXCRTXNYCD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078045,KOQOOXCRTXNYCD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3613642,KORKKQLDGMHNKO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26235950.0,INHIBITION,=,4,%,,,,,,,,,,,,,,,Binding affinity to human H1 receptor assessed as inhibition of control specific binding at 10 uM,Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208435,KOUMCBHTVFDPSI-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208435,KOUMCBHTVFDPSI-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,12.59,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1065,KPJZHOPZRAFDTN-ZRGWGRIASA-N,METHYSERGIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1065,KPJZHOPZRAFDTN-ZRGWGRIASA-N,METHYSERGIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL498847,KPQZUUQMTUIKBP-UHFFFAOYSA-N,SECNIDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL498847,KPQZUUQMTUIKBP-UHFFFAOYSA-N,SECNIDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL557555,KPSRODZRAIWAKH-UHFFFAOYSA-N,CIPROFIBRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL557555,KPSRODZRAIWAKH-UHFFFAOYSA-N,CIPROFIBRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL62804,KPXVCGPCRXEDLT-HNNXBMFYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,53703.18,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL302196,KPXVCGPCRXEDLT-OAHLLOKOSA-N,A-304121,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,69183.1,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL302196,KPXVCGPCRXEDLT-OAHLLOKOSA-N,A-304121,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12606603.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL701,KPYSYYIEGFHWSV-UHFFFAOYSA-N,BACLOFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL701,KPYSYYIEGFHWSV-UHFFFAOYSA-N,BACLOFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL141343,KPZQRBACZSLMPH-UHFFFAOYSA-N,U-78517F,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,14791,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL141343,KPZQRBACZSLMPH-UHFFFAOYSA-N,U-78517F,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1718,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL128,KQKPFRSPSRPDEB-UHFFFAOYSA-N,SUMATRIPTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL128,KQKPFRSPSRPDEB-UHFFFAOYSA-N,SUMATRIPTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL21727,KQLLARJZDCLFHS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,7.18,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2165647,KQNBLEJTQJSXMZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,<,6,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL447,KQPKPCNLIDLUMF-UHFFFAOYSA-N,SECOBARBITAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL447,KQPKPCNLIDLUMF-UHFFFAOYSA-N,SECOBARBITAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1208572,KQXDHUJYNAXLNZ-XQSDOZFQSA-N,SALINOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1208572,KQXDHUJYNAXLNZ-XQSDOZFQSA-N,SALINOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2326501,KRCLPAGVJVBLJR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23237837.0,INHIBITION,=,22,%,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]pyrilamine from human recombinant H1 receptor expressed in HEK293 cells at 1 uM,Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1261,KRKNYBCHXYNGOX-UHFFFAOYSA-N,CITRIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1261,KRKNYBCHXYNGOX-UHFFFAOYSA-N,CITRIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1669423,KRLJKEOQHOYBSK-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,28,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,0.67,NM,,,,,,,,,,,,,,,,,,,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,0.95,NM,,,,,,,,,,,,,,,,,,,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,1.12,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,4.78,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.555,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL605081,KRPHBUMURAALTO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,112,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1752,KSCFJBIXMNOVSH-UHFFFAOYSA-N,DYPHYLLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1752,KSCFJBIXMNOVSH-UHFFFAOYSA-N,DYPHYLLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL32749,KSEBMYQBYZTDHS-HWKANZROSA-N,FERULIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL32749,KSEBMYQBYZTDHS-HWKANZROSA-N,FERULIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL540445,KTEXNACQROZXEV-SLXBATTESA-N,PARTHENOLIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL540445,KTEXNACQROZXEV-SLXBATTESA-N,PARTHENOLIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,IMATINIB,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,IMATINIB,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL82635,KTWZXHKXAGXWOB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,6.03,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1917468,KTXVIHVCQVKSMA-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944855.0,INHIBITION,<,30,%,,,,,,,,,,,,,,,Inhibition of human H1R at 10 uM,Synthesis and evaluation of pyridazinone-phenethylamine derivatives as selective and orally bioavailable histamine H(3) receptor antagonists with robust wake-promoting activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL330719,KUAJFMGQGXJNCK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.55,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL330719,KUAJFMGQGXJNCK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,285,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL96158,KUCRPWOVGMMXDP-FDMCOVCTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,14,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL330713,KUCRPWOVGMMXDP-MRJVUNAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,32.6,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205814,KULMFBVVFDTVNX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL61396,KUPWVSPABUWQQB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,104.71,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL24944,KVSKGMLNBAPGKH-UHFFFAOYSA-N,TRIBROMSALAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL24944,KVSKGMLNBAPGKH-UHFFFAOYSA-N,TRIBROMSALAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,0.65,NM,,,,,,,,,,,,,,,,,,,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,0.087,NM,,,,,,,,,,,,,,,,,,,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11170639.0,KI,=,5.6,NM,,,,,,,,,,,,,,,Binding affinity towards human H1 receptor,Current and novel approaches to the drug treatment of schizophrenia.,J. Med. Chem.,PUBLICATION,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,2,NM,,,,,,,,,,,,,,,,,,,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14998318.0,KI,=,3.5,NM,,,,,,,,,,,,,,,Binding affinity towards human histamine H1 receptor,Selective optimization of side activities: another way for drug discovery.,J. Med. Chem.,PUBLICATION,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,1.2,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,2.8,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21062081.0,KD,=,0.087,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Histamine H3 receptor as a drug discovery target.,J. Med. Chem.,PUBLICATION,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24559051.0,KI,=,2,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin),Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,13,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1.47,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,7,NM,,,,,,,,,,,,,,,In vitro binding affinity of compound against histamine H1 neuronal receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,10,NM,,,,,,,,,,,,,,,Binding affinity to H1 histamine receptor (unknown origin) by PDSP assay,,MedChemComm,PUBLICATION,
CHEMBL94788,KVYXGCNCFPIESF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,5,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3094212,KWEZWIYXNRSXFQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,PKI,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL327306,KWUQZAPLAOREKL-FDMCOVCTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,4.3,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3409256,KWZBJWOQFABHPF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25557493.0,INHIBITION,>,50,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in HEK-293 cells at 1 uM,Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3409256,KWZBJWOQFABHPF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25557493.0,KI,=,160,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in HEK-293 cells,Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3092995,KXSAIQPPGSSNKX-ZETCQYMHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24205976.0,INHIBITION,=,23,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM relative to control,"Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112).",J. Med. Chem.,PUBLICATION,
CHEMBL2208437,KXSMUDWNWWFRRE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208437,KXSMUDWNWWFRRE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,1258.93,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL9514,KYRVNWMVYQXFEU-UHFFFAOYSA-N,NOCODAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL9514,KYRVNWMVYQXFEU-UHFFFAOYSA-N,NOCODAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1097859,KYSFTXJTWSDCSC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20382540.0,ACTIVITY,=,39,%,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells at 10 uM after 60 mins by beta scintillation counting,In silico directed chemical probing of the adenosine receptor family.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1118,KYYIDSXMWOZKMP-UHFFFAOYSA-N,DESVENLAFAXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16675639.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL304714,KZBINGTZAGPLQP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,741.31,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1910384,KZGYBDPASGTNOZ-QHCPKHFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,457.09,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2165447,KZONDTNPVHWVKU-NSHDSACASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,EFFICACY,=,49.2,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL468176,KZPYBMNBUZPMKP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18640038.0,EC50,>,50000,NM,,,,,,,,,,,,,,,Agonist activity at histamine H1 receptor,Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL468176,KZPYBMNBUZPMKP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18640038.0,IC50,>,50000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL493014,KZWRVJZTROHTQZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18433114.0,INHIBITION,<,20,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL293802,KZZIVOLMJPSDEP-UHFFFAOYSA-N,ARPROMIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12626648.0,KI,=,353,NM,,,,,,,,,,,,,,,,,,,
CHEMBL3094130,LABRWGKKPFQRIQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,KI,=,1258.93,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258090,LAGGNVKIMAMGMQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL416378,LAGKZORWQABGEE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,7.84,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1910378,LAKQJOXTAMPPOO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,169.82,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2031884,LBAKRWRQQGNMEB-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22313242.0,KI,=,7230,NM,,,,,,,,,,,,,,,Binding affinity to H1 receptor,"2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL64321,LBCXFPZCIKKGSB-RUZDIDTESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,3311.31,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62808,LBCXFPZCIKKGSB-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,2290.87,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030630,LCBQDWKMNGEPLD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1088899,LCEUDZGEEHIOMS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,35,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220636,LCGNLHLIZIMPIZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.06,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220636,LCGNLHLIZIMPIZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1078631,LCJIVFNCQGPKLP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078631,LCJIVFNCQGPKLP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL81485,LCKBEOTXTNWYRG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,10.72,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL179590,LDAIZSJPULESPS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15686917.0,KI,=,5.89,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human Histamine H1 receptor in CHO K1 cells,5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1094510,LDKQFEPUPKIHCG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,0.8,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL549599,LDMXQNXCFMLIER-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,2.4,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL360666,LDPRUJUFFYEDJC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15686917.0,KI,=,17.8,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human Histamine H1 receptor in CHO K1 cells,5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL85155,LDUDMYAXGOQOGO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,15.85,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201193,LEBVLXFERQHONN-INIZCTEOSA-N,LEVOBUPIVACAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201193,LEBVLXFERQHONN-INIZCTEOSA-N,LEVOBUPIVACAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL340816,LECUUDCCVOYUHG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,973.5,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2158792,LEHDCEDFGAFVGX-NDEPHWFRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,50.12,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL309141,LEIPNUMRCVGRIS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL309141,LEIPNUMRCVGRIS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta; no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL1200391,LENZDBCJOHFCAS-UHFFFAOYSA-N,TROMETHAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200391,LENZDBCJOHFCAS-UHFFFAOYSA-N,TROMETHAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL61231,LESFXMYDPQCDFJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,933.25,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL43594,LEVRYVCMBBJQLU-HSZRJFAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10937710.0,KI,=,616,NM,,,,,,,,,,,,,,,Selectivity screen against human Histamine H1 receptor,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL437002,LEVTWCPGXIVKEH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL437002,LEVTWCPGXIVKEH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL366563,LEVWYRKDKASIDU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL808,LEZWWPYKPKIXLL-UHFFFAOYSA-N,ECONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL808,LEZWWPYKPKIXLL-UHFFFAOYSA-N,ECONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL63036,LFKNMWWWQLOXKE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,416.87,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL545,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,ALCOHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL545,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,ALCOHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL557210,LFSBNTMFCXGIEC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,3.2,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL18797,LFWHFZJPXXOYNR-MFOYZWKCSA-N,SULINDAC SULFIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL18797,LFWHFZJPXXOYNR-MFOYZWKCSA-N,SULINDAC SULFIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL102390,LGBGBJRXINUEFH-AZUAARDMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,80000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL316968,LGBGBJRXINUEFH-ICSRJNTNSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,75000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL194659,LGHLMADLDHUIJY-MQSINFNDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,7.5,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL195706,LGHLMADLDHUIJY-SHZHJNINSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,33,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL593988,LGIIUKGHECNJNZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,6,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2171029,LGNOCEJCJLXMEA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,39.81,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220627,LGQUIEZBGYNSEX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.01,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220627,LGQUIEZBGYNSEX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL156455,LGXVIGDEPROXKC-UHFFFAOYSA-N,"1,1-DICHLOROETHENE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL156455,LGXVIGDEPROXKC-UHFFFAOYSA-N,"1,1-DICHLOROETHENE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1643902,LGZPNSXZRKGUES-DKSPCFMDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21146989.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643902,LGZPNSXZRKGUES-DKSPCFMDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,>,10000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3233142,LHAPOGAFBLSJJQ-GUTACTQSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24559051.0,KI,>,1000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin),Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL1258723,LHSWZGXDIPQNGE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20727749.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL82966,LHTXSHOSMCEFFX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,2.29,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL293762,LHVRFUVVRXGZPV-UHFFFAOYSA-N,AMTHAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,EC50,=,15848.93,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1090176,LHYWGVZKOTTYSZ-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,2.7,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1090176,LHYWGVZKOTTYSZ-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20800486.0,KI,=,2.7,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2037604,LIEAKONJVOLXFZ-LSDHHAIUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22578490.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Synthesis and evaluation of 4- and 5-pyridazin-3-one phenoxypropylamine analogues as histamine-3 receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2205824,LIKZWSUAMNZHAE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL271631,LJDQESSYTJNKOI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL449828,LJPSBFAATROTES-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,9300,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL440512,LJVNYCDXBXGQIK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,87,NM,,,,,,,,,,,,,,,In vitro binding affinity of compound against histamine H1 neuronal receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2079587,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,STANOZOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2079587,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,STANOZOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL177,LKCWBDHBTVXHDL-RMDFUYIESA-N,AMIKACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL177,LKCWBDHBTVXHDL-RMDFUYIESA-N,AMIKACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220883,LKECALCFPQAQHZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.1,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220883,LKECALCFPQAQHZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,=,5.41,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL2171035,LKFICSFQSQYFJF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432043,LKFSLMWAVKMONG-KPCGFGSOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL63560,LKJPYSCBVHEWIU-KRWDZBQOSA-N,(R)-BICALUTAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL63560,LKJPYSCBVHEWIU-KRWDZBQOSA-N,(R)-BICALUTAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1910386,LLBZLFNYOYVBFX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,5.5,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158793,LLEJNWFSXZIFMW-NDEPHWFRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,79.43,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1241348,LLGDPTDZOVKFDU-XUHJSTDZSA-N,FALDAPREVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20823284.0,INHIBITION,=,3,%,,,,,,,,,,,,,,,Inhibition of human H1 receptor at 10 uM,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL200210,LLHFDYRCKMNGML-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16275087.0,INHIBITION,<,50,%,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1088898,LLKGAHXEIBHUNC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,63,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1542,LMEKQMALGUDUQG-UHFFFAOYSA-N,AZATHIOPRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1542,LMEKQMALGUDUQG-UHFFFAOYSA-N,AZATHIOPRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL302231,LMFNLINKCDGRTE-NTSWFWBYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,>,0.0001,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL292924,LMFNLINKCDGRTE-PHDIDXHHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,>,0.0001,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL292558,LMFNLINKCDGRTE-RITPCOANSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,>,0.0001,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL305135,LMFNLINKCDGRTE-WDSKDSINSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,>,0.0001,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL1054,LMJSLTNSBFUCMU-UHFFFAOYSA-N,TRICHLORMETHIAZIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1054,LMJSLTNSBFUCMU-UHFFFAOYSA-N,TRICHLORMETHIAZIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,1886.79,NM,,,,,,,,,,,,,,,,,,,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,1700,NM,,,,,,,,,,,,,,,,,,,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,1900,NM,,,,,,,,,,,,,,,,,,,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,790,NM,,,,,,,,,,,,,,,,,,,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,260,NM,,,,,,,,,,,,,,,,,,,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,1800,NM,,,,,,,,,,,,,,,,,,,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14998318.0,KI,=,730,NM,,,,,,,,,,,,,,,Binding affinity towards human histamine H1 receptor,Selective optimization of side activities: another way for drug discovery.,J. Med. Chem.,PUBLICATION,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,440,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22245230.0,KI,=,440,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor by liquid scintillation counting,Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25070422.0,KI,=,440,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,2781,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,323,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL865,LNPDTQAFDNKSHK-UHFFFAOYSA-N,VALDECOXIB,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL865,LNPDTQAFDNKSHK-UHFFFAOYSA-N,VALDECOXIB,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432042,LNTMHZZRTAQEJQ-CPVTZQMHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL244279,LOGDXDWDCZTLOS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,7.2,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1744448,LOLFAJUUOFBGSF-KYIYJVAASA-N,BLEOMYCIN A2,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1744448,LOLFAJUUOFBGSF-KYIYJVAASA-N,BLEOMYCIN A2,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL283527,LOSCMRFIWFEQRR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,6.93,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1824778,LPAMOYXJLQSGRI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21788137.0,KI,<,10000,NM,,,,,,,,,,,,,,,Inhibition of H1 receptor by NIMH PDSP,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171013,LPHIWCBAJGQIIF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,2.51,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL441687,LPLVUJXQOOQHMX-QWBHMCJMSA-N,GLYCYRRHIZIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL441687,LPLVUJXQOOQHMX-QWBHMCJMSA-N,GLYCYRRHIZIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL222863,LPMXVESGRSUGHW-HBYQJFLCSA-N,OUABAIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL222863,LPMXVESGRSUGHW-HBYQJFLCSA-N,OUABAIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL404,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,TAZOBACTAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL404,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,TAZOBACTAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL111861,LPYXTAPPNYMYOP-XDBTXSBWSA-N,CORTISONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL111861,LPYXTAPPNYMYOP-XDBTXSBWSA-N,CORTISONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207672,LQCZDIMQFUOGJG-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,50.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207636,LQGNDHYNCHVOGU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL94480,LQNLNHOIPAAEJI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.25,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL891,LQOLIRLGBULYKD-JKIFEVAISA-N,CLOXACILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL891,LQOLIRLGBULYKD-JKIFEVAISA-N,CLOXACILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257604,LQOORYLWYFASDQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 1 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257604,LQOORYLWYFASDQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 10 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL309106,LQTJOPPTSIYEES-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10841797.0,RATIO,=,115,,,,,,,,,,,,,,,,Selectivity ratio against central Histamine H1 receptor,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL506247,LRBQNJMCXXYXIU-PPKXGCFTSA-N,TANNIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL506247,LRBQNJMCXXYXIU-PPKXGCFTSA-N,TANNIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL221988,LRBSLCJILMAIJQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15566302.0,ACTIVITY,=,28,%,,,,,,,,,,,,,,,Displacement of [3H]ketanserin from histamine H1 receptor in human cortex membranes at 500 mM,Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL204449,LRQBXHMVEXEFBO-GFCCVEGCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16263279.0,ACTIVITY,=,4,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL346230,LRTHKJMSTYBFFO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,0.5,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3220644,LRWYDNGJVXAUGR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,-0.02,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220644,LRWYDNGJVXAUGR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL2207659,LSHDMKHXFDYKLP-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,25.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL158595,LSLKPVQOFVGVSL-HSZRJFAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14741266.0,KI,=,890,NM,,,,,,,,,,,,,,,Binding affinity towards histamine H1 receptor of human colon cells was determined,"Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1566249,LSNWBKACGXCGAJ-UHFFFAOYSA-N,AMPIROXICAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1566249,LSNWBKACGXCGAJ-UHFFFAOYSA-N,AMPIROXICAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL549598,LSOVNGNFKVHURS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,IC50,=,4.4,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1082,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,AMOXICILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1082,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,AMOXICILLIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL62949,LSVDVSGWHKKGEU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,501.19,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077596,LSZWATPWPJETFE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1751,LTMHDMANZUZIPE-PUGKRICDSA-N,DIGOXIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1751,LTMHDMANZUZIPE-PUGKRICDSA-N,DIGOXIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2012728,LTQWNQOQFFXHAJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22342142.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM by radioligand displacement assay,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3113642,LUDBNRIKUAJOOY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24393810.0,INHIBITION,=,4,%,,,,,,,,,,,,,,,Displacement of histamine from human histamine H1 receptor at 1 uM relative to control,A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1935435,LUFOXAFMTZDQHJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,8.1,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935435,LUFOXAFMTZDQHJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,13.1,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1909051,LUHHARLTABWBTO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909051,LUHHARLTABWBTO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL165,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,RESVERATROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL165,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,RESVERATROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54126,LULNWZDBKTWDGK-UHFFFAOYSA-M,NEOSTIGMINE BROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54126,LULNWZDBKTWDGK-UHFFFAOYSA-M,NEOSTIGMINE BROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL273241,LUPMVYRKJBZCCI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Inhibition,<,50,%,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL552026,LUSFVKKEBIMJTI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,6.6,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1732,LUZRJRNZXALNLM-JGRZULCMSA-N,DIHYDROERGOTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1732,LUZRJRNZXALNLM-JGRZULCMSA-N,DIHYDROERGOTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64259,LVCDOFXANXULSM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,309.03,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1231107,LVQDKIWDGQRHTE-UHFFFAOYSA-N,CYROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1231107,LVQDKIWDGQRHTE-UHFFFAOYSA-N,CYROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL560061,LVQDPXHGLLUJTK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,69,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL105967,LVTJCSTYQPNIJJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,3890.45,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1672288,LVXAMCKZCLWWTF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21207959.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.,J. Med. Chem.,PUBLICATION,
CHEMBL21898,LVZOXUCPVVPLIK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,7.68,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL624,LWKSMQXIHQRJJJ-UHFFFAOYSA-N,2-[(2-METHYLAMINOETHYL)(P-METHOXYBENZYL)AMINO]PYRIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,8.12,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL187264,LWOMEPYLSGEMDX-SSEXGKCCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,9,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL325372,LXCFILQKKLGQFO-UHFFFAOYSA-N,METHYLPARABEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL325372,LXCFILQKKLGQFO-UHFFFAOYSA-N,METHYLPARABEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1908355,LXIKEPCNDFVJKC-QXMHVHEDSA-N,TENIDAP,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1908355,LXIKEPCNDFVJKC-QXMHVHEDSA-N,TENIDAP,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1393,LXMSZDCAJNLERA-ZHYRCANASA-N,SPIRONOLACTONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1393,LXMSZDCAJNLERA-ZHYRCANASA-N,SPIRONOLACTONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1935443,LXOHJARDVFSOPS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,1.9,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935443,LXOHJARDVFSOPS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,365,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL457299,LYCAIKOWRPUZTN-UHFFFAOYSA-N,ETHYLENE GLYCOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL457299,LYCAIKOWRPUZTN-UHFFFAOYSA-N,ETHYLENE GLYCOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220635,LYCGXPRAZPLFAM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL3220635,LYCGXPRAZPLFAM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL2165632,LYEWBZFHFDTNJX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,=,6.01,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL59931,LYZKHJXQSGMRGZ-OAQYLSRUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,10232.93,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL302795,LZNWYQJJBLGYLT-UHFFFAOYSA-N,TENOXICAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL302795,LZNWYQJJBLGYLT-UHFFFAOYSA-N,TENOXICAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1935434,LZTBBMYTELVXQM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,16.6,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2112451,LZZBODFOSOSLCF-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,20000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL593734,MAAQGZFMFXQVOG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,1670,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2158840,MANRLQSCJCTMOZ-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,125.89,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208434,MAWNODXTLNGOAA-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208434,MAWNODXTLNGOAA-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,3.98,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL313493,MBABOKRGFJTBAE-UHFFFAOYSA-N,METHANESULFONIC ACID METHYL ESTER,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL313493,MBABOKRGFJTBAE-UHFFFAOYSA-N,METHANESULFONIC ACID METHYL ESTER,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207382,MBFLODNVCSXSKE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23141912.0,INHIBITION,=,2.38,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM by radioligand displacement assay,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL832,MBGGBVCUIVRRBF-UHFFFAOYSA-N,SULFINPYRAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL832,MBGGBVCUIVRRBF-UHFFFAOYSA-N,SULFINPYRAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207670,MBMAQWYADJFPMU-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,251.19,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL186125,MBQMCWRJVSGZMF-WJOKGBTCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,30,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL639,MBUVEWMHONZEQD-UHFFFAOYSA-N,AZELASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,INHIBITION,,,,Active,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization at 100 nM incubated for 30 mins measured after washout followed by repeat histamine challenge at intervals of 90 and 270 mins by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL639,MBUVEWMHONZEQD-UHFFFAOYSA-N,AZELASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KD,=,0.2,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization at 100 nM after 30 mins by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL639,MBUVEWMHONZEQD-UHFFFAOYSA-N,AZELASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,1.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL639,MBUVEWMHONZEQD-UHFFFAOYSA-N,AZELASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.2,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL639,MBUVEWMHONZEQD-UHFFFAOYSA-N,AZELASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,1.2,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1767137,MBVVVQZOMZFVJF-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,0.1,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL502339,MCAARVUCNCRTPF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,ACTIVITY,=,1.8,%,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL502339,MCAARVUCNCRTPF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,2100,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL502339,MCAARVUCNCRTPF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,10700,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1222623,MCEBFAPNLMTKDG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,50.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL310555,MCJGNVYPOGVAJF-UHFFFAOYSA-N,OXYQUINOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL310555,MCJGNVYPOGVAJF-UHFFFAOYSA-N,OXYQUINOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923729,MCNAJLPLCULBOJ-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22014551.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Synthesis and evaluation of pyridone-phenoxypropyl-R-2-methylpyrrolidine analogues as histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL571987,MCPUZZJBAHRIPO-UHFFFAOYSA-N,LERSIVIRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20660667.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at up to 10 uM,"Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL1078346,MCSIYZQWCBJHGE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078346,MCSIYZQWCBJHGE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1935444,MCVGJQYUOLRXOM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,1.3,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935444,MCVGJQYUOLRXOM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,1.5,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935444,MCVGJQYUOLRXOM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,63,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1091790,MDTGYTUAMOVSAG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,IC50,=,23000,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272702,MDWSQWMMLXSJIP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,1000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220660,MEARZKSAHATTMZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1536,MECHNRXZTMCUDQ-RKHKHRCZSA-N,ERGOCALCIFEROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1536,MECHNRXZTMCUDQ-RKHKHRCZSA-N,ERGOCALCIFEROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2413154,MEKSQRMXWZHFIP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17221184.0,KI,=,1030,NM,,,,,,,,,,,,,,,,,,,
CHEMBL2413154,MEKSQRMXWZHFIP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23816046.0,KI,=,1030,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin),"Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL24,METKIMKYRPQLGS-UHFFFAOYSA-N,ATENOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL24,METKIMKYRPQLGS-UHFFFAOYSA-N,ATENOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1222626,MEWLTRGECZFZDU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,12.59,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1222626,MEWLTRGECZFZDU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,25.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL972,MEZLKOACVSPNER-GFCCVEGCSA-N,SELEGILINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL972,MEZLKOACVSPNER-GFCCVEGCSA-N,SELEGILINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL569,MFDFERRIHVXMIY-UHFFFAOYSA-N,PROCAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL569,MFDFERRIHVXMIY-UHFFFAOYSA-N,PROCAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL260549,MFJVHWQDKIEBCM-UHFFFAOYSA-N,VUF-10214,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18357976.0,INHIBITION,=,7,%,,,cell_based,,,,,NIH3T3,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in NIH3T3 cells at 10 uM,Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.,J. Med. Chem.,PUBLICATION,
CHEMBL2171033,MFJWXRIWIGLCGD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,31.62,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030624,MFKYGKXYJBKSQN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL289469,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,GRANISETRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL289469,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,GRANISETRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1086105,MGPIMNVSULKFFK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20452213.0,EC50,>,10000,NM,,,cell_based,,,,,SK-N-MC,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in human SK-N-MC cells,Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205827,MGYAQEPRQTVZOM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205827,MGYAQEPRQTVZOM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2207667,MHAQTEBGBYFXKL-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,251.19,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL268258,MHPMXTGKTXJIDI-IBGZPJMESA-N,A-80426,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771448.0,KI,>,1000,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to Histamine H1 receptor,Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity.,J. Med. Chem.,PUBLICATION,
CHEMBL1687,MHXYWXHKLBMJKL-QBYKQQEBSA-N,TUBOCURARINE CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1687,MHXYWXHKLBMJKL-QBYKQQEBSA-N,TUBOCURARINE CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL407030,MIFVTYPADKEWAV-HGRQBIKSSA-N,GAMMA-CYCLODEXTRIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL407030,MIFVTYPADKEWAV-HGRQBIKSSA-N,GAMMA-CYCLODEXTRIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL340978,MITFXPHMIHQXPI-UHFFFAOYSA-N,BENOXAPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL340978,MITFXPHMIHQXPI-UHFFFAOYSA-N,BENOXAPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2030633,MIZXZRHARATZMK-UHFFFAOYSA-N,"N-(3,4-DIMETHOXYBENZYL)PYRROLIDINE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1774101,MJDLYRJRCRLNGE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21366332.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor at 3.16 uM,1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis.,J. Med. Chem.,PUBLICATION,
CHEMBL480,MJIHNNLFOKEZEW-UHFFFAOYSA-N,LANSOPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL480,MJIHNNLFOKEZEW-UHFFFAOYSA-N,LANSOPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL305660,MJJALKDDGIKVBE-UHFFFAOYSA-N,EBASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,28.3,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL305660,MJJALKDDGIKVBE-UHFFFAOYSA-N,EBASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,3.29,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL322873,MJKGHXXXMDVBEW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,275.42,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476839,MJKRYUCQHJLOIV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19329329.0,KI,=,439,NM,,,,,,,,,,,,,,,Inhibition of human cloned histamine H1 receptor by competitive binding experiment,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL402087,MJLHCRFMFPSGBF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,1584.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220665,MJOSRXMZZADWFY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.21,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220665,MJOSRXMZZADWFY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,=,5.34,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL2432058,MJOVYQVAQIHDSE-DKSPCFMDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2207376,MJYQMQCVUXOIFY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23141912.0,INHIBITION,=,9.33,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM by radioligand displacement assay,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563647,MKKJPIHSAMRGEO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,41,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL184,MKUXAQIIEYXACX-UHFFFAOYSA-N,ACYCLOVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL184,MKUXAQIIEYXACX-UHFFFAOYSA-N,ACYCLOVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL806,MKXKFYHWDHIYRV-UHFFFAOYSA-N,FLUTAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL806,MKXKFYHWDHIYRV-UHFFFAOYSA-N,FLUTAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL52440,MKXZASYAUGDDCJ-NJAFHUGGSA-N,DEXTROMETHORPHAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL52440,MKXZASYAUGDDCJ-NJAFHUGGSA-N,DEXTROMETHORPHAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL271072,MLGRCKZMFCALCK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL15770,MLKXDPUZXIRXEP-MFOYZWKCSA-N,SULINDAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL15770,MLKXDPUZXIRXEP-MFOYZWKCSA-N,SULINDAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2165637,MLVBVDKCQYPOBL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,<,6,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL256473,MMAVGOXTOMTHGO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL83073,MMEQHMVQEKIHIG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,37.15,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL243897,MMHPZQOEUVHNBB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,5.7,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL561377,MMKZIPYPZZNRTO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,53,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1221931,MMOBEVMIJDLKKG-UHFFFAOYSA-N,2-(METHYLSULFONOTHIOYL)ETHANAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16408006.0,INHIBITION,,,,Not Active,,cell_based,,,,,COS-7,,,,,,,Displacement of [3H]mepyramine from human wild-type histamine H1 receptor expressed in COS-7 cells after 5 mins by liquid scintillation counting,Linking agonist binding to histamine H1 receptor activation.,Nat. Chem. Biol.,PUBLICATION,
CHEMBL238871,MMRPNJJCBOGWTP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1923531,MMWJPRSBOSCWBE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,4168.69,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL560120,MMXKXXGRZUAQGP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,28,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL560120,MMXKXXGRZUAQGP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,58,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL475620,MMZFKVNBNHUWDT-UHFFFAOYSA-N,UR-PI182,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,=,0.16,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL475620,MMZFKVNBNHUWDT-UHFFFAOYSA-N,UR-PI182,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,PKB,=,4.96,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as inhibition of histamine-induced gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL93645,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,ACECLOFENAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL93645,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,ACECLOFENAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL539093,MNOZJGDIRIYZSQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,3162.28,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2158828,MNSGCVNHLLGCDG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,15.85,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207643,MNVDCQLMHFFYCU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208418,MNXRFTOYSSFEST-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208418,MNXRFTOYSSFEST-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,316.23,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3357041,MOFVGVFZWIHAPO-DUXPYHPUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25318072.0,KI,=,153,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells by scintillation counting method,Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2.,J. Med. Chem.,PUBLICATION,
CHEMBL2158780,MOHMWXTYADLKCG-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,79.43,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432040,MPBJQDFYALBXED-CAUKCHDASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3220645,MPRLYBPYXQODHA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,-0.02,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220645,MPRLYBPYXQODHA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL3321790,MPWWGTFDWDZHRM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25070422.0,KI,=,977,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1632411,MQAUVLYNYCPXHD-ICFOKQHNSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,KI,>,10000,NM,,,cell_based,,,,,SK-N-MC,,,,,,,Binding affinity to human recombinant histamine H1 receptor expressed in human SK-N-MC cells by radioligand displacement assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL529,MQTOSJVFKKJCRP-BICOPXKESA-N,AZITHROMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL529,MQTOSJVFKKJCRP-BICOPXKESA-N,AZITHROMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL597,MRBDMNSDAVCSSF-UHFFFAOYSA-N,PHENTOLAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,4000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL597,MRBDMNSDAVCSSF-UHFFFAOYSA-N,PHENTOLAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,IC50,=,316227.77,NM,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL597,MRBDMNSDAVCSSF-UHFFFAOYSA-N,PHENTOLAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL597,MRBDMNSDAVCSSF-UHFFFAOYSA-N,PHENTOLAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3577957,MRTJHEDYFUFHHQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25893048.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 1 uM,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL62066,MRYDVIQPLWEQDJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,1659.59,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL330367,MRZJFWSFVDADTA-WLHGVMLRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,158,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669418,MSDXVUCMHKOWGT-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,8.1,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1257139,MSGAWMMCGSGKOV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,-1,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL515170,MSJCAWWJIHDUAU-OSTNNTLRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17428923.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 20 uM,Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe.,Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
CHEMBL1669406,MSMKOTVNTGCTFQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,41,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL65849,MSNSHZJXNNLNOS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12798320.0,KI,=,7696,NM,,,,,,,,,,,,,,,Compound was tested for its binding affinity towards human H1 receptor,"A new class of histamine H(3)-receptor antagonists: synthesis and structure-activity relationships of 7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1093607,MSPFRPWEGPBFTC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,122,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL84931,MSQRTETUBFIHMP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,2.57,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432041,MSTPNDDVMWUDFF-CAUKCHDASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3215892,MTATYSOUXXNXHF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23141912.0,INHIBITION,=,9.82,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM by radioligand displacement assay,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1929411,MTDODFSDMGLTDF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22019465.0,INHIBITION,,,,Not Active,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at histamine H1 receptor expressed in HEK293 cells co-transfected with pCRE-Luc gene assessed as inhibition of forskolin/histamine-induced cAMP accumulation at 1 uM after 5 hrs by luciferase reporter gene assay,"Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL484952,MTEFLXYKMHWTNG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19338356.0,ACTIVITY,<,50,%,Active,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL116735,MUAYITOFLINYIL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11585444.0,IC50,=,1660,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
CHEMBL386630,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,TESTOSTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL386630,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,TESTOSTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207282,MUPZZNZQFUCJBT-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200845,MUQNGPZZQDCDFT-JNQJZLCISA-N,HALCINONIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200845,MUQNGPZZQDCDFT-JNQJZLCISA-N,HALCINONIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2037608,MURCULVYVOMYIO-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22578490.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Synthesis and evaluation of 4- and 5-pyridazin-3-one phenoxypropylamine analogues as histamine-3 receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1194,MVFGUOIZUNYYSO-UHFFFAOYSA-N,PRILOCAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1194,MVFGUOIZUNYYSO-UHFFFAOYSA-N,PRILOCAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL488025,MVGSNCBCUWPVDA-MFOYZWKCSA-N,EXISULIND,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL488025,MVGSNCBCUWPVDA-MFOYZWKCSA-N,EXISULIND,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL476108,MVKKLGNVARQKRP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,188.6,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL564226,MVMQESMQSYOVGV-HNNXBMFYSA-N,(S)-(+)-DIMETHINDENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12593665.0,KI,=,0.437,NM,,,cell_based,,,,,CHO-K1,,,,,,,Compound was evaluated for binding affinity towards cloned human histamine H1 receptors stably expressed in CHO-K1 cells using [3H]mepyramine,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL564226,MVMQESMQSYOVGV-HNNXBMFYSA-N,(S)-(+)-DIMETHINDENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19663387.0,KI,=,0.4,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.,J. Med. Chem.,PUBLICATION,
CHEMBL1493369,MVMQESMQSYOVGV-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12593665.0,KI,=,69.18,NM,,,cell_based,,,,,CHO-K1,,,,,,,Compound was evaluated for binding affinity towards cloned human histamine H1 receptors stably expressed in CHO-K1 cells using [3H]mepyramine,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL22108,MVMQESMQSYOVGV-UHFFFAOYSA-N,DIMETHINDENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12593665.0,KI,=,0.692,NM,,,cell_based,,,,,CHO-K1,,,,,,,Compound was evaluated for binding affinity towards cloned human histamine H1 receptors stably expressed in CHO-K1 cells using [3H]mepyramine,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL708,MVWVFYHBGMAFLY-UHFFFAOYSA-N,ZIPRASIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,15,NM,,,,,,,,,,,,,,,,,,,
CHEMBL708,MVWVFYHBGMAFLY-UHFFFAOYSA-N,ZIPRASIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,4.6,NM,,,,,,,,,,,,,,,,,,,
CHEMBL708,MVWVFYHBGMAFLY-UHFFFAOYSA-N,ZIPRASIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11170639.0,KI,=,510,NM,,,,,,,,,,,,,,,Binding affinity towards human H1 receptor,Current and novel approaches to the drug treatment of schizophrenia.,J. Med. Chem.,PUBLICATION,
CHEMBL708,MVWVFYHBGMAFLY-UHFFFAOYSA-N,ZIPRASIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,43,NM,,,,,,,,,,,,,,,,,,,
CHEMBL708,MVWVFYHBGMAFLY-UHFFFAOYSA-N,ZIPRASIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14998318.0,KI,=,5.3,NM,,,,,,,,,,,,,,,Binding affinity towards human histamine H1 receptor,Selective optimization of side activities: another way for drug discovery.,J. Med. Chem.,PUBLICATION,
CHEMBL708,MVWVFYHBGMAFLY-UHFFFAOYSA-N,ZIPRASIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,47,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2387288,MWATVQYCLGPJBC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL21833,MWJREWWGBRMMAS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,8.17,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL93,MWLSOWXNZPKENC-UHFFFAOYSA-N,ZILEUTON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,,,,Not Determined,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells; not tested,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL93,MWLSOWXNZPKENC-UHFFFAOYSA-N,ZILEUTON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL93,MWLSOWXNZPKENC-UHFFFAOYSA-N,ZILEUTON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL69530,MXLOXTMJEAHTMC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,93,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL69530,MXLOXTMJEAHTMC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; + means Histamine-like pharmacological effect was retained,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL3238447,MXRUKGSLFINORK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24650714.0,KI,=,2238.72,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHO cell membrane after 120 mins by liquid scintillation counting analysis,Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL271632,MXYJVPGKILUPBU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,1000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2103769,MXYUKLILVYORSK-HKBOAZHASA-N,LOBELINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,IC50,=,44668.36,NM,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL600325,MYEJFUXQJGHEQK-ALRJYLEOSA-N,PROSCILLARIDIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL600325,MYEJFUXQJGHEQK-ALRJYLEOSA-N,PROSCILLARIDIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL262777,MYPYJXKWCTUITO-LYRMYLQWSA-N,VANCOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL262777,MYPYJXKWCTUITO-LYRMYLQWSA-N,VANCOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL8,MYSWGUAQZAJSOK-UHFFFAOYSA-N,CIPROFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL8,MYSWGUAQZAJSOK-UHFFFAOYSA-N,CIPROFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1257965,MYTSILBAQHYOET-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,3,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL417215,MYYDLAXWFPHASV-XMMPIXPASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,9332.54,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077588,MYYHJJQKWYFQTJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1077588,MYYHJJQKWYFQTJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2205815,MYZBXDLMEOAPIJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158788,MYZGZNJBQOQRTJ-DEOSSOPVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,63.1,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095699,MZZGOOYMKKIOOX-VKHMYHEASA-N,AZASERINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1095699,MZZGOOYMKKIOOX-VKHMYHEASA-N,AZASERINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257717,NAFIXABLSKOHPB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL558339,NAGKIWFBALBSMD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,59.3,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL564144,NANQRVOKMXDMNL-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19663387.0,KI,=,4,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.,J. Med. Chem.,PUBLICATION,
CHEMBL564144,NANQRVOKMXDMNL-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,4000,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL564144,NANQRVOKMXDMNL-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20800486.0,KI,=,4,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1090433,NANQRVOKMXDMNL-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,IC50,=,256000,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1090432,NANQRVOKMXDMNL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,12,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL157328,NAQBCIUOBUOYRD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Determined,,,,,,,,,,,,,,Intrinsic activity; Low affinity for the receptor: not tested for the efficacy,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157328,NAQBCIUOBUOYRD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,79432823472428.2,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157328,NAQBCIUOBUOYRD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL62115,NAVVYTVXMQUKNO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,2041.74,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL24940,NBLURSAFWMIMMI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,8.4,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1586,NBMKJKDGKREAPL-DVTGEIKXSA-N,BECLOMETHASONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1586,NBMKJKDGKREAPL-DVTGEIKXSA-N,BECLOMETHASONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL163,NCDNCNXCDXHOMX-XGKFQTDJSA-N,RITONAVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL163,NCDNCNXCDXHOMX-XGKFQTDJSA-N,RITONAVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL421,NCEXYHBECQHGNR-QZQOTICOSA-N,SULFASALAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL421,NCEXYHBECQHGNR-QZQOTICOSA-N,SULFASALAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220632,NCNMCQJOXQNURX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1210208,NCVQBIQQTNMSSG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,-1.2,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200656,NCXMLFZGDNKEPB-FFPOYIOWSA-N,NATAMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200656,NCXMLFZGDNKEPB-FFPOYIOWSA-N,NATAMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL714,NDAUXUAQIAJITI-UHFFFAOYSA-N,ALBUTEROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL714,NDAUXUAQIAJITI-UHFFFAOYSA-N,ALBUTEROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL406,NDDAHWYSQHTHNT-UHFFFAOYSA-N,INDAPAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL406,NDDAHWYSQHTHNT-UHFFFAOYSA-N,INDAPAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL475621,NDEWHFAPFGGMKU-UHFFFAOYSA-N,UR-PI294,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,=,0.3,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL475621,NDEWHFAPFGGMKU-UHFFFAOYSA-N,UR-PI294,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,EC50,=,3467.37,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL475621,NDEWHFAPFGGMKU-UHFFFAOYSA-N,UR-PI294,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0.3,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1970071,NDKGACIWVAOUQH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24135724.0,INHIBITION,>=,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 30 uM,"Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL187637,NDNBZMHADGKSLT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,295,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL578170,NDWXGJDJKXDMOV-HDICACEKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773162.0,IC50,=,170,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207661,NDXPOARUSJMOJN-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,12.59,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL214312,NESASFDNMLPZIR-KBPBESRZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16942032.0,EC50,>,10000,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in 293-EBNA cells by luciferase reporter gene assay,Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.,J. Med. Chem.,PUBLICATION,
CHEMBL214312,NESASFDNMLPZIR-KBPBESRZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16942032.0,IC50,>,10000,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1 receptor expressed in 293-EBNA cells assessed as inhibition of histamine agonist activity by luciferase reporter gene assay,Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.,J. Med. Chem.,PUBLICATION,
CHEMBL895,NETZHAKZCGBWSS-CEDHKZHLSA-N,NALBUPHINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL895,NETZHAKZCGBWSS-CEDHKZHLSA-N,NALBUPHINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL325516,NEUFWHZAVWYYSZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11585444.0,IC50,=,1280,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
CHEMBL711,NFBAXHOPROOJAW-UHFFFAOYSA-N,PHENINDIONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL711,NFBAXHOPROOJAW-UHFFFAOYSA-N,PHENINDIONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL113956,NFBNIRNKYJTDIE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11585444.0,IC50,=,1820,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
CHEMBL2012737,NFEVAAXMHCVVQF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22342142.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM by radioligand displacement assay,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200406,NFLLKCVHYJRNRH-UHFFFAOYSA-N,DIMENHYDRINATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,319,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200406,NFLLKCVHYJRNRH-UHFFFAOYSA-N,DIMENHYDRINATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,37,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL577904,NFQWOMAFZMZYOX-FZNQNYSPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773162.0,IC50,=,920,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL24665,NFUYVKMAGIJYKB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.91,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL24665,NFUYVKMAGIJYKB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,1000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL24665,NFUYVKMAGIJYKB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,251188643150958,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL24665,NFUYVKMAGIJYKB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,EC50,=,251.19,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL24665,NFUYVKMAGIJYKB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,INTRINSIC ACTIVITY,=,0.7,,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1148,NGBFQHCMQULJNZ-UHFFFAOYSA-N,TORSEMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1148,NGBFQHCMQULJNZ-UHFFFAOYSA-N,TORSEMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2158779,NHOMRPYETSURDH-DEOSSOPVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,100,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200862,NHTGHBARYWONDQ-JTQLQIEISA-N,METYROSINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200862,NHTGHBARYWONDQ-JTQLQIEISA-N,METYROSINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL453,NHUHCSRWZMLRLA-UHFFFAOYSA-N,SULFISOXAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL453,NHUHCSRWZMLRLA-UHFFFAOYSA-N,SULFISOXAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3094311,NHUZHVAPAIJQRS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24238903.0,INHIBITION,=,0.3,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL112710,NHVRIDDXGZPJTJ-UHFFFAOYSA-N,CGP-35024,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7650684.0,INHIBITION,=,30,%,,,,,,,,,,,,,,,Inhibition of [3H]- doxepine binding to histamine 1 receptor at 10e-5 M,Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL109,NIJJYAXOARWZEE-UHFFFAOYSA-N,VALPROIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL109,NIJJYAXOARWZEE-UHFFFAOYSA-N,VALPROIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1774501,NIKHLOHBEKSSNM-LIMNOBDPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,540,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1774500,NIKHLOHBEKSSNM-NYAPKIOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,84,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2206397,NIRASHDWADNQJU-UHFFFAOYSA-N,RO-4992479,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22795332.0,INHIBITION,=,1,%,,,,,,,,,,,,,,,Inhibition of human H1 receptor at 10 uM by CEREP assay,Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078359,NIVSSSJAKDSECS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078359,NIVSSSJAKDSECS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078359,NIVSSSJAKDSECS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL486962,NJDNYPJEXDZZKT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL486962,NJDNYPJEXDZZKT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,7100,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL406678,NJIAHBGDDDILFN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL322678,NJOYBVVACVXAAZ-SFHVURJKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,91000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL83,NKANXQFJJICGDU-QPLCGJKRSA-N,TAMOXIFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL83,NKANXQFJJICGDU-QPLCGJKRSA-N,TAMOXIFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1257138,NKZJSHCNJFDLTG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,-15,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1946126,NLEQSFUEJXECJY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,=,509,NM,,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3094314,NLGKYLSBSOGION-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24238903.0,INHIBITION,=,14.7,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1747,NLVFBUXFDBBNBW-PBSUHMDJSA-N,TOBRAMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1747,NLVFBUXFDBBNBW-PBSUHMDJSA-N,TOBRAMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL563055,NMEALLMQARPNTN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,14.1,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2024094,NMIIKXFGCKOYRV-WHOFXGATSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22171543.0,INHIBITION,=,-4.8,%,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from H1 histamine receptor at 10 uM,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,PUBLICATION,
CHEMBL2158777,NMLHPAJBQUFHAV-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,158.49,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL104808,NMOWFTXQHLZDDV-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,9200,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL59798,NMTPIRAMYOPHIO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,457.09,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1489,NMUSYJAQQFHJEW-KVTDHHQDSA-N,AZACITIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1489,NMUSYJAQQFHJEW-KVTDHHQDSA-N,AZACITIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL462605,NNACHAUCXXVJSP-UHFFFAOYSA-N,TIPROLISANT,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24650714.0,KI,=,1148.15,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHO cell membrane after 120 mins by liquid scintillation counting analysis,Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL28607,NNGCXJPRHBHODU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL79,NNJVILVZKWQKPM-UHFFFAOYSA-N,LIDOCAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL79,NNJVILVZKWQKPM-UHFFFAOYSA-N,LIDOCAINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL622,NNYBQONXHNTVIJ-UHFFFAOYSA-N,ETODOLAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL622,NNYBQONXHNTVIJ-UHFFFAOYSA-N,ETODOLAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL394015,NOBSINPJDRJYCC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL66949,NOTOMXGHDLEQBF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL66949,NOTOMXGHDLEQBF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta; no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL757,NPAGDVCDWIYMMC-IZPLOLCNSA-N,NANDROLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL757,NPAGDVCDWIYMMC-IZPLOLCNSA-N,NANDROLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3039597,NPEFREDMMVQEPL-RWPARATISA-N,GENTAMICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3039597,NPEFREDMMVQEPL-RWPARATISA-N,GENTAMICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL57,NQDJXKOVJZTUJA-UHFFFAOYSA-N,NEVIRAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL57,NQDJXKOVJZTUJA-UHFFFAOYSA-N,NEVIRAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL238503,NQEWRKQNDSWJNM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL418691,NQLCAHXYVYXKBG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,812.83,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077860,NQQWDTFCJAJWQW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2171026,NQTXEWZDVUMZDO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,31.62,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62050,NQVNEFLFZVEJSK-RUZDIDTESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,13489.63,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL291394,NQWIESOLCWAUTM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,478.63,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1177,NRNCYVBFPDDJNE-UHFFFAOYSA-N,PEMOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1177,NRNCYVBFPDDJNE-UHFFFAOYSA-N,PEMOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1092650,NRNPLYWFPSCQAF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,1.5,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256015,NRQJARQPULKWBG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL201933,NSEVJPOKAGLQCK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16275087.0,INHIBITION,<,50,%,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1940418,NSMCYUMPIGJKHV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22245230.0,KI,=,167,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor by liquid scintillation counting,Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL256658,NSOOFJHAXVGHFH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1222552,NSRMKMSTPLJNHM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,0.631,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL96471,NTBSVMCWAHSWAK-YLOCQQLVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,29.7,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL195437,NTDQQZYCCIDJRK-UHFFFAOYSA-N,4-OCTYLPHENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL195437,NTDQQZYCCIDJRK-UHFFFAOYSA-N,4-OCTYLPHENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1096428,NTHUVTORAXKPJS-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,=,6165.95,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1096428,NTHUVTORAXKPJS-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EMAX,=,0.34,%,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL483406,NTHUVTORAXKPJS-UHFFFAOYSA-N,UR-AK24,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,ACTIVITY,=,1.3,%,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL483406,NTHUVTORAXKPJS-UHFFFAOYSA-N,UR-AK24,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,EFFICACY,=,0.35,,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL483406,NTHUVTORAXKPJS-UHFFFAOYSA-N,UR-AK24,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,3000,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL483406,NTHUVTORAXKPJS-UHFFFAOYSA-N,UR-AK24,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,14300,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL483406,NTHUVTORAXKPJS-UHFFFAOYSA-N,UR-AK24,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,=,0.35,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL483406,NTHUVTORAXKPJS-UHFFFAOYSA-N,UR-AK24,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,PKB,<,4.9,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as inhibition of histamine-induced gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL483406,NTHUVTORAXKPJS-UHFFFAOYSA-N,UR-AK24,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,INTRINSIC ACTIVITY,=,0.4,,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL483406,NTHUVTORAXKPJS-UHFFFAOYSA-N,UR-AK24,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,PKB,=,4.8,,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1096429,NTHUVTORAXKPJS-ZDUSSCGKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,=,831.76,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1096429,NTHUVTORAXKPJS-ZDUSSCGKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EMAX,=,0.53,%,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL243712,NTJOBXMMWNYJFB-UHFFFAOYSA-N,AMISULPRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19337725.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL534512,NTMBNTAWSSELPH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,=,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2205830,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205830,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,284,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; + means Histamine-like pharmacological effect was retained,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7925364.0,KI,=,1258.92,NM,,,,,,,,,,,,,,,,,,,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8335064.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8903934.0,KI,=,1258.92,NM,,,,,,,,,,,,,,,,,,,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11809864.0,KI,=,1258.93,NM,,,,,,,,,,,,,,,,,,,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12626648.0,KI,=,2060,NM,,,,,,,,,,,,,,,,,,,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,=,13,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,1,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,158.49,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,15848931924611.1,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15033391.0,KI,=,7010,NM,,,,,,,,,,,,,,,,,,,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16408006.0,KI,=,79432.82,NM,,,cell_based,,,,,COS-7,,,,,,,Displacement of [3H]mepyramine from human wild-type histamine H1 receptor expressed in COS-7 cells by liquid scintillation counting,Linking agonist binding to histamine H1 receptor activation.,Nat. Chem. Biol.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,190,NM,,,,,,,,,,,,,,,,,,,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16942032.0,EC50,=,45,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in 293-EBNA cells by luciferase reporter gene assay,Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.,J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,EC50,=,190,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,EC50,=,190.55,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,EC50,=,190.55,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,=,190.55,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EMAX,=,1,%,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,EC50,=,199.53,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25993395.0,KI,=,6000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin),Functional Profiling of 2-Aminopyrimidine Histamine H4 Receptor Modulators.,J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,EC50,=,190,NM,,,,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 or RGS9 assessed as increase in 32Pi level incubated for 20 mins by liquid scintillation counting in presence of [gamma32P]GTP,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,EC50,=,190.55,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL90,NTYJJOPFIAHURM-UHFFFAOYSA-N,HISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,~,1000,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL154047,NTZJIQAKZMLDFO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Active,,,,,,,,,,,,,,Intrinsic activity; Tested up to 100 uM: no effects up to 10 uM,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL154047,NTZJIQAKZMLDFO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,79432823472428.2,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL154047,NTZJIQAKZMLDFO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2207635,NUTCIQIPIDPFOT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,=,1400,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1784671,NVCJMYLJSSPEKR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21570838.0,INHIBITION,<,50,%,Not Active,,,,,,,,,,,,,,Inhibition of human recombinant H1 receptor at 10 uM by radioligand binding assay,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL27769,NVKAWKQGWWIWPM-ABEVXSGRSA-N,STANOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL27769,NVKAWKQGWWIWPM-ABEVXSGRSA-N,STANOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL63363,NVMJQHXXGAZVAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL63363,NVMJQHXXGAZVAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; - means no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL1278115,NWCYKTKORNLIRC-AVKWCDSFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,25.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL1278114,NWCYKTKORNLIRC-BPARTEKVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,10,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL105,NWIBSHFKIJFRCO-WUDYKRTCSA-N,MITOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL105,NWIBSHFKIJFRCO-WUDYKRTCSA-N,MITOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171044,NWUBEEIEKUQVJL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL155314,NWWFCAFBMXDHNK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.9,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL155314,NWWFCAFBMXDHNK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,1995.26,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL155314,NWWFCAFBMXDHNK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,3981071705534970,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL572,NXFQHRVNIOXGAQ-YCRREMRBSA-N,NITROFURANTOIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL572,NXFQHRVNIOXGAQ-YCRREMRBSA-N,NITROFURANTOIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171032,NXHYSNCNFYHMIU-NFBKMPQASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,199.53,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3094216,NXSLQNZNLLDVBI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,KI,=,1995.26,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL393436,NYAIYQKWZFWRCU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,826,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1210268,NYHCZXKEQVHUAS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,55,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL70586,NYKCGQQJNVPOLU-ONTIZHBOSA-N,SPIRADOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL70586,NYKCGQQJNVPOLU-ONTIZHBOSA-N,SPIRADOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL92401,NYMGNSNKLVNMIA-UHFFFAOYSA-N,IPRONIAZID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL92401,NYMGNSNKLVNMIA-UHFFFAOYSA-N,IPRONIAZID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1079686,NYMPDEKHLLUZPU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,5000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277126,NYWUAMYWDNANQG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,50.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL2207654,NZFSPDVTABQASR-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,2.51,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL415324,NZHGWWWHIYHZNX-CSKARUKUSA-N,TRANILAST,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL415324,NZHGWWWHIYHZNX-CSKARUKUSA-N,TRANILAST,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402853,NZPLLWYDJFVQEH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,1000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1237174,OAKJQQAXSVQMHS-UHFFFAOYSA-N,HYDRAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1237174,OAKJQQAXSVQMHS-UHFFFAOYSA-N,HYDRAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL59733,OBMUCKQULKBRME-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,100000,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL445332,OBSYBRPAKCASQB-AGQYDFLVSA-N,SALVINORIN A,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12192085.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1210271,ODABXLCSMKWJEM-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,58,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1774502,ODFDIJBCTCNYMX-OPVMPGTRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,92,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL314968,ODJIGTDOQQQJKM-JKRBJUMTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,47.1,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL917,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,FLOXURIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL917,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,FLOXURIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207663,ODKRBJGIPOQDPJ-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,10,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1632174,ODMLUIATXKBXOW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21075638.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to Histamine receptor H1,Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL101740,ODQWQRRAPPTVAG-BOPFTXTBSA-N,CIDOXEPIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,0.49,NM,,,,,,,,,,,,,,,,,,,
CHEMBL101740,ODQWQRRAPPTVAG-BOPFTXTBSA-N,CIDOXEPIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,0.17,NM,,,,,,,,,,,,,,,,,,,
CHEMBL101740,ODQWQRRAPPTVAG-BOPFTXTBSA-N,CIDOXEPIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,0.09,NM,,,,,,,,,,,,,,,,,,,
CHEMBL101740,ODQWQRRAPPTVAG-BOPFTXTBSA-N,CIDOXEPIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,0.32,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1628227,ODQWQRRAPPTVAG-UHFFFAOYSA-N,DOXEPIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,ACTIVITY,,,,Active,,cell_based,,,,,HEK293,,,,,,,Inverse agonist activity at human histamine H1 receptor expressed in HEK293 cells assessed as inhibition of histamine-induced [3Hinositol phosphate accumulation after 1 hr by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1628227,ODQWQRRAPPTVAG-UHFFFAOYSA-N,DOXEPIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,0.178,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1628227,ODQWQRRAPPTVAG-UHFFFAOYSA-N,DOXEPIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,0.57,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1628227,ODQWQRRAPPTVAG-UHFFFAOYSA-N,DOXEPIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.066,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL514217,ODRJZKUJAYVKSJ-VVOJOOEHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18768318.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Synthesis and evaluation of a spiro-isobenzofuranone class of histamine H3 receptor inverse agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL167911,OEBRKCOSUFCWJD-UHFFFAOYSA-N,DICHLORVOS,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL167911,OEBRKCOSUFCWJD-UHFFFAOYSA-N,DICHLORVOS,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL327888,OEJHRMYSNOPXGZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.2,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL783,OELFLUMRDSZNSF-BRWVUGGUSA-N,NATEGLINIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL783,OELFLUMRDSZNSF-BRWVUGGUSA-N,NATEGLINIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220891,OEPVBKWJLSFTFP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1767158,OEYDBWKMXFZENQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,2.51,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL407,OFBIFZUFASYYRE-UHFFFAOYSA-N,FLUMAZENIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL407,OFBIFZUFASYYRE-UHFFFAOYSA-N,FLUMAZENIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,ALLOPURINOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,ALLOPURINOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL236788,OFGZKSUTEKHHAS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,2600,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1601669,OFHCOWSQAMBJIW-AVJTYSNKSA-N,ALFACALCIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1601669,OFHCOWSQAMBJIW-AVJTYSNKSA-N,ALFACALCIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3262896,OFHXXBRBGWUOHR-NYYWCZLTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24678947.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) at 10 uM,Identification and characterization of small molecule modulators of the Epstein-Barr virus-induced gene 2 (EBI2) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1929401,OFJDLSDRRRGLBI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22019465.0,INHIBITION,,,,Not Active,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at histamine H1 receptor expressed in HEK293 cells co-transfected with pCRE-Luc gene assessed as inhibition of forskolin/histamine-induced cAMP accumulation at 1 uM after 5 hrs by luciferase reporter gene assay,"Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL95029,OFMHVSNETOZSQH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1071,OFPXSFXSNFPTHF-UHFFFAOYSA-N,OXAPROZIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1071,OFPXSFXSNFPTHF-UHFFFAOYSA-N,OXAPROZIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1440,OFVLGDICTFRJMM-WESIUVDSSA-N,TETRACYCLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1440,OFVLGDICTFRJMM-WESIUVDSSA-N,TETRACYCLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL936,OGAKLTJNUQRZJU-UHFFFAOYSA-N,DIPHENIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL936,OGAKLTJNUQRZJU-UHFFFAOYSA-N,DIPHENIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2165634,OGDYCPQMQHJZLZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,<,6,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL70598,OGEAASSLWZDQBM-UHFFFAOYSA-N,TEMELASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8335064.0,KI,=,3.2,NM,,,,,,,,,,,,,,,,,,,
CHEMBL723,OGHNVEJMJSYVRP-UHFFFAOYSA-N,CARVEDILOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL723,OGHNVEJMJSYVRP-UHFFFAOYSA-N,CARVEDILOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267014,OGJGQVFWEPNYSB-UHFFFAOYSA-N,L-745870,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL9,OGJPXUAPXNRGGI-UHFFFAOYSA-N,NORFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL9,OGJPXUAPXNRGGI-UHFFFAOYSA-N,NORFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL264761,OGLKHSQISDJZCG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,977.24,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669416,OGQADGYHVAQLNE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,249,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL870,OGSPWJRAVKPPFI-UHFFFAOYSA-N,ALENDRONIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL870,OGSPWJRAVKPPFI-UHFFFAOYSA-N,ALENDRONIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1669409,OGTGPRXXTIEASF-HNNXBMFYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,32,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL372453,OGWAJJGAXANYMJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16143528.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards cloned Histamine H1 receptor,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL90555,OGWKCGZFUXNPDA-XQKSVPLYSA-N,VINCRISTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL90555,OGWKCGZFUXNPDA-XQKSVPLYSA-N,VINCRISTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL244945,OHAOVJVRDRFORL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.6,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL181085,OHBPVXVMMZZMKM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15686917.0,KI,=,7.59,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human Histamine H1 receptor in CHO K1 cells,5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370128,OHBRURMYVYWCLY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16143528.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards cloned Histamine H1 receptor,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL444307,OHFUDGRGQOZMIF-IZZDOVSWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,426.58,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783965,OHKBLWVRXBNICP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,160,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783965,OHKBLWVRXBNICP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,3980,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL520349,OHOQFGDSEWQDAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19338356.0,ACTIVITY,<,50,%,Active,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL131,OIGNJSKKLXVSLS-VWUMJDOOSA-N,PREDNISOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL131,OIGNJSKKLXVSLS-VWUMJDOOSA-N,PREDNISOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL68174,OILYHGUWEKVOQT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL68174,OILYHGUWEKVOQT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; - means no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL3609372,OINGHOPGNMYCAB-INIZCTEOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26191365.0,IC50,>,30000,NM,,,,,,,,,,,,,,,Inhibition of recombinant human histamine H1 receptor,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2178580,OIXSYJAHIPQFMO-RUZDIDTESA-N,YM-344484,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22931505.0,KI,=,47,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at histamine H1 receptor expressed in human PC3 cells inhibition of histamine-induced calcium influx by cell based assay,Chemokine receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1767155,OIZYYUJMNZAXNN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,6.31,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL253376,OJGDCBLYJGHCIH-UHFFFAOYSA-N,BROMHEXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL253376,OJGDCBLYJGHCIH-UHFFFAOYSA-N,BROMHEXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2387290,OJGQPGKTJLEYTJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1447,OJMMVQQUTAEWLP-KIDUDLJLSA-N,LINCOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1447,OJMMVQQUTAEWLP-KIDUDLJLSA-N,LINCOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL94739,OJSFTALXCYKKFQ-YLJYHZDGSA-N,FEMOXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,4200,NM,,,,,,,,,,,,,,,,,,,
CHEMBL2432038,OKCSFONJDXUZOU-CAUKCHDASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL386281,OKJKIOJUDZFVDL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17234405.0,INHIBITION,=,36,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10uM,"An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL598753,OKSDPUBPIUWZPV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20045641.0,KI,=,2640,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human cloned histamine H1 receptor,"9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1917464,OLADFXRHWWGOMN-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944855.0,INHIBITION,<,30,%,,,,,,,,,,,,,,,Inhibition of human H1R at 10 uM,Synthesis and evaluation of pyridazinone-phenethylamine derivatives as selective and orally bioavailable histamine H(3) receptor antagonists with robust wake-promoting activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL526,OLBCVFGFOZPWHH-UHFFFAOYSA-N,PROPOFOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL526,OLBCVFGFOZPWHH-UHFFFAOYSA-N,PROPOFOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL452847,OLJSGKYQYTWQNJ-UHFFFAOYSA-N,VUF-10497,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19053770.0,KI,=,19.95,NM,,,cell_based,,,,,NIH3T3,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in NIH3T3 cells,Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach.,J. Med. Chem.,PUBLICATION,
CHEMBL452847,OLJSGKYQYTWQNJ-UHFFFAOYSA-N,VUF-10497,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,549.54,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL479683,OLLHYYCQHNBTQC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24582985.0,INHIBITION,=,13,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by radioligand binding assay relative to control,5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL85606,OLWRVVHPJFLNPW-LSNLESRRSA-N,SB-277011,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.2,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL85606,OLWRVVHPJFLNPW-LSNLESRRSA-N,SB-277011,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,630.96,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL85606,OLWRVVHPJFLNPW-LSNLESRRSA-N,SB-277011,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,630.96,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1210082,OMARKUBVZGBSTE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3233067,ONISVGVNTCDONI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24650714.0,KI,=,6165.95,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHO cell membrane after 120 mins by liquid scintillation counting analysis,Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1200624,ONKUMRGIYFNPJW-KIEAKMPYSA-N,ETHYNODIOL DIACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200624,ONKUMRGIYFNPJW-KIEAKMPYSA-N,ETHYNODIOL DIACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL112797,ONNMDRQRSGKZCN-UHFFFAOYSA-N,CGP-36742,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7650685.0,INHIBITION,=,7,%,,,,,,,,,,,,,,,Inhibition of [3H]doxepine binding to histamine-1 receptor of central nervous system.,"Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1617548,ONRXABULYAHOMS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,10715.19,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL565833,ONUBXRCAOBQBRS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19632840.0,IC50,>,5000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL311231,ONUZLDLDGNZGFE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL602305,ONWOFJCPRAZRKC-BOPFTXTBSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20020710.0,ACTIVITY,=,0,%,,,,,,,,,,,,,,,Displacement of radioligand from histamine H1 receptor at 10 uM,Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.,J. Med. Chem.,PUBLICATION,
CHEMBL282424,OOKNJSVAHXTYKL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783956,OORNIOGZQUYGRW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,610,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783956,OORNIOGZQUYGRW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,940,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL566075,OOUPDYBXVFKJRL-UJKQEGAGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773162.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL287367,OPICWPJAKDPOOB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12626648.0,KI,=,1760,NM,,,,,,,,,,,,,,,,,,,
CHEMBL685,OPXLLQIJSORQAM-UHFFFAOYSA-N,MEBENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL685,OPXLLQIJSORQAM-UHFFFAOYSA-N,MEBENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL459730,OQIBXTHHXDTIBJ-OAQYLSRUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18754613.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human cloned histamine H1 receptor,"Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.",J. Med. Chem.,PUBLICATION,
CHEMBL1697694,OQIQSTLJSLGHID-WNWIJWBNSA-N,AFLATOXIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1697694,OQIQSTLJSLGHID-WNWIJWBNSA-N,AFLATOXIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL200906,OQMLSKSSPKAKJQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16275071.0,ACTIVITY,=,7,%,,,,,,,,,,,,,,,Percentage binding to histamine H1 at 10 uM,A new chemical tool for exploring the physiological function of the PDE2 isozyme.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669415,OQSOOFROGDVPSV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,4605,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL521179,OQWZIAVXCYIZNN-UHFFFAOYSA-N,SR-3677,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18834107.0,INHIBITION,=,7,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 3 uM,Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL97240,ORBDOXUKPRMJQT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.26,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3113644,ORDPXOCNLOPGLX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24393810.0,INHIBITION,=,13,%,,,,,,,,,,,,,,,Displacement of histamine from human histamine H1 receptor at 1 uM relative to control,A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL410270,ORMPNUUVYNSLES-WLHGVMLRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,500,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2387284,OSBYOAIKJPMFDA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL398440,OSDLLIBGSJNGJE-UHFFFAOYSA-N,CHLOROXYLENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL398440,OSDLLIBGSJNGJE-UHFFFAOYSA-N,CHLOROXYLENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64317,OSENGOVQGXZHHZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,575.44,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1929412,OSHFDBMABRTSHC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22019465.0,INHIBITION,,,,Not Active,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at histamine H1 receptor expressed in HEK293 cells co-transfected with pCRE-Luc gene assessed as inhibition of forskolin/histamine-induced cAMP accumulation at 1 uM after 5 hrs by luciferase reporter gene assay,"Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1909072,OSJJYEUEJRVVOD-UHFFFAOYSA-N,PIPAMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,9.94,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909072,OSJJYEUEJRVVOD-UHFFFAOYSA-N,PIPAMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1.15,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171039,OSUVEVWOPQLILG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,50.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277401,OSWDQWCAAIWPDM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,1000,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL108545,OSWPMRLSEDHDFF-UHFFFAOYSA-N,METHYL SALICYLATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL108545,OSWPMRLSEDHDFF-UHFFFAOYSA-N,METHYL SALICYLATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL418470,OTBYLNCJHFPRTL-NKWVEPMBSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,>,0.0001,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL60716,OTBYLNCJHFPRTL-RQJHMYQMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,>,0.0001,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL1236282,OTVAEFIXJLOWRX-NXEZZACHSA-N,THIAMPHENICOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1236282,OTVAEFIXJLOWRX-NXEZZACHSA-N,THIAMPHENICOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL597528,OUBNFHMJUXSZKL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20045641.0,KI,=,964,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human cloned histamine H1 receptor,"9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL817,OUDSBRTVNLOZBN-UHFFFAOYSA-N,TOLAZAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL817,OUDSBRTVNLOZBN-UHFFFAOYSA-N,TOLAZAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2146809,OUEZWZJJIKBFFV-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.316,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146809,OUEZWZJJIKBFFV-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.316,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL26260,OUGIDAPQYNCXRA-UHFFFAOYSA-N,BETA-NAPHTHOFLAVONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL26260,OUGIDAPQYNCXRA-UHFFFAOYSA-N,BETA-NAPHTHOFLAVONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3358509,OURPZJJZFFKVJH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25343529.0,KI,=,110,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,"Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies.",J. Med. Chem.,PUBLICATION,
CHEMBL1946255,OUSOPIMSKOMYQI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,=,665,NM,,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL157264,OUVNPGHJCOISPW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Active,,,,,,,,,,,,,,Intrinsic activity; Tested up to 10 uM: no effects up to 1 uM,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157264,OUVNPGHJCOISPW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,100000000000000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157264,OUVNPGHJCOISPW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL244087,OVGUUSWJYHCFLN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.9,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1092767,OVTUKEYYZWXZMJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,35,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1092663,OWMBYQVIMDTSAW-HNNXBMFYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,4.2,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476933,OWMYGKYXZFSRMD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL160893,OWPHKTVZEZNCMB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,137,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL77675,OWRCNXZUPFZXOS-UHFFFAOYSA-N,"N,N'-DIPHENYL-GUANIDINE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL77675,OWRCNXZUPFZXOS-UHFFFAOYSA-N,"N,N'-DIPHENYL-GUANIDINE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL59389,OWWNABDDYQLERE-CRCLSJGQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,>,0.0001,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL13559,OWWNABDDYQLERE-RFZPGFLSSA-N,VUF-5296,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,>,0.0001,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL294061,OWWNABDDYQLERE-UHNVWZDZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,>,0.0001,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL13795,OWWNABDDYQLERE-WHFBIAKZSA-N,VUF-5297,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12723960.0,EC50,=,864,NM,,,,,,,,,,,,,,,Inhibition of human Histamine H1 receptor using [3H]pyrilamine,"Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.",J. Med. Chem.,PUBLICATION,
CHEMBL188921,OWYLAEYXIQKAOL-UHFFFAOYSA-N,BUFLOMEDIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL188921,OWYLAEYXIQKAOL-UHFFFAOYSA-N,BUFLOMEDIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL429458,OXAGECQHLDNVCY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL270595,OXEFHEYEQUISKC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL455288,OXJGPZFAZUEPIX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,390,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL392354,OXLSTDPYCCQCDK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL564168,OYGQVRYZRZJCQY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,124,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078632,OYSPQBLWSYBOCR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078632,OYSPQBLWSYBOCR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL255827,OYUFXMRRZYKKDL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL79838,OZETYYSIKGRYTO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935425,OZMRAMSUYZLMIG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153342.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,"Synthesis and evaluation of 4-alkoxy-[1'-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4'-piperidine)] analogues as histamine-3 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1923535,OZUNHSMQAVTNLW-UHFFFAOYSA-N,2-(2-PHENOXYPHENYL)ETHANAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,10964.78,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL493,OZVBMTJYIDMWIL-AYFBDAFISA-N,BROMOCRIPTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL493,OZVBMTJYIDMWIL-AYFBDAFISA-N,BROMOCRIPTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469,OZWKMVRBQXNZKK-UHFFFAOYSA-N,KETOROLAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469,OZWKMVRBQXNZKK-UHFFFAOYSA-N,KETOROLAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257946,OZZLMZAQJKSGCB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,100,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL431850,PARRBDIQICRPTM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,437,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1243,PBCZLFBEBARBBI-UHFFFAOYSA-N,SULFABENZAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1243,PBCZLFBEBARBBI-UHFFFAOYSA-N,SULFABENZAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1259172,PBYSLXLVOFLVAY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,64,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL2208425,PCRWWFINVOSHRN-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208425,PCRWWFINVOSHRN-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,15.85,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL503,PCZOHLXUXFIOCF-BXMDZJJMSA-N,LOVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL503,PCZOHLXUXFIOCF-BXMDZJJMSA-N,LOVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1258079,PDDXKTLXEAXUKO-INIZCTEOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,10,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171027,PDJBLXDNFLXACI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,79.43,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL18701,PDMUULPVBYQBBK-UHFFFAOYSA-N,RO-201724,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL18701,PDMUULPVBYQBBK-UHFFFAOYSA-N,RO-201724,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
,PDNJLMZEGXHSCU-GSVOUGTGSA-N,D-HOMOCYSTEINE SULFINIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1516176,PDNJLMZEGXHSCU-VKHMYHEASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL2349533,PDUYPEOJRTWPFT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23434029.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL291166,PEDXQUUSXXYPJU-HSZRJFAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10937710.0,KI,=,355,NM,,,,,,,,,,,,,,,Selectivity screen against human Histamine H1 receptor,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL106483,PFEJJOZKVMFZED-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,3235.94,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL107293,PFSYJJKLBNXBAA-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,5500,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL196169,PGAUZNVGTNAJSV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16143528.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards cloned Histamine H1 receptor,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL184618,PGBHMTALBVVCIT-VCIWKGPPSA-N,NEOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL184618,PGBHMTALBVVCIT-VCIWKGPPSA-N,NEOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL426317,PGGCRGAETLNAJC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16458504.0,KI,=,839,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor by radioligand binding assay,"Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-HT1A receptor PET ligand.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077580,PGKDLJHDJQXSHU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1077580,PGKDLJHDJQXSHU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1201190,PGLIUCLTXOYQMV-GHVWMZMZSA-N,LEVOCETIRIZINE DIHYDROCHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771458.0,KI,=,50,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for H1 histamine receptor expressed in CHO cells,"Norpiperidine imidazoazepines as a new class of potent, selective, and nonsedative H1 antihistamines.",J. Med. Chem.,PUBLICATION,
CHEMBL1221512,PGOKBMWPBDRDGN-IBXSQZDTSA-N,L-744832,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1221512,PGOKBMWPBDRDGN-IBXSQZDTSA-N,L-744832,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171042,PHHPFXWDLDXLPN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,31.62,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1149,PHIQHXFUZVPYII-ZCFIWIBFSA-N,LEVOCARNITINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1149,PHIQHXFUZVPYII-ZCFIWIBFSA-N,LEVOCARNITINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1105,PHJFLPMVEFKEPL-UHFFFAOYSA-N,6-METHOXY-2-NAPHTHYLACETIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1105,PHJFLPMVEFKEPL-UHFFFAOYSA-N,6-METHOXY-2-NAPHTHYLACETIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL621,PHLBKPHSAVXXEF-UHFFFAOYSA-N,TRAZODONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,1100,NM,,,,,,,,,,,,,,,,,,,
CHEMBL621,PHLBKPHSAVXXEF-UHFFFAOYSA-N,TRAZODONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,361,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL621,PHLBKPHSAVXXEF-UHFFFAOYSA-N,TRAZODONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,42,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL41543,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL41543,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL319231,PHNZBVSSQHIXIP-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,90000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL319231,PHNZBVSSQHIXIP-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,100000,NM,,,,,,,,,,,,,,,Binding affinity towards human Histamine H1 receptor (For compound 11),Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2387318,PHOGKWBKNQASCX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,8.4,NM,,,,,,,,,,,,,,,,,,,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,6.3,NM,,,,,,,,,,,,,,,,,,,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,50,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,5.86,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL833,PHWBOXQYWZNQIN-UHFFFAOYSA-N,TICLOPIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL833,PHWBOXQYWZNQIN-UHFFFAOYSA-N,TICLOPIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1090175,PIHREWZGYZJCNQ-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,3.1,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL302468,PIIKAHNRVYTSPK-HSZRJFAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,4570.88,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL94,PIJVFDBKTWXHHD-HIFRSBDPSA-N,PHYSOSTIGMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL94,PIJVFDBKTWXHHD-HIFRSBDPSA-N,PHYSOSTIGMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL47244,PIMZUZSSNYHVCU-YKWPQBAZSA-N,PICROTOXININ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL47244,PIMZUZSSNYHVCU-YKWPQBAZSA-N,PICROTOXININ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL474449,PIWSSTXHMGKDJO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,,,,Not Determined,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL474449,PIWSSTXHMGKDJO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL534958,PJJQGSLLJOVYBM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,=,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1712923,PJLVTVAIERNDEQ-BTJKTKAUSA-N,IRSOGLADINE MALEATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1712923,PJLVTVAIERNDEQ-BTJKTKAUSA-N,IRSOGLADINE MALEATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL349543,PJLWLZAKVLPHRL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20045641.0,KI,,,,Not Determined,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human cloned histamine H1 receptor,"9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL596,PJMPHNIQZUBGLI-UHFFFAOYSA-N,FENTANYL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,IC50,=,147910.84,NM,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1539,PJSFRIWCGOHTNF-UHFFFAOYSA-N,SULFADOXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1539,PJSFRIWCGOHTNF-UHFFFAOYSA-N,SULFADOXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1464,PJVWKTKQMONHTI-UHFFFAOYSA-N,WARFARIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1464,PJVWKTKQMONHTI-UHFFFAOYSA-N,WARFARIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL390429,PKAXIMFUJIQFKS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.7,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1090528,PKONXOYDGGORHO-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,2.2,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL726,PLDUPXSUYLZYBN-UHFFFAOYSA-N,FLUPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,20.83,NM,,,,,,,,,,,,,,,,,,,
CHEMBL726,PLDUPXSUYLZYBN-UHFFFAOYSA-N,FLUPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,21,NM,,,,,,,,,,,,,,,,,,,
CHEMBL726,PLDUPXSUYLZYBN-UHFFFAOYSA-N,FLUPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,21,NM,,,,,,,,,,,,,,,,,,,
CHEMBL726,PLDUPXSUYLZYBN-UHFFFAOYSA-N,FLUPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,40,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL726,PLDUPXSUYLZYBN-UHFFFAOYSA-N,FLUPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,40,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL726,PLDUPXSUYLZYBN-UHFFFAOYSA-N,FLUPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,4.66,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1103,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,FURAZOLIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1103,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,FURAZOLIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL126224,PLIGPBGDXASWPX-UHFFFAOYSA-N,IPRINDOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,120,NM,,,,,,,,,,,,,,,,,,,
CHEMBL3310802,PLIHWCCORFZAAL-WLHGVMLRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24856064.0,INHIBITION,=,-2,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 3 uM by radioligand binding assay,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207640,PLYQWXWXIUOYQJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,>,10000,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL160,PMATZTZNYRCHOR-CGLBZJNRSA-N,CYCLOSPORINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL160,PMATZTZNYRCHOR-CGLBZJNRSA-N,CYCLOSPORINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL421482,PMHVAECKAAOWIJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL421482,PMHVAECKAAOWIJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; - means no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL67601,PMKJGGBYYNEYPA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; no data,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL1783954,PMLYIGFXJXRZKK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,500,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783954,PMLYIGFXJXRZKK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,10000,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL270387,PMOFOATUAABMTD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,1258.93,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1515,PMRYVIKBURPHAH-UHFFFAOYSA-N,METHIMAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1515,PMRYVIKBURPHAH-UHFFFAOYSA-N,METHIMAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1729417,PMTIWRPLQBVEMR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24690494.0,KI,<,1000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin),Antagonists of the kappa opioid receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220647,PMTLJEUKNBQARC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.03,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220647,PMTLJEUKNBQARC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1621,PMXMIIMHBWHSKN-UHFFFAOYSA-N,PALIPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,32,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1621,PMXMIIMHBWHSKN-UHFFFAOYSA-N,PALIPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,3.4,NM,,,,,,,,,,,,,,,,,,,
CHEMBL3220633,PNIRYPLJVRYNAS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL3220633,PNIRYPLJVRYNAS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1669407,PNSJAJNXVSKCBP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,24,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11750180.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1078357,PONRMGFNMBCHOU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL141209,POOPPNNSPMKABZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11784148.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of mepyramine binding to Histamine H1 receptor,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,PUBLICATION,
CHEMBL1201012,POPFMWWJOGLOIF-XWCQMRHXSA-N,FLURANDRENOLIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201012,POPFMWWJOGLOIF-XWCQMRHXSA-N,FLURANDRENOLIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL67282,POWCEFXIBWGZIW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL67282,POWCEFXIBWGZIW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; - means no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL1091874,POXFWGOYGQTRMD-SECBINFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20299215.0,IC50,>,30000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1479,POZRVZJJTULAOH-LHZXLZLDSA-N,DANAZOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1479,POZRVZJJTULAOH-LHZXLZLDSA-N,DANAZOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL372588,PPABRKQHBMJESP-VYYCAZPPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,KI,=,20,NM,,,,,,,,,,,,,,,Inhibition constant against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL551457,PPLDJNZKOFVZGW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,37,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL40583,PPQNQXQZIWHJRB-UHFFFAOYSA-N,3-METHYLCHOLANTHRENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL40583,PPQNQXQZIWHJRB-UHFFFAOYSA-N,3-METHYLCHOLANTHRENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL431172,PPWTZQUEISGLGF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,26302.68,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL490632,PPXOTGGYVKBLCQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19329329.0,KI,=,665,NM,,,,,,,,,,,,,,,Inhibition of human cloned histamine H1 receptor by competitive binding experiment,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1098230,PQPVHIHIJVIEQG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20384344.0,KI,>,1000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.,J. Med. Chem.,PUBLICATION,
CHEMBL1098230,PQPVHIHIJVIEQG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20541426.0,KI,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]rilamine from human histamine H1 receptor expressed in CHO cells after 1 hr by liquid scintillation counting,Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1808424,PQQHOBXFKJXQAU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21724392.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220889,PQQQSJRFQLHIHI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL261551,PQQUQVYOCGJWAX-UHFFFAOYSA-N,VUF-10148,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18357976.0,INHIBITION,=,86,%,,,cell_based,,,,,NIH3T3,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in NIH3T3 cells at 10 uM,Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.,J. Med. Chem.,PUBLICATION,
CHEMBL261551,PQQUQVYOCGJWAX-UHFFFAOYSA-N,VUF-10148,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18357976.0,KI,=,741.31,NM,,,cell_based,,,,,NIH3T3,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in NIH3T3 cells,Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.,J. Med. Chem.,PUBLICATION,
CHEMBL1644612,PQTKLDRCMUNDCS-IZZQQSIFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21112782.0,INHIBITION,<,60,%,,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3289656,PQVQCEDGSJVHMK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24800940.0,KI,=,724.44,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor by PDSP assay,Identification of a new selective dopamine D4 receptor ligand.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3289656,PQVQCEDGSJVHMK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24800940.0,KI,=,730,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor by PDSP assay,Identification of a new selective dopamine D4 receptor ligand.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2207669,PREVLKLSVWYCAY-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,125.89,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2376800,PREVTMRNRJIUDH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23558237.0,KI,=,33884.42,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]histamine from human histamine H1 receptor expressed in HEK cells,"A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030632,PRKCBGIXZFUCEF-UHFFFAOYSA-N,N-(3-FLUOROBENZYL)PYRROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL193482,PROQIPRRNZUXQM-ZXXIGWHRSA-N,ESTRIOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL193482,PROQIPRRNZUXQM-ZXXIGWHRSA-N,ESTRIOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL488248,PRPSMPHMELIHFQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553110.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Development of a selective and potent radioactive ligand for histamine H(3) receptors: A compound potentially useful for receptor occupancy studies.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783967,PRSVXRUERNSVCI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,120,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783967,PRSVXRUERNSVCI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,470,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935572,PRWLDKKWXOINJS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153663.0,KI,=,2800,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]histamine from human H1 receptor expressed in HEK cell membranes,Ligand based design of novel histamine H4 receptor antagonists; fragment optimization and analysis of binding kinetics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205836,PSBBAGWMKGXQRW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,=,3727,NM,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL717,PSGAAPLEWMOORI-PEINSRQWSA-N,MEDROXYPROGESTERONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL717,PSGAAPLEWMOORI-PEINSRQWSA-N,MEDROXYPROGESTERONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL191,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,LOSARTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL191,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,LOSARTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL255621,PSMOCFUMBCKOPV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,5011.87,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL402377,PSTMOSWQMHZABO-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18077160.0,KI,>,1000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by [35S]GTP-gamma-S binding assay,In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1807053,PSUFQBRCUSJTDO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21618986.0,INHIBITION,>,16,%,,,,,,,,,,,,,,,Inhibition of Histamine H1 receptor at 4 uM,Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.,J. Med. Chem.,PUBLICATION,
CHEMBL84081,PSVLBKXIZLIMQR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,1.29,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL67602,PSYDAFYPUVMSLN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL67602,PSYDAFYPUVMSLN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; means no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL129542,PTKHFRNHJULJKT-UHFFFAOYSA-N,JNJ-5207852,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 1 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL129542,PTKHFRNHJULJKT-UHFFFAOYSA-N,JNJ-5207852,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 10 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL422093,PTLFMGDNZYQISN-UHFFFAOYSA-N,NCI-142496,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26599718.0,Inhibition,=,90.8,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) assessed as inhibition of histamine-induced beta-arrestin internalization preincubated at 10 nM for 3 hrs followed by addition of 0.25 uM histamine measured after 2 hrs by PathHunter cell based assay,"Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.",J. Med. Chem.,PUBLICATION,
CHEMBL1909078,PTLRDCMBXHILCL-UHFFFAOYSA-M,SODIUM ARSENITE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909078,PTLRDCMBXHILCL-UHFFFAOYSA-M,SODIUM ARSENITE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1619,PTOAARAWEBMLNO-KVQBGUIXSA-N,CLADRIBINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1619,PTOAARAWEBMLNO-KVQBGUIXSA-N,CLADRIBINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL328662,PTZUOUKVZMOWMQ-NFOSLFKVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,1.9,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL470790,PUDXEVBPMISDEU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,9200,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL562894,PUYPQZLPNDWKQC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,7.1,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL475534,PVHUJELLJLJGLN-UHFFFAOYSA-N,NITRENDIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL475534,PVHUJELLJLJGLN-UHFFFAOYSA-N,NITRENDIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL408868,PVISFTMIHRDVDS-QZTJIDSGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,KI,=,26,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260259,PVISFTMIHRDVDS-ROUUACIJSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,INHIBITION,<,20,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL94454,PVLJETXTTWAYEW-UHFFFAOYSA-N,MIZOLASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,2.7,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL573,PVNIIMVLHYAWGP-UHFFFAOYSA-N,NIACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL573,PVNIIMVLHYAWGP-UHFFFAOYSA-N,NIACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL264007,PVOZTVLKZYEWDB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.36,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL264007,PVOZTVLKZYEWDB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,436,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256482,PVPUOHNCMSOAEE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2392692,PVTFEAGMCGMRRS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23664879.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 1 uM relative to control,"Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL595158,PVWQFOKNAQZORV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,48,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3238445,PWBFJEIJPADHLX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24650714.0,KI,=,10471.29,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHO cell membrane after 120 mins by liquid scintillation counting analysis,Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3577955,PWDBREUBRYUEGC-BTJKTKAUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25893048.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 1 uM,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL443896,PWESNUDCWDBFNS-UHFFFAOYSA-N,UR-PI288,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,=,0.24,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL443896,PWESNUDCWDBFNS-UHFFFAOYSA-N,UR-PI288,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,EC50,=,12882.5,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL314885,PWJDUASUWRTROR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,3.8,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL317900,PWKIXUGLRAVBKW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,181.97,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2391166,PWLRRJAFPMHNQH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591112.0,KI,>,9300,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL643,PWWVAXIEGOYWEE-UHFFFAOYSA-N,PROMETHAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23919353.0,IC50,=,5.4,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by radioligand binding assay,Polypharmacology - foe or friend?,J. Med. Chem.,PUBLICATION,
CHEMBL643,PWWVAXIEGOYWEE-UHFFFAOYSA-N,PROMETHAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,2.87,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL643,PWWVAXIEGOYWEE-UHFFFAOYSA-N,PROMETHAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.334,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL589150,PWXLJFASAVPIDI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,32,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030636,PXBKRGXXBYALIH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL66660,PXCSHWXWJPYMAD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12798320.0,KI,=,15733,NM,,,,,,,,,,,,,,,Compound was tested for its binding affinity towards human H1 receptor,"A new class of histamine H(3)-receptor antagonists: synthesis and structure-activity relationships of 7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277855,PXJLHYOGLFJGQN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,39.81,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL244084,PXLGTQTYMBVHFH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.3,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL401728,PXMXBPLOQSHMBE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208423,PXQMPHKMJWQPRD-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208423,PXQMPHKMJWQPRD-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1946125,PXQSRAWVKJTJBP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,=,800.2,NM,,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL557461,PXUAIMJAHKAYPP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19524437.0,INHIBITION,=,-14.7,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 3 uM,Selective naphthalene H(3) receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL244085,PYDCBKVOIWIWLP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.2,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL3220630,PYEWHWCMPYDVMP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL599376,PYPVCBLWSWFYNN-MOSHPQCFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20020710.0,ACTIVITY,=,22,%,,,,,,,,,,,,,,,Displacement of radioligand from histamine H1 receptor at 10 uM,Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.,J. Med. Chem.,PUBLICATION,
CHEMBL3609328,PYSIAKZWZJNMNM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26191365.0,IC50,=,1,NM,,,,,,,,,,,,,,,Inhibition of recombinant human histamine H1 receptor,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL196258,PYUBHJHQYILWFE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16250647.0,INHIBITION,<,10,%,,,,,,,,,,,,,,,Percent inhibition against Histamine H1 receptor at 1 uM,"2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.",J. Med. Chem.,PUBLICATION,
CHEMBL2387285,PYUCVLVRHYGSER-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL741,PYZRQGJRPPTADH-UHFFFAOYSA-N,LAMOTRIGINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL741,PYZRQGJRPPTADH-UHFFFAOYSA-N,LAMOTRIGINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257391,PZBOEBLXMXAJNX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,3,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 1 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257391,PZBOEBLXMXAJNX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18353639.0,INHIBITION,=,21,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in monkey COS7 cells at 10 uM,Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL243898,PZBTVBSLNQDOCG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.7,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL189,PZRHRDRVRGEVNW-UHFFFAOYSA-N,MILRINONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL189,PZRHRDRVRGEVNW-UHFFFAOYSA-N,MILRINONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL309981,PZVJEHWECRAJMM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL584,QAGYKUNXZHXKMR-HKWSIXNMSA-N,NELFINAVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL584,QAGYKUNXZHXKMR-HKWSIXNMSA-N,NELFINAVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL103027,QAPJOZONDSMYPF-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,6600,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL16068,QARVLSVVCXYDNA-UHFFFAOYSA-N,BROMOBENZENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL16068,QARVLSVVCXYDNA-UHFFFAOYSA-N,BROMOBENZENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171025,QAXGZLPJWOSHHV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,15.85,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL536991,QBEYTQZMQMRCRI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,=,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL486974,QBGKYFYOFBXHFM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,1600,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL315834,QBPDZEVGAGDUQY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,1.74,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2031474,QBTUTPWIRYNKEB-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22617490.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM by radioligand binding assay,"Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H(3) receptor inverse agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL551888,QBUBIPIOMZYFEI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,3.6,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3357027,QCAINJLOQVFTKT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25318072.0,KI,>,10000,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells by scintillation counting method,Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2.,J. Med. Chem.,PUBLICATION,
CHEMBL1779059,QCBXRMVDVAHCPR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21555222.0,KI,,,,Not Determined,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,"Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (s) receptor ligands modulates off-target activity and subtype selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1779059,QCBXRMVDVAHCPR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL515472,QCFZUTYIUYQTPW-JOCHJYFZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19329329.0,KI,=,509,NM,,,,,,,,,,,,,,,Inhibition of human cloned histamine H1 receptor by competitive binding experiment,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL402143,QCFZUTYIUYQTPW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19329329.0,KI,=,374,NM,,,,,,,,,,,,,,,Inhibition of human cloned histamine H1 receptor by competitive binding experiment,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1210373,QCJRQVJPUYADQP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,25,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220885,QDHVYTXLRGWECL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.06,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220885,QDHVYTXLRGWECL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,=,5.04,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL554031,QDMPFGBUXBHFTH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Determined,,,,,,,,,,,,,,Intrinsic activity; Low affinity for the receptor: not tested for the efficacy,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL554031,QDMPFGBUXBHFTH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,1995262314968.88,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL554031,QDMPFGBUXBHFTH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibitory activity against human histamine H1 receptor;Low affinity for the receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2376801,QEDDBMMRWNQKSG-SNVBAGLBSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23558237.0,KI,=,11220.18,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]histamine from human histamine H1 receptor expressed in HEK cells,"A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: Comparison of hERG binding and target residence time with PF-3893787.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL290916,QELUYTUMUWHWMC-UHFFFAOYSA-N,EDARAVONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL290916,QELUYTUMUWHWMC-UHFFFAOYSA-N,EDARAVONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2113241,QENBLMVKRYFDIR-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16821797.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,"(R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.",J. Med. Chem.,PUBLICATION,
CHEMBL772,QEVHRUUCFGRFIF-MDEJGZGSSA-N,RESERPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL772,QEVHRUUCFGRFIF-MDEJGZGSSA-N,RESERPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1935416,QEWJHGKQGHFKCH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153342.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,"Synthesis and evaluation of 4-alkoxy-[1'-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4'-piperidine)] analogues as histamine-3 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL413,QFJCIRLUMZQUOT-HPLJOQBZSA-N,SIROLIMUS,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL413,QFJCIRLUMZQUOT-HPLJOQBZSA-N,SIROLIMUS,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1098441,QFKNUCVKOWGNCX-GFCCVEGCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,>,10000,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1098442,QFKNUCVKOWGNCX-LBPRGKRZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,>,10000,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1098110,QFKNUCVKOWGNCX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,>,10000,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205834,QFMGHZDEZHDVJJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2436555,QFNMPNWOYBWECY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24035337.0,KI,>,10000,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor expressed in HEK cells after 90 mins by scintillation counting analysis,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL420108,QFTNRJFCJNHEPW-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,6200,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL240565,QGFBWPZGQZAHLL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3589977,QGKLLEYCXJRYRS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25936259.0,ACTIVITY,=,-2,%,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant H1 receptor expressed in HEK-293 cells assessed as intracellular Ca2+ release at 1 uM by fluorimetry,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3589977,QGKLLEYCXJRYRS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25936259.0,INHIBITION,=,5,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]-pyrilamine from human cloned H1 receptor expressed in HEK293 cells at 1 uM by scintillation counting analysis,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3589977,QGKLLEYCXJRYRS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25936259.0,INHIBITION,=,58,%,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant H1 receptor expressed in HEK-293 cells assessed as inhibition of histamine-induced intracellular Ca2+ release at 1 uM by fluorimetry,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1210142,QGLWUTISHLFURW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,4.7,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL87285,QGXBDMJGAMFCBF-HLUDHZFRSA-N,ANDROSTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL87285,QGXBDMJGAMFCBF-HLUDHZFRSA-N,ANDROSTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3321792,QHLAPIQLWATZKM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25070422.0,KI,=,1009,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432057,QHQJBDOHEUWLBB-CAUKCHDASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2387286,QIACIVDGXFNLRA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1210029,QIIXXVGBJFWMRL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,85,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL430502,QIPPGLRRKJCTOV-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,13000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158770,QIUVHPATBGGVRR-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,25.12,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL105762,QJFIAPPKZLXTPP-QZTJIDSGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,562.34,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL269732,QJJXYPPXXYFBGM-LFZNUXCKSA-N,TACROLIMUS,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL269732,QJJXYPPXXYFBGM-LFZNUXCKSA-N,TACROLIMUS,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL594731,QJNCEPWQQYZJCX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773175.0,KI,>,1000,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in Sf9 cells co-expressing RGS4,"2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL437792,QJNRRDWLNVGLID-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,1584.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL292195,QJPBTFRGWJLPSI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,KI,=,7,NM,,,,,,,,,,,,,,,Inhibition constant against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL292195,QJPBTFRGWJLPSI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21062081.0,KI,=,7,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Histamine H3 receptor as a drug discovery target.,J. Med. Chem.,PUBLICATION,
CHEMBL330430,QJSGTTMHFKBELN-WLHGVMLRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,124,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260374,QKDDJDBFONZGBW-UHFFFAOYSA-N,THIOPERAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7925364.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL260374,QKDDJDBFONZGBW-UHFFFAOYSA-N,THIOPERAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12606603.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL260374,QKDDJDBFONZGBW-UHFFFAOYSA-N,THIOPERAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15033391.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL260374,QKDDJDBFONZGBW-UHFFFAOYSA-N,THIOPERAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18683917.0,KI,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor,The alkaloid conessine and analogues as potent histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL260374,QKDDJDBFONZGBW-UHFFFAOYSA-N,THIOPERAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22019465.0,INHIBITION,,,,Not Active,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at histamine H1 receptor expressed in HEK293 cells co-transfected with pCRE-Luc gene assessed as inhibition of forskolin/histamine-induced cAMP accumulation at 1 uM after 5 hrs by luciferase reporter gene assay,"Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL260374,QKDDJDBFONZGBW-UHFFFAOYSA-N,THIOPERAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24650714.0,KI,>,10000,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHO cell membrane after 120 mins by liquid scintillation counting analysis,Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL260374,QKDDJDBFONZGBW-UHFFFAOYSA-N,THIOPERAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL277100,QKDHBVNJCZBTMR-UHFFFAOYSA-N,TEMAFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL277100,QKDHBVNJCZBTMR-UHFFFAOYSA-N,TEMAFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1088900,QKNADAQNYDFJFJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,2.2,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2031877,QKNQLRSRULGFBA-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22313242.0,KI,=,7010,NM,,,,,,,,,,,,,,,Binding affinity to H1 receptor,"2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL2031876,QKNQLRSRULGFBA-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22313242.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to H1 receptor,"2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1669426,QLDMAQDSTHZTSU-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,24.7,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158774,QLGIWKYNMSCERQ-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,79.43,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669410,QLIYPKVJEXOVDM-INIZCTEOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,109,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL9419,QLNWXBAGRTUKKI-UHFFFAOYSA-N,METACETAMOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL9419,QLNWXBAGRTUKKI-UHFFFAOYSA-N,METACETAMOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1767161,QLOCEFPHCAKSLE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,19.95,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1946257,QLTASWSCCMMISJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,=,129,NM,,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL110691,QMBJSIBWORFWQT-DFXBJWIESA-N,CHLORMADINONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL110691,QMBJSIBWORFWQT-DFXBJWIESA-N,CHLORMADINONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL227934,QMGVPVSNSZLJIA-FVWCLLPLSA-N,STRYCHNINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL227934,QMGVPVSNSZLJIA-FVWCLLPLSA-N,STRYCHNINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL157548,QMLVECGLEOSESV-RYUDHWBXSA-N,DANOFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL157548,QMLVECGLEOSESV-RYUDHWBXSA-N,DANOFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64235,QMUNKLLETTWTBJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,1096.48,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL291607,QNIVPXHOVMGAFZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL291607,QNIVPXHOVMGAFZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; - means no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL366925,QNNXKPSMUIHGIZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15686917.0,KI,=,5.01,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human Histamine H1 receptor in CHO K1 cells,5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2144958,QNRODODTMXCRKU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22172704.0,INHIBITION,=,65,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM by radioligand displacement assay,Discovery of a new molecular probe ML228: an activator of the hypoxia inducible factor (HIF) pathway.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3321791,QOECKZUXJGSVMP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25070422.0,KI,=,1207,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669425,QORUSIWOKHYRCP-SFHVURJKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,4.9,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL46516,QOYHHIBFXOOADH-UHFFFAOYSA-N,FLUSPIRILENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,12,NM,,,,,,,,,,,,,,,,,,,
CHEMBL96466,QPFYLKDZMPQIPZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.89,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1258309,QPIPBVKEZITOKG-GJZGRUSLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,16,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL438,QPPBRPIAZZHUNT-UHFFFAOYSA-N,SULFAMERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL438,QPPBRPIAZZHUNT-UHFFFAOYSA-N,SULFAMERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL483749,QPUXUSUONDVIKY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19338356.0,ACTIVITY,<,50,%,Active,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1767163,QQERDUJEEYWVED-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,39.81,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL318320,QQJIHDLIMPSIHG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,81.28,NM,,,,,,,,,,,,,,,Binding affinity at human cortical Histamine 1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL515914,QQOBRRFOVWGIMD-OJAKKHQRSA-N,AZARIBINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL515914,QQOBRRFOVWGIMD-OJAKKHQRSA-N,AZARIBINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207655,QQODNMGQNZBOAF-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,25.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432054,QQUOSDRKLSIRED-DKSPCFMDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL331077,QQWLSTBNUSPPGV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12443779.0,IC50,<,1000,NM,,,,,,,,,,,,,,,Binding affinity against Histamine H1 receptor,2-(Dimethylaminomethyl)-tetrahydroisoxazolopyridobenzazepine derivatives. Synthesis of a new 5-HT(2C) antagonist with potential anxiolytic properties.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1774497,QQXGHFOKGJXCOQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,70,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1262,QRJJEGAJXVEBNE-HKOYGPOVSA-N,OXICONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1262,QRJJEGAJXVEBNE-HKOYGPOVSA-N,OXICONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL28833,QRQZDZPCRVUFNL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL271096,QRWDBCPLADXSGV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL64,QRXWMOHMRWLFEY-UHFFFAOYSA-N,ISONIAZID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64,QRXWMOHMRWLFEY-UHFFFAOYSA-N,ISONIAZID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1257487,QRYUISZNMDTTDA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,4,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL413965,QRZAKQDHEVVFRX-UHFFFAOYSA-N,FELBINAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL413965,QRZAKQDHEVVFRX-UHFFFAOYSA-N,FELBINAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL21731,QSLMDECMDJKHMQ-UHFFFAOYSA-N,MAPROTILINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,0.79,NM,,,,,,,,,,,,,,,,,,,
CHEMBL21731,QSLMDECMDJKHMQ-UHFFFAOYSA-N,MAPROTILINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,1.67,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL21731,QSLMDECMDJKHMQ-UHFFFAOYSA-N,MAPROTILINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,8.79,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL21731,QSLMDECMDJKHMQ-UHFFFAOYSA-N,MAPROTILINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1.02,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30713,QSQQQURBVYWZKJ-UHFFFAOYSA-N,ALPHA-METHYLTRYPTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23602445.0,KI,>,10000,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200748,QTAOMKOIBXZKND-PPHPATTJSA-N,CARBIDOPA,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200748,QTAOMKOIBXZKND-PPHPATTJSA-N,CARBIDOPA,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3099716,QTAONPFQLNZKSD-XJABCFGWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,>,48500,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin),,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL434063,QTQMRBZOBKYXCG-MHZLTWQESA-N,GW1929,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL434063,QTQMRBZOBKYXCG-MHZLTWQESA-N,GW1929,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL552140,QTTXAJZYVFABKM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19524437.0,INHIBITION,=,-4.5,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 3 uM,Selective naphthalene H(3) receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL513755,QUIMJSLKSHDXOA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,4600,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL2205828,QUMVESOWCHBEEV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1774506,QUPFMAXRMLKPQC-WMDMUMDLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,135,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
,QUROTGLADLKIIK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,1778.28,NM,,,,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL3220887,QUSIHKADCGIRCQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.08,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220887,QUSIHKADCGIRCQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL238504,QUXZAXNZEZALDL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,3162.28,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2387283,QVEYYVHLQBRQNF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158814,QVLZVRFIGXNZMN-UHFFFAOYSA-N,AZD-3778,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22931505.0,IC50,=,40,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Chemokine receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2158814,QVLZVRFIGXNZMN-UHFFFAOYSA-N,AZD-3778,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,31.62,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158814,QVLZVRFIGXNZMN-UHFFFAOYSA-N,AZD-3778,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,31.62,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL900,QVYRGXJJSLMXQH-UHFFFAOYSA-N,ORPHENADRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,IC50,=,97723.72,NM,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL900,QVYRGXJJSLMXQH-UHFFFAOYSA-N,ORPHENADRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,1241,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL900,QVYRGXJJSLMXQH-UHFFFAOYSA-N,ORPHENADRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,144,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220629,QVYRMWULYINFSR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.09,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220629,QVYRMWULYINFSR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL114,QWAXKHKRTORLEM-UGJKXSETSA-N,SAQUINAVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL114,QWAXKHKRTORLEM-UGJKXSETSA-N,SAQUINAVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1109,QWCJHSGMANYXCW-UHFFFAOYSA-N,SULFAPHENAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1109,QWCJHSGMANYXCW-UHFFFAOYSA-N,SULFAPHENAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL49,QWCRAEMEVRGPNT-UHFFFAOYSA-N,BUSPIRONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL49,QWCRAEMEVRGPNT-UHFFFAOYSA-N,BUSPIRONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2165628,QWDSWUASBPMPBR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,=,6.27,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1113,QWGDMFLQWFTERH-UHFFFAOYSA-N,AMOXAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,99,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1113,QWGDMFLQWFTERH-UHFFFAOYSA-N,AMOXAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,11,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3622360,QWHKGOUNYNQXJA-FEHRVWHQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25801931.0,INHIBITION,=,13,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM relative to control,Pseudosaccharin amines as potent and selective KV1.5 blockers.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL105268,QWIRSRRDSYVSEG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,380.19,NM,,,,,,,,,,,,,,,Binding affinity at human cortical Histamine 1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL411293,QWMBVXDLQBRGEQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,794.33,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL255826,QWRZAQFQULNINP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL551340,QWTQKWHOWDAFRM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19663387.0,KI,=,75,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.,J. Med. Chem.,PUBLICATION,
CHEMBL1365675,QXAITBQSYVNQDR-ZIOPAAQOSA-N,AMITRAZ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1365675,QXAITBQSYVNQDR-ZIOPAAQOSA-N,AMITRAZ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,METHOXSALEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,METHOXSALEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1767159,QYAXGGUCDQSHIT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,50.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL3612693,QYOJMNDDVVEPFN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26372073.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Displacement of [3H]-pyrilamine from histamine H1 receptor (unknown origin) at 0.1 to 10 mM,Reengineered tricyclic anti-cancer agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1210270,QYPIBWMLKDIVCA-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1210269,QYPIBWMLKDIVCA-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,98,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL527,QYSPLQLAKJAUJT-UHFFFAOYSA-N,PIROXICAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL527,QYSPLQLAKJAUJT-UHFFFAOYSA-N,PIROXICAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1042,QYSXJUFSXHHAJI-YRZJJWOYSA-N,CHOLECALCIFEROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1042,QYSXJUFSXHHAJI-YRZJJWOYSA-N,CHOLECALCIFEROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,EC50,=,0.4,NM,,inverse_agonist,,binding,,,,,,,,,,,,,,,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,2.77,NM,,,,,,,,,,,,,,,,,,,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,1.2,NM,,,,,,,,,,,,,,,,,,,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,2.8,NM,,,,,,,,,,,,,,,,,,,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,0.23,NM,,,,,,,,,,,,,,,,,,,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,3.1,NM,,,,,,,,,,,,,,,,,,,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11170639.0,KI,=,17,NM,,,,,,,,,,,,,,,Binding affinity against histamine H1 receptor,Current and novel approaches to the drug treatment of schizophrenia.,J. Med. Chem.,PUBLICATION,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,1.54,NM,,,,,,,,,,,,,,,,,,,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,1.63,NM,,,,,,,,,,,,,,,,,,,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,1.2,NM,,,,,,,,,,,,,,,,,,,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14998318.0,KI,=,2.1,NM,,,,,,,,,,,,,,,Binding affinity towards human histamine H1 receptor,Selective optimization of side activities: another way for drug discovery.,J. Med. Chem.,PUBLICATION,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,1.1,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,1.8,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,2.38,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21062081.0,KD,=,3.1,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Histamine H3 receptor as a drug discovery target.,J. Med. Chem.,PUBLICATION,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22245230.0,KI,=,1.8,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor by liquid scintillation counting,Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24559051.0,KI,=,1,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin),Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,4.91,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.571,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,10,NM,,,,,,,,,,,,,,,Binding affinity to H1 histamine receptor (unknown origin) by PDSP assay,,MedChemComm,PUBLICATION,
CHEMBL153994,QZYRMAITXZSSGA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Active,,,,,,,,,,,,,,Intrinsic activity; Tested up to 10 uM: no effects up to 1 uM,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL153994,QZYRMAITXZSSGA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,316227766016838,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL153994,QZYRMAITXZSSGA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL240185,RAGNKICHAZGMOB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL105385,RAHWSYMHXYDXJB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,354.81,NM,,,,,,,,,,,,,,,Binding affinity at human cortical Histamine 1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27639363.0,Ki,=,42.6,NM,,,,,,,,,,,,,,,,,,,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,27,NM,,,,,,,,,,,,,,,,,,,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,5.2,NM,,,,,,,,,,,,,,,,,,,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11170639.0,KI,=,88,NM,,,,,,,,,,,,,,,Binding affinity towards human H1 receptor,Current and novel approaches to the drug treatment of schizophrenia.,J. Med. Chem.,PUBLICATION,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,15,NM,,,,,,,,,,,,,,,,,,,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14998318.0,KI,=,2.6,NM,,,,,,,,,,,,,,,Binding affinity towards human histamine H1 receptor,Selective optimization of side activities: another way for drug discovery.,J. Med. Chem.,PUBLICATION,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,33,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,19,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27173799.0,IC50,=,868,NM,,,,,,,,,,,,,,,Antagonistic activity at histamine1 receptor (unknown origin) after 10 mins by FLIPR assay,"Synthesis, structure-activity relationships, and biological evaluation of a series of benzamides as potential multireceptor antipsychotics.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,25,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,2.87,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,100,NM,,,,,,,,,,,,,,,Binding affinity to H1 histamine receptor (unknown origin) by PDSP assay,,MedChemComm,PUBLICATION,
CHEMBL1909048,RBCUCXILXJXLTB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909048,RBCUCXILXJXLTB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL95243,RBJZEZVXAVEQFQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.02,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1630578,RBKASMJPSJDQKY-RBFSKHHSSA-N,TIRILIZAD,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1630578,RBKASMJPSJDQKY-RBFSKHHSSA-N,TIRILIZAD,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL270209,RBZIHZIBFQXVQY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL311350,RCIMBBZXSXFZBV-UHFFFAOYSA-N,PIROMIDIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL311350,RCIMBBZXSXFZBV-UHFFFAOYSA-N,PIROMIDIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL428647,RCINICONZNJXQF-MZXODVADSA-N,PACLITAXEL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL428647,RCINICONZNJXQF-MZXODVADSA-N,PACLITAXEL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL314133,RCJWVLIRJLNAIE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,PIC50,,,,Not Determined,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand; not tested,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL102331,RDGBZPAYYHGGML-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,7400,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2165640,RDIRTKGXGDOIAE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,=,6.13,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1297,RDJGLLICXDHJDY-UHFFFAOYSA-N,FENOPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1297,RDJGLLICXDHJDY-UHFFFAOYSA-N,FENOPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL841,RDOIQAHITMMDAJ-UHFFFAOYSA-N,LOPERAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL841,RDOIQAHITMMDAJ-UHFFFAOYSA-N,LOPERAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200993,REEUVFCVXKWOFE-UHFFFAOYSA-K,GALLAMINE TRIETHIODIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200993,REEUVFCVXKWOFE-UHFFFAOYSA-K,GALLAMINE TRIETHIODIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220652,REHDXPBQOIWZRI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL2158833,REJVZJBLJWRHQL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,125.89,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL640,REQCZEXYDRLIBE-UHFFFAOYSA-N,PROCAINAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL640,REQCZEXYDRLIBE-UHFFFAOYSA-N,PROCAINAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2146801,REXDQAIKTDDWAC-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.251,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146801,REXDQAIKTDDWAC-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.251,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1767160,REXVRCXDIWIKGL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,15.85,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL28079,REZGGXNDEMKIQB-UHFFFAOYSA-N,ZAPRINAST,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL28079,REZGGXNDEMKIQB-UHFFFAOYSA-N,ZAPRINAST,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL179234,REZSROOERNUDJU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15634025.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human H1 histamine receptor,2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL320178,RFDSGHNJJQPTLS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,158.49,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL106,RFHAOTPXVQNOHP-UHFFFAOYSA-N,FLUCONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL106,RFHAOTPXVQNOHP-UHFFFAOYSA-N,FLUCONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL243707,RFIKMECJVGIKGU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.2,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1201216,RFWZESUMWJKKRN-UHFFFAOYSA-N,DAPIPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201216,RFWZESUMWJKKRN-UHFFFAOYSA-N,DAPIPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567,RGCVKNLCSQQDEP-UHFFFAOYSA-N,PERPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,8.33,NM,,,,,,,,,,,,,,,,,,,
CHEMBL567,RGCVKNLCSQQDEP-UHFFFAOYSA-N,PERPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,8,NM,,,,,,,,,,,,,,,,,,,
CHEMBL567,RGCVKNLCSQQDEP-UHFFFAOYSA-N,PERPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,8,NM,,,,,,,,,,,,,,,,,,,
CHEMBL567,RGCVKNLCSQQDEP-UHFFFAOYSA-N,PERPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567,RGCVKNLCSQQDEP-UHFFFAOYSA-N,PERPHENAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923525,RGFBLHAWTZMUAK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,707.95,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL572034,RGGWURWNJUDTIH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,121,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL411,RGLYKWWBQGJZGM-ISLYRVAYSA-N,DIETHYLSTILBESTROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL411,RGLYKWWBQGJZGM-ISLYRVAYSA-N,DIETHYLSTILBESTROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2208429,RGQXJYRGDMABLT-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208429,RGQXJYRGDMABLT-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,7.94,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL105515,RGULNTQENHHTRC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,3981.07,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208422,RHDOFWFMSRHNFN-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208422,RHDOFWFMSRHNFN-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,79.43,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL65518,RHEMXJFXAARMOY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,4168.69,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2387313,RHEVIGLLTLURAQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL245119,RHHJVFYYCJWYII-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,5.9,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL435301,RHPCETHLGGFAQB-MQSINFNDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,4.3,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL364270,RHPCETHLGGFAQB-SHZHJNINSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,14,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL2171023,RIEFZSRXHBEIFW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,25.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1308,RIKMMFOAQPJVMX-UHFFFAOYSA-N,FOMEPIZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1308,RIKMMFOAQPJVMX-UHFFFAOYSA-N,FOMEPIZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL560917,RIUIDVINUPJOQH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,105,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL154068,RIXQVRQUELEXES-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.5,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL154068,RIXQVRQUELEXES-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,50118.72,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL154068,RIXQVRQUELEXES-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,50118723362727.1,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1092652,RJAXVZUSTIFVGP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,2.1,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL103,RJKFOVLPORLFTN-LEKSSAKUSA-N,PROGESTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL103,RJKFOVLPORLFTN-LEKSSAKUSA-N,PROGESTERONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1554,RJURFGZVJUQBHK-IIXSONLDSA-N,DACTINOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1554,RJURFGZVJUQBHK-IIXSONLDSA-N,DACTINOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL83777,RJYJDEQXOIQEGZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL271097,RKDBVDKLNHXCIZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL185825,RKEGNNLTPLWIIC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,109,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2165636,RKSXQJRAAANUNM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,<,6,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL517712,RKUNBYITZUJHSG-SPUOUPEWSA-N,ATROPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL517712,RKUNBYITZUJHSG-SPUOUPEWSA-N,ATROPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL9751,RKUNBYITZUJHSG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,1600,NM,,,,,,,,,,,,,,,,,,,
CHEMBL498,RKWGIWYCVPQPMF-UHFFFAOYSA-N,CHLORPROPAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL498,RKWGIWYCVPQPMF-UHFFFAOYSA-N,CHLORPROPAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1237,RLAWWYSOJDYHDC-BZSNNMDCSA-N,LISINOPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1237,RLAWWYSOJDYHDC-BZSNNMDCSA-N,LISINOPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL295001,RLMGUPUESXPDFJ-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10937710.0,KI,=,108,NM,,,,,,,,,,,,,,,Selectivity screen against human Histamine H1 receptor,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62803,RLVMZEQCHVFJEJ-UHFFFAOYSA-N,A-923,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,275.42,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272478,RLYPJRVMOKDHBV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL273199,RLZDEABBOHACIP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,794.33,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL21721,RMABJXDRZPHEJF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,8.94,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207639,RMDQSWIVOHIFNT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,=,6500,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1108,RMEDXOLNCUSCGS-UHFFFAOYSA-N,DROPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,4519,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1108,RMEDXOLNCUSCGS-UHFFFAOYSA-N,DROPERIDOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,525,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207280,RMQXJQUUIKBXMM-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,6.31,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158776,RMSWKUOSOVPFPF-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,63.1,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1089,RMUCZJUITONUFY-UHFFFAOYSA-N,PHENELZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1089,RMUCZJUITONUFY-UHFFFAOYSA-N,PHENELZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923526,RMZULTRHWHVHDS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,707.95,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL12856,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,INAMRINONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12856,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,INAMRINONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL524153,RNPCOHCWKNMBRI-QHCPKHFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18799310.0,ACTIVITY,=,33,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor 1 uM,"Identification and SAR around N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethyl}-2-phenoxy-nicotinamide, a selective alpha2C adrenergic receptor antagonist.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1632158,RNXYMZNGMNWKMC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21075638.0,KI,=,1258.93,NM,,,,,,,,,,,,,,,Binding affinity to Histamine receptor H1,Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL488,ROBVIMPUHSLWNV-UHFFFAOYSA-N,AMINOGLUTETHIMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL488,ROBVIMPUHSLWNV-UHFFFAOYSA-N,AMINOGLUTETHIMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL184238,ROFVXGGUISEHAM-UHFFFAOYSA-N,URB597,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16352709.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL476935,ROKAKGMAWJNFEN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,157.6,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL654,RONZAEMNMFQXRA-UHFFFAOYSA-N,MIRTAZAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,1.6,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL2158834,ROQGCKBWSKAVEH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,10,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL276832,RPTUSVTUFVMDQK-UHFFFAOYSA-N,HYDRALAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL276832,RPTUSVTUFVMDQK-UHFFFAOYSA-N,HYDRALAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL167223,RPUXCIYWJSVFFV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12593665.0,KI,=,0.813,NM,,,cell_based,,,,,CHO-K1,,,,,,,Compound was evaluated for binding affinity towards cloned human histamine H1 receptors stably expressed in CHO-K1 cells using [3H]mepyramine,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1794855,RPZYOWNZYQHSLJ-SPIKMXEPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15203136.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards histamine H1 receptor,"(+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3104092,RQBRUGMHSQYCNU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24365159.0,KI,=,47.86,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from histamine H1 receptor (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3104092,RQBRUGMHSQYCNU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24365159.0,KI,=,48,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from histamine H1 receptor (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310035,RQPAEAIGXOANQF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,ACTIVITY,,,,Not Active,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 histamine receptor expressed in HEK cells at 10 uM after 90 mins by microbeta counting analysis,,J. Nat. Prod.,PUBLICATION,
CHEMBL43491,RQTZTSPFFYDZKA-HSZRJFAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10937710.0,KI,=,58,NM,,,,,,,,,,,,,,,Selectivity screen against human Histamine H1 receptor,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201139,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,MEGESTROL ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201139,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,MEGESTROL ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42710,RRAFCDWBNXTKKO-UHFFFAOYSA-N,EUGENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42710,RRAFCDWBNXTKKO-UHFFFAOYSA-N,EUGENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL559118,RRAGUTZCGCIMCD-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19722526.0,ACTIVITY,<,10,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM,Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity.,J. Med. Chem.,PUBLICATION,
CHEMBL2205831,RRBNCHNWWUXYEM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205831,RRBNCHNWWUXYEM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL105267,RRBSCZCNYAJFEJ-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,13803.84,NM,,,,,,,,,,,,,,,Binding affinity at human cortical Histamine 1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL799,RRGUKTPIGVIEKM-UHFFFAOYSA-N,CILOSTAZOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL799,RRGUKTPIGVIEKM-UHFFFAOYSA-N,CILOSTAZOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1257256,RSBVKZRTPBAMAK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,16,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207634,RSTJJQONPRJAIE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,,,,Not Determined,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1909076,RSTSYGXUDMJEFP-SECBINFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909076,RSTSYGXUDMJEFP-SECBINFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3094316,RSZFCDGHJLBYEB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24238903.0,INHIBITION,=,7.6,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL315044,RTEBNFQOFLORPE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,14.45,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1456,RTGDFNSFWBGLEC-SYZQJQIISA-N,MYCOPHENOLATE MOFETIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1456,RTGDFNSFWBGLEC-SYZQJQIISA-N,MYCOPHENOLATE MOFETIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,1100,NM,,,,,,,,,,,,,,,,,,,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,5400,NM,,,,,,,,,,,,,,,,,,,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8496700.0,INHIBITION,>,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 100 nM,The role of receptor binding in drug discovery.,J. Nat. Prod.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL403181,RTMHXVRCXRAHLV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,125.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2391167,RTNOWHVTNCEMDM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591112.0,KI,>,9300,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL361355,RTRADBQSZJIRMT-GOSISDBHSA-N,A-317920,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12606603.0,KI,=,3981.07,NM,,,,,,,,,,,,,,,,,,,
CHEMBL430471,RTZKLQYXUHBGFX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,5.04,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL329685,RUKTXHCGSFMYLO-JCNKGUCWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,9.3,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2112371,RUKTXHCGSFMYLO-SNRMKQJTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,3.5,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171049,RUMOWLXMMCFECC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,125.89,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL79568,RUNAWWHMBJYHQQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1257975,RUQIIZGSRSUFTC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801651.0,INHIBITION,,,,Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL60360,RURVOBDSGULLAW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,60.26,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1099202,RUSSMSXMTHFLEU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20382540.0,ACTIVITY,=,17,%,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells at 10 uM after 60 mins by beta scintillation counting,In silico directed chemical probing of the adenosine receptor family.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL315308,RUWZQSJWDUNAEU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,7.94,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL707,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,DOXAZOSIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL707,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,DOXAZOSIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL189118,RVSLLQIPFFIMSB-KPKJPENVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16134937.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibitory concentration against Histamine H1 receptor,"6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and investigation of binding mode.",J. Med. Chem.,PUBLICATION,
CHEMBL1946258,RWCQKGYXYLNOEC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1256017,RWTGFMPOODRXIM-UHFFFAOYSA-N,ARCAINE SULFATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1256017,RWTGFMPOODRXIM-UHFFFAOYSA-N,ARCAINE SULFATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11809864.0,KI,=,10,NM,,,,,,,,,,,,,,,,,,,
CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,78,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,78,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,27,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,78,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25494650.0,IC50,=,15,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin),CNS drug design: balancing physicochemical properties for optimal brain exposure.,J. Med. Chem.,PUBLICATION,
CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909065,RWVUEZAROXKXRT-VQLSFVLHSA-N,LYSERGOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909065,RWVUEZAROXKXRT-VQLSFVLHSA-N,LYSERGOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL245120,RWYXCRGPSKEBSD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,<,5.6,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL522555,RXIURVGGLQTWNU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19456097.0,INHIBITION,=,6,%,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells at 3 uM by liquid scintillation counting,5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.,J. Med. Chem.,PUBLICATION,
CHEMBL10780,RXMTUVIKZRXSSM-UHFFFAOYSA-N,"2,2-DIPHENYLETHYLAMINE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,>,10000,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL469912,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,PUROMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469912,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,PUROMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1214185,RXZBMPWDPOLZGW-XMRMVWPWSA-N,ROXITHROMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1214185,RXZBMPWDPOLZGW-XMRMVWPWSA-N,ROXITHROMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL392760,RYBOXBBYCVOYNO-UHFFFAOYSA-N,WAY-181187,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17948978.0,ACTIVITY,<,50,%,,,,,,,,,,,,,,,Displacement of radio ligand from histamine H1 receptor at 100 nM,"Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.",J. Med. Chem.,PUBLICATION,
CHEMBL1929406,RYDVGAFXMZFSBM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22019465.0,INHIBITION,,,,Not Active,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at histamine H1 receptor expressed in HEK293 cells co-transfected with pCRE-Luc gene assessed as inhibition of forskolin/histamine-induced cAMP accumulation at 1 uM after 5 hrs by luciferase reporter gene assay,"Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1064,RYMZZMVNJRMUDD-HGQWONQESA-N,SIMVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1064,RYMZZMVNJRMUDD-HGQWONQESA-N,SIMVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL113,RYYVLZVUVIJVGH-UHFFFAOYSA-N,CAFFEINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL113,RYYVLZVUVIJVGH-UHFFFAOYSA-N,CAFFEINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2146804,RZBPSXCZVILRNE-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,2.51,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146804,RZBPSXCZVILRNE-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.692,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CELECOXIB,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CELECOXIB,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL45245,RZFVLEJOHSLEFR-UHFFFAOYSA-N,PHENANTHRIDIN-6(5H)-ONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL45245,RZFVLEJOHSLEFR-UHFFFAOYSA-N,PHENANTHRIDIN-6(5H)-ONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL122,RZJQGNCSTQAWON-UHFFFAOYSA-N,ROFECOXIB,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL122,RZJQGNCSTQAWON-UHFFFAOYSA-N,ROFECOXIB,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1480,RZTAMFZIAATZDJ-UHFFFAOYSA-N,FELODIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1480,RZTAMFZIAATZDJ-UHFFFAOYSA-N,FELODIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL112,RZVAJINKPMORJF-UHFFFAOYSA-N,ACETAMINOPHEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL112,RZVAJINKPMORJF-UHFFFAOYSA-N,ACETAMINOPHEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL138809,RZZAEVQHACUOGI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11784148.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of mepyramine binding to Histamine H1 receptor,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,PUBLICATION,
CHEMBL1767135,SAKVKDBLCRHLAV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,10,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL2146811,SAMYTBZVLLYSKN-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.537,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL87708,SAPNXPWPAUFAJU-UHFFFAOYSA-N,LOFEPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,360,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1831166,SAUWBVJOXSKPQX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21899931.0,INHIBITION,,,,Active,,,,,,,,,,,,,,Displacement of radioligand from histamine H1 receptor assessed as 50% receptor inhibition at 10'-5 M,Synthesis and pharmacological evaluation of indole-based sigma receptor ligands.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1831166,SAUWBVJOXSKPQX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21899931.0,INHIBITION,,,,Active,,,,,,,,,,,,,,Displacement of radioligand from histamine H2 receptor assessed as 50% receptor inhibition at 10'-5 M,Synthesis and pharmacological evaluation of indole-based sigma receptor ligands.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1831166,SAUWBVJOXSKPQX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21899931.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Displacement of radioligand from histamine H1 receptor assessed as 50% receptor inhibition at 10'-7 M,Synthesis and pharmacological evaluation of indole-based sigma receptor ligands.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1831166,SAUWBVJOXSKPQX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21899931.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Displacement of radioligand from histamine H2 receptor assessed as 50% receptor inhibition at 10'-7 M,Synthesis and pharmacological evaluation of indole-based sigma receptor ligands.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL509,SBDNJUWAMKYJOX-UHFFFAOYSA-N,MECLOFENAMIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL509,SBDNJUWAMKYJOX-UHFFFAOYSA-N,MECLOFENAMIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL95127,SBMCXVUSNRZQAG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.53,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL95127,SBMCXVUSNRZQAG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,293,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL31354,SBPRIAGPYFYCRT-UHFFFAOYSA-N,"WAY-100,635",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16915381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1384,SBUJHOSQTJFQJX-NOAMYHISSA-N,KANAMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1384,SBUJHOSQTJFQJX-NOAMYHISSA-N,KANAMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL104700,SCDKHPSUXHBJDJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1413,SCKYRAXSEDYPSA-UHFFFAOYSA-N,CICLOPIROX,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1413,SCKYRAXSEDYPSA-UHFFFAOYSA-N,CICLOPIROX,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL551347,SDEZSIUXMXPOCO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,18.3,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171015,SDPQHMHFTWVGGO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,100,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,GEMCITABINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,GEMCITABINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923530,SDYJUASJEOPULH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,3235.94,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1277034,SECVFAJWTWEYDD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,316.23,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL439,SEEPANYCNGTZFQ-UHFFFAOYSA-N,SULFADIAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL439,SEEPANYCNGTZFQ-UHFFFAOYSA-N,SULFADIAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1477,SEERZIQQUAZTOL-ANMDKAQQSA-N,CERIVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1477,SEERZIQQUAZTOL-ANMDKAQQSA-N,CERIVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2158783,SEIOTCVWLCUESB-DEOSSOPVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,39.81,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077862,SESBNJZEWNWYQM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL165790,SFBODOKJTYAUCM-UHFFFAOYSA-N,IPRIFLAVONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL165790,SFBODOKJTYAUCM-UHFFFAOYSA-N,IPRIFLAVONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1946123,SFPSQBFPUCFLEZ-AIZNXBIQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,=,1719,NM,,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3321788,SFPSQBFPUCFLEZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25070422.0,KI,=,1719,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220662,SFSJSTBGNLEEBM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.03,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220662,SFSJSTBGNLEEBM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL2165630,SFWHKNCKBDIXLZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,<,6,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL852,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,MELPHALAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL852,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,MELPHALAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL360953,SGFIBQBVOOVDSS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771458.0,KI,=,22,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for H1 histamine receptor expressed in CHO cells,"Norpiperidine imidazoazepines as a new class of potent, selective, and nonsedative H1 antihistamines.",J. Med. Chem.,PUBLICATION,
CHEMBL2432052,SGFPDDMJMPKKTB-RAOGCBAWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,>,10000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1946744,SGGMEYGWAJEGIP-WPUZRXDDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1094208,SGKVPHOMCZNDPT-UHFFFAOYSA-N,"1-(2,3-DICHLOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20427184.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL390649,SGLJPXQOJMBPBR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.3,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL282468,SGMZJAMFUVOLNK-UHFFFAOYSA-M,CHOLINE CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL282468,SGMZJAMFUVOLNK-UHFFFAOYSA-M,CHOLINE CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL472441,SGQYOPBUMICDBU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,ACTIVITY,=,1,%,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL472441,SGQYOPBUMICDBU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,6800,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL472441,SGQYOPBUMICDBU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,19000,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL273915,SGSDMASCYPMWHE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,4.56,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL6966,SGTNSNPWRIOYBX-UHFFFAOYSA-N,VERAPAMIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6966,SGTNSNPWRIOYBX-UHFFFAOYSA-N,VERAPAMIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL429,SGUAFYQXFOLMHL-UHFFFAOYSA-N,LABETALOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL429,SGUAFYQXFOLMHL-UHFFFAOYSA-N,LABETALOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220631,SGXQZQNDONZEJS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.04,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220631,SGXQZQNDONZEJS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,=,5.07,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL653,SGXXNSQHWDMGGP-IZZDOVSWSA-N,NIZATIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL653,SGXXNSQHWDMGGP-IZZDOVSWSA-N,NIZATIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL547,SHGAZHPCJJPHSC-XFYACQKRSA-N,ISOTRETINOIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL547,SHGAZHPCJJPHSC-XFYACQKRSA-N,ISOTRETINOIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL38,SHGAZHPCJJPHSC-YCNIQYBTSA-N,TRETINOIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL38,SHGAZHPCJJPHSC-YCNIQYBTSA-N,TRETINOIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL316438,SHNQYDFOONPSKV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,3.02,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL489493,SHQNNJIERWMYHK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18433114.0,INHIBITION,<,20,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2171215,SHRVEEBUQYOBLS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,50.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1259190,SHVCHMGRIYXVAY-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,5,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL1259189,SHVCHMGRIYXVAY-OAQYLSRUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,4.5,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL1259145,SHVCHMGRIYXVAY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,,,,Non-toxic,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL1767143,SHXAAVWRLZPGKQ-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,630.96,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL43048,SHXWCVYOXRDMCX-UHFFFAOYSA-N,METHYLENEDIOXYMETHAMPHETAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12761331.0,KI,=,2138,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1200396,SIEYLFHKZGLBNX-UHFFFAOYSA-N,BUPIVACAINE HYDROCHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200396,SIEYLFHKZGLBNX-UHFFFAOYSA-N,BUPIVACAINE HYDROCHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL303737,SIFNBTNSQZZNNX-XMMPIXPASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,14454.4,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL102384,SJDGVHQTEPPTSY-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,4500,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1946745,SJEXSMOVRPPLBZ-VXMMSVGHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,=,187,NM,,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL291338,SJQBHPJLLIJASD-UHFFFAOYSA-N,"3,3',4',5-TETRACHLOROSALICYLANILIDE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL291338,SJQBHPJLLIJASD-UHFFFAOYSA-N,"3,3',4',5-TETRACHLOROSALICYLANILIDE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL60401,SJQFNVCRPKMBTI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,100000,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL307115,SJTCXXXSWIQXOU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL307115,SJTCXXXSWIQXOU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL2432050,SJWCMFMHVZULSJ-DKSPCFMDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL62741,SKDLGPGMOATMSN-HSZRJFAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,14454.4,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL291847,SKDLGPGMOATMSN-QHCPKHFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,9772.37,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1278021,SKOALCKWENTDHG-NRWPOFLRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,158.49,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL1277935,SKOALCKWENTDHG-TUXUZCGSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,19.95,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL1277935,SKOALCKWENTDHG-TUXUZCGSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,25.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL115280,SKVXOYIMICHFPV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11585444.0,IC50,=,496,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
CHEMBL2207662,SKXJKSJHHFLVAP-GFCCVEGCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,3.98,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL27577,SKZKKFZAGNVIMN-UHFFFAOYSA-N,SALICYLAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL27577,SKZKKFZAGNVIMN-UHFFFAOYSA-N,SALICYLAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL412873,SLRCCWJSBJZJBV-TUVASFSCSA-N,SPARTEINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL412873,SLRCCWJSBJZJBV-TUVASFSCSA-N,SPARTEINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1088,SLVMESMUVMCQIY-UHFFFAOYSA-N,MESORIDAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,1.81,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1088,SLVMESMUVMCQIY-UHFFFAOYSA-N,MESORIDAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,1.8,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1046,SLXKOJJOQWFEFD-UHFFFAOYSA-N,AMINOCAPROIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1046,SLXKOJJOQWFEFD-UHFFFAOYSA-N,AMINOCAPROIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30008,SMANXXCATUTDDT-QPJJXVBHSA-N,FLUNARIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,158,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30008,SMANXXCATUTDDT-QPJJXVBHSA-N,FLUNARIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,18,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1258874,SMRRGJLLFFKDID-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,-6,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201195,SNBUBQHDYVFSQF-HIFRSBDPSA-N,CEFMETAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201195,SNBUBQHDYVFSQF-HIFRSBDPSA-N,CEFMETAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3,SNICXCGAKADSCV-JTQLQIEISA-N,NICOTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3,SNICXCGAKADSCV-JTQLQIEISA-N,NICOTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1090198,SNPICWUEPVAZAM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,15,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1371937,SNPLKNRPJHDVJA-UHFFFAOYSA-N,PANTHENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1371937,SNPLKNRPJHDVJA-UHFFFAOYSA-N,PANTHENOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1774493,SNSVDJAVYWDAAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,128,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3091491,SOURGACQIXFLGX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,PKI,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1222693,SOXIOTAVNTWQJT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,39.81,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201353,SOYKEARSMXGVTM-HNNXBMFYSA-N,DEXCHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,1967317.0,KB,=,0.000000015,,,,,,,,,,,,,,,,Evaluated for antagonist activity against histamine H1 receptor and represented as KB,Histamine H3 ligands: just pharmacological tools or potential therapeutic agents?,J. Med. Chem.,PUBLICATION,
CHEMBL1201353,SOYKEARSMXGVTM-HNNXBMFYSA-N,DEXCHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.29,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201353,SOYKEARSMXGVTM-HNNXBMFYSA-N,DEXCHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.73,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL505,SOYKEARSMXGVTM-UHFFFAOYSA-N,CHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,30,NM,,,,,,,,,,,,,,,,,,,
CHEMBL505,SOYKEARSMXGVTM-UHFFFAOYSA-N,CHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,15,NM,,,,,,,,,,,,,,,,,,,
CHEMBL505,SOYKEARSMXGVTM-UHFFFAOYSA-N,CHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7925364.0,KI,=,2.51,NM,,,,,,,,,,,,,,,,,,,
CHEMBL505,SOYKEARSMXGVTM-UHFFFAOYSA-N,CHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8903934.0,KI,=,2.51,NM,,,,,,,,,,,,,,,,,,,
CHEMBL505,SOYKEARSMXGVTM-UHFFFAOYSA-N,CHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,2.67,NM,,,,,,,,,,,,,,,,,,,
CHEMBL505,SOYKEARSMXGVTM-UHFFFAOYSA-N,CHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,4.81,NM,,,,,,,,,,,,,,,,,,,
CHEMBL505,SOYKEARSMXGVTM-UHFFFAOYSA-N,CHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17846138.0,IC50,=,66,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL505,SOYKEARSMXGVTM-UHFFFAOYSA-N,CHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,7,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL505,SOYKEARSMXGVTM-UHFFFAOYSA-N,CHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24365159.0,KI,=,0.92,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from histamine H1 receptor (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL505,SOYKEARSMXGVTM-UHFFFAOYSA-N,CHLORPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24365159.0,KI,=,4.47,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from histamine H1 receptor (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL157842,SOZBJQHYMWHOEA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.76,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157842,SOZBJQHYMWHOEA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,2511.89,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157842,SOZBJQHYMWHOEA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,125892541179417,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1200633,SPBDXSGPUHCETR-JFUDTMANSA-N,IVERMECTIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200633,SPBDXSGPUHCETR-JFUDTMANSA-N,IVERMECTIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL15511,SPFYMRJSYKOXGV-UHFFFAOYSA-N,ENROFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL15511,SPFYMRJSYKOXGV-UHFFFAOYSA-N,ENROFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1493,SPIUTQOUKAMGCX-UHFFFAOYSA-N,FLAVOXATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1493,SPIUTQOUKAMGCX-UHFFFAOYSA-N,FLAVOXATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2031885,SPKOQCHHYOCMGR-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22313242.0,KI,=,8750,NM,,,,,,,,,,,,,,,Binding affinity to H1 receptor,"2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL294519,SPQNXJVWMXXMNU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,288.4,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1255837,SPXACGZWWVIDGR-SPZWACKZSA-N,DIHYDROERGOCRISTINE MESYLATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1255837,SPXACGZWWVIDGR-SPZWACKZSA-N,DIHYDROERGOCRISTINE MESYLATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1774507,SPYSLLTXIWIQNL-MWYAZZEHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,153,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1092599,SQDIKQKCDLMHCF-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,3.1,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669411,SQGLQUFJVYRVPS-HNNXBMFYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,91,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL243860,SQQYHALTXOFUNG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.7,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1902981,SQUNAWUMZGQQJD-UHFFFAOYSA-N,EPERISONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1902981,SQUNAWUMZGQQJD-UHFFFAOYSA-N,EPERISONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1412853,SRFABRWQVPCPRG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INHIBITION,=,89,%,,,,,,,,,,,,,,,Inhibition of H1 histamine receptor at 10 uM,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1091069,SROGIGROUAOOFN-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,5,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL40733,SRPXSILJHWNFMK-ZBEGNZNMSA-N,DESMETHYLSERTRALINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,9000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL2030629,SRRZEMVAQOSBLB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL551394,SSIZXVUYAOUIQY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,41,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL338790,SSMIFVHARFVINF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL338790,SSMIFVHARFVINF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1902627,SSMSBSWKLKKXGG-UHFFFAOYSA-N,CLORPRENALINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1902627,SSMSBSWKLKKXGG-UHFFFAOYSA-N,CLORPRENALINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL537027,SSNHYUGXRZNUCY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,3420,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432062,SSQDVMAIIMMISV-SEDVZXITSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL49080,STJMRWALKKWQGH-UHFFFAOYSA-N,CLENBUTEROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL49080,STJMRWALKKWQGH-UHFFFAOYSA-N,CLENBUTEROL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL178,STQGQHZAVUOBTE-VGBVRHCVSA-N,DAUNORUBICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL178,STQGQHZAVUOBTE-VGBVRHCVSA-N,DAUNORUBICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171046,STXMJDYUJFBELE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,15.85,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1503,SUBDBMMJDZJVOS-UHFFFAOYSA-N,OMEPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1503,SUBDBMMJDZJVOS-UHFFFAOYSA-N,OMEPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL134423,SUBRNIMHHUWIJU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,>,1000,NM,,,,,,,,,,,,,,,Binding affinity towards histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
,SUGVYNSRNKFXQM-ACSDJOOWSA-N,SR144528,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,9454810.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL2158823,SUHCNXHLKUQVER-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,5.01,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1567463,SUHOQUVVVLNYQR-MRVPVSSYSA-N,CHOLINE ALFOSCERATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1567463,SUHOQUVVVLNYQR-MRVPVSSYSA-N,CHOLINE ALFOSCERATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL559061,SULKMHQPINMVTR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,2.9,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL346574,SUOANLAYTVIAIR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Determined,,,,,,,,,,,,,,Intrinsic activity; Low affinity for the receptor: not tested for the efficacy,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL346574,SUOANLAYTVIAIR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,<,10000000000000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL346574,SUOANLAYTVIAIR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibitory activity against human H1 receptor; Low affinity for the receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL272150,SUTBGEJWOOOUFT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,501.19,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207656,SUYKBMCECCINPJ-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,2.51,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401752,SVBOCVYSHIJYID-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1945845,SWBBNWYFIHQGLU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22197136.0,INHIBITION,<,20,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,"Synthesis and structure-activity relationship of 5-pyridazin-3-one phenoxypiperidines as potent, selective histamine H(3) receptor inverse agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935447,SWDWBOARDFBZAD-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,1.4,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935448,SWDWBOARDFBZAD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,92,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2431120,SWEOAXMICIJCQC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1420,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin),,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1935446,SWFSQSZMVIJILA-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,1.3,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935445,SWFSQSZMVIJILA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,4,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935445,SWFSQSZMVIJILA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,95,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL313189,SWGWJQBPCJEQJC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,83.18,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL319244,SWUARLUWKZWEBQ-VQHVLOKHSA-N,CAFFEIC ACID PHENETHYL ESTER,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL319244,SWUARLUWKZWEBQ-VQHVLOKHSA-N,CAFFEIC ACID PHENETHYL ESTER,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2413153,SXCVVYUSUGUSMW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23816046.0,KI,=,512,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin),"Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146484,SXNOWQCFHNZUIX-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.501,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146484,SXNOWQCFHNZUIX-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.355,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1929400,SXTDBNDGQWAIKW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22019465.0,INHIBITION,,,,Not Active,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at histamine H1 receptor expressed in HEK293 cells co-transfected with pCRE-Luc gene assessed as inhibition of forskolin/histamine-induced cAMP accumulation at 1 uM after 5 hrs by luciferase reporter gene assay,"Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL566534,SXYIRMFQILZOAM-HVNFFKDJSA-N,ARTEMETHER,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL566534,SXYIRMFQILZOAM-HVNFFKDJSA-N,ARTEMETHER,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1935433,SYDJFDHCVPRQIP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,4.9,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL195927,SYERHDJULLPKRY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16143528.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards cloned Histamine H1 receptor,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL393718,SYNXMLXHBZIEOT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,520,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62716,SYSBZXCPPMQIMC-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,21877.62,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563,SYTBZMRGLBWNTM-UHFFFAOYSA-N,FLURBIPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL563,SYTBZMRGLBWNTM-UHFFFAOYSA-N,FLURBIPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201010,SYWHXTATXSMDSB-GSLJADNHSA-N,FLUDROCORTISONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201010,SYWHXTATXSMDSB-GSLJADNHSA-N,FLUDROCORTISONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL61120,SZCLNIBNFBNHIY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,28183.83,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1669405,SZKXEXNSYILRKM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,7.2,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295416,SZRPDCCEHVWOJX-UHFFFAOYSA-N,PIRINIXIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL295416,SZRPDCCEHVWOJX-UHFFFAOYSA-N,PIRINIXIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL86,TTWJBBZEZQICBI-UHFFFAOYSA-N,METOCLOPRAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL86,TTWJBBZEZQICBI-UHFFFAOYSA-N,METOCLOPRAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL410414,TUOSYWCFRFNJBS-BHVANESWSA-N,DIRLOTAPIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17276061.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,"In vitro and in vivo profile of 5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide (dirlotapide), a novel potent MTP inhibitor for obesity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1946124,TUSPVTWVRDALHT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL271449,TUZSKSVCURDDOD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1144,TUZYXOIXSAXUGO-PZAWKZKUSA-N,PRAVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1144,TUZYXOIXSAXUGO-PZAWKZKUSA-N,PRAVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL63125,TVAKGPNWRYKDTE-OAQYLSRUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,6760.83,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1222762,TVBIHDSWRDFHAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,39.81,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205826,TVDFWGUKMIRJAD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL558663,TVKCCIBAUDHHBL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,14.1,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL242598,TVMNFBNOOMKBOO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,5.8,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1237044,TVYLLZQTGLZFBW-UHFFFAOYSA-N,TRAMADOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1237044,TVYLLZQTGLZFBW-UHFFFAOYSA-N,TRAMADOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL376180,TVZGACDUOSZQKY-LBPRGKRZSA-N,AMINOPTERIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL376180,TVZGACDUOSZQKY-LBPRGKRZSA-N,AMINOPTERIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL60620,TWDZILVPGOSJTO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,1584.89,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205812,TWMXGXSGGIIQDM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,=,3839,NM,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030626,TWUZJTIHFYRNSV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL683,TXCGAZHTZHNUAI-UHFFFAOYSA-N,CLOFIBRIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL683,TXCGAZHTZHNUAI-UHFFFAOYSA-N,CLOFIBRIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1371125,TXVHTIQJNYSSKO-UHFFFAOYSA-N,BENZO[E]PYRENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1371125,TXVHTIQJNYSSKO-UHFFFAOYSA-N,BENZO[E]PYRENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2387312,TXYHNJMNQMYNTO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
,TXZPMHLMPKIUGK-UHFFFAOYSA-N,PFI-1,,P35367,HISTAMINE H1 RECEPTOR,HRH1,wild_type,,23576556.0,INHIBITION,=,6.5,%,,cytotoxocity,cell_based,"phenotypic
",viability,,luminescence,,10,MICROM,,,,,TO ASSESS ACTIVITY OF PFI-1 AGAINST MEMBRANE RECEPTORS ,"PFI-1, A HIGHLY SELECTIVE PROTEIN INTERACTION INHIBITOR, TARGETING BET BROMODOMAINS.",CANCER RESEARCH,,
CHEMBL2087421,TYDKAHFZLFMNQX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22369198.0,INHIBITION,=,11,%,,,cell_based,,,,,,,,,,,,Inhibition of central H1 receptor at 5 uM by cell based assay,From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL28651,TYDSNTMUQPPTLL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11378358.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to cloned Histamine H1 receptor,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158789,TYDWSEQLTIBAPO-NDEPHWFRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,199.53,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2220427,TYQXKHPOXXXCTP-CSLYCKPJSA-N,ERYTHROMYCIN ESTOLATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2220427,TYQXKHPOXXXCTP-CSLYCKPJSA-N,ERYTHROMYCIN ESTOLATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1783972,TZBFBARTOUGERH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,7160,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783972,TZBFBARTOUGERH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL44,TZBJGXHYKVUXJN-UHFFFAOYSA-N,GENISTEIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44,TZBJGXHYKVUXJN-UHFFFAOYSA-N,GENISTEIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1371,TZFWDZFKRBELIQ-UHFFFAOYSA-N,CHLORZOXAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1371,TZFWDZFKRBELIQ-UHFFFAOYSA-N,CHLORZOXAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL560177,TZQRQWWAQZCVET-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19560918.0,ACTIVITY,<,50,%,,,,,,,,,,,,,,,Binding affinity to human recombinant H1 receptor at 1 uM by radioligand binding assay,Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identification.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL560177,TZQRQWWAQZCVET-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19635669.0,ACTIVITY,<,50,%,,,,,,,,,,,,,,,Binding affinity to H1 receptor at 1 uM,Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256472,TZVRVTZSSPWUGF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL70927,TZXKOCQBRNJULO-UHFFFAOYSA-N,DEFERIPRONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL70927,TZXKOCQBRNJULO-UHFFFAOYSA-N,DEFERIPRONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1078736,TZZDUDPJVPMIAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078736,TZZDUDPJVPMIAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL459350,TZZKWSLLNPOOCC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,79,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL302886,UAFWEWMUOVIYPG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,1778.28,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272546,UALAMQRWRIVLLQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL10602,UAUJDKBNVRSJBD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,5172,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL959,UBCHPRBFMUDMNC-UHFFFAOYSA-N,RIMANTADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL959,UBCHPRBFMUDMNC-UHFFFAOYSA-N,RIMANTADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL322695,UBCZIICPWSGHLS-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,10000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935574,UBEJREHBDACTGD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153663.0,KI,=,10500,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]histamine from human H1 receptor expressed in HEK cell membranes,Ligand based design of novel histamine H4 receptor antagonists; fragment optimization and analysis of binding kinetics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL43882,UBOXGVDOUJQMTN-UHFFFAOYSA-N,TRICHLOROETHANE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL43882,UBOXGVDOUJQMTN-UHFFFAOYSA-N,TRICHLOROETHANE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1835609,UBQRACCCHXXOJB-ZOWNYOTGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21905669.0,INHIBITION,=,-19.9,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor at 10 uM by radioligand displacement assay,Discovery of Isoxazole Analogues of Sazetidine-A as Selective a4ß2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression.,J. Med. Chem.,PUBLICATION,
CHEMBL14690,UCAIEVHKDLMIFL-UHFFFAOYSA-N,CLOBENPROPIT,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12606603.0,KI,=,2754.23,NM,,,,,,,,,,,,,,,,,,,
CHEMBL102929,UCAOEOZGCIGAIW-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,16000,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL84,UCFGDBYHRUNTLO-QHCPKHFHSA-N,TOPOTECAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL84,UCFGDBYHRUNTLO-QHCPKHFHSA-N,TOPOTECAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL787,UCHDWCPVSPXUMX-TZIWLTJVSA-N,MONTELUKAST,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL787,UCHDWCPVSPXUMX-TZIWLTJVSA-N,MONTELUKAST,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1950351,UCMNIYFDRVBMFV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22284817.0,ACTIVITY,<,50,%,,,,,,,,,,,,,,,Activity at human histamine H1 receptor at 10 uM,¿-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL318235,UCNOTTVNPRSTFW-XSFNXXSESA-N,R-226161,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17407815.0,KI,=,74,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human cloned histamine H1 receptor,Tricyclic isoxazolines: identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and alpha2-adrenoceptor antagonism.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL459373,UCQNMJXTWOYVNH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,205,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL372795,UCSJYZPVAKXKNQ-HZYVHMACSA-N,STREPTOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL372795,UCSJYZPVAKXKNQ-HZYVHMACSA-N,STREPTOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2419581,UCTRCZYTETZMOI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23978359.0,ACTIVITY,,,,Not Active,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at human histamine H1 receptor expressed in HEK293 cells assessed by forskolin induced cAMP response element activation after 5 hrs by luciferase reporter gene assay,Design and synthesis of novel 3-substituted-indole derivatives as selective H3 receptor antagonists and potent free radical scavengers.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL679,UCTWMZQNUQWSLP-VIFPVBQESA-N,EPINEPHRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL679,UCTWMZQNUQWSLP-VIFPVBQESA-N,EPINEPHRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564370,UDCCWKBPMHTQIP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,23,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL68109,UDEWZBIDDHRLSM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL68109,UDEWZBIDDHRLSM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta; no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL537218,UDGQQGZVMXRRQI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL512716,UEIOTBCPFPELAN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,1200,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL558551,UEJJHQNACJXSKW-SECBINFHSA-N,(R)-THALIDOMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL558551,UEJJHQNACJXSKW-SECBINFHSA-N,(R)-THALIDOMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,THALIDOMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,THALIDOMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL426123,UEJJHQNACJXSKW-VIFPVBQESA-N,(-)-THALIDOMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL426123,UEJJHQNACJXSKW-VIFPVBQESA-N,(-)-THALIDOMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171019,UEMKNKCKJCNUSX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,7.94,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL252719,UEQUQVLFIPOEMF-GOSISDBHSA-N,(S)-MIANSERIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,0.36,NM,,,,,,,,,,,,,,,,,,,
CHEMBL6437,UEQUQVLFIPOEMF-UHFFFAOYSA-N,MIANSERIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,3.39,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL6437,UEQUQVLFIPOEMF-UHFFFAOYSA-N,MIANSERIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771415.0,KI,=,1.7,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor ,Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.,J. Med. Chem.,PUBLICATION,
CHEMBL6437,UEQUQVLFIPOEMF-UHFFFAOYSA-N,MIANSERIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,1.51,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6437,UEQUQVLFIPOEMF-UHFFFAOYSA-N,MIANSERIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.175,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL60837,UFCWZCWTDINVOS-HSZRJFAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,16982.44,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277216,UFCXUUIZIMGORH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,79.43,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL1241,UFLGIAIHIAPJJC-UHFFFAOYSA-N,TRIPELENNAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.84,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1241,UFLGIAIHIAPJJC-UHFFFAOYSA-N,TRIPELENNAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,39.81,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1241,UFLGIAIHIAPJJC-UHFFFAOYSA-N,TRIPELENNAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,100000000000000000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL940,UGJMXCAKCUNAIE-UHFFFAOYSA-N,GABAPENTIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL940,UGJMXCAKCUNAIE-UHFFFAOYSA-N,GABAPENTIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL275443,UGYXPZQILZRKJJ-UHFFFAOYSA-N,4-METHYLHISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,EC50,=,15848.93,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL275443,UGYXPZQILZRKJJ-UHFFFAOYSA-N,4-METHYLHISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,INTRINSIC ACTIVITY,=,0.9,,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL275443,UGYXPZQILZRKJJ-UHFFFAOYSA-N,4-METHYLHISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0.9,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL803,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,CYTARABINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL803,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,CYTARABINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1092649,UHPLDFSEISHDBD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,1.4,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2426677,UHUCZYJVWVZKAH-AREMUKBSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24900864.0,ACTIVITY,,,,Active,,,,,,,,,,,,,,Activity at histamine H1 receptor (unknown origin) at 10 uM,"Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate.",ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL203266,UHWVSEOVJBQKBE-UHFFFAOYSA-N,TRIMETAZIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL203266,UHWVSEOVJBQKBE-UHFFFAOYSA-N,TRIMETAZIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL255806,UHZJBSJVGFOSSA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1258.93,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1428,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,NIMODIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1428,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,NIMODIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL34431,UIAYVIIHMORPSJ-UHFFFAOYSA-N,CILOSTAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL34431,UIAYVIIHMORPSJ-UHFFFAOYSA-N,CILOSTAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564446,UIDVVYFYTIPHHE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,IC50,=,3.3,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL211501,UIFFUZWRFRDZJC-SBOOETFBSA-N,ANTIMYCIN A,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL211501,UIFFUZWRFRDZJC-SBOOETFBSA-N,ANTIMYCIN A,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2158841,UJDYUOWUTALBPP-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,50.12,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767138,UJMUXUJLIHKBEA-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,0.158,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL2165641,UJVLJZYSFWQURQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22216892.0,PKB,=,6.7,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1R-RGS4 expressed in Sf9 cells by steady state GTPase activity assay,The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1385840,UJYGDMFEEDNVBF-OGGGUQDZSA-N,ERGOCORNINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1385840,UJYGDMFEEDNVBF-OGGGUQDZSA-N,ERGOCORNINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402826,UKHPZHQUPSAUMR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL64406,UKHVQZVXQRGRSL-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,8128.31,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1080773,UKLBZMWVHINBQC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1080773,UKLBZMWVHINBQC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1922614,UKQMQTGGUNTZKM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22029285.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM by ligand displacement assay,"Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL532,ULGZDMOVFRHVEP-RWJQBGPGSA-N,ERYTHROMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL532,ULGZDMOVFRHVEP-RWJQBGPGSA-N,ERYTHROMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1185,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,ZOLMITRIPTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7658443.0,P[A50],=,5.5,,,,,,,,,,,,,,,,Binding affinity against H1 receptor using rabbit saphenous vein assay.,Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine properties.,J. Med. Chem.,PUBLICATION,
CHEMBL277850,UMNFRBCAPUJRHJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,8.53,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158822,UMSPPMMERAOIRT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,6.31,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1419,UNAANXDKBXWMLN-UHFFFAOYSA-N,SIBUTRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1419,UNAANXDKBXWMLN-UHFFFAOYSA-N,SIBUTRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201356,UNBRKDKAWYKMIV-QWQRMKEZSA-N,METHYLERGONOVINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201356,UNBRKDKAWYKMIV-QWQRMKEZSA-N,METHYLERGONOVINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1167,UNFWWIHTNXNPBV-WXKVUWSESA-N,SPECTINOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1167,UNFWWIHTNXNPBV-WXKVUWSESA-N,SPECTINOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL59870,UNKGZIGUDPASTI-AREMUKBSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,4677.35,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL63112,UNKGZIGUDPASTI-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,8128.31,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1243335,UNQMLUWBMWGIRY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20690643.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.,J. Med. Chem.,PUBLICATION,
CHEMBL1946254,UNTNFKPMHAXOEK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22336245.0,KI,=,61,NM,,,,,,,,,,,,,,,Displacement of [3H]-Pyrilamine from human histamine H1 receptor by liquid scintillation counter,"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL243900,UOCMXNLGBQWJPG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.9,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL22749,UOCSMPABENXVNX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,7.76,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL84293,UOSUONQDJGNZCQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,13.49,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1278019,UOSUQZZICNGJPM-QNVARPAVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,794.33,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL2171040,UOWPMQNCLJZBEA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1020,UPSPUYADGBWSHF-UHFFFAOYSA-N,TOLMETIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1020,UPSPUYADGBWSHF-UHFFFAOYSA-N,TOLMETIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL471413,UPTJWSNQGUAZJA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,ACTIVITY,=,6.4,%,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL471413,UPTJWSNQGUAZJA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,EFFICACY,=,0.19,,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL471413,UPTJWSNQGUAZJA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,2980,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL471413,UPTJWSNQGUAZJA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,INTRINSIC ACTIVITY,=,0.2,,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL471413,UPTJWSNQGUAZJA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,PKB,=,5.5,,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL552057,UQAJLTTZWHXNJH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,35,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL325258,UQMFUNLNAONENR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11585444.0,IC50,=,280,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
CHEMBL1489254,URAYPUMNDPQOKB-UHFFFAOYSA-N,TRIACETIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1489254,URAYPUMNDPQOKB-UHFFFAOYSA-N,TRIACETIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL384467,UREBDLICKHMUKA-CXSFZGCWSA-N,DEXAMETHASONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL384467,UREBDLICKHMUKA-CXSFZGCWSA-N,DEXAMETHASONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL632,UREBDLICKHMUKA-DVTGEIKXSA-N,BETAMETHASONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL632,UREBDLICKHMUKA-DVTGEIKXSA-N,BETAMETHASONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL221753,UREZNYTWGJKWBI-UHFFFAOYSA-M,BENZETHONIUM CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL221753,UREZNYTWGJKWBI-UHFFFAOYSA-M,BENZETHONIUM CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,2.2,NM,,,,,,,,,,,,,,,,,,,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,19,NM,,,,,,,,,,,,,,,,,,,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11170639.0,KI,=,21,NM,,,,,,,,,,,,,,,Binding affinity towards human H1 receptor,Current and novel approaches to the drug treatment of schizophrenia.,J. Med. Chem.,PUBLICATION,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,11,NM,,,,,,,,,,,,,,,,,,,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14998318.0,KI,=,19,NM,,,,,,,,,,,,,,,Binding affinity towards human histamine H1 receptor,Selective optimization of side activities: another way for drug discovery.,J. Med. Chem.,PUBLICATION,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,8.7,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,39.6,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,4.6,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,10,NM,,,,,,,,,,,,,,,Binding affinity to H1 histamine receptor (unknown origin) by PDSP assay,,MedChemComm,PUBLICATION,
CHEMBL2030628,URNOPSHFIGOPOJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767139,URSKGEZFWCRYMD-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,5.01,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL221886,URWAJWIAIPFPJE-YFMIWBNJSA-N,SISOMICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL221886,URWAJWIAIPFPJE-YFMIWBNJSA-N,SISOMICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923534,URWAMRSFMYPXOS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,8128.31,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL429914,URXBXRUUVSTMJM-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18077160.0,KI,>,1000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by [35S]GTP-gamma-S binding assay,In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL318659,URZPDWAADSKBHJ-QENMJEOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,3,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL319352,USCDVFNXTCISHV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,500,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL2037528,USGLWFZAXHASGB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22520153.0,KI,=,46,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 histamine receptor by liquid scintillation assay,Benzothiazoles as probes for the 5HT(1A) receptor and the serotonin transporter (SERT): A search for new dual-acting agents as potential antidepressants.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL402015,USKZVJAZXRLUHK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1584.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL320002,USQNYIPSWUNBEC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.69,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1784694,USRJTKDRTOTPRU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21570838.0,INHIBITION,<,50,%,Active,,,,,,,,,,,,,,Inhibition of human recombinant H1 receptor at 10 uM by radioligand binding assay,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL502896,USROQQUKEBHOFF-SKKCDYJJSA-N,CETRAXATE HYDROCHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL502896,USROQQUKEBHOFF-SKKCDYJJSA-N,CETRAXATE HYDROCHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL305371,USVPOSBOAJRHOO-XMMPIXPASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,9772.37,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL502620,USZYSDMBJDPRIF-SVEJIMAYSA-N,ACLARUBICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL502620,USZYSDMBJDPRIF-SVEJIMAYSA-N,ACLARUBICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1333512,UTGQNNCQYDRXCH-UHFFFAOYSA-N,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1333512,UTGQNNCQYDRXCH-UHFFFAOYSA-N,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL272379,UTIUIZHJMLEUQC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,PKI,,,,Not Determined,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL472273,UTJRWVBWVPCMQL-UHFFFAOYSA-N,OXO-ARPROMIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,5200,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL35226,UTMXFLLOSBJGIE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12502367.0,INHIBITION,=,0,%,,,,,,,,,,,,,,,Ability to displace [3H]mepyramine from histamine H1 receptor at concentration of 10e-7 M,"New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization.",J. Med. Chem.,PUBLICATION,
CHEMBL35226,UTMXFLLOSBJGIE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12502367.0,INHIBITION,=,91,%,,,,,,,,,,,,,,,Ability to displace [3H]-mepyramine from histamine H1 receptor at concentration of 10e-5 M,"New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization.",J. Med. Chem.,PUBLICATION,
CHEMBL569270,UTPGRZGMQVAYAA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24147864.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor by PDSP assay,Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1).,J. Med. Chem.,PUBLICATION,
CHEMBL2171031,UTVOOLLPUMDSJS-IRLDBZIGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,>,5011.87,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171030,UTVOOLLPUMDSJS-RBBKRZOGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,>,6309.57,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL609328,UTYFBWKQSXSRBL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20045641.0,KI,=,725,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human cloned histamine H1 receptor,"9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL13378,UUDAMDVQRQNNHZ-UHFFFAOYSA-N,"(R,S)-AMPA",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL13378,UUDAMDVQRQNNHZ-UHFFFAOYSA-N,"(R,S)-AMPA",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1092259,UUEDQZRCAVWNIH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,1.4,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL357995,UUOJIACWOAYWEZ-UHFFFAOYSA-N,BOPINDOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL357995,UUOJIACWOAYWEZ-UHFFFAOYSA-N,BOPINDOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL24441,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,BETAHISTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL24441,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,BETAHISTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL570033,UURQFLKKSYYPEF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,203,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1172754,UUTLATQGKXUVDD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20541426.0,KI,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]rilamine from human histamine H1 receptor expressed in CHO cells after 1 hr by liquid scintillation counting,Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL535631,UUVMYIPSOIHEGH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,ALTRETAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,ALTRETAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1767162,UUYDLXMNWLLYQV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,39.81,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL62527,UVFIYINSVIEJKT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,3981.07,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL648,UVKZSORBKUEBAZ-UHFFFAOYSA-N,CYCLIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,38,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL648,UVKZSORBKUEBAZ-UHFFFAOYSA-N,CYCLIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,4.44,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL404811,UVYVLBIGDKGWPX-YCCXZQINSA-N,DIGITONIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL404811,UVYVLBIGDKGWPX-YCCXZQINSA-N,DIGITONIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL139835,UWFYSQMTEOIJJG-FDTZYFLXSA-N,CYPROTERONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL139835,UWFYSQMTEOIJJG-FDTZYFLXSA-N,CYPROTERONE ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL481,UWKQSNNFCGGAFS-XIFFEERXSA-N,IRINOTECAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL481,UWKQSNNFCGGAFS-XIFFEERXSA-N,IRINOTECAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2146807,UXQVMDVKHFQOEU-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.316,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146807,UXQVMDVKHFQOEU-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.631,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL86754,UXZFQZANDVDGMM-UHFFFAOYSA-N,IODOQUINOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL86754,UXZFQZANDVDGMM-UHFFFAOYSA-N,IODOQUINOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL282575,UYIFTLBWAOGQBI-BZDYCCQFSA-N,ESTRADIOL BENZOATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL282575,UYIFTLBWAOGQBI-BZDYCCQFSA-N,ESTRADIOL BENZOATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL305187,UYNVMODNBIQBMV-UHFFFAOYSA-N,IFENPRODIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,1681106.0,IC50,=,1000,NM,,,,,,,,,,,,,,,Compound was tested for the binding affinity against histamine H1 receptor by using [3H]mepyramine as radioligand,Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds.,J. Med. Chem.,PUBLICATION,
CHEMBL152126,UYZUQDLFLZXDNQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.99,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL152126,UYZUQDLFLZXDNQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,630.96,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL152126,UYZUQDLFLZXDNQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,251188643150958,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2151156,UZFUMFWJEGINFP-UHFFFAOYSA-N,GSK541636,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21062081.0,KI,=,12.59,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Histamine H3 receptor as a drug discovery target.,J. Med. Chem.,PUBLICATION,
CHEMBL514641,UZGNSWKIWQZYQQ-UHFFFAOYSA-N,UR-PI141,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,=,0.09,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL514641,UZGNSWKIWQZYQQ-UHFFFAOYSA-N,UR-PI141,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,PKB,=,5.4,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as inhibition of histamine-induced gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL80,UZHSEJADLWPNLE-GRGSLBFTSA-N,NALOXONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL80,UZHSEJADLWPNLE-GRGSLBFTSA-N,NALOXONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3094320,UZVSKGBBGCJIRV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24238903.0,INHIBITION,=,1.4,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1191,VACCAVUAMIDAGB-UHFFFAOYSA-N,SULFAMETHIZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1191,VACCAVUAMIDAGB-UHFFFAOYSA-N,SULFAMETHIZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL137,VAOCPAMSLUNLGC-UHFFFAOYSA-N,METRONIDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL137,VAOCPAMSLUNLGC-UHFFFAOYSA-N,METRONIDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL94249,VAPDJJGAJMZUCA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.54,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL94249,VAPDJJGAJMZUCA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,501.19,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL94249,VAPDJJGAJMZUCA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,199526231496888,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL567292,VARGWBUXBMFVJN-UHFFFAOYSA-N,GSK554418A,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19743867.0,ACTIVITY,<,10,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 1 uM,"Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL263881,VAYOSLLFUXYJDT-RDTXWAMCSA-N,LYSERGIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12213075.0,KI,=,1540,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor,"Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).",J. Med. Chem.,PUBLICATION,
CHEMBL200693,VBKBVALDNMYEBZ-WTQRLHSKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16275087.0,INHIBITION,<,50,%,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030637,VBKWQJLSFFFYLC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL95125,VBMKWPABKWXAOB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.36,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
,VBOQYPQEPHKASR-GSVOUGTGSA-N,D-HOMOCYSTEIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL230951,VBOQYPQEPHKASR-VKHMYHEASA-N,L-HOMOCYSTEATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL244276,VBQPFBIQLMTMNM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.2,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL454890,VCADIWSEVTZZOR-UHFFFAOYSA-N,VUF-10499,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19053770.0,KI,=,97.72,NM,,,cell_based,,,,,NIH3T3,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in NIH3T3 cells,Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach.,J. Med. Chem.,PUBLICATION,
CHEMBL3094317,VCEAPZBMHGKMHI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24238903.0,INHIBITION,=,6.7,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1081319,VCFBARYQQKOTIN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1081319,VCFBARYQQKOTIN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL402215,VCJRZGBNXMAJCB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL65806,VCJYUWWJCUBKJW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL65806,VCJYUWWJCUBKJW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL1765684,VCKIDQVWSDVZCZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21428406.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor at 10 uM by radioligand binding assay,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,PUBLICATION,
CHEMBL611,VCKUSRYTPJJLNI-UHFFFAOYSA-N,TERAZOSIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL611,VCKUSRYTPJJLNI-UHFFFAOYSA-N,TERAZOSIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1277678,VCLTUEPMXZBALZ-FHZUCYEKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,39.81,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL403804,VCXXQIVAVCLUOT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL64059,VCYFASOCVKPRSB-RUZDIDTESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,10000,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL98079,VDAMCZUHIJCJPK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.63,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207642,VDCBDIRJDJYCIZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23099096.0,KI,=,490,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in insect Sf9 cell membrane preparation after 60 mins by scintillation counting analysis,Novel azulene derivatives for the treatment of erectile dysfunction.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208421,VDFDTTRCUDMUDX-HNNXBMFYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208421,VDFDTTRCUDMUDX-HNNXBMFYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171028,VDNHGXHYXNDCOW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,15.85,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077859,VDQXTAAYTDBOTM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1077859,VDQXTAAYTDBOTM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3099899,VDWKDBPHAPPUBO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24215892.0,INHIBITION,=,10,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM relative to control,"Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1093294,VDXIBLBHDRKGBK-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,2.9,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL239321,VDZPNNUVDOABNY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL419912,VECOVVSVBRZIJA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,3715.35,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2031874,VEGKMRUZYWQMBZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22313242.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to H1 receptor,"2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL119385,VEPKQEUBKLEPRA-UHFFFAOYSA-N,VX-745,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL119385,VEPKQEUBKLEPRA-UHFFFAOYSA-N,VX-745,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200629,VEPSYABRBFXYIB-PWXDFCLTSA-M,VECURONIUM BROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200629,VEPSYABRBFXYIB-PWXDFCLTSA-M,VECURONIUM BROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL277474,VEQOALNAAJBPNY-UHFFFAOYSA-N,ANTIPYRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL277474,VEQOALNAAJBPNY-UHFFFAOYSA-N,ANTIPYRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL571389,VFCNPRIWDSWJIG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,39,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2146806,VFIDGXZRONKQBZ-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.1,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146806,VFIDGXZRONKQBZ-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.398,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1277854,VFKIKYZNUCGJGD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,39.81,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL283196,VFMMPHCGEFXGIP-UHFFFAOYSA-N,ALPHA-NAPHTHOFLAVONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL283196,VFMMPHCGEFXGIP-UHFFFAOYSA-N,ALPHA-NAPHTHOFLAVONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL117537,VGBOISIRCIDEGP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11585444.0,IC50,=,1930,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
,VGFZCFWVSYIXEK-UHFFFAOYSA-N,K604,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15798001.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL29292,VGGGPCQERPFHOB-RDBSUJKOSA-N,UBENIMEX,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL29292,VGGGPCQERPFHOB-RDBSUJKOSA-N,UBENIMEX,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL589388,VGJCKVYMMJXTIH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,68,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL809,VGKDLMBJGBXTGI-SJCJKPOMSA-N,SERTRALINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL809,VGKDLMBJGBXTGI-SJCJKPOMSA-N,SERTRALINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL284994,VGKDLMBJGBXTGI-YVEFUNNKSA-N,"(1R,4S)-TRANS-SERTRALINE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL555146,VGSYEFOBFMUWGO-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22313227.0,KI,=,5440,NM,,,,,,,,,,,,,,,Binding affinity to human recombinant H1 receptor,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,PUBLICATION,
CHEMBL1210210,VGTBCHGQRVWGCK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,-1.2,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2335706,VGUIDVOAJKITDB-UHFFFAOYSA-N,MARISTACHONE A,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23268694.0,INHIBITION,,,,Not Active,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from H1 receptor (unknown origin) at 10 uM,Unprecedented Polyketides from a Marine Sponge-Associated Stachylidium sp.,J. Nat. Prod.,PUBLICATION,
CHEMBL2429890,VGYQUDBPYFLBLJ-PTCVETCVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,=,4178,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1258843,VHENJOBTWCOIPN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20727749.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of H1 receptor at 10 uM,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL299052,VHGCDTVCOLNTBX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,5500,NM,,,,,,,,,,,,,,,,,,,
CHEMBL299052,VHGCDTVCOLNTBX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12431845.0,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1767152,VHHWNRROUCRXSK-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,31.62,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL250699,VHKBTPQDHDSBSP-UHFFFAOYSA-N,A-803467,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17483457.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from histamine H1 receptor,"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.",Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
CHEMBL270299,VHKZGNPOHPFPER-ONNFQVAWSA-N,BAY-11-7085,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL270299,VHKZGNPOHPFPER-ONNFQVAWSA-N,BAY-11-7085,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL960,VHOGYURTWQBHIL-UHFFFAOYSA-N,LEFLUNOMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL960,VHOGYURTWQBHIL-UHFFFAOYSA-N,LEFLUNOMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL650,VHRSUDSXCMQTMA-PJHHCJLFSA-N,METHYLPREDNISOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL650,VHRSUDSXCMQTMA-PJHHCJLFSA-N,METHYLPREDNISOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL22587,VHVPQPYKVGDNFY-ZPGVKDDISA-N,ITRACONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL22587,VHVPQPYKVGDNFY-ZPGVKDDISA-N,ITRACONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1935437,VIEHHRQCEMIKCL-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,1.2,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1162,VIKNJXKGJWUCNN-XGXHKTLJSA-N,NORETHINDRONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1162,VIKNJXKGJWUCNN-XGXHKTLJSA-N,NORETHINDRONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1087493,VILNAIPEYFWQQH-AWEZNQCLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20347297.0,KI,=,4.8,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,"The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL267894,VIROVYVQCGLCII-UHFFFAOYSA-N,AMOBARBITAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267894,VIROVYVQCGLCII-UHFFFAOYSA-N,AMOBARBITAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL60383,VJAQRKGFVIGFJD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,97.72,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,ETOPOSIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,ETOPOSIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL565083,VKAAMGNCPQOWFB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,72,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1276308,VKHAHZOOUSRJNA-GCNJZUOMSA-N,MIFEPRISTONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1276308,VKHAHZOOUSRJNA-GCNJZUOMSA-N,MIFEPRISTONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12089,VKJGBAJNNALVAV-UHFFFAOYSA-M,BERBERINE CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12089,VKJGBAJNNALVAV-UHFFFAOYSA-M,BERBERINE CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL325327,VKPJPAPCRZIUMA-UHFFFAOYSA-N,SK&F-91486,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,,,,Not Determined,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL325327,VKPJPAPCRZIUMA-UHFFFAOYSA-N,SK&F-91486,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as inhibition of histamine-induced gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL1726,VKQFCGNPDRICFG-UHFFFAOYSA-N,NISOLDIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1726,VKQFCGNPDRICFG-UHFFFAOYSA-N,NISOLDIPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL559557,VKVAJQSZVWNRMB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,2.4,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL558,VLPIATFUUWWMKC-UHFFFAOYSA-N,MEXILETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL558,VLPIATFUUWWMKC-UHFFFAOYSA-N,MEXILETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2158829,VLUYCVQWTQUWPI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,5.01,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2387316,VMHFMQVWQIGSIQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL310183,VMLLHZVDHFWOOM-UHFFFAOYSA-N,R-95292,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,102.33,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1612004,VMPITZXILSNTON-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1612004,VMPITZXILSNTON-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1222763,VMTWXOTZXVFSPH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,39.81,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1790041,VMXUWOKSQNHOCA-UHFFFAOYSA-N,RANITIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1790041,VMXUWOKSQNHOCA-UHFFFAOYSA-N,RANITIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL512,VMXUWOKSQNHOCA-UKTHLTGXSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL512,VMXUWOKSQNHOCA-UKTHLTGXSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7925364.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1093044,VMZBJCIUNPGQKF-ZDUSSCGKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,32000,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL64247,VMZMMCADYHQFBW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,562.34,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL104,VNFPBHJOKIVQEB-UHFFFAOYSA-N,CLOTRIMAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,29406,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL104,VNFPBHJOKIVQEB-UHFFFAOYSA-N,CLOTRIMAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,3416,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432055,VNGQWOKKSKAESQ-RAOGCBAWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL156071,VNMMBNWUESETSJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.84,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL156071,VNMMBNWUESETSJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,1258.93,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL156071,VNMMBNWUESETSJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,2511886431509580,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1092597,VNNFGZRIODMCIW-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,1,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL472039,VNRCMCFRWRKGPN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,11100,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL155328,VNRWRBJKPUBFDY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Active,,,,,,,,,,,,,,Intrinsic activity was determined; Tested up to 100 uM: no effects up to 10 uM,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL155328,VNRWRBJKPUBFDY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,<,10000000000000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL155328,VNRWRBJKPUBFDY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL257524,VNUWHBRXYDCOFA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL21514,VNUWOUCEBGHEKF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,7.81,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158771,VNYAKKUPVDUAEG-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,15.85,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220634,VOCOJUGNHXJRKH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.06,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220634,VOCOJUGNHXJRKH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,=,5.06,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1632412,VOIJIMTXMUBFDD-VLGSPTGOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,KI,>,10000,NM,,,cell_based,,,,,SK-N-MC,,,,,,,Binding affinity to human recombinant histamine H1 receptor expressed in human SK-N-MC cells by radioligand displacement assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158775,VOPUEJLKUSXAOZ-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,63.1,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1082296,VORZMLWIEYTBEN-JPYJTQIMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20452213.0,EC50,>,10000,NM,,,cell_based,,,,,SK-N-MC,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in human SK-N-MC cells,Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2112461,VOSJYQCPCAXSLK-OAQYLSRUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,3890.45,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1370,VOVIALXJUBGFJZ-KWVAZRHASA-N,BUDESONIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1370,VOVIALXJUBGFJZ-KWVAZRHASA-N,BUDESONIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL135,VOXZDWNPVJITMN-ZBRFXRBCSA-N,ESTRADIOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL135,VOXZDWNPVJITMN-ZBRFXRBCSA-N,ESTRADIOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL239724,VPAXWNMEGKLSOJ-FERBBOLQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL239299,VPAXWNMEGKLSOJ-GMUIIQOCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL256475,VPCYWMAVRBKXBM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,PKI,,,,Not Determined,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1909073,VPUGSHLBERYQGC-UHFFFAOYSA-M,PIPERILATE ETHOBROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909073,VPUGSHLBERYQGC-UHFFFAOYSA-M,PIPERILATE ETHOBROMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL331188,VPZDYZMLWKUTOB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12443779.0,IC50,=,16.6,NM,,,,,,,,,,,,,,,Binding affinity against Histamine H1 receptor,2-(Dimethylaminomethyl)-tetrahydroisoxazolopyridobenzazepine derivatives. Synthesis of a new 5-HT(2C) antagonist with potential anxiolytic properties.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL92333,VQILFXAHDTXCBG-KUOLHFIUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,471,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201207,VQODGRNSFPNSQE-DVTGEIKXSA-N,BETAMETHASONE PHOSPHORIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,10060,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201207,VQODGRNSFPNSQE-DVTGEIKXSA-N,BETAMETHASONE PHOSPHORIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1169,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL229383,VQOXZBDYSJBXMA-VHFLTRTASA-N,NYSTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL229383,VQOXZBDYSJBXMA-VHFLTRTASA-N,NYSTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL353792,VQSXCZMVUMSITD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16730977.0,KB,>,30000,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant H1R expressed in sf9 cells assessed as inhibition of histamine-stimulated GTP hydrolysis,Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL623,VRBKIVRKKCLPHA-UHFFFAOYSA-N,NEFAZODONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL661,VREFGVBLTWBCJP-UHFFFAOYSA-N,ALPRAZOLAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL661,VREFGVBLTWBCJP-UHFFFAOYSA-N,ALPRAZOLAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923533,VRGIOLYGCLOIJI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,6309.57,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1323355,VRQVVMDWGGWHTJ-AWEZNQCLSA-N,DEXTROMEPROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,0.58,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1400945,VSBHRRMYCDQLJF-ZDNYCOCVSA-N,PREGNENOLONE CARBONITRILE ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1400945,VSBHRRMYCDQLJF-ZDNYCOCVSA-N,PREGNENOLONE CARBONITRILE ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3094217,VSGRIQNOEXFJLL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,KI,>,1995.26,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL65,VSJKWCGYPAHWDS-FQEVSTJZSA-N,CAMPTOTHECIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL65,VSJKWCGYPAHWDS-FQEVSTJZSA-N,CAMPTOTHECIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL26116,VSKJPAMQPJDPLL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12626648.0,KI,=,2220,NM,,,,,,,,,,,,,,,,,,,
CHEMBL26116,VSKJPAMQPJDPLL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,EC50,=,199.53,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL26116,VSKJPAMQPJDPLL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,INTRINSIC ACTIVITY,=,0.7,,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,HYDROXYUREA,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,HYDROXYUREA,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL243708,VSUKSHADZRDBII-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,,,,Not Determined,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL3187365,VSWBSWWIRNCQIJ-UHFFFAOYSA-N,ASENAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8935801.0,KI,=,0.16,NM,,,,,,,,,,,,,,,,,,,
CHEMBL3187365,VSWBSWWIRNCQIJ-UHFFFAOYSA-N,ASENAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,9.3,NM,,,,,,,,,,,,,,,,,,,
CHEMBL570915,VTDHRHRPPVJGSU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,,,,Not Active,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158826,VTIFNIOOCLEWLJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,5.01,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL76904,VTJXFTPMFYAJJU-UHFFFAOYSA-N,TYRPHOSTIN 23,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL76904,VTJXFTPMFYAJJU-UHFFFAOYSA-N,TYRPHOSTIN 23,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2205818,VTLZIWJSKWWYHL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257369,VTSMNPQRBXHIOD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,1258.93,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62903,VTWBFMFJUOTCOL-MUUNZHRXSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,16982.44,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62266,VTWBFMFJUOTCOL-NDEPHWFRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,9332.54,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL104947,VUNCADMBSQOCKP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,1479.11,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL63306,VURALOBWSBCELU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,90,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL63306,VURALOBWSBCELU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta was determined; + means Histamine-like pharmacological effect was retained,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL272545,VURVNYUMSCKMDC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1258.93,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL76480,VUTJSJLMAPBIJY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,9240350.0,PKB,<,5,,,,,,,,,,,,,,,,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the Histamine H1 receptor in the rabbit thoracic aorta,"A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL397222,VVGHIMUWASPVQJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.9,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1669419,VVGNEGYIOFKVTA-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,6.7,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1222554,VVGXLRREHSRFOF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,25.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1679,VVIAGPKUTFNRDU-ABLWVSNPSA-N,LEUCOVORIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1679,VVIAGPKUTFNRDU-ABLWVSNPSA-N,LEUCOVORIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1091792,VVIWSBGDDVESJJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,59,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1430,VVNCNSJFMMFHPL-VKHMYHEASA-N,PENICILLAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1430,VVNCNSJFMMFHPL-VKHMYHEASA-N,PENICILLAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1092258,VWGHJDXVTAUEQY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,8.9,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL154566,VWLKACVZBHNAND-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.92,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL154566,VWLKACVZBHNAND-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,7943.28,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL154566,VWLKACVZBHNAND-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,31622776601683.8,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL649,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,NADOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL649,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,NADOLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1766,VWVSBHGCDBMOOT-IIEHVVJPSA-N,DESOXIMETASONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1766,VWVSBHGCDBMOOT-IIEHVVJPSA-N,DESOXIMETASONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1222553,VXQLVBTWUUQZBI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,50.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL153919,VXSXTQRWBIOLHD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Determined,,,,,,,,,,,,,,Intrinsic activity; Low affinity for the receptor: not tested for the efficacy,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL153919,VXSXTQRWBIOLHD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,31622776601683.8,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL153919,VXSXTQRWBIOLHD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL272086,VYGLNPIKDOAMBL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL101,VYMDGNCVAMGZFE-UHFFFAOYSA-N,PHENYLBUTAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL101,VYMDGNCVAMGZFE-UHFFFAOYSA-N,PHENYLBUTAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1388,VYQNWZOUAUKGHI-UHFFFAOYSA-N,MONOBENZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1388,VYQNWZOUAUKGHI-UHFFFAOYSA-N,MONOBENZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1230333,VYTXLSQVYGNWLV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1230333,VYTXLSQVYGNWLV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL255778,VYZFKCYKUBTWCJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,501.19,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL431458,VZFRWFDQRYRONC-WLHGVMLRSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,233,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL44814,VZGDMQKNWNREIO-UHFFFAOYSA-N,CARBON TETRACHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44814,VZGDMQKNWNREIO-UHFFFAOYSA-N,CARBON TETRACHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL241330,WAQMOZNGKRFENV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18020391.0,KI,>,5000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,From astemizole to a novel hit series of small-molecule somatostatin 5 receptor antagonists via GPCR affinity profiling.,J. Med. Chem.,PUBLICATION,
CHEMBL1259203,WAWSGWZTHJAPIA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,,,,Not Determined,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL257900,WAWZDKTUQQRILI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208433,WBCSOAILRDZMDJ-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208433,WBCSOAILRDZMDJ-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,3.98,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL164290,WBNQDOYYEUMPFS-UHFFFAOYSA-N,N-NITROSODIETHYLAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL164290,WBNQDOYYEUMPFS-UHFFFAOYSA-N,N-NITROSODIETHYLAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1079180,WCUAFHYQNZBNRN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,1374,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158769,WCXUWQZNCRRRDD-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,15.85,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL107162,WCZJQEWLLYRYTJ-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,4400,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL254219,WDJUZGPOPHTGOT-XUDUSOBPSA-N,DIGITOXIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL254219,WDJUZGPOPHTGOT-XUDUSOBPSA-N,DIGITOXIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL571174,WDNSSDFBUPTPTP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,61,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1660,WDZCUPBHRAEYDL-GZAUEHORSA-N,RIFAPENTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1660,WDZCUPBHRAEYDL-GZAUEHORSA-N,RIFAPENTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL420,WDZVGELJXXEGPV-YIXHJXPBSA-N,GUANABENZ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL420,WDZVGELJXXEGPV-YIXHJXPBSA-N,GUANABENZ,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL485259,WEEGYLXZBRQIMU-UHFFFAOYSA-N,EUCALYPTOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL485259,WEEGYLXZBRQIMU-UHFFFAOYSA-N,EUCALYPTOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL562676,WEFSNJOGTPXLGH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,123,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL140872,WEVJMQOBCRCIPF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,911.8,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL140872,WEVJMQOBCRCIPF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22245230.0,KI,=,912,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor by liquid scintillation counting,Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL559206,WEVNWEYCEGALHH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,=,1258.93,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL448,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,PENTOBARBITAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1473875,WFNAKBGANONZEQ-SFHVURJKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26599718.0,Inhibition,=,49.5,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) assessed as inhibition of histamine-induced beta-arrestin internalization preincubated at 10 nM for 3 hrs followed by addition of 0.25 uM histamine measured after 2 hrs by PathHunter cell based assay,"Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.",J. Med. Chem.,PUBLICATION,
CHEMBL22150,WFNAKBGANONZEQ-UHFFFAOYSA-N,CHLORCYCLIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26599718.0,Inhibition,=,16,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) assessed as inhibition of histamine-induced beta-arrestin internalization preincubated at 10 nM for 3 hrs followed by addition of 0.25 uM histamine measured after 2 hrs by PathHunter cell based assay,"Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.",J. Med. Chem.,PUBLICATION,
CHEMBL1278088,WFQOETMVYMINSA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20931963.0,IC50,=,1000,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,PUBLICATION,
CHEMBL106602,WFRROHNULMGADM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,446.68,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL20883,WFWLQNSHRPWKFK-UHFFFAOYSA-N,TEGAFUR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL20883,WFWLQNSHRPWKFK-UHFFFAOYSA-N,TEGAFUR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2387317,WGDBSIUKEGGNAD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1079079,WGIPGQAPFNVWIX-XXFZXMJFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19767206.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from histamine H1 (receptor) at 10 uM by scintillation counting,Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1278112,WGNYIJNJSDBPLE-JVPYDEADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,63.1,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL415690,WHGYBXFWUBPSRW-FOUAGVGXSA-N,BETADEX,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL415690,WHGYBXFWUBPSRW-FOUAGVGXSA-N,BETADEX,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402016,WHKXNUMKCCTWNI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1584.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL21735,WHLOMXQALGYOFH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,8.06,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL388590,WHQCHUCQKNIQEC-UHFFFAOYSA-N,BENZBROMARONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL388590,WHQCHUCQKNIQEC-UHFFFAOYSA-N,BENZBROMARONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1481,WIGIZIANZCJQQY-RUCARUNLSA-N,GLIMEPIRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1481,WIGIZIANZCJQQY-RUCARUNLSA-N,GLIMEPIRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL244946,WIHMMKGUBDZGEG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.1,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL244946,WIHMMKGUBDZGEG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,794.33,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL130,WIIZWVCIJKGZOK-RKDXNWHRSA-N,CHLORAMPHENICOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL130,WIIZWVCIJKGZOK-RKDXNWHRSA-N,CHLORAMPHENICOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1091793,WIKAXVDAJYMGCT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,38,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL728,WIKYUJGCLQQFNW-UHFFFAOYSA-N,PROCHLORPERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,18.86,NM,,,,,,,,,,,,,,,,,,,
CHEMBL728,WIKYUJGCLQQFNW-UHFFFAOYSA-N,PROCHLORPERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,19,NM,,,,,,,,,,,,,,,,,,,
CHEMBL728,WIKYUJGCLQQFNW-UHFFFAOYSA-N,PROCHLORPERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,24,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL728,WIKYUJGCLQQFNW-UHFFFAOYSA-N,PROCHLORPERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,2.79,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL465123,WIQRCHMSJFFONW-HNNXBMFYSA-N,SEPROXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1210376,WISBOMVTORMKRV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295395,WIVOLWKUZIBRAF-OAQYLSRUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10937710.0,KI,=,302,NM,,,,,,,,,,,,,,,Selectivity screen against human Histamine H1 receptor,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2113738,WIVVHNDNAXIGIV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,446.68,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL625,WJCNZQLZVWNLKY-UHFFFAOYSA-N,THIABENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL625,WJCNZQLZVWNLKY-UHFFFAOYSA-N,THIABENDAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL97357,WJEAYMAHIVBPGF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.55,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL828,WJFKNYWRSNBZNX-UHFFFAOYSA-N,PHENOTHIAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL828,WJFKNYWRSNBZNX-UHFFFAOYSA-N,PHENOTHIAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3094209,WJMSULOBJJLPMD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,PKI,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1501,WJOHZNCJWYWUJD-IUGZLZTKSA-N,FLUOCINONIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1501,WJOHZNCJWYWUJD-IUGZLZTKSA-N,FLUOCINONIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL395741,WJWXIOHJLIZWJX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,,,,Not Determined,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL197408,WJYDVXOBGXFRGI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16143528.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards cloned Histamine H1 receptor,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL271511,WKIHYCMRGGUMCH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158784,WKNWCTUFTMDACE-DEOSSOPVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,31.62,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL486746,WKXIZVSDLMORMY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16554355.0,KI,=,990,NM,,,,,,,,,,,,,,,,,,,
CHEMBL486746,WKXIZVSDLMORMY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,1100,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL188021,WLCVFIFUKJWBRL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,14,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL288768,WLHRCQLHMHKOKG-JOCHJYFZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,10937710.0,KI,=,63,NM,,,,,,,,,,,,,,,Selectivity screen against human Histamine H1 receptor,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL104809,WLLPQVLLLQINAX-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,5900,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599760,WLMBSKSEPQCRJV-OAHLLOKOSA-N,RO-85,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20045645.0,ACTIVITY,>,50,%,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells at 10 uM after 60 mins by scintillation counting,"Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL570961,WMENQMDKVSUACK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,,,,Not Active,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1081320,WMUNXKRFQUPNCI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1081320,WMUNXKRFQUPNCI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3238446,WMVDPHRVWOFAIP-HNNXBMFYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24650714.0,KI,=,31622.78,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHO cell membrane after 120 mins by liquid scintillation counting analysis,Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1774505,WNMOZKUIGRNEMN-JAHAZDFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,195,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL58922,WOFSEDMIUMNYEJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12626648.0,KI,=,255,NM,,,,,,,,,,,,,,,,,,,
CHEMBL3686863,WOJKYHBOHSQZDW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27020304.0,Inhibition,=,-3,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,Identification and biological activity of 6-alkyl-substituted 3-methyl-pyridine-2-carbonyl amino dimethyl-benzoic acid EP4 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL252766,WOYCDVDURLTMAW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18078311.0,ACTIVITY,<,50,%,,,,,,,,,,,,,,,Displacement of [3H]PIB from histamine H1 receptor at 10 uM,"Synthesis and evaluation of N-methyl and S-methyl 11C-labeled 6-methylthio-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridines as radioligands for imaging beta-amyloid plaques in Alzheimer's disease.",J. Med. Chem.,PUBLICATION,
CHEMBL541483,WPBLHQJDLOPHGT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19524437.0,INHIBITION,=,1.6,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 3 uM,Selective naphthalene H(3) receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3233143,WPJSNLWFVMFFSG-FPOVZHCZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24559051.0,INHIBITION,=,12,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 100 nM,Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL86091,WPLHYZJLPBROHU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224034,WPNGDOZEXVRNMZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20692833.0,INHIBITION,=,-4.3,%,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor at 10 uM,N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL19236,WPNJAUFVNXKLIM-UHFFFAOYSA-N,MOXONIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19236,WPNJAUFVNXKLIM-UHFFFAOYSA-N,MOXONIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923532,WPPQAAJWSRLDOO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,4570.88,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL274768,WPUIFWUHNWGBNW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.02,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL274768,WPUIFWUHNWGBNW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,630957344480194,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL274768,WPUIFWUHNWGBNW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL541,WPYMKLBDIGXBTP-UHFFFAOYSA-N,BENZOIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL541,WPYMKLBDIGXBTP-UHFFFAOYSA-N,BENZOIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2105807,WQGJEAMPBSZCIF-HKSLRPGUSA-N,MADURAMICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2105807,WQGJEAMPBSZCIF-HKSLRPGUSA-N,MADURAMICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL307145,WQGWDDDVZFFDIG-UHFFFAOYSA-N,PYROGALLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL307145,WQGWDDDVZFFDIG-UHFFFAOYSA-N,PYROGALLOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL105594,WQTAFNUFMGEGDM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,8912.51,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767134,WRGOSJVRKURGMQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,0.251,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL517140,WROHEWWOCPRMIA-UHFFFAOYSA-N,GSK189254,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24269482.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL328356,WSAMXDVPPULVBH-KCDYIMILSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,6,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,3194,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,371,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL908,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,CHLORPROTHIXENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,3.75,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL908,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,CHLORPROTHIXENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,IC50,=,1,NM,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL908,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,CHLORPROTHIXENE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,IC50,=,870.96,NM,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL272302,WSSKPYCMFWWDPQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL467094,WSVWKHTVFGTTKJ-UHFFFAOYSA-N,NANTENINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19963380.0,KI,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor,Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL239744,WSXMMXMXSWZQOD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1584.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1009,WTDRDQBEARUVNC-LURJTMIESA-N,LEVODOPA,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1009,WTDRDQBEARUVNC-LURJTMIESA-N,LEVODOPA,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL229429,WTLBLIGPXACYET-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17571866.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Synthesis and simple 18F-labeling of 3-fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile as a high affinity radioligand for imaging monkey brain metabotropic glutamate subtype-5 receptors with positron emission tomography.,J. Med. Chem.,PUBLICATION,
CHEMBL1783953,WTMKJZWIEBUUNH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,930,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783953,WTMKJZWIEBUUNH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,1820,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL307609,WTUOCEYWCJZOOS-HSZRJFAPSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15081022.0,KI,=,4,NM,,,cell_based,,,,,CHO-K1,,,,,,,In vitro binding affinity towards histamine H1 receptor expressed in CHO-K1 cells,5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL304888,WUAKHYKTJKHZOM-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,46773.51,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1169,WUBBRNOQWQTFEX-UHFFFAOYSA-N,AMINOSALICYLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1169,WUBBRNOQWQTFEX-UHFFFAOYSA-N,AMINOSALICYLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1598608,WUKZPHOXUVCQOR-UHFFFAOYSA-N,AZASETRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1598608,WUKZPHOXUVCQOR-UHFFFAOYSA-N,AZASETRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL381623,WUMIJQZPHGJALC-JOCHJYFZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16275087.0,INHIBITION,<,50,%,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL273348,WUWFMDMBOJLQIV-UHFFFAOYSA-N,TOSUFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL273348,WUWFMDMBOJLQIV-UHFFFAOYSA-N,TOSUFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL236587,WUXDFTYUVPKGCE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18020390.0,KI,=,624,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,"Discovery of the first nonpeptidic, small-molecule, highly selective somatostatin receptor subtype 5 antagonists: a chemogenomics approach.",J. Med. Chem.,PUBLICATION,
CHEMBL236587,WUXDFTYUVPKGCE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,624,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL91397,WUZYKBABMWJHDL-UHFFFAOYSA-N,RUPATADINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,IC50,=,3.9,NM,,,,,,,,,,,,,,,Inhibitory concentration against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL558933,WVCNWPFTYDURBB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,2.8,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL720,WVDDGKGOMKODPV-UHFFFAOYSA-N,BENZYL ALCOHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL720,WVDDGKGOMKODPV-UHFFFAOYSA-N,BENZYL ALCOHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1278202,WVFQWSQTENHWCH-MTQWGCILSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,12.59,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL499092,WVGMEGPGIYKHTE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,2800,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1935432,WVNZODFRLMLDAL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,6.3,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL428,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,TROVAFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL428,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,TROVAFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL119443,WVVSZNPYNCNODU-XTQGRXLLSA-N,ERGONOVINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL119443,WVVSZNPYNCNODU-XTQGRXLLSA-N,ERGONOVINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL154111,WVYADZUPLLSGPU-UHFFFAOYSA-N,SALSALATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL154111,WVYADZUPLLSGPU-UHFFFAOYSA-N,SALSALATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1094452,WWEBJYNVUIMDCZ-GFCCVEGCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,>,10000,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1094144,WWEBJYNVUIMDCZ-LBPRGKRZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,>,10000,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1094142,WWEBJYNVUIMDCZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20409707.0,EC50,>,10000,NM,,,cell_based,,,,,Sf9,,,,,,,Activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205823,WWXCWTRLUXMAHX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2107797,WWYNJERNGUHSAO-CULCCENASA-N,NORGESTREL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2107797,WWYNJERNGUHSAO-CULCCENASA-N,NORGESTREL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1210144,WXIPBSOPCYLJTO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,13,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL10961,WXSURELOKDGQNF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,>,10000,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL86715,WYDUSKDSKCASEF-UHFFFAOYSA-N,PROCYCLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,IC50,=,17782.79,NM,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL250403,WYEGTIGJSHGEID-ZDUSSCGKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17976986.0,KI,>,2000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL328511,WYLMUYOKAITMJI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,5.93,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL328511,WYLMUYOKAITMJI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,1210,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767154,WYRUGBCTQBZIHO-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,0.316,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767136,WYRUGBCTQBZIHO-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,0.158,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767136,WYRUGBCTQBZIHO-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.1,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1767136,WYRUGBCTQBZIHO-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.162,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,THIOGUANINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,THIOGUANINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL762,WYWIFABBXFUGLM-UHFFFAOYSA-N,OXYMETAZOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL762,WYWIFABBXFUGLM-UHFFFAOYSA-N,OXYMETAZOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564201,WYXSYVWAUAUWLD-SHUUEZRQSA-N,6-AZAURIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564201,WYXSYVWAUAUWLD-SHUUEZRQSA-N,6-AZAURIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2103774,WZDGZWOAQTVYBX-XOINTXKNSA-N,TIBOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2103774,WZDGZWOAQTVYBX-XOINTXKNSA-N,TIBOLONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2031873,WZHAQWFZACLGKI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22313242.0,KI,=,9620,NM,,,,,,,,,,,,,,,Binding affinity to H1 receptor,"2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1480987,WZHCOOQXZCIUNC-UHFFFAOYSA-N,CYCLANDELATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1480987,WZHCOOQXZCIUNC-UHFFFAOYSA-N,CYCLANDELATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19215,WZHJKEUHNJHDLS-QTGUNEKASA-N,METERGOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20451398.0,ACTIVITY,=,98.2,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human cloned histamine H1 receptor,Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL19215,WZHJKEUHNJHDLS-QTGUNEKASA-N,METERGOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,4133,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19215,WZHJKEUHNJHDLS-QTGUNEKASA-N,METERGOLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,480,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL330366,WZMVQZJKOVPVGZ-XIFFEERXSA-N,MDL-105212,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,IC50,=,3,NM,,,,,,,,,,,,,,,Inhibitory concentration against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL330366,WZMVQZJKOVPVGZ-XIFFEERXSA-N,MDL-105212,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,10000,NM,,,,,,,,,,,,,,,Compound was evaluated for the antagonistic activity against H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL245416,WZNJWVWKTVETCG-YFKPBYRVSA-N,L-MIMOSINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL245416,WZNJWVWKTVETCG-YFKPBYRVSA-N,L-MIMOSINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL328114,WZOMJNATDSYQHS-ZPWQMVEJSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771448.0,KI,>,1000,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to Histamine H1 receptor,Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity.,J. Med. Chem.,PUBLICATION,
CHEMBL158,WZPBZJONDBGPKJ-VEHQQRBSSA-N,AZTREONAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL158,WZPBZJONDBGPKJ-VEHQQRBSSA-N,AZTREONAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1923524,WZYLEAJVJMZIFE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,537.03,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL540633,XAMKLIVWXRZDBC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL37858,XBHBWNFJWIASRO-UHFFFAOYSA-N,SARAFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL37858,XBHBWNFJWIASRO-UHFFFAOYSA-N,SARAFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6273,XBJBPGROQZJDOJ-UHFFFAOYSA-N,FLEROXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6273,XBJBPGROQZJDOJ-UHFFFAOYSA-N,FLEROXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2208431,XBJQRDCFABQBGT-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208431,XBJQRDCFABQBGT-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,6.31,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220628,XBROVCNWKRBKPS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,0.01,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220628,XBROVCNWKRBKPS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL93519,XBURWGMHOIWDHZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.3,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL270567,XBWBWCMBNYVAKR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL79249,XCCCRVPCDJNFIY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,26.3,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3545252,XCDIRYDKECHIPE-QHEQPUDQSA-N,DOCETAXEL HYDRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3545252,XCDIRYDKECHIPE-QHEQPUDQSA-N,DOCETAXEL HYDRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL442,XCGSFFUVFURLIX-VFGNJEKYSA-N,ERGOTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL442,XCGSFFUVFURLIX-VFGNJEKYSA-N,ERGOTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1774503,XCIDTTYEFDTNFF-UYOCIXKTSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,325,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1403257,XCVMKCYUNNAQAM-UHFFFAOYSA-N,BAS 03602647,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,1905.46,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL95764,XDDAORKBJWWYJS-UHFFFAOYSA-N,GLYPHOSATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL95764,XDDAORKBJWWYJS-UHFFFAOYSA-N,GLYPHOSATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12620,XDKYTXBAVJELDQ-UHFFFAOYSA-N,2-METHYLHISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,EC50,=,794.33,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL12620,XDKYTXBAVJELDQ-UHFFFAOYSA-N,2-METHYLHISTAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,INTRINSIC ACTIVITY,=,0.9,,,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase activity assay relative to histamine,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL55,XDRYMKDFEDOLFX-UHFFFAOYSA-N,PENTAMIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL55,XDRYMKDFEDOLFX-UHFFFAOYSA-N,PENTAMIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1117,XDXDZDZNSLXDNA-TZNDIEGXSA-N,IDARUBICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1117,XDXDZDZNSLXDNA-TZNDIEGXSA-N,IDARUBICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL60509,XDXVWRAGPFLSNP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,4265.8,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL577912,XEOSDWIUBUJPES-CALCHBBNSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773162.0,IC50,=,760,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1754,XFDJYSQDBULQSI-UHFFFAOYSA-N,DOXAPRAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1754,XFDJYSQDBULQSI-UHFFFAOYSA-N,DOXAPRAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3220639,XFKVGPGQUBQBGA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,,,,Not Active,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220639,XFKVGPGQUBQBGA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL3220639,XFKVGPGQUBQBGA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,,,,Not Active,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL3094213,XFMAJARUDAULHP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,KI,>,2511.89,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL270177,XFMPGBXLGWZMQP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17998160.0,KI,=,1100,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935442,XFQZALCRWJDNNK-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,0.8,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2103747,XFSBVAOIAHNAPC-FKHWODAVSA-N,ACONITINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2103747,XFSBVAOIAHNAPC-FKHWODAVSA-N,ACONITINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1210206,XGRCTAUNWOLIAN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,7.1,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1172775,XGWXPMUNGMSGIF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20541426.0,KI,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]rilamine from human histamine H1 receptor expressed in CHO cells after 1 hr by liquid scintillation counting,Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL271280,XHDPHPBWQCZQAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL330499,XHIAYAAKBSHSOX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.3,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL330499,XHIAYAAKBSHSOX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,500,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1940414,XHIUHIDIRNZTAW-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22245230.0,KI,=,67.9,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor by liquid scintillation counting,Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL92860,XHLHZPFSBCZVEA-HOFKKMOUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771448.0,KI,=,460,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to Histamine H1 receptor,Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity.,J. Med. Chem.,PUBLICATION,
CHEMBL474448,XHPXJEMBVQVQEF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,=,0.42,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL474448,XHPXJEMBVQVQEF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,EC50,=,1698.24,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL242602,XHYYPLOOWDKARF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,<,5.6,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL62726,XIDMFZPTPXURCO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,74.13,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2387319,XIGBTIXFXCZLOP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1231,XIQVNETUBQGFHX-UHFFFAOYSA-N,OXYBUTYNIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1231,XIQVNETUBQGFHX-UHFFFAOYSA-N,OXYBUTYNIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3357024,XIUQXOBEGLVYPC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25318072.0,KI,=,1955,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells by scintillation counting method,Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2.,J. Med. Chem.,PUBLICATION,
CHEMBL576781,XIVUGRBSBIXXJE-UHFFFAOYSA-N,UNC0224,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19891491.0,INHIBITION,=,31,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,"Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.",J. Med. Chem.,PUBLICATION,
CHEMBL1909070,XJGBDJOMWKAZJS-UHFFFAOYSA-N,NAFENOPIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909070,XJGBDJOMWKAZJS-UHFFFAOYSA-N,NAFENOPIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL831,XJGVXQDUIWGIRW-UHFFFAOYSA-N,LOXAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,5,NM,,,,,,,,,,,,,,,,,,,
CHEMBL831,XJGVXQDUIWGIRW-UHFFFAOYSA-N,LOXAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,4.9,NM,,,,,,,,,,,,,,,,,,,
CHEMBL831,XJGVXQDUIWGIRW-UHFFFAOYSA-N,LOXAPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,7,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1077737,XJHMPWJJUJEWNO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1077737,XJHMPWJJUJEWNO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL439065,XJLKTBWZJKVXJX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3981.07,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3104093,XKGPHJMKJBEURD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24365159.0,KI,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from histamine H1 receptor (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL425994,XKJWHIKEQTVYTN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17498953.0,ACTIVITY,=,-2.5,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor at 10 uM,A new class of histamine H3 receptor antagonists derived from ligand based design.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL313703,XKZZKFWMYWZWDI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295698,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,KETOCONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL295698,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,KETOCONAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64408,XMLVVFKBGQDKNU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,1071.52,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL96441,XMRHEUULHFVWJE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,5.71,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1321154,XMVJITFPVVRMHC-UHFFFAOYSA-N,ROXARSONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1321154,XMVJITFPVVRMHC-UHFFFAOYSA-N,ROXARSONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14376,XMXHEBAFVSFQEX-UHFFFAOYSA-N,ILOPERIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,12.3,NM,,,,,,,,,,,,,,,,,,,
CHEMBL991,XNKLLVCARDGLGL-JGVFFNPUSA-N,STAVUDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL991,XNKLLVCARDGLGL-JGVFFNPUSA-N,STAVUDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1277585,XNPQDIOALLTRKK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,25.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL3220642,XNTDAAJNOPKYFY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,-0.03,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220642,XNTDAAJNOPKYFY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5.3,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1222764,XNVKJWRHFRDBHD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,125.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL635,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,PREDNISONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL635,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,PREDNISONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL975,XOGTZOOQQBDUSI-UHFFFAOYSA-M,MESNA,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL975,XOGTZOOQQBDUSI-UHFFFAOYSA-M,MESNA,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2031470,XOHLGPHQMURXNY-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22617490.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM by radioligand binding assay,"Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H(3) receptor inverse agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1210375,XOKQXPCDCRWFMF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,54,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL243901,XOPUTZJGNOKLDY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,7.7,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL838,XPCFTKFZXHTYIP-PMACEKPBSA-N,BENAZEPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL838,XPCFTKFZXHTYIP-PMACEKPBSA-N,BENAZEPRIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL472272,XPEMILVWHHWGBE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,4900,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL918,XPFRXWCVYUEORT-UHFFFAOYSA-N,PHENACEMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL918,XPFRXWCVYUEORT-UHFFFAOYSA-N,PHENACEMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2387287,XPNGRYZHYABEFS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL32813,XPQIPUZPSLAZDV-UHFFFAOYSA-N,2-(2-AMINOETHYL)PYRIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,1.11,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL32813,XPQIPUZPSLAZDV-UHFFFAOYSA-N,2-(2-AMINOETHYL)PYRIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,1258.93,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL32813,XPQIPUZPSLAZDV-UHFFFAOYSA-N,2-(2-AMINOETHYL)PYRIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,6309573444801.94,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL562638,XPYYQHFSTUXSTG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,>,1000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL605405,XQDRWCFJBHLWPR-RAXLEYEMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,70,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL605405,XQDRWCFJBHLWPR-RAXLEYEMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,154,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as reduction of histamine-induced intracellular calcium spike at phase 2 treated 20 to 30 seconds after histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL788,XQFRJNBWHJMXHO-RRKCRQDMSA-N,IDOXURIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL788,XQFRJNBWHJMXHO-RRKCRQDMSA-N,IDOXURIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1210207,XQGOSGUJZCQEOJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,5.9,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL269959,XQYFTHHWGHOOSS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL19224,XQYZDYMELSJDRZ-UHFFFAOYSA-N,PAPAVERINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19224,XQYZDYMELSJDRZ-UHFFFAOYSA-N,PAPAVERINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL712,XRCFXMGQEVUZFC-UHFFFAOYSA-N,ANISINDIONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL712,XRCFXMGQEVUZFC-UHFFFAOYSA-N,ANISINDIONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2179222,XRDVQWJPAZZLKN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23006002.0,KI,=,586,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1463,XRECTZIEBJDKEO-UHFFFAOYSA-N,FLUCYTOSINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1463,XRECTZIEBJDKEO-UHFFFAOYSA-N,FLUCYTOSINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL61792,XRPRRDYTGFENHV-OAQYLSRUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,95499.26,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL303313,XRYLGRGAWQSVQW-KRWDZBQOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,15,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL64875,XRYLGRGAWQSVQW-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,12,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL64249,XRYLGRGAWQSVQW-UHFFFAOYSA-N,CLOROTEPINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,0.19,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL1935431,XRZMHKTZJWSXPQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,5.7,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935431,XRZMHKTZJWSXPQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,8.9,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL244280,XSBNGDJHMKLOOQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.6,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL945,XSDQTOBWRPYKKA-UHFFFAOYSA-N,AMILORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL945,XSDQTOBWRPYKKA-UHFFFAOYSA-N,AMILORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1512,XSFJVAJPIHIPKU-XWCQMRHXSA-N,FLUNISOLIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1512,XSFJVAJPIHIPKU-XWCQMRHXSA-N,FLUNISOLIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL294087,XSLVAIIZNFBGBI-OAQYLSRUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,34673.69,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3357043,XSNLDSYJHLYUGZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25318072.0,KI,=,147,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells by scintillation counting method,Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2.,J. Med. Chem.,PUBLICATION,
CHEMBL240141,XSOFCOCSPTUCJQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL259765,XSZZVXRYXJUWCA-QZTJIDSGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,KI,=,10,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260258,XSZZVXRYXJUWCA-ROUUACIJSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783957,XTVVBTLUOSFTHO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,120,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783957,XTVVBTLUOSFTHO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL31,XUBOMFCQGDBHNK-UHFFFAOYSA-N,GATIFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL31,XUBOMFCQGDBHNK-UHFFFAOYSA-N,GATIFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL461727,XUCIJNAGGSZNQT-JHSLDZJXSA-N,AMYGDALIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL461727,XUCIJNAGGSZNQT-JHSLDZJXSA-N,AMYGDALIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL902,XUFQPHANEAPEMJ-UHFFFAOYSA-N,FAMOTIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL902,XUFQPHANEAPEMJ-UHFFFAOYSA-N,FAMOTIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1566,XUFXOAAUWZOOIT-SXARVLRPSA-N,ACARBOSE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1566,XUFXOAAUWZOOIT-SXARVLRPSA-N,ACARBOSE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54943,XUJNEKJLAYXESH-UHFFFAOYSA-N,CYSTEINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1829335,XUKROCVZGZNGSI-CQSZACIVSA-N,IRDABISANT,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21634396.0,INHIBITION,<,11,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,"Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.",J. Med. Chem.,PUBLICATION,
CHEMBL1487,XUKUURHRXDUEBC-KAYWLYCHSA-N,ATORVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1487,XUKUURHRXDUEBC-KAYWLYCHSA-N,ATORVASTATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL255618,XURXMJIMPKTNSF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,501.19,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1774495,XURYOEGYBXTQTO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,150,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1910381,XUSZWVLIKIUVKA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,7.08,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3094313,XVKBXJCHXRLYAQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24238903.0,INHIBITION,=,12.1,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1171434,XVOYSCVBGLVSOL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12649361.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL465170,XVZKDKXYAADAMU-UHFFFAOYSA-N,UR-PI295,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,ACTIVITY,=,0.33,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL465170,XVZKDKXYAADAMU-UHFFFAOYSA-N,UR-PI295,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19317445.0,EC50,=,2187.76,NM,,,cell_based,,,,,,,,,,,,Agonist activity at human H1 receptor expressed in insect Sf9 cells co-expressing RGS4 assessed as gamma[32P]GTP binding by liquid scintillation counting,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
CHEMBL1235242,XWHHYOYVRVGJJY-QMMMGPOBSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1235242,XWHHYOYVRVGJJY-QMMMGPOBSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64253,XWOZMTAARRXLLU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,2238.72,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1760,XWTYSIMOBUGWOL-UHFFFAOYSA-N,TERBUTALINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1760,XWTYSIMOBUGWOL-UHFFFAOYSA-N,TERBUTALINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL273575,XXPANQJNYNUNES-UHFFFAOYSA-N,NOMIFENSINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,2700,NM,,,,,,,,,,,,,,,,,,,
CHEMBL234926,XXROGKLTLUQVRX-UHFFFAOYSA-N,ALLYL ALCOHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL234926,XXROGKLTLUQVRX-UHFFFAOYSA-N,ALLYL ALCOHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1535,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,HYDROXYCHLOROQUINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1535,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,HYDROXYCHLOROQUINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL485549,XXUXXCZCUGIGPP-WLRTZDKTSA-N,NIFURSOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL485549,XXUXXCZCUGIGPP-WLRTZDKTSA-N,NIFURSOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL844,XYLJNLCSTIOKRM-UHFFFAOYSA-N,BRIMONIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL844,XYLJNLCSTIOKRM-UHFFFAOYSA-N,BRIMONIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3608450,XYYAWEJOUNEPTR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26227772.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) at 10 uM,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL318801,XZKDSZJJFHAYFJ-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,5623.41,NM,,,,,,,,,,,,,,,Binding affinity at human cortical Histamine 1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL104669,XZKDSZJJFHAYFJ-LJQANCHMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,4466.84,NM,,,,,,,,,,,,,,,Binding affinity at human cortical Histamine 1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,METFORMIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,METFORMIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1774496,YAMCEGJVTDPCJX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,530,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1767168,YANGEESWIGIKOP-UMSFTDKQSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,25.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767164,YANGEESWIGIKOP-UUWRZZSWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21062081.0,KI,=,15.85,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Histamine H3 receptor as a drug discovery target.,J. Med. Chem.,PUBLICATION,
CHEMBL1767164,YANGEESWIGIKOP-UUWRZZSWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,INHIBITION,,,,Active,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization at 100 nM incubated for 30 mins measured after washout followed by repeat histamine challenge at intervals of 90 and 270 mins by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767164,YANGEESWIGIKOP-UUWRZZSWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KD,=,0.794,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization at 100 nM after 30 mins by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767164,YANGEESWIGIKOP-UUWRZZSWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,10,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1767164,YANGEESWIGIKOP-UUWRZZSWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.794,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1767164,YANGEESWIGIKOP-UUWRZZSWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,10,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL121,YASAKCUCGLMORW-UHFFFAOYSA-N,ROSIGLITAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL121,YASAKCUCGLMORW-UHFFFAOYSA-N,ROSIGLITAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,ANASTROZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,ANASTROZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1259174,YBCFDDCJLZVHPZ-FQEVSTJZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,2.5,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL1259173,YBCFDDCJLZVHPZ-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,=,3.6,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL1259144,YBCFDDCJLZVHPZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20857909.0,KI,,,,Non-toxic,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
CHEMBL1669422,YBDNLKCSUIZMPU-INIZCTEOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,8.8,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL85728,YBRVSVVVWCFQMG-UHFFFAOYSA-N,"4,4'-METHYLENEDIANILINE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL85728,YBRVSVVVWCFQMG-UHFFFAOYSA-N,"4,4'-METHYLENEDIANILINE",,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL272775,YBTBFDQBPQHZEV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,<,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL501589,YCBUFCVYAPXWON-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,7400,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL599570,YCFWTCQCXNKWLE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20045641.0,KI,,,,Not Determined,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human cloned histamine H1 receptor,"9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL280998,YCIMNLLNPGFGHC-UHFFFAOYSA-N,CATECHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL280998,YCIMNLLNPGFGHC-UHFFFAOYSA-N,CATECHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL495778,YCOFRPYSZKIPBQ-UHFFFAOYSA-N,PENICILLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL495778,YCOFRPYSZKIPBQ-UHFFFAOYSA-N,PENICILLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1078747,YCQTVOPSJIIHAH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1078747,YCQTVOPSJIIHAH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL15928,YDBCEBYHYKAFRX-UHFFFAOYSA-N,GR-127935,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16143528.0,KI,>,10000,NM,,,,,,,,,,,,,,,Affinity towards cloned Histamine H1 receptor,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL315424,YDCWINJIBUMKOY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL269646,YDDXVAXDYKBWDX-UHFFFAOYSA-N,TIOTIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL2158787,YDHQRFQQOKRWAD-MHZLTWQESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,79.43,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1403281,YDOTUXAWKBPQJW-NSLWYYNWSA-N,ERGOCRYPTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1403281,YDOTUXAWKBPQJW-NSLWYYNWSA-N,ERGOCRYPTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2158836,YDRCHQQFHSPVMO-RUZDIDTESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,100,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158835,YDRCHQQFHSPVMO-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,50.12,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL346993,YDUBNWZTTFIXEZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,,,,Not Active,,,,,,,,,,,,,,Intrinsic activity; Tested up to 10 uM: no effects up to 1 uM,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL346993,YDUBNWZTTFIXEZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,398107170553497,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL346993,YDUBNWZTTFIXEZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,LOG IC50,,,,Not Determined,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL294349,YDZORJBZHVTZSS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,21379.62,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27876250.0,IC50,=,1.4,NM,,,cell_based,binding,,,,,,,,,,,,,,,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,4,NM,,,,,,,,,,,,,,,,,,,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7925364.0,KI,=,3.98,NM,,,,,,,,,,,,,,,,,,,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8335064.0,KI,=,4.7,NM,,,,,,,,,,,,,,,,,,,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8903934.0,KI,=,3.7,NM,,,,,,,,,,,,,,,,,,,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,2.5,NM,,,,,,,,,,,,,,,,,,,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,1.01,NM,,,,,,,,,,,,,,,,,,,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,1.18,NM,,,,,,,,,,,,,,,,,,,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12657255.0,PKB,=,9.3,,,,,,,,,,,,,,,,Histamine H1 receptor antagonistic activity in U373MG human glioblastoma cells using fluorescence-labeled H1 as radioligand in Ca+2 assay,Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,1,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,12.59,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,501187233627271000,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16408006.0,ACTIVITY,,,,Active,,,,,,,,,,,,,,Inverse agonist activity at human wild-type histamine H1 receptor assessed as NF-kappaB activation at 10 uM after 48 hrs by luciferase reporter gene assay,Linking agonist binding to histamine H1 receptor activation.,Nat. Chem. Biol.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16408006.0,IC50,=,10,NM,,,,,,,,,,,,,,,Inverse agonist activity at human wild-type histamine H1 receptor assessed as NF-kappaB activation after 48 hrs by luciferase reporter gene assay,Linking agonist binding to histamine H1 receptor activation.,Nat. Chem. Biol.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16562853.0,EC50,=,2.6,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO-K1 cells,Alkaloids from Eschscholzia californica and their capacity to inhibit binding of [3H]8-Hydroxy-2-(di-N-propylamino)tetralin to 5-HT1A receptors in Vitro.,J. Nat. Prod.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18588282.0,IC50,=,1.8,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18983139.0,IC50,=,6.2,NM,,,,,,,,,,,,,,,Displacement of radiolabeled pyrilamine from human histamine H1 receptor,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18983139.0,KI,=,2.2,NM,,,,,,,,,,,,,,,Displacement of radiolabeled pyrilamine from human histamine H1 receptor,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,4.47,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,ACTIVITY,,,,Active,,cell_based,,,,,HEK293,,,,,,,Inverse agonist activity at human histamine H1 receptor expressed in HEK293 cells assessed as inhibition of histamine-induced [3Hinositol phosphate accumulation after 1 hr by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,2.09,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,IC50,=,46.77,NM,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23403082.0,IC50,=,3.3,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells after 3 hrs,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23403082.0,INHIBITION,=,6,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells at 10 uM after 3 hrs relative to control,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23403082.0,KI,=,1.6,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells after 3 hrs,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23466604.0,IC50,=,1.5,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor by radioligand displacement assay,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23466604.0,KI,=,0.95,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor by radioligand displacement assay,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23582449.0,IC50,=,0.82,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor by radioligand displacement assay,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24805037.0,IC50,=,3,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant H1 receptor assessed as inhibition of histamine-induced intracellular Ca2+ release,Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia.,J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24805037.0,KI,=,1.7,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant H1 receptor expressed in HEK293 cells,Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia.,J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25557493.0,KI,=,1.7,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in HEK-293 cells,Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26988801.0,IC50,=,0.014,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,3.72,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.432,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2407174,YECILIXPPXYQHK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23816371.0,INHIBITION,=,30,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 8 uM by radioligand binding assay,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL603,YEEZWCHGZNKEEK-UHFFFAOYSA-N,ZAFIRLUKAST,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibitory concentration against H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL603,YEEZWCHGZNKEEK-UHFFFAOYSA-N,ZAFIRLUKAST,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL603,YEEZWCHGZNKEEK-UHFFFAOYSA-N,ZAFIRLUKAST,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1767146,YEFYNZHDZSJWCN-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,1.58,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL2207281,YEGSREZTMOWGTG-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,50.12,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL531,YEHCICAEULNIGD-MZMPZRCHSA-N,PERGOLIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL531,YEHCICAEULNIGD-MZMPZRCHSA-N,PERGOLIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL148489,YFCWBKBNFCDPDF-UHFFFAOYSA-N,N-(3-PYRIDYLMETHYL)PYRROLIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22607684.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of H1 receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1373,YFGHCGITMMYXAQ-UHFFFAOYSA-N,MODAFINIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1373,YFGHCGITMMYXAQ-UHFFFAOYSA-N,MODAFINIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL104618,YFHPQEMWPYAXGG-IBGZPJMESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372500.0,KI,=,9400,NM,,,,,,,,,,,,,,,Binding affinity to the human Histamine H1 receptor,Synthesis and evaluation of potent pyrrolidine H(3) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3092650,YFRBKEVUUCQYOW-UHFFFAOYSA-N,GSK239512,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24269482.0,KI,=,2511.89,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158839,YFTFPJHCROIDGR-VWLOTQADSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,50.12,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL243474,YFWICZORWGKFIF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.5,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL542908,YFWUUKSPYPKQPB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,9447,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL395742,YGDMWGYWZVBWDP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.5,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL272378,YGOJZWAMJUGUJD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,2511.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556450,YGQQBKYVKLZEMA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,6.9,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556450,YGQQBKYVKLZEMA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20347297.0,KI,=,6.9,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,"The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556450,YGQQBKYVKLZEMA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,6.9,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL424,YGSDEFSMJLZEOE-UHFFFAOYSA-N,SALICYLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL424,YGSDEFSMJLZEOE-UHFFFAOYSA-N,SALICYLIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207671,YGYJEYXHZXOPGM-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272695,YHBNNSZPKVUPMG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,1584.89,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL610739,YHDCGYWZEFIUHE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,75,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL129199,YHFMZBHLJMFAID-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,PKI,,,,Not Determined,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563711,YHGNRINQDQUNFR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19524437.0,INHIBITION,=,0.9,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 3 uM,Selective naphthalene H(3) receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277400,YHPLTCSZJDWTFK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,79.43,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL583014,YHSRTUXPXLVIAG-CALCHBBNSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773162.0,IC50,=,1210,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL86304,YHXISWVBGDMDLQ-UHFFFAOYSA-N,MOCLOBEMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL86304,YHXISWVBGDMDLQ-UHFFFAOYSA-N,MOCLOBEMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL491889,YHXSELHUXJAOLR-UHFFFAOYSA-N,KF-A6,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17846138.0,IC50,=,3600,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL1258753,YIMUYPNUNRVCQR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,,,,Not Determined,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783955,YIVBCXIAPLXDDK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,4670,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783955,YIVBCXIAPLXDDK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL61,YJGVMLPVUAXIQN-XVVDYKMHSA-N,PODOFILOX,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL61,YJGVMLPVUAXIQN-XVVDYKMHSA-N,PODOFILOX,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL559665,YJGZARVVQHKNAU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,23,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL271034,YJTUMJAALUNJJT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL562792,YJYGESNCQHFTHG-BENRWUELSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,323,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL177756,YKGGGCXBWXHKIZ-UHFFFAOYSA-N,FLUORESCEIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL177756,YKGGGCXBWXHKIZ-UHFFFAOYSA-N,FLUORESCEIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL423192,YKJYKKNCCRKFSL-RDBSUJKOSA-N,ANISOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL423192,YKJYKKNCCRKFSL-RDBSUJKOSA-N,ANISOMYCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1257377,YKMUZVIXBRZDHR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,6,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935438,YKMYFJKVCCQVAY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,1,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL294199,YKPUWZUDDOIDPM-SOFGYWHQSA-N,CAPSAICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL294199,YKPUWZUDDOIDPM-SOFGYWHQSA-N,CAPSAICIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL407135,YKQOSKADJPQZHB-YNWHQGOSSA-N,COLISTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL407135,YKQOSKADJPQZHB-YNWHQGOSSA-N,COLISTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL185905,YKSKLZDPBLSMIO-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,19,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL95,YLJREFDVOIBQDA-UHFFFAOYSA-N,TACRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL95,YLJREFDVOIBQDA-UHFFFAOYSA-N,TACRINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2151155,YLMVVEDAZPUKCY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21062081.0,KI,=,2511.89,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Histamine H3 receptor as a drug discovery target.,J. Med. Chem.,PUBLICATION,
CHEMBL66224,YLUWMLNNKVWCEC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL66224,YLUWMLNNKVWCEC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta; no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL2432059,YLVXPEMITKSDOS-RAOGCBAWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146808,YLWRKTVVIPNRDE-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.794,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146808,YLWRKTVVIPNRDE-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,1,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL116,YMARZQAQMVYCKC-OEMFJLHTSA-N,AMPRENAVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL116,YMARZQAQMVYCKC-OEMFJLHTSA-N,AMPRENAVIR,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19299,YMBXTVYHTMGZDW-UHFFFAOYSA-N,LOXOPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19299,YMBXTVYHTMGZDW-UHFFFAOYSA-N,LOXOPROFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1767148,YMFHXRKTKHBRIX-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,0.794,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL329055,YMHZUQFCCIVBOA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,6.67,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1910385,YMLNOWNONRZEDQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,213.8,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220646,YMRCPCCWBCAQNJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,-0.01,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220646,YMRCPCCWBCAQNJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL672,YMTINGFKWWXKFG-UHFFFAOYSA-N,FENOFIBRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL672,YMTINGFKWWXKFG-UHFFFAOYSA-N,FENOFIBRATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL275035,YMVWDVNGNLXSKR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12626648.0,KI,=,370,NM,,,,,,,,,,,,,,,,,,,
CHEMBL419316,YMYZKGIHGMHZDL-WDAWEKNVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15771448.0,KI,>,1000,NM,,,,,,,,,,,,,,,Inhibition of [3H]pyrilamine binding to Histamine H1 receptor,Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity.,J. Med. Chem.,PUBLICATION,
CHEMBL2207283,YMYZSITWBGWUAF-MRXNPFEDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,63.1,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1504,YNDXUCZADRHECN-JNQJZLCISA-N,TRIAMCINOLONE ACETONIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1504,YNDXUCZADRHECN-JNQJZLCISA-N,TRIAMCINOLONE ACETONIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1834184,YNFDIGJKJPNFFD-SJORKVTESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21873051.0,INHIBITION,=,13,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM by radioligand binding assay,"Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14053,YNJBWRMUSHSURL-UHFFFAOYSA-N,TRICHLOROACETIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14053,YNJBWRMUSHSURL-UHFFFAOYSA-N,TRICHLOROACETIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL432144,YNNQILILZIBLOF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,3388.44,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1626,YNNUSGIPVFPVBX-NHCUHLMSSA-N,CLEMASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,0.421,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1626,YNNUSGIPVFPVBX-NHCUHLMSSA-N,CLEMASTINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.049,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1633,YNQQEYBLVYAWNX-WLHGVMLRSA-N,KETOTIFEN FUMARATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,1,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257716,YNRYXTYLZKMJRP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,1000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL983,YOEWQQVKRJEPAE-UHFFFAOYSA-L,SUCCINYLCHOLINE CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL983,YOEWQQVKRJEPAE-UHFFFAOYSA-L,SUCCINYLCHOLINE CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1513,YOSHYTLCDANDAN-UHFFFAOYSA-N,IRBESARTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1513,YOSHYTLCDANDAN-UHFFFAOYSA-N,IRBESARTAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL60889,YPELFRMCRYSPKZ-UHFFFAOYSA-N,MOSAPRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL60889,YPELFRMCRYSPKZ-UHFFFAOYSA-N,MOSAPRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL123292,YPHMISFOHDHNIV-FSZOTQKASA-N,CYCLOHEXIMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL123292,YPHMISFOHDHNIV-FSZOTQKASA-N,CYCLOHEXIMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1935114,YPQYVVMLRSSTFW-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22142542.0,INHIBITION,<,30,%,,,,,,,,,,,,,,,Inhibition human histamine H1 receptor at 10 uM,"4,5-dihydropyridazin-3-one derivatives as histamine H3 receptor inverse agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1668584,YPVOSIDECMYMTD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21333408.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Binding affinity to Histaminergic H1 receptor at 10 uM by radioligand binding assay,"2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1372,YPZRWBKMTBYPTK-BJDJZHNGSA-N,OXIGLUTATIONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1372,YPZRWBKMTBYPTK-BJDJZHNGSA-N,OXIGLUTATIONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL742,YQEZLKZALYSWHR-UHFFFAOYSA-N,KETAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL742,YQEZLKZALYSWHR-UHFFFAOYSA-N,KETAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL172233,YRDKYTTYDOWYLC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12593665.0,KI,=,7.24,NM,,,cell_based,,,,,CHO-K1,,,,,,,Compound was evaluated for binding affinity towards cloned human histamine H1 receptors stably expressed in CHO-K1 cells using [3H]mepyramine,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1219,YREYEVIYCVEVJK-UHFFFAOYSA-N,RABEPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1219,YREYEVIYCVEVJK-UHFFFAOYSA-N,RABEPRAZOLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1783971,YRIQXMPDJZLBBB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,1290,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783971,YRIQXMPDJZLBBB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404404,YROMCCIDISNCOF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL399203,YRQLRCRBEYSAIN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17524641.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,"3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1923529,YRYLHJCFIVNEIH-UHFFFAOYSA-N,BAS 04061445,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,2630.27,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL83731,YRZFLXOYFQEHFH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,=,199.53,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1632413,YSEFYTJOKARSSH-VKAVYKQESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,KI,>,10000,NM,,,cell_based,,,,,SK-N-MC,,,,,,,Binding affinity to human recombinant histamine H1 receptor expressed in human SK-N-MC cells by radioligand displacement assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1189234,YSEXVIPNIGQQMN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1189234,YSEXVIPNIGQQMN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,>,10000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1935440,YSFFIZSLOXOSOV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,24.6,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1277770,YSGLQQUCJIOYSX-TUXUZCGSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,50.12,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL1566956,YSIITVVESCNIPR-UHFFFAOYSA-N,TROXIPIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1566956,YSIITVVESCNIPR-UHFFFAOYSA-N,TROXIPIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3357045,YSJZQHPNURRVLN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25318072.0,KI,=,441,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in Sf9 cells by scintillation counting method,Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2.,J. Med. Chem.,PUBLICATION,
CHEMBL2207666,YSQQOGOBORIIMG-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23116889.0,KI,=,3.98,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human recombinant H1 histamine receptor expressed in CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part II: Optimising in vivo clearance.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207666,YSQQOGOBORIIMG-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207666,YSQQOGOBORIIMG-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,3.98,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1101,YSXKPIUOCJLQIE-UHFFFAOYSA-N,BIPERIDEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,INHIBITION,,,,Active,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at histamine H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release at 100 uM by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1210143,YTAVDPJGDIZDSB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,35,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14812,YTCGNPGLMAECND-UHFFFAOYSA-N,GT-2016,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15033391.0,KI,=,2560,NM,,,,,,,,,,,,,,,,,,,
CHEMBL60598,YTEDUXKJYQFEKR-AREMUKBSSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,3311.31,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL312958,YTEDUXKJYQFEKR-SANMLTNESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,21379.62,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078896,YTIWDXUZCLTCIF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19786348.0,KI,=,923,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1210083,YTYBDUVKLIFXAG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,33,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL38737,YUKQRDCYNOVPGJ-UHFFFAOYSA-N,THIOACETAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL38737,YUKQRDCYNOVPGJ-UHFFFAOYSA-N,THIOACETAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL537219,YUWFKFBORNVPBT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,=,2511.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3217984,YVENIGOVHPMTDH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,3.16,NM,,,,,,,,,,,,,,,Binding affinity to H1 histamine receptor (unknown origin) by PDSP assay,,MedChemComm,PUBLICATION,
CHEMBL1767150,YVEQOJSJKIAGFC-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,1584.89,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1092662,YVEWHDHDFNFTCD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,1.7,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1092662,YVEWHDHDFNFTCD-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20800486.0,KI,=,1.7,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1243366,YVGCLDBDDBQLIK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20690643.0,KI,>,10000,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.,J. Med. Chem.,PUBLICATION,
CHEMBL243899,YVOIVVWXMHBXQF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,=,6.1,,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1738699,YVPGZQLRPAGKLA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21570838.0,INHIBITION,<,50,%,Not Active,,,,,,,,,,,,,,Inhibition of human recombinant H1 receptor at 10 uM by radioligand binding assay,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201220,YVPYQUNUQOZFHG-UHFFFAOYSA-N,DIATRIZOIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201220,YVPYQUNUQOZFHG-UHFFFAOYSA-N,DIATRIZOIC ACID,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1423,YVUQSNJEYSNKRX-UHFFFAOYSA-N,PIMOZIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11132243.0,KI,=,25,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1423,YVUQSNJEYSNKRX-UHFFFAOYSA-N,PIMOZIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,692,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1829477,YVXDOSIKSIZMGR-CQSZACIVSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21782432.0,INHIBITION,<,30,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,"Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476109,YWOYXYWGFUHWBM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18595716.0,KI,=,1014,NM,,,,,,,,,,,,,,,Binding affinity to human cloned histamine H1 receptor,"Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1257257,YWRUWMBYWLUSJM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,24,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1243367,YXEZVHWJNRFKSI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20690643.0,KI,=,540,NM,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor,Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.,J. Med. Chem.,PUBLICATION,
CHEMBL570296,YYCDRZDDLBLWPS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19632840.0,IC50,>,5000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62948,YYEJTQDGUKFSBP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,1412.54,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3094319,YYONFKYBFNEIKC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24238903.0,INHIBITION,=,-5.8,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1093623,YYRVJJWBIQUZNR-CYBMUJFWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,2.5,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2146802,YZAHEHXQIMZHAJ-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KD,=,0.0398,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human CHO cells H1 receptor at 100 nM after 30 mins by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2146802,YZAHEHXQIMZHAJ-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22985961.0,KI,=,0.912,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human H1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL7002,YZFWTZACSRHJQD-UHFFFAOYSA-N,CIGLITAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL7002,YZFWTZACSRHJQD-UHFFFAOYSA-N,CIGLITAZONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL92337,YZIDTWIJPIHTCE-BPAKYRGESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,3.7,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL255620,YZVLQPHHXCJUBM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3162.28,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1767153,ZAIFESHMEUUZQE-OAHLLOKOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21381763.0,KI,=,1.58,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in intact CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization by FLIPR assay,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,PUBLICATION,
CHEMBL1727,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,CEPHALEXIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1727,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,CEPHALEXIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL609624,ZBHICRAJUNKGFK-QNGOZBTKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20020710.0,ACTIVITY,=,0,%,,,,,,,,,,,,,,,Displacement of radioligand from histamine H1 receptor at 10 uM,Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.,J. Med. Chem.,PUBLICATION,
CHEMBL471,ZBMZVLHSJCTVON-UHFFFAOYSA-N,SOTALOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL471,ZBMZVLHSJCTVON-UHFFFAOYSA-N,SOTALOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1077,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,BROMFENAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1077,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,BROMFENAC,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL74688,ZBUWQTCXTJMDCD-JIMJEQGWSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15081022.0,KI,=,180,NM,,,cell_based,,,,,CHO-K1,,,,,,,In vitro binding affinity towards histamine H1 receptor expressed in CHO-K1 cells,5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL305662,ZBUWQTCXTJMDCD-UODIDJSMSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15081022.0,KI,=,50,NM,,,cell_based,,,,,CHO-K1,,,,,,,In vitro binding affinity towards histamine H1 receptor expressed in CHO-K1 cells,5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1087367,ZCRCTVHOBQJBNB-QGZVFWFLSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20347297.0,KI,=,8.4,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,"The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095872,ZCSCJDHELUFNBQ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20382540.0,ACTIVITY,=,17,%,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells at 10 uM after 60 mins by beta scintillation counting,In silico directed chemical probing of the adenosine receptor family.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL534,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,KETOTIFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,IC50,=,2300,NM,,,,binding,,,,,,,,,,,,,,,
CHEMBL534,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,KETOTIFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20942472.0,KI,=,0.158,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human histamine H1 receptor expressed in CHO cells by FLIPR assay,Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL534,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,KETOTIFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21470866.0,IC50,=,1,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL534,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,KETOTIFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,1.19,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL534,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,KETOTIFEN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.138,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL811,ZDIGNSYAACHWNL-UHFFFAOYSA-N,BROMPHENIRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7855217.0,KI,=,6.06,NM,,,,,,,,,,,,,,,,,,,
CHEMBL105483,ZDLIRTGAWPEEKB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12372505.0,KI,=,354.81,NM,,,,,,,,,,,,,,,Binding affinity of human cortical histamine H1 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL561,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,LOMEFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL561,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,LOMEFLOXACIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1915534,ZELKFGCESYLZNT-NSHDSACASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21955944.0,KI,>,40000,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256652,ZENBFJWQHFZSBC-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,251.19,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11750180.0,KI,=,2300,NM,,,,,,,,,,,,,,,,,,,
CHEMBL422,ZEWQUBUPAILYHI-UHFFFAOYSA-N,TRIFLUOPERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,62.5,NM,,,,,,,,,,,,,,,,,,,
CHEMBL422,ZEWQUBUPAILYHI-UHFFFAOYSA-N,TRIFLUOPERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,62,NM,,,,,,,,,,,,,,,,,,,
CHEMBL422,ZEWQUBUPAILYHI-UHFFFAOYSA-N,TRIFLUOPERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,63,NM,,,,,,,,,,,,,,,,,,,
CHEMBL422,ZEWQUBUPAILYHI-UHFFFAOYSA-N,TRIFLUOPERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL422,ZEWQUBUPAILYHI-UHFFFAOYSA-N,TRIFLUOPERAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL464099,ZFLRVRLYWHNAEC-AWEZNQCLSA-N,N-METHYLLAUROTETANINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25695425.0,INHIBITION,<,50,%,,,cell_based,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in HEK cell membranes by radioligand binding assay,Semisynthetic Studies on and Biological Evaluation of N-Methyllaurotetanine Analogues as Ligands for 5-HT Receptors.,J. Nat. Prod.,PUBLICATION,
CHEMBL802,ZFMITUMMTDLWHR-UHFFFAOYSA-N,MINOXIDIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL802,ZFMITUMMTDLWHR-UHFFFAOYSA-N,MINOXIDIL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL316705,ZFPPUHTZTYNOKP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,994,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935439,ZFUMGFQOKSXSLS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,4.9,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935439,ZFUMGFQOKSXSLS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153347.0,KI,=,11.9,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL482496,ZFUOLNAKPBFDIJ-VQBNBCTGSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18468904.0,KI,=,189,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,"High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2171043,ZFVQRQOPWCBDOI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,7.94,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2387314,ZFXGNBOXQNGCFE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23591110.0,INHIBITION,<,40,%,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor assessed as inhibition of calcium mobilization at 10 uM by FLIPR assay relative to control,Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL190,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,THEOPHYLLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL190,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,THEOPHYLLINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432061,ZFZXJOHWFSRUAO-LLOIJXFCSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL200319,ZGBSEJYQXDWFRF-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16275087.0,INHIBITION,<,50,%,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL564,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,PROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,2,NM,,,,,,,,,,,,,,,,,,,
CHEMBL564,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,PROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,2,NM,,,,,,,,,,,,,,,,,,,
CHEMBL564,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,PROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22793499.0,IC50,=,2454.71,NM,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity at H1 receptor in human HeLa cells assessed as inhibition of histamine-induced Ca2+ release by using fura-2AM-based fluorescence assay,Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL564,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,PROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,3.44,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,PROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,0.399,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1824777,ZHHLHBNBIKLLJG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21788137.0,KI,<,10000,NM,,,,,,,,,,,,,,,Inhibition of H1 receptor by NIMH PDSP,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL244083,ZHQUFEJLPBTKSM-WVPZODRTSA-N,SB-414796,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,17867665.0,PKB,,,,Not Determined,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H1 receptor expressed in CHO cells by FLIPR assay,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL260823,ZHYJMAJSBAQRIU-IAGOWNOFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,KI,=,10,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL407732,ZHYJMAJSBAQRIU-IRXDYDNUSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18387300.0,ACTIVITY,,,,Not Active,,,,,,,,,,,,,,Inhibition of histamine H1 receptor,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220638,ZIHJEHFTDUKNGR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,INTRINSIC ACTIVITY,=,-0.01,,,,cell_based,,,,,,,,,,,,Intrinsic activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay relative to histamine,,MedChemComm,PUBLICATION,
CHEMBL3220638,ZIHJEHFTDUKNGR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PKB,<,5.3,,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 assessed as inhibition of histamine-induced [gamma33P]GTP hydrolysis preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1824785,ZILQWXOKQUVSTI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21788137.0,KI,<,10000,NM,,,,,,,,,,,,,,,Inhibition of H1 receptor by NIMH PDSP,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL481863,ZIQGASWXUSSORV-UHFFFAOYSA-N,JNJ-10392980,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18588282.0,INHIBITION,<,10,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 1 uM,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,PUBLICATION,
CHEMBL666,ZJAOAACCNHFJAH-UHFFFAOYSA-N,FOSCARNET,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL666,ZJAOAACCNHFJAH-UHFFFAOYSA-N,FOSCARNET,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL442456,ZJBDUXLBLPXVOM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,501.19,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1073,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,GLIPIZIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1073,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,GLIPIZIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3233412,ZJYUQATUAGWNGI-FPOVZHCZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24559051.0,KI,,,,Not Determined,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin),Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,PUBLICATION,
CHEMBL571073,ZJZNOPQUDXUEDU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,3200,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783960,ZKAVOICTUKPVNY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,500,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783960,ZKAVOICTUKPVNY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,3160,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1080772,ZKCADQAZIJSWPX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PEC50,,,,Not Determined,,cell_based,,,,,,,,,,,,Agonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1080772,ZKCADQAZIJSWPX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19791743.0,PKB,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 by steady-state GTPase assay,Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1632414,ZKDRIYJOVIMHFC-AQTBWJFISA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21044842.0,KI,>,1000,NM,,,cell_based,,,,,SK-N-MC,,,,,,,Binding affinity to human recombinant histamine H1 receptor expressed in human SK-N-MC cells by radioligand displacement assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2441619,ZKHOZLXKYFBVMY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,399,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin),,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL28902,ZKHUZIGQNHJVGZ-WEVVVXLNSA-N,CP-96486,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibitory concentration against H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL329450,ZKIRNRZUIHQPCN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,446,NM,,,,,,,,,,,,,,,Antagonism of the human histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1334217,ZKLPARSLTMPFCP-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8903934.0,KI,=,3.16,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1334217,ZKLPARSLTMPFCP-NRFANRHFSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11809864.0,KI,=,79.43,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1201191,ZKLPARSLTMPFCP-OAQYLSRUSA-N,LEVOCETIRIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,8903934.0,KI,=,100,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1000,ZKLPARSLTMPFCP-UHFFFAOYSA-N,CETIRIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11809864.0,KI,=,3.16,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1000,ZKLPARSLTMPFCP-UHFFFAOYSA-N,CETIRIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15081022.0,KI,=,14,NM,,,cell_based,,,,,CHO-K1,,,,,,,In vitro binding affinity towards histamine H1 receptor expressed in CHO-K1 cells,5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1000,ZKLPARSLTMPFCP-UHFFFAOYSA-N,CETIRIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,14,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1000,ZKLPARSLTMPFCP-UHFFFAOYSA-N,CETIRIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15686917.0,KI,=,5.89,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human Histamine H1 receptor in CHO K1 cells,5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1000,ZKLPARSLTMPFCP-UHFFFAOYSA-N,CETIRIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16220969.0,KI,=,14,NM,,,,,,,,,,,,,,,Inhibition constant against histamine H1 receptor,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL1000,ZKLPARSLTMPFCP-UHFFFAOYSA-N,CETIRIZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16408006.0,KI,=,50.12,NM,,,cell_based,,,,,COS-7,,,,,,,Displacement of [3H]mepyramine from human wild-type histamine H1 receptor expressed in COS-7 cells by liquid scintillation counting,Linking agonist binding to histamine H1 receptor activation.,Nat. Chem. Biol.,PUBLICATION,
CHEMBL2205811,ZKOQRCXMSDAJIR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,=,8858,NM,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256442,ZLAONGKKHFSBFL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18178090.0,KI,=,398.11,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL550405,ZLGFDPBROZZHML-GOSISDBHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19722526.0,ACTIVITY,<,10,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM,Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity.,J. Med. Chem.,PUBLICATION,
CHEMBL2171036,ZLPRNWIDJZJYMH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23031591.0,KI,=,19.95,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHOK1 cells,The discovery of CCR3/H1 dual antagonists with reduced hERG risk.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224382,ZLRRLSAVNUFCQT-LBPRGKRZSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20724153.0,INHIBITION,<,20,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor at 10 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599913,ZLTIDZRETNUAHX-KAMYIIQDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,33,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599913,ZLTIDZRETNUAHX-KAMYIIQDSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,181,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as reduction of histamine-induced intracellular calcium spike at phase 2 treated 20 to 30 seconds after histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL343324,ZLTWNSXILLAQPT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22007643.0,KI,=,794.33,NM,,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting,Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL411691,ZLXCEBAWAKEHFS-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,4.47,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL127508,ZMISODWVFHHWNR-UHFFFAOYSA-N,AZACYCLONOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19660947.0,KI,=,659,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1258873,ZMIWBFCFIBJHCH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20801030.0,INHIBITION,=,-4,%,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor,"Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1627,ZMOPTLXEYOVARP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18783208.0,ACTIVITY,>,50,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor at 10 uM,Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function.,J. Med. Chem.,PUBLICATION,
CHEMBL1627,ZMOPTLXEYOVARP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18783208.0,KI,=,4.2,NM,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor,Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function.,J. Med. Chem.,PUBLICATION,
CHEMBL242273,ZMQAAUBTXCXRIC-UHFFFAOYSA-N,SAFROLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL242273,ZMQAAUBTXCXRIC-UHFFFAOYSA-N,SAFROLE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL98076,ZMTLNBBVFMZHTB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,7.33,NM,,,,,,,,,,,,,,,Antagonistic activity against histamine H1 receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL268291,ZMXDDKWLCZADIW-UHFFFAOYSA-N,DIMETHYLFORMAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL268291,ZMXDDKWLCZADIW-UHFFFAOYSA-N,DIMETHYLFORMAMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1669417,ZMXXHEQIAQJFTR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,10.5,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL306864,ZNEWKFPYDSIEPE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,CHANGE,=,0,%,,,,,,,,,,,,,,,Effect on peripheral vasculature of the rabbit as percentage change in contractility.,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL306864,ZNEWKFPYDSIEPE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2959777.0,EFFECT,=,,,,,,,,,,,,,,,,,Effect on histamine type 1 receptor mediated contraction of the isolated rabbit aorta; no response,Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives.,J. Med. Chem.,PUBLICATION,
CHEMBL472,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,GLYBURIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL472,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,GLYBURIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2158786,ZNOFXQRZLXBDTB-MHZLTWQESA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23021991.0,KI,=,100,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783966,ZNPXEYURFNQPAK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,390,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783966,ZNPXEYURFNQPAK-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL56564,ZNRGQMMCGHDTEI-ITGUQSILSA-N,TROPISETRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL56564,ZNRGQMMCGHDTEI-ITGUQSILSA-N,TROPISETRON,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL84810,ZNWOCPPAOLYORT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,47.86,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL63632,ZOABVQXODSFSPN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,13489.63,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783958,ZOAGXBRERPVMMX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,560,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783958,ZOAGXBRERPVMMX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,=,1590,NM,,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1779060,ZOAKYUHDXICZSY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21555222.0,KI,,,,Not Determined,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor,"Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (s) receptor ligands modulates off-target activity and subtype selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1779060,ZOAKYUHDXICZSY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,Not Determined,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL513056,ZOBGKPFWPWGQOI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18950149.0,KB,=,8500,NM,,,cell_based,,,,,U373 MG,,,,,,,Antagonist activity at histamine H1 receptor in human U373 MG cells assessed as inhibition of histamine-induced intracellular calcium level preincubated for 15 mins prior to histamine challenge,"Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.",J. Med. Chem.,PUBLICATION,
CHEMBL240394,ZOCDSDXGMIDSSE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18052318.0,KI,<,1995.26,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced cellular calcium mobilization,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2208419,ZOYPHDPQFYRSLG-INIZCTEOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,INHIBITION,>,70,%,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells at 1 uM after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2208419,ZOYPHDPQFYRSLG-INIZCTEOSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23142617.0,KI,=,3.16,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]-pyrilamine from human histamine H1 receptor expressed in recombinant CHOK1 cells after 1 hr,Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H(1) antagonists. Part I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL593103,ZPAHWVAWJGJPSL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19773175.0,KI,>,1000,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in Sf9 cells co-expressing RGS4,"2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL563520,ZPASDZSMHRZWEN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19362477.0,IC50,=,46,NM,,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHOK1 cells by scintillation counting,Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL71,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CHLORPROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,9.09,NM,,,,,,,,,,,,,,,,,,,
CHEMBL71,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CHLORPROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,3,NM,,,,,,,,,,,,,,,,,,,
CHEMBL71,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CHLORPROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,9,NM,,,,,,,,,,,,,,,,,,,
CHEMBL71,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CHLORPROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12629531.0,KI,=,6,NM,,,,,,,,,,,,,,,,,,,
CHEMBL71,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CHLORPROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19091563.0,KI,=,4.25,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL71,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CHLORPROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23919353.0,IC50,=,12,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by radioligand binding assay,Polypharmacology - foe or friend?,J. Med. Chem.,PUBLICATION,
CHEMBL71,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CHLORPROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,17,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL71,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CHLORPROMAZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,1.96,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL117287,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,PRUCALOPRIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11438309.0,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,
CHEMBL2179217,ZPUAIXYROPYWKA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23006002.0,KI,=,681.8,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1092495,ZQADELCMZHYIPT-ZDUSSCGKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20188547.0,KI,=,13,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells after 90 mins by scintillation counting,Novel benzothiophene H1-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
,ZQAHOENZMFACFJ-UHFFFAOYSA-N,AC1O5RVW,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,1200,NM,,,,,,,,,,,,,,,,,,,
,ZQAHOENZMFACFJ-UHFFFAOYSA-N,AC1O5RVW,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11809864.0,KI,=,2.51,NM,,,,,,,,,,,,,,,,,,,
,ZQAHOENZMFACFJ-UHFFFAOYSA-N,AC1O5RVW,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,211,NM,,,,,,,,,,,,,,,,,,,
,ZQAHOENZMFACFJ-UHFFFAOYSA-N,AC1O5RVW,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,361,NM,,,,,,,,,,,,,,,,,,,
CHEMBL1651219,ZQBPXBADOJMCRU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23009245.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of radioligand binding to human histamine H1 receptor,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,PUBLICATION,
CHEMBL1651219,ZQBPXBADOJMCRU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23009245.0,INHIBITION,=,56,%,,,,,,,,,,,,,,,Inhibition of radioligand binding to human histamine H1 receptor at 10 uM,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,PUBLICATION,
CHEMBL896,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,HYDROXYZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11809864.0,KI,=,1,NM,,,,,,,,,,,,,,,,,,,
CHEMBL896,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,HYDROXYZINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11809864.0,KI,=,2,NM,,,,,,,,,,,,,,,,,,,
CHEMBL305313,ZQJARSFDPKNFNT-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,354.81,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3220650,ZQODQNNRCUJZNL-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL556449,ZQXPNWSXFWKXRZ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19553115.0,KI,=,1.3,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1255901,ZRJBHWIHUMBLCN-HZRLMBICSA-N,HUPERZINE A,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1255901,ZRJBHWIHUMBLCN-HZRLMBICSA-N,HUPERZINE A,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL291821,ZRMVWXJDKQRJLR-HXUWFJFHSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113836.0,KI,=,46773.51,NM,,,,,,,,,,,,,,,Binding affinity towards Histamine H1 receptor of human membranes.,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,MELOXICAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL599,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,MELOXICAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64799,ZRYOOEBGABRJDU-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,933.25,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL644,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,TRIMIPRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,1.4,NM,,,,,,,,,,,,,,,,,,,
CHEMBL3220648,ZSDXPCUFDUAKJY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,PEC50,,,,Not Active,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in Sf9 cells coexpressing RGS4 preincubated for 2 mins before [gamma32P]GTP addition measured after 20 mins by steady-state GTPase activity assay,,MedChemComm,PUBLICATION,
CHEMBL1651906,ZSJLQEPLLKMAKR-YDEIVXIUSA-N,STREPTOZOTOCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1651906,ZSJLQEPLLKMAKR-YDEIVXIUSA-N,STREPTOZOTOCIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL213176,ZSZGFVHIFRILAB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,16730977.0,KB,>,30000,NM,,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant H1R expressed in sf9 cells assessed as inhibition of histamine-stimulated GTP hydrolysis,Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1940402,ZTBBOIYRZHAFIN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,25070422.0,KI,=,128.5,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2391147,ZTGRWYMPQCQTHD-ONGXEEELSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23582449.0,INHIBITION,=,-7,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM by radioligand displacement assay relative to control,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL112203,ZTHNRNOOZGJLRR-UHFFFAOYSA-N,CGP-27492,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,7650684.0,INHIBITION,=,0,%,,,,,,,,,,,,,,,Inhibition of [3H]- doxepine binding to histamine 1 receptor at 10e-5 M,Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL269995,ZTSFFHIKWHSHGP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,>,3981.07,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL314795,ZTXJDBYCWAXXCA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755365.0,IC50,=,11.75,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned Histamine H1 receptor expressed in CHO cells by [3H]pyrilamine displacement.,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205832,ZUHLFYHHSNMSRE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1935571,ZULPGIJFVSVHRG-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22153663.0,KI,=,7373,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]histamine from human H1 receptor expressed in HEK cell membranes,Ligand based design of novel histamine H4 receptor antagonists; fragment optimization and analysis of binding kinetics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL444083,ZUSSMNOENOGGGY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15482930.0,KI,=,26,NM,,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards human histamine H1 receptor expressed in CHO-K1 cells,Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL444083,ZUSSMNOENOGGGY-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15686917.0,KI,=,3.63,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for recombinant human Histamine H1 receptor expressed in CHO K1 cells,5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783973,ZVMAXLHJDKBSDN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,>,10000,NM,,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium level increase during phase-1 compound incubated before histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1783973,ZVMAXLHJDKBSDN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19443217.0,IC50,,,,Not Determined,,organism_based,,,,,SK-N-SH,,,,,,,Antagonist activity at human histamine H1 receptor in SK-N-SH cells assessed as inhibition of histamine-induced calcium flow during phase-II compound dosed after histamine addition by Fura-2 based fluorometric assay,Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1765683,ZVRXOXFSMYJETP-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21428406.0,INHIBITION,<,50,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor at 10 uM by radioligand binding assay,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,PUBLICATION,
CHEMBL1130,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,DOXIFLURIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1130,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,DOXIFLURIDINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL157217,ZWBZUWWQDRQBAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,ALPHA,=,0.61,,,,,,,,,,,,,,,,Intrinsic activity was determined,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157217,ZWBZUWWQDRQBAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,IC50,=,398.11,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL157217,ZWBZUWWQDRQBAX-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,14667234.0,KI,=,251188643150958,NM,,,,,,,,,,,,,,,Inhibitory activity against human Histamine H1 receptor,Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2432045,ZWCQZHOWEDKJBN-CAUKCHDASA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,23981939.0,KI,>,10000,NM,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) by PDSP assay,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL257534,ZWHFNBRLUSRMFB-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18248991.0,KI,=,1995.26,NM,,,,,,,,,,,,,,,Antagonist activity at histamine H1 receptor by FLIPR assay,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL485543,ZWUFGBNOUKQGBR-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,18841880.0,IC50,>,10000,NM,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor,Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3094210,ZWWFVQNBBLZGNH-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,24161834.0,PKI,,,,Not Determined,,cell_based,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as inhibition of histamine-induced effect by FLIPR assay,The discovery of the benzazepine class of histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559251,ZWZGWXZGAUJLHN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19663387.0,KI,=,4,NM,,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO Flp-In cells by liquid scintillation counting,Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.,J. Med. Chem.,PUBLICATION,
CHEMBL559251,ZWZGWXZGAUJLHN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20227880.0,KI,=,4,NM,,,,,,,,,,,,,,,Binding affinity at histamine H1 receptor,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559251,ZWZGWXZGAUJLHN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21232954.0,KI,=,4,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor,Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1222624,ZXFALDNPMLUADA-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20674357.0,KI,=,19.95,NM,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells by FLPR assay,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL81435,ZXIPGUHBRFTYRJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,11755364.0,IC50,>,1000,NM,,,cell_based,,,,,CHO,,,,,,,Binding affinity for human cloned Histamine H1 receptor expressed in CHO cells using [3H]pyrilamine as radioligand,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL64894,ZXJXZNDDNMQXFV-UHFFFAOYSA-M,GENTIAN VIOLET,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64894,ZXJXZNDDNMQXFV-UHFFFAOYSA-M,GENTIAN VIOLET,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL36994,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,ANIRACETAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL36994,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,ANIRACETAM,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6466,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,COUMARIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6466,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,COUMARIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1210031,ZYOQAKUMKCVBLE-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,20580234.0,INHIBITION,=,48,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor ar 3 uM,Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62840,ZYPSPPAGXNKFQM-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,2238.72,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL328209,ZYRROKHYEJZYKQ-RMNMTYGKSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,15125929.0,KI,=,20.6,NM,,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]pyrilamine from human cloned histamine H1 receptor expressed in CHO cells,"Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL73307,ZZEQOXMRTJPRMI-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19700330.0,KI,=,189,NM,,,cell_based,,,,,,,,,,,,Displacement of [3H]chlorphniramine from human histamine H1 receptor expressed in cells,"Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL8514,ZZJYIKPMDIWRSN-HWBMXIPRSA-N,BUTACLAMOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,384.61,NM,,,,,,,,,,,,,,,,,,,
CHEMBL8514,ZZJYIKPMDIWRSN-HWBMXIPRSA-N,BUTACLAMOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6149136.0,KI,=,390,NM,,,,,,,,,,,,,,,,,,,
CHEMBL62193,ZZORFUFYDOWNEF-UHFFFAOYSA-N,SULFADIMETHOXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL62193,ZZORFUFYDOWNEF-UHFFFAOYSA-N,SULFADIMETHOXINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL35,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,FUROSEMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL35,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,FUROSEMIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,-1.0,IC50,=,84000,NM,,,,binding,,,,,,,,,,,,,,,
CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,2904784.0,KI,=,14.08,NM,,,,,,,,,,,,,,,,,,,
CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,6146381.0,KI,=,62,NM,,,,,,,,,,,,,,,,,,,
CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,11.7,NM,,,,,,,,,,,,,,,,,,,
CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12065734.0,KI,=,13.5,NM,,,,,,,,,,,,,,,,,,,
CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,21944853.0,KI,=,14.79,NM,,,cell_based,,,,,Sf9,,,,,,,Displacement of [3H]mepyramine from human H1R expressed in Sf9 cells co-expressing RGS4 after 90 mins by liquid scintillation counting,"Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,=,171,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,=,20,NM,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL449040,ZZZDSDWPAFVIDN-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,12113835.0,KI,=,562.34,NM,,,,,,,,,,,,,,,Binding affinity for the human Histamine H1 Receptor,Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200431,,GADOPENTETATE DIMEGLUMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200431,,GADOPENTETATE DIMEGLUMINE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200528,,CHROMIC CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200528,,CHROMIC CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200693,,MANGANESE CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200693,,MANGANESE CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201469,,GRAMICIDIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201469,,GRAMICIDIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201631,,INSULIN HUMAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201631,,INSULIN HUMAN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1351,,CARBOPLATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1351,,CARBOPLATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL136478,,SODIUM NITROPRUSSIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL136478,,SODIUM NITROPRUSSIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1366,,AURANOFIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1366,,AURANOFIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1386,,TRANSPLATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1386,,TRANSPLATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1458880,,CADMIUM DICHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1458880,,CADMIUM DICHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1476898,,CADMIUM ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1476898,,CADMIUM ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909054,,CARBOXYMETHYLCELLULOSE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909054,,CARBOXYMETHYLCELLULOSE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909055,,COBALTOUS CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909055,,COBALTOUS CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909056,,COBALT(II) ACETYLACETONATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909056,,COBALT(II) ACETYLACETONATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909057,,COPPER(II) OXIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909057,,COPPER(II) OXIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909062,,LEAD (II) ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909062,,LEAD (II) ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909063,,LEAD(IV) ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909063,,LEAD(IV) ACETATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909064,,LIPOPOLYSACCHARIDE E. COLI O55:B5,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909064,,LIPOPOLYSACCHARIDE E. COLI O55:B5,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909067,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909067,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909068,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909068,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909069,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909069,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909071,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909071,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909074,,POLYVINYLPYRROLIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909074,,POLYVINYLPYRROLIDONE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909075,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909075,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909079,,STANNOUS FLUORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909079,,STANNOUS FLUORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909083,,ZIRCONIUM(IV) CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909083,,ZIRCONIUM(IV) CHLORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2068237,,CISPLATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2068237,,CISPLATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL306043,,GOLD SODIUM THIOMALATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL306043,,GOLD SODIUM THIOMALATE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3559671,,POLYVINYL ALCOHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3559671,,POLYVINYL ALCOHOL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3735756,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,Ki,=,1297,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 Histamine receptors stably expressed in HEK cell membrane after 90 mins by scintillation counting method,Identification of tris-(phenylalkyl)amines as new selective h5-HT2Breceptor antagonists,MedChemComm,PUBLICATION,
CHEMBL3739949,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor expressed in HEK293T cells after 1 to 1.5 hrs by liquid scintillation counting analysis,Structure-based virtual screening for fragment-like ligands of the G protein-coupled histamine H4receptor,MedChemComm,PUBLICATION,
CHEMBL3740054,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,Activity,<,74,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) at 1 uM,Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7receptor antagonists and their psychotropic properties,MedChemComm,PUBLICATION,
CHEMBL3740472,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26363507.0,Inhibition,<,50,%,,,,,,,,,,,,,,,Agonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as cAMP level at 10 uM after 4 hrs by luciferase reporter gene assay,"Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.",Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3740472,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26363507.0,Inhibition,<,50,%,,,,,,,,,,,,,,,Antagonist activity at human recombinant histamine H1 receptor expressed in CHO cells assessed as cAMP level at 10 uM after 4 hrs by luciferase reporter gene assay,"Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.",Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3740846,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,Ki,<,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]-mepyramine from human histamine H1 receptor expressed in HEK293T cells after 1 to 1.5 hrs by liquid scintillation counting analysis,Structure-based virtual screening for fragment-like ligands of the G protein-coupled histamine H4receptor,MedChemComm,PUBLICATION,
CHEMBL3741992,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26460788.0,Inhibition,<,30,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3742076,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,Activity,<,74,%,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) at 1 uM,Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7receptor antagonists and their psychotropic properties,MedChemComm,PUBLICATION,
CHEMBL3746493,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26706111.0,Inhibition,<,64,%,,,,,,,,,,,,,,,Displacement of [3H]-pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells at 1 uM after 60 mins by Scintillation counting method,N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3746771,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26706111.0,Inhibition,<,64,%,,,,,,,,,,,,,,,Displacement of [3H]-pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells at 1 uM after 60 mins by Scintillation counting method,N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3747003,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26706111.0,Inhibition,<,64,%,,,,,,,,,,,,,,,Displacement of [3H]-pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells at 1 uM after 60 mins by Scintillation counting method,N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3747240,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26706111.0,Inhibition,<,64,%,,,,,,,,,,,,,,,Displacement of [3H]-pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells at 1 uM after 60 mins by Scintillation counting method,N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3752085,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,1122.02,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752195,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,5248.07,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752225,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,5754.4,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752270,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,2089.3,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752383,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,3311.31,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752576,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,<,10000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752576,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,=,125.89,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752885,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,891.25,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752900,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,<,10000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752900,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,=,100,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752972,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,1071.52,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752978,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,1949.84,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753318,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,<,10000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753318,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,=,676.08,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753334,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,1949.84,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753621,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,8128.31,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753705,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,1174.9,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753784,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,6309.57,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753849,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,2511.89,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753962,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,9332.54,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753967,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,1905.46,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753985,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,1862.09,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3754008,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,4168.69,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3754085,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26764191.0,Inhibition,=,5,%,,,,,,,,,,,,,,,Inhibition of human histamine H1 receptor at 10 uM,"Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3754166,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,<,10000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3754166,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,=,100,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3754176,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26718844.0,Ki,=,3388.44,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine 1 receptor expressed in Sf9 cell membranes by liquid scintillation counting,"2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3754496,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,<,10000,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3754496,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26739781.0,Ki,=,79.43,NM,,,,,,,,,,,,,,,Binding affinity to histamine H1 receptor (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3763166,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26653033.0,Inhibition,<,50,%,,,,,,,,,,,,,,,Inhibition of Histamine H1 receptor (unknown origin) at 10 uM,"Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.",J. Med. Chem.,PUBLICATION,
CHEMBL3769592,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26599718.0,Inhibition,=,60.7,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) assessed as inhibition of histamine-induced beta-arrestin internalization preincubated at 10 nM for 3 hrs followed by addition of 0.25 uM histamine measured after 2 hrs by PathHunter cell based assay,"Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.",J. Med. Chem.,PUBLICATION,
CHEMBL3769741,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26599718.0,Inhibition,=,88.1,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) assessed as inhibition of histamine-induced beta-arrestin internalization preincubated at 10 nM for 3 hrs followed by addition of 0.25 uM histamine measured after 2 hrs by PathHunter cell based assay,"Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.",J. Med. Chem.,PUBLICATION,
CHEMBL3769877,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26599718.0,Inhibition,=,23.7,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) assessed as inhibition of histamine-induced beta-arrestin internalization preincubated at 10 nM for 3 hrs followed by addition of 0.25 uM histamine measured after 2 hrs by PathHunter cell based assay,"Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.",J. Med. Chem.,PUBLICATION,
CHEMBL3770133,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26599718.0,Inhibition,=,21.5,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) assessed as inhibition of histamine-induced beta-arrestin internalization preincubated at 10 nM for 3 hrs followed by addition of 0.25 uM histamine measured after 2 hrs by PathHunter cell based assay,"Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.",J. Med. Chem.,PUBLICATION,
CHEMBL3770586,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26599718.0,Inhibition,=,54.1,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) assessed as inhibition of histamine-induced beta-arrestin internalization preincubated at 10 nM for 3 hrs followed by addition of 0.25 uM histamine measured after 2 hrs by PathHunter cell based assay,"Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.",J. Med. Chem.,PUBLICATION,
CHEMBL3770919,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26599718.0,Inhibition,=,31.7,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) assessed as inhibition of histamine-induced beta-arrestin internalization preincubated at 10 nM for 3 hrs followed by addition of 0.25 uM histamine measured after 2 hrs by PathHunter cell based assay,"Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.",J. Med. Chem.,PUBLICATION,
CHEMBL3771316,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26599718.0,Inhibition,=,18.5,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) assessed as inhibition of histamine-induced beta-arrestin internalization preincubated at 10 nM for 3 hrs followed by addition of 0.25 uM histamine measured after 2 hrs by PathHunter cell based assay,"Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.",J. Med. Chem.,PUBLICATION,
CHEMBL3774784,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26774927.0,Activity,=,1.8,%,,,,,,,,,,,,,,,Binding affinity to human histamine H1 receptor at 10 uM by radioligand binding assay,Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3774852,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26897089.0,Inhibition,=,65,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774871,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26897089.0,Inhibition,=,97,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775370,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26897089.0,Inhibition,=,1,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775389,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26897089.0,Inhibition,=,77,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775436,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26988801.0,Inhibition,=,22.7,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells at 10'-5 M,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775464,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26897089.0,Inhibition,=,60,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775473,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26897089.0,Inhibition,=,33,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775476,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26897089.0,Inhibition,=,47,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775752,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26897089.0,Inhibition,=,26,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775769,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26988801.0,Inhibition,=,14.1,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells at 10'-5 M,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775798,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26897089.0,Inhibition,=,49,%,,,,,,,,,,,,,,,Inhibition of histamine H1 receptor (unknown origin) at 10 uM,Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3785736,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,26942860.0,Activity,>,77,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in HEK293 cells assessed as remaining radioligand binding at 10 uM after 60 mins by scintillation counting method relative to control,Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.,J. Med. Chem.,PUBLICATION,
CHEMBL3804837,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3804837,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3804862,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3804862,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3804906,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3804906,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805003,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805003,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,=,8350,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805178,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805178,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805220,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805220,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,=,7910,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805264,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805264,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805361,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805361,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Kb,=,6000,NM,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 assessed as inhibition of histamine-induced increase in 32Pi level preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805361,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,=,6080,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805361,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,=,6520,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805431,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805431,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,=,6780,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805437,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805437,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805518,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27173799.0,IC50,=,972,NM,,,,,,,,,,,,,,,Antagonistic activity at histamine1 receptor (unknown origin) after 10 mins by FLIPR assay,"Synthesis, structure-activity relationships, and biological evaluation of a series of benzamides as potential multireceptor antipsychotics.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3805559,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27173799.0,IC50,=,2560,NM,,,,,,,,,,,,,,,Antagonistic activity at histamine1 receptor (unknown origin) after 10 mins by FLIPR assay,"Synthesis, structure-activity relationships, and biological evaluation of a series of benzamides as potential multireceptor antipsychotics.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3805663,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805663,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,=,9350,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805813,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805813,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805995,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0.11,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3805995,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806015,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806015,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806079,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806079,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Kb,=,3800,NM,,,,,,,,,,,,,,,Antagonist activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 assessed as inhibition of histamine-induced increase in 32Pi level preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806079,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,=,3050,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806079,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,=,3800,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806098,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,-0.19,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806098,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806146,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806146,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806162,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806162,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806206,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806206,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,>,10000,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806255,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Intrinsic activity,=,0,,,,,,,,,,,,,,,,Intrinsic activity at human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 at 10 uM preincubated for 2 mins followed by [gamma-32P]GTP addition measured after 20 mins by liquid scintillation counting method relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3806255,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27007611.0,Ki,=,8750,NM,,,,,,,,,,,,,,,Displacement of [3H]mepyramine from human histamine H1 receptor expressed in sf9 cell membrane co-expressing RGS4 incubated for 60 mins by liquid scintillation counting method,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3817898,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,199.53,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3817898,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,216,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3817911,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,3630.78,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3817911,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,3632,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818047,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,597,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818047,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,602.56,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818056,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Inhibition,<,50,%,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818124,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,263,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818124,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,275.42,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818128,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,738,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818128,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,741.31,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818200,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,158.49,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818200,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,177,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818478,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,273,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818478,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,275.42,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818669,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Inhibition,<,50,%,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818805,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,245.47,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818805,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,255,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818881,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,1023.29,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818881,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,1028,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818935,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,535,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818935,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,537.03,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818989,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,63.1,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818989,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,68,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818994,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,86.3,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819153,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,501.19,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819153,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,510,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819366,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,380.19,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819366,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,382,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819427,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,1427,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819427,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,1584.89,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819434,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,186.21,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819434,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,187,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819494,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,831.76,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819494,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27312422.0,Ki,=,836,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human H1 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819567,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,1.175,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819567,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,27364609.0,Ki,=,504,NM,,,,,,,,,,,,,,,Displacement of [3H]Pyrilamine from human recombinant histamine H1 receptor incubated for 1.5 hrs by microbeta scintillation counting method,Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3823832,,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,Inhibition,=,86,%,,,,,,,,,,,,,,,Displacement of [3H]pyrilamine from human recombinant H1 receptor expressed in HEK293 cells at 10 uM after 60 mins by scintillation counting analysis,In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents,MedChemComm,PUBLICATION,
CHEMBL414804,,OXALIPLATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL414804,,OXALIPLATIN,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL508338,,THIOMERSAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL508338,,THIOMERSAL,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
